data_1slj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1slj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 108.56 -0.904 . . . . 1.3200000000000001 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.61 114.45 3.28 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.255 -0.578 . . . . 3.1400000000000001 110.82 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 103' ' ' GLN . 8.7 tp -81.27 146.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.385 -0.825 . . . . 1.47 109.421 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.55 152.76 41.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.7 0.286 . . . . 1.6299999999999999 110.296 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.4 tttm -134.11 96.58 3.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.206 0.527 . . . . 1.96 109.716 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -140.46 175.67 21.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.952 -0.859 . . . . 0.31 110.952 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.34 159.47 15.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.648 0.737 . . . . 2.0499999999999998 112.054 -175.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 1.001 HG21 HD13 ' A' ' 49' ' ' ILE . 1.6 mp -67.64 138.47 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.363 -1.29 . . . . 1.1100000000000001 109.386 171.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.635 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.2 p -130.69 -7.17 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.763 0.316 . . . . 1.1499999999999999 111.725 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.59 ' HD3' ' HD2' ' A' ' 57' ' ' PHE . 29.9 ttt85 -158.43 123.02 4.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.326 -0.397 . . . . 2.2999999999999998 110.282 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 1.001 HD13 HG21 ' A' ' 46' ' ' ILE . 56.6 mt -136.76 109.04 7.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.096 0.474 . . . . 1.0800000000000001 109.877 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.32 113.2 65.38 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 2.2400000000000002 110.796 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.84 -19.56 55.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.012 2.475 . . . . 0.63 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.4 m -73.1 -26.01 61.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.208 -0.905 . . . . 1.8400000000000001 111.321 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.5 HD12 ' HZ ' ' A' ' 67' ' ' PHE . 2.5 pp -119.71 -8.91 9.85 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.212 0.819 . . . . 1.22 113.212 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 59.43 57.18 3.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.784 0.433 . . . . 2.5099999999999998 111.451 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -168.09 162.58 13.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.322 -0.399 . . . . 1.05 110.53 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -129.22 142.0 50.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.035 -0.529 . . . . 1.03 111.956 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.59 ' HD2' ' HD3' ' A' ' 48' ' ' ARG . 40.1 m-85 -94.3 142.07 27.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.691 -0.686 . . . . 0.66000000000000003 109.551 170.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' HD13 ' A' ' 116' ' ' LEU . 56.1 t -120.37 133.38 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 1.0800000000000001 109.947 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.635 ' CB ' HG21 ' A' ' 47' ' ' THR . 35.4 t70 -103.69 99.67 9.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.899 -0.591 . . . . 0.79000000000000004 110.716 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -126.8 66.59 1.26 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.703 -0.68 . . . . 1.28 109.337 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.1 21.95 26.82 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.733 -0.746 . . . . 0.82999999999999996 112.436 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 118.42 33.86 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.817 -0.225 . . . . 1.1499999999999999 110.53 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.99 -3.67 30.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 2.4300000000000002 111.453 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -117.11 -13.25 10.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.777 -0.647 . . . . 5.2199999999999998 110.189 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 63.84 141.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.039 -0.982 . . . . 1.0600000000000001 111.879 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -83.12 126.43 7.48 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.602 -0.808 . . . . 0.52000000000000002 111.193 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 55' ' ' ALA . 29.0 t80 -107.18 111.47 23.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.381 0.61 . . . . 0.51000000000000001 110.933 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -106.8 111.56 63.78 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.128 -0.942 . . . . 1.04 110.838 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 16.4 Cg_exo -69.23 145.03 58.91 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.155 2.57 . . . . 0.28000000000000003 111.981 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.636 HD12 ' HB ' ' A' ' 90' ' ' ILE . 13.4 tp -57.06 -39.69 75.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.804 -1.089 . . . . 1.04 113.102 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.735 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 19.9 pttp -67.54 -9.73 45.2 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.571 -0.451 . . . . 2.6200000000000001 111.174 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -92.84 -21.98 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.999 -0.371 . . . . 0.85999999999999999 109.999 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.589 HG22 HG13 ' A' ' 93' ' ' VAL . 8.0 mt -48.76 134.75 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.838 1.051 . . . . 1.3999999999999999 113.838 -168.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.76 156.32 16.74 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.717 -1.128 . . . . 1.1599999999999999 110.898 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 123' ' ' ALA . 12.6 tpt180 -56.84 -16.86 7.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.153 -0.93 . . . . 3.4399999999999999 112.127 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 1.003 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 1.8 tp10 -65.06 -24.57 67.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.86 -0.525 . . . . 1.76 111.001 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.537 ' HH ' HD12 ' A' ' 122' ' ' LEU . 10.1 m-30 -82.37 -50.73 8.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.459 0.647 . . . . 1.51 110.141 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.543 ' HB3' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -97.77 101.11 9.73 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.044 -1.465 . . . . 0.57999999999999996 107.044 169.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -39.13 141.76 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 124.85 3.7 . . . . 0.98999999999999999 114.062 -161.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.71 -13.86 0.46 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.779 -1.1 . . . . 1.5 112.921 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.27 -11.05 53.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.3 0.571 . . . . 2.6200000000000001 110.524 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.66 139.56 30.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.682 -0.69 . . . . 1.6499999999999999 109.616 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -65.62 125.56 25.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 2.4399999999999999 111.161 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.433 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -130.01 114.68 16.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.162 -0.472 . . . . 1.74 110.986 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -139.62 77.25 1.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.286 -0.415 . . . . 4.8300000000000001 110.536 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.0 -113.58 1.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.691 -0.766 . . . . 1.3600000000000001 112.498 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.858 ' HD3' ' HD2' ' A' ' 88' ' ' PRO . 13.5 tpp180 -121.63 121.61 28.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.63 0.252 . . . . 5.0099999999999998 110.417 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.858 ' HD2' ' HD3' ' A' ' 87' ' ' ARG . 9.9 Cg_endo -59.84 166.23 8.81 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.999 2.466 . . . . 0.35999999999999999 112.733 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 107.24 13.65 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.923 0.392 . . . . 2.3300000000000001 110.445 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.636 ' HB ' HD12 ' A' ' 70' ' ' LEU . 20.2 tt -56.84 -37.69 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.115 0.783 . . . . 1.1100000000000001 113.115 -165.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -56.1 -24.74 42.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.879 0.696 . . . . 4.46 112.879 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -125.29 20.92 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.845 0.831 . . . . 1.9099999999999999 110.173 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.589 HG13 HG22 ' A' ' 73' ' ' ILE . 14.2 t -117.09 -48.67 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.605 -0.725 . . . . 1.1499999999999999 109.893 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.6 mt -103.15 151.35 22.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.833 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 138.84 24.63 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.603 -0.726 . . . . 3.1000000000000001 109.643 176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.688 ' HA ' HG22 ' A' ' 46' ' ' ILE . 13.1 mt-10 -54.15 121.37 8.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.538 -0.755 . . . . 1.25 110.773 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.2 -8.02 28.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.40999999999999998 111.791 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 77' ' ' TYR . 9.1 tt0 -90.49 129.02 36.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.876 -0.416 . . . . 1.1799999999999999 109.876 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 13.8 pt-20 -84.95 157.03 20.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.981 0.419 . . . . 0.81000000000000005 111.025 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 32.8 m -139.33 155.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.539 -0.755 . . . . 1.02 110.416 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 120' ' ' ILE . 4.0 mm -102.66 110.38 29.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.038 -1.097 . . . . 1.28 108.038 172.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.49 ' CG2' HD21 ' A' ' 116' ' ' LEU . 3.5 m -147.3 147.55 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.104 0.409 . . . . 1.0600000000000001 112.104 -170.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.603 ' HB3' HD11 ' A' ' 41' ' ' ILE . 13.4 pt20 -128.07 158.72 37.18 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 2.0800000000000001 108.72 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.473 HD11 HD22 ' A' ' 116' ' ' LEU . 25.5 mm -83.94 109.66 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.441 0.639 . . . . 1.3400000000000001 111.638 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.644 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 13.5 t70 -85.4 -40.84 16.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.687 -1.142 . . . . 1.3 109.47 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.604 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . 2.3 mptp? -111.52 126.09 54.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.552 -0.749 . . . . 2.9700000000000002 109.239 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -85.67 158.38 20.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.012 -0.54 . . . . 2.5699999999999998 110.889 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.527 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -66.97 131.07 45.11 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.657 0.742 . . . . 3.1400000000000001 110.14 177.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -144.1 12.13 1.59 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.627 -1.169 . . . . 3.9700000000000002 108.833 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.71 84.72 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.974 -1.012 . . . . 1.74 112.499 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -130.5 -31.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.76 0.652 . . . . 3.25 112.76 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -120.25 -38.8 2.86 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.102 -0.639 . . . . 3.79 110.008 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . 99.48 -159.14 19.85 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.122 -1.037 . . . . 1.02 111.674 169.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.528 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.94 90.14 7.35 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.713 -0.847 . . . . 1.0800000000000001 108.713 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' A' ' 106' ' ' LYS . . . -85.66 126.02 33.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 1.1000000000000001 111.695 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.861 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 50.6 mt -90.27 135.42 33.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 1.1499999999999999 110.428 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 13.1 t -95.31 172.43 8.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.925 -0.58 . . . . 1.25 109.801 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.565 HG23 HD22 ' A' ' 68' ' ' LEU . 4.9 p -126.76 18.61 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.433 0.635 . . . . 1.52 110.191 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -81.07 46.93 0.95 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.962 0.887 . . . . 4.9900000000000002 109.304 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.557 HG12 HD13 ' A' ' 41' ' ' ILE . 1.8 mp -127.44 170.03 17.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.808 -1.087 . . . . 1.4299999999999999 108.898 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.452 ' N ' HG21 ' A' ' 120' ' ' ILE . 16.2 m -72.41 72.4 0.96 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.378 0.609 . . . . 1.53 110.92 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.537 HD12 ' HH ' ' A' ' 77' ' ' TYR . 26.3 mt -116.17 171.77 7.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.886 -0.783 . . . . 2.1099999999999999 108.886 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 1.003 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.012 0.82 . . . . 1.3700000000000001 109.854 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 108.637 -0.875 . . . . 1.3200000000000001 108.637 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.483 ' C ' HD21 ' A' ' 40' ' ' ASN . 0.2 OUTLIER -50.66 109.52 0.32 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.577 0.548 . . . . 3.1400000000000001 110.19 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.22 143.8 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.775 . . . . 1.47 109.961 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.79 144.99 49.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.079 -0.341 . . . . 1.6299999999999999 110.079 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.65 105.72 12.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.631 -1.248 . . . . 1.96 107.631 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.89 179.48 21.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.69 -0.767 . . . . 0.31 111.561 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.508 ' HD3' ' HA2' ' A' ' 97' ' ' GLY . 94.3 mttt -109.45 162.73 14.08 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.557 0.694 . . . . 2.0499999999999998 111.917 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.845 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -72.44 136.75 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.563 -1.199 . . . . 1.1100000000000001 108.893 170.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.697 HG21 ' CB ' ' A' ' 59' ' ' ASP . 73.2 p -127.1 -17.64 4.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.05 0.452 . . . . 1.1499999999999999 111.782 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 39.7 ttt180 -154.66 121.72 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.192 -0.67 . . . . 2.2999999999999998 109.192 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.845 HD11 HG21 ' A' ' 46' ' ' ILE . 96.7 mt -125.47 102.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.245 -0.65 . . . . 1.0800000000000001 109.245 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -99.17 108.0 47.4 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.005 -0.998 . . . . 2.2400000000000002 109.933 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.784 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 45.0 Cg_exo -57.12 -29.8 84.64 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.96 2.44 . . . . 0.63 112.093 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -59.9 -29.76 68.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.81 -0.632 . . . . 1.8400000000000001 111.247 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.636 HD11 ' HZ ' ' A' ' 67' ' ' PHE . 2.2 pp -122.56 11.28 9.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.937 0.347 . . . . 1.22 111.937 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.87 58.01 2.18 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.656 0.782 . . . . 2.5099999999999998 112.034 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.99 160.75 25.03 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.387 -0.824 . . . . 1.05 110.846 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.59 140.79 51.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 1.03 112.285 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.512 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.8 m-85 -95.17 130.79 41.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.109 -0.95 . . . . 0.66000000000000003 110.106 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.16 132.46 58.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.208 -0.451 . . . . 1.0800000000000001 109.789 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.697 ' CB ' HG21 ' A' ' 47' ' ' THR . 13.8 t70 -100.81 103.32 14.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.95 0.405 . . . . 0.79000000000000004 111.223 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.433 ' HH ' ' HB1' ' A' ' 114' ' ' ALA . 16.5 p90 -126.17 66.71 1.21 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.688 -0.856 . . . . 1.28 108.688 172.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.04 31.71 56.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.823 -0.703 . . . . 0.82999999999999996 112.427 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.74 137.89 50.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.588 0.232 . . . . 1.1499999999999999 110.625 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.23 -44.24 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 2.4300000000000002 111.312 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -78.09 -16.55 57.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.778 -0.369 . . . . 5.2199999999999998 110.242 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.485 ' HD1' ' HB3' ' A' ' 57' ' ' PHE . 8.8 m170 68.59 146.77 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.044 -0.98 . . . . 1.0600000000000001 111.501 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.9 106.07 1.94 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.426 -1.07 . . . . 0.52000000000000002 110.426 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.636 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 2.7 t80 -96.19 106.3 18.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.097 0.475 . . . . 0.51000000000000001 110.709 -172.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.786 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -97.49 118.5 64.26 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 1.04 109.826 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.654 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 6.7 Cg_exo -69.91 141.04 43.57 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.128 1.885 . . . . 0.28000000000000003 111.344 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.795 ' HA ' HG13 ' A' ' 73' ' ' ILE . 9.3 tp -57.39 -32.85 67.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 1.04 111.184 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.654 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.9 ptmm? -59.76 -20.89 59.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.678 -0.692 . . . . 2.6200000000000001 111.624 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.58 -11.91 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.85999999999999999 110.738 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.795 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.6 mt -49.88 127.37 5.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 113.588 0.958 . . . . 1.3999999999999999 113.588 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -80.28 149.84 30.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.222 -1.354 . . . . 1.1599999999999999 111.211 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.457 ' HB3' ' HB2' ' A' ' 123' ' ' ALA . 0.5 OUTLIER -66.33 -14.71 62.47 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.901 -0.59 . . . . 3.4399999999999999 111.243 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.676 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 7.0 tp10 -69.97 -17.63 63.3 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.324 -0.86 . . . . 1.76 109.912 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -81.01 -52.97 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.912 -0.586 . . . . 1.51 109.733 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HB3' HG11 ' A' ' 93' ' ' VAL . 5.2 p90 -100.82 110.19 60.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.412 -1.329 . . . . 0.57999999999999996 107.412 169.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.7 Cg_endo -37.97 135.45 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.454 0 C-N-CA 124.351 3.368 . . . . 0.98999999999999999 113.766 -165.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.51 -7.19 0.37 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.712 -1.131 . . . . 1.5 113.127 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.64 -14.68 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.631 0.729 . . . . 2.6200000000000001 109.391 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.874 ' HH ' ' HE2' ' A' ' 85' ' ' HIS . 78.9 t80 -92.43 119.37 31.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.281 -0.872 . . . . 1.6499999999999999 109.294 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.3 t -63.08 125.91 25.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.924 0.393 . . . . 2.4399999999999999 110.805 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.01 75.93 4.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.36 0.6 . . . . 1.74 110.634 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . 0.874 ' HE2' ' HH ' ' A' ' 82' ' ' TYR . 3.0 p80 -78.29 111.59 14.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 4.8300000000000001 110.452 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.87 -101.16 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.708 -0.678 . . . . 1.3600000000000001 111.651 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -138.21 150.78 68.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 5.0099999999999998 109.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.488 ' C ' HD12 ' A' ' 70' ' ' LEU . 5.6 Cg_endo -59.77 162.62 15.25 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.29 1.993 . . . . 0.35999999999999999 112.983 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.684 HD21 ' HB2' ' A' ' 92' ' ' ASP . 0.8 OUTLIER -121.26 103.66 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 2.3300000000000001 109.685 176.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.731 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 16.3 tt -57.02 -43.32 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 114.201 1.186 . . . . 1.1100000000000001 114.201 -161.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.784 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 18.5 pttp -62.74 -15.05 51.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.157 0.428 . . . . 4.46 112.157 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.684 ' HB2' HD21 ' A' ' 89' ' ' ASN . 24.6 m-20 -122.89 19.13 10.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.498 0.666 . . . . 1.9099999999999999 109.784 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.643 HG12 HG22 ' A' ' 73' ' ' ILE . 8.8 t -120.3 -51.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.814 . . . . 1.1499999999999999 109.555 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 46' ' ' ILE . 96.6 mt -101.35 164.6 11.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.404 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 152.66 32.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.99 -0.55 . . . . 3.1000000000000001 109.637 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.614 ' HA ' HG22 ' A' ' 46' ' ' ILE . 25.5 mt-10 -63.46 118.09 7.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 1.25 110.262 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.508 ' HA2' ' HD3' ' A' ' 45' ' ' LYS . . . 112.96 -11.84 24.75 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.707 -0.759 . . . . 0.40999999999999998 112.145 -174.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 17.6 tt0 -86.68 137.88 32.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 1.1799999999999999 109.785 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.95 157.13 19.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.81000000000000005 112.067 -175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 102' ' ' VAL . 32.9 m -143.47 156.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 1.02 109.833 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 120' ' ' ILE . 5.7 mm -104.92 110.83 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.083 -1.08 . . . . 1.28 108.083 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 100' ' ' VAL . 3.2 m -144.84 136.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.225 0.535 . . . . 1.0600000000000001 112.384 -169.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -114.56 149.21 36.86 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.862 -0.792 . . . . 2.0800000000000001 108.862 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.494 HD13 HD23 ' A' ' 116' ' ' LEU . 23.2 mm -74.69 101.97 2.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 1.3400000000000001 110.447 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.73 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 32.8 t70 -83.5 -36.04 24.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.641 -1.163 . . . . 1.3 109.666 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.707 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . 12.7 mptt -111.99 121.84 46.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.809 -1.182 . . . . 2.9700000000000002 107.809 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.98 147.58 46.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.763 0.653 . . . . 2.5699999999999998 112.763 -164.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -66.85 90.87 0.18 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.852 -1.067 . . . . 3.1400000000000001 110.002 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -115.47 -61.94 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.238 -0.892 . . . . 3.9700000000000002 110.422 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.68 -21.9 0.92 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.603 -1.18 . . . . 1.74 110.72 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -63.05 -50.85 68.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.99 0.424 . . . . 3.25 110.161 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -124.56 -37.53 2.49 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.43 0.633 . . . . 3.79 109.486 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.1 -153.19 17.7 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.874 -1.057 . . . . 1.02 110.588 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB1' ' HH ' ' A' ' 60' ' ' TYR . . . -79.03 91.28 4.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.559 -0.534 . . . . 1.0800000000000001 109.559 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 106' ' ' LYS . . . -95.1 133.3 39.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.134 0.492 . . . . 1.1000000000000001 111.553 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.786 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 68.8 mt -90.23 157.09 17.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.853 -0.612 . . . . 1.1499999999999999 110.133 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.73 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 14.0 t -116.72 170.06 8.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.301 -0.629 . . . . 1.25 109.301 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.591 HG22 HD22 ' A' ' 68' ' ' LEU . 15.8 p -126.39 25.67 6.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.271 0.558 . . . . 1.52 110.404 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.4 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.282 1.039 . . . . 4.9900000000000002 108.905 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 101' ' ' ILE . 2.7 mp -128.15 163.48 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.472 -1.24 . . . . 1.4299999999999999 108.029 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -74.15 53.81 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.335 0.588 . . . . 1.53 111.709 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.645 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 11.6 mt -116.91 109.44 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.481 -0.781 . . . . 2.1099999999999999 110.048 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.676 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.755 0 O-C-N 124.469 1.106 . . . . 1.3700000000000001 109.783 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.705 -0.48 . . . . 1.3200000000000001 109.705 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.415 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 43.2 m-80 -66.28 91.57 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.326 -0.397 . . . . 3.1400000000000001 110.982 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.572 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 9.5 tp -78.44 137.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.433 -0.349 . . . . 1.47 110.147 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 40' ' ' ASN . 90.5 m-85 -138.25 138.45 38.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.216 0.531 . . . . 1.6299999999999999 110.49 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.01 104.94 14.78 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.549 -1.278 . . . . 1.96 107.549 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -137.45 -177.77 15.39 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.538 -0.839 . . . . 0.31 111.636 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 73.1 mttt -114.98 157.67 23.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.525 0.679 . . . . 2.0499999999999998 111.016 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 1.024 HG22 HD12 ' A' ' 49' ' ' ILE . 1.5 mp -69.63 139.57 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.604 -1.18 . . . . 1.1100000000000001 109.908 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.625 HG21 ' CB ' ' A' ' 59' ' ' ASP . 47.3 p -129.04 -23.26 3.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.096 0.474 . . . . 1.1499999999999999 111.938 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.594 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 40.1 ttm180 -146.2 124.61 12.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.338 -0.392 . . . . 2.2999999999999998 110.529 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 1.024 HD12 HG22 ' A' ' 46' ' ' ILE . 40.4 mt -140.29 112.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.408 -0.59 . . . . 1.0800000000000001 109.408 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -119.55 130.67 24.72 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.828 0.347 . . . . 2.2400000000000002 110.734 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.789 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 2.8 Cg_exo -71.04 -22.47 26.2 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.953 2.435 . . . . 0.63 111.409 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.89 -15.32 61.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.375 -0.83 . . . . 1.8400000000000001 111.315 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.515 HD11 ' HZ ' ' A' ' 67' ' ' PHE . 2.9 pp -128.3 -5.54 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 119.309 -0.377 . . . . 1.22 111.488 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 41.39 64.37 1.04 Allowed 'General case' 0 C--N 1.351 0.638 0 CA-C-O 121.772 0.796 . . . . 2.5099999999999998 111.616 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -169.25 167.92 10.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.052 -1.431 . . . . 1.05 109.069 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -135.82 142.71 44.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 1.03 112.547 -172.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.594 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 49.7 m-85 -96.59 134.72 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.66000000000000003 110.195 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.41 128.0 64.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.094 -0.957 . . . . 1.0800000000000001 109.372 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.625 ' CB ' HG21 ' A' ' 47' ' ' THR . 13.0 t0 -98.61 108.44 21.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.002 0.43 . . . . 0.79000000000000004 110.021 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' HH ' HG13 ' A' ' 104' ' ' ILE . 22.7 p90 -124.64 65.43 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.459 0.647 . . . . 1.28 109.434 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.08 34.6 52.88 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.336 -0.935 . . . . 0.82999999999999996 111.452 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.88 115.15 24.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.655 0.264 . . . . 1.1499999999999999 110.555 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -64.59 -27.06 68.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.911 -0.774 . . . . 2.4300000000000002 108.911 175.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.476 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 19.9 mtm-85 -84.06 -11.47 56.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.662 -1.154 . . . . 5.2199999999999998 110.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.413 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 61.28 -159.77 0.31 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.485 -0.779 . . . . 1.0600000000000001 109.998 -172.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.79 120.24 0.98 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 109.867 -1.293 . . . . 0.52000000000000002 109.867 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.1 t80 -103.78 113.22 26.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.192 0.52 . . . . 0.51000000000000001 111.169 -169.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -100.0 115.2 65.74 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.315 -0.857 . . . . 1.04 110.143 177.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 25.4 Cg_exo -64.66 143.61 81.54 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.752 2.301 . . . . 0.28000000000000003 111.803 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.843 HD13 ' HB ' ' A' ' 90' ' ' ILE . 24.3 tp -66.4 -26.5 67.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.959 -0.564 . . . . 1.04 111.514 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 20.9 pttp -73.05 -9.65 58.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.359 . . . . 2.6200000000000001 110.999 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.538 ' OE2' ' HG3' ' A' ' 71' ' ' LYS . 17.0 mm-40 -100.04 -14.93 18.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.85999999999999999 110.078 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.657 HG21 HG13 ' A' ' 93' ' ' VAL . 6.1 mm -49.04 133.57 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 113.47 0.915 . . . . 1.3999999999999999 113.47 -168.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -89.11 151.06 22.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.311 -1.313 . . . . 1.1599999999999999 111.864 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.884 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 3.0 tmm_? -65.24 -21.69 66.78 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.198 -0.91 . . . . 3.4399999999999999 111.1 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.527 ' HB3' HD21 ' A' ' 122' ' ' LEU . 4.5 tp10 -73.99 -14.95 61.11 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.446 -0.784 . . . . 1.76 110.852 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -81.76 -52.71 6.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.856 -0.611 . . . . 1.51 109.861 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.545 ' HB3' ' HA ' ' A' ' 93' ' ' VAL . 8.2 p90 -96.62 109.09 46.55 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.14 -1.43 . . . . 0.57999999999999996 107.14 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.2 Cg_endo -40.56 137.14 1.68 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 123.87 3.047 . . . . 0.98999999999999999 113.025 -166.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.884 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -48.99 -16.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.841 1.052 . . . . 1.5 113.841 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.52 -7.2 59.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 2.6200000000000001 110.786 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.424 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 69.6 t80 -84.89 144.01 28.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.099 -0.704 . . . . 1.6499999999999999 109.099 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -78.67 100.69 7.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 2.4399999999999999 111.777 -175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.411 ' HB3' ' HE2' ' A' ' 78' ' ' PHE . . . -81.13 120.09 24.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 1.74 110.525 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -138.82 105.45 5.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.034 -0.53 . . . . 4.8300000000000001 110.647 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.87 -83.74 1.04 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.806 -0.711 . . . . 1.3600000000000001 111.824 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 133.49 17.3 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.791 0.329 . . . . 5.0099999999999998 110.252 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB2' HG22 ' A' ' 93' ' ' VAL . 11.6 Cg_endo -59.64 153.6 54.44 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.87 2.38 . . . . 0.35999999999999999 113.131 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.62 ' O ' HG21 ' A' ' 93' ' ' VAL . 6.9 t30 -106.28 111.26 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.644 -0.873 . . . . 2.3300000000000001 108.644 172.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.843 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.4 tt -62.78 -36.29 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.691 0.626 . . . . 1.1100000000000001 112.691 -164.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.789 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 32.4 mmmt -67.27 -5.59 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.482 0.549 . . . . 4.46 112.482 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 23.07 7.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 1.9099999999999999 109.58 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.657 HG13 HG21 ' A' ' 73' ' ' ILE . 48.0 t -121.94 -54.86 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.12 -0.945 . . . . 1.1499999999999999 109.833 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.757 ' HB3' HG12 ' A' ' 46' ' ' ILE . 93.5 mt -109.95 158.83 17.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.071 -0.968 . . . . 1.0 110.548 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 146.0 26.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.128 -0.942 . . . . 3.1000000000000001 109.352 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.585 ' HA ' HG23 ' A' ' 46' ' ' ILE . 47.8 mt-10 -55.6 119.48 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.25 110.893 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.47 -16.49 24.2 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.682 -0.69 . . . . 0.40999999999999998 112.129 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.2 tt0 -82.39 138.58 34.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.796 -0.446 . . . . 1.1799999999999999 109.796 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 12.5 pt-20 -87.54 156.73 19.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.256 0.55 . . . . 0.81000000000000005 111.936 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 102' ' ' VAL . 33.5 m -141.02 147.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.973 -1.012 . . . . 1.02 109.397 171.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.589 ' O ' HD11 ' A' ' 120' ' ' ILE . 10.2 mm -99.57 110.29 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.26 -1.015 . . . . 1.28 108.26 171.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 100' ' ' VAL . 3.4 m -144.64 132.5 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 1.0600000000000001 111.447 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 13.0 pt20 -107.02 133.13 52.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.249 -0.432 . . . . 2.0800000000000001 109.921 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 104' ' ' ILE . 19.6 mm -67.14 102.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 1.3400000000000001 110.159 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.26 -38.63 24.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 1.3 109.531 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . 54.9 mttp -117.77 132.51 56.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.358 -0.837 . . . . 2.9700000000000002 110.09 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -102.34 158.57 16.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.908 -1.042 . . . . 2.5699999999999998 111.0 -168.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 1.044 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 0.2 OUTLIER -52.52 117.41 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 3.1400000000000001 111.298 -176.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -143.98 18.91 1.79 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.858 -1.064 . . . . 3.9700000000000002 109.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.65 -43.37 3.17 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.824 -0.626 . . . . 1.74 112.893 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.55 -51.28 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.853 0.316 . . . . 3.25 111.853 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -125.02 -38.93 2.29 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.378 0.609 . . . . 3.79 110.971 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 1.044 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 92.07 -126.79 8.65 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.469 -0.872 . . . . 1.02 111.687 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.07 94.19 7.16 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.812 0.339 . . . . 1.0800000000000001 110.747 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 106' ' ' LYS . . . -94.52 124.96 38.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.474 -0.33 . . . . 1.1000000000000001 111.604 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.861 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 25.1 mt -90.8 135.66 33.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.729 -0.471 . . . . 1.1499999999999999 109.729 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 119' ' ' PHE . 7.1 t -97.38 167.57 10.92 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.446 -0.575 . . . . 1.25 109.446 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.597 HG23 HD22 ' A' ' 68' ' ' LEU . 11.9 p -125.32 19.83 8.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.165 0.507 . . . . 1.52 111.224 173.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 73.7 m-85 -80.89 54.13 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.826 0.822 . . . . 4.9900000000000002 109.918 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.589 HD11 ' O ' ' A' ' 101' ' ' ILE . 2.0 mp -127.63 175.85 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.579 -1.191 . . . . 1.4299999999999999 108.054 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.462 ' H ' HG23 ' A' ' 120' ' ' ILE . 1.5 m -66.85 19.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.425 0.898 . . . . 1.53 113.425 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.554 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 6.6 mp -115.9 106.5 13.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.22 -0.3 . . . . 2.1099999999999999 110.433 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 124.727 1.211 . . . . 1.3700000000000001 109.254 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.459 -0.941 . . . . 1.3200000000000001 108.459 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -57.54 117.6 4.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 3.1400000000000001 110.447 -175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.412 HD11 HG12 ' A' ' 120' ' ' ILE . 7.5 tp -84.39 146.74 6.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.294 -0.866 . . . . 1.47 111.292 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.78 147.29 40.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.409 -0.36 . . . . 1.6299999999999999 110.556 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 41.3 ttmt -108.37 116.63 32.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 1.96 109.045 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.21 23.85 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.83 -0.908 . . . . 0.31 110.83 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 68.4 mttt -102.33 161.37 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.27 0.557 . . . . 2.0499999999999998 110.814 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.814 HG12 ' HB3' ' A' ' 94' ' ' LEU . 1.8 mp -70.23 136.47 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.842 -1.072 . . . . 1.1100000000000001 109.239 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.718 HG22 ' HB2' ' A' ' 59' ' ' ASP . 1.9 p -121.52 -33.52 3.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.419 0.628 . . . . 1.1499999999999999 111.139 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.611 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 39.4 ttm180 -147.68 122.14 9.73 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.269 -0.878 . . . . 2.2999999999999998 110.384 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.805 HD11 HG23 ' A' ' 46' ' ' ILE . 51.1 mt -131.62 130.11 62.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.525 -0.546 . . . . 1.0800000000000001 109.525 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.846 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 22.6 tt0 -129.29 131.51 23.7 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.868 -0.606 . . . . 2.2400000000000002 109.461 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.736 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 9.4 Cg_exo -68.3 -24.92 36.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.475 2.117 . . . . 0.63 111.31 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.378 -0.828 . . . . 1.8400000000000001 111.079 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.1 pp -118.48 -1.85 11.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 119.086 -0.483 . . . . 1.22 111.758 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 41.04 54.22 3.3 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-O 121.979 0.895 . . . . 2.5099999999999998 111.396 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.37 166.52 27.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.269 -1.332 . . . . 1.05 109.499 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.499 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -133.47 134.24 43.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.406 -0.361 . . . . 1.03 111.55 -175.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.611 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 76.4 m-85 -85.86 133.1 33.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.387 -0.597 . . . . 0.66000000000000003 109.387 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.543 ' HB ' HD11 ' A' ' 116' ' ' LEU . 31.5 t -115.34 128.75 72.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.469 -0.787 . . . . 1.0800000000000001 109.626 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.718 ' HB2' HG22 ' A' ' 47' ' ' THR . 12.3 t0 -101.94 108.77 20.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.886 -0.597 . . . . 0.79000000000000004 110.321 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.14 65.49 1.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.369 -0.974 . . . . 1.28 108.369 171.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.48 30.5 50.04 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.525 -0.845 . . . . 0.82999999999999996 111.699 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.06 153.05 18.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 1.1499999999999999 111.552 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.77 -27.35 15.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.686 -0.688 . . . . 2.4300000000000002 110.52 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.601 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 2.4 mmp_? -113.57 -9.36 13.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.083 -0.508 . . . . 5.2199999999999998 110.532 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.517 ' HD1' ' HB3' ' A' ' 57' ' ' PHE . 9.7 m170 70.34 144.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.243 -0.889 . . . . 1.0600000000000001 111.221 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.78 104.23 2.07 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.413 -0.898 . . . . 0.52000000000000002 110.965 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.695 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 1.7 t80 -91.32 97.73 11.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.178 0.513 . . . . 0.51000000000000001 110.191 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 1.002 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -86.42 115.44 62.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.56 -0.746 . . . . 1.04 110.188 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.641 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 10.3 Cg_exo -69.52 141.33 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.245 1.963 . . . . 0.28000000000000003 111.471 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 90' ' ' ILE . 21.2 tp -54.78 -30.62 57.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.335 -0.848 . . . . 1.04 112.144 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.641 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.0 ptmm? -61.76 -22.99 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 2.6200000000000001 111.768 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -93.57 -21.75 19.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.48 -0.327 . . . . 0.85999999999999999 111.256 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 93' ' ' VAL . 17.0 mt -49.01 132.21 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.155 0.798 . . . . 1.3999999999999999 113.155 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -93.67 151.9 19.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.197 -0.91 . . . . 1.1599999999999999 111.363 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.49 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 10.0 tpt180 -54.38 -16.1 2.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.525 -1.216 . . . . 3.4399999999999999 112.777 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.953 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 29.7 tp10 -63.5 -29.89 71.09 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.788 -0.57 . . . . 1.76 110.823 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.645 ' CE1' HG12 ' A' ' 100' ' ' VAL . 26.1 m-85 -86.14 -41.61 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.317 -0.856 . . . . 1.51 110.733 -172.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB3' HG13 ' A' ' 93' ' ' VAL . 2.1 p90 -102.3 92.13 3.03 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 107.551 -1.277 . . . . 0.57999999999999996 107.551 166.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.503 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 23.4 Cg_exo -26.72 137.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.675 4.25 . . . . 0.98999999999999999 115.374 -167.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.6 -25.39 17.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.356 -1.293 . . . . 1.5 112.579 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.59 -6.57 59.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.196 0.522 . . . . 2.6200000000000001 111.253 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 79' ' ' PRO . 58.1 t80 -87.85 135.38 33.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.313 -0.625 . . . . 1.6499999999999999 109.313 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -71.61 116.37 11.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.051 -0.722 . . . . 2.4399999999999999 109.051 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.486 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -63.73 -21.03 66.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.886 0.699 . . . . 1.74 112.886 -170.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 40.6 m80 65.55 23.93 11.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.284 0.564 . . . . 4.8300000000000001 110.412 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.41 -57.93 4.18 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.513 -0.767 . . . . 1.3600000000000001 111.953 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -137.3 130.27 17.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.864 0.364 . . . . 5.0099999999999998 110.46 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.4 154.59 57.78 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.163 2.575 . . . . 0.35999999999999999 113.697 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.516 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.3 t30 -114.98 110.7 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.24 -0.652 . . . . 2.3300000000000001 109.24 171.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 70' ' ' LEU . 7.9 tt -55.63 -43.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 113.649 0.981 . . . . 1.1100000000000001 113.649 -164.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.736 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 4.7 mmmp? -56.7 -26.37 56.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.245 0.831 . . . . 4.46 113.245 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -110.18 9.38 23.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.145 0.497 . . . . 1.9099999999999999 111.079 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.682 HG11 HG21 ' A' ' 73' ' ' ILE . 53.2 t -115.21 -51.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.638 -0.71 . . . . 1.1499999999999999 109.849 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.814 ' HB3' HG12 ' A' ' 46' ' ' ILE . 83.1 mt -103.16 154.05 19.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.44 -0.8 . . . . 1.0 109.691 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 151.99 36.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.521 -0.763 . . . . 3.1000000000000001 108.95 174.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.561 ' HA ' HG21 ' A' ' 46' ' ' ILE . 36.6 mt-10 -62.06 118.69 7.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 1.25 110.237 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.35 -18.33 20.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.85 -0.614 . . . . 0.40999999999999998 112.209 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 tt0 -78.02 135.86 37.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.479 -0.563 . . . . 1.1799999999999999 109.479 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.9 157.37 19.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.136 0.493 . . . . 0.81000000000000005 111.361 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.645 HG12 ' CE1' ' A' ' 77' ' ' TYR . 35.0 m -138.07 151.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.169 -0.923 . . . . 1.02 109.959 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.576 HG12 HD23 ' A' ' 122' ' ' LEU . 3.5 mm -103.06 110.14 28.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.67 -1.233 . . . . 1.28 107.67 171.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -143.61 134.79 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.559 . . . . 1.0600000000000001 111.783 -170.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.403 ' O ' HG21 ' A' ' 117' ' ' THR . 10.7 pt20 -108.33 141.26 40.41 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.56 -0.904 . . . . 2.0800000000000001 108.56 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.426 ' CD1' HD21 ' A' ' 116' ' ' LEU . 18.3 mm -74.98 104.53 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.667 0.746 . . . . 1.3400000000000001 111.367 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.47 -43.33 32.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.686 -1.143 . . . . 1.3 109.776 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 115' ' ' ALA . 60.4 mttp -118.04 137.42 52.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.66 -0.7 . . . . 2.9700000000000002 109.895 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.64 144.38 32.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.007 -0.997 . . . . 2.5699999999999998 112.547 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.601 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 40.8 tt0 -71.63 90.91 1.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.31 -0.859 . . . . 3.1400000000000001 110.321 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.594 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 17.8 mtt180 -105.53 -82.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.453 -0.794 . . . . 3.9700000000000002 110.665 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.93 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.561 -0.828 . . . . 1.74 112.569 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.412 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 21.6 t-20 -61.59 -49.71 75.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.579 0.214 . . . . 3.25 111.579 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 29.3 mtpp -123.55 -38.05 2.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.321 0.581 . . . . 3.79 109.812 171.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.594 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 85.64 -132.71 11.28 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.149 -0.932 . . . . 1.02 112.531 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 65' ' ' HIS . . . -75.57 108.01 8.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.148 -0.526 . . . . 1.0800000000000001 111.326 -171.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.609 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . . . -104.22 125.24 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.213 -0.449 . . . . 1.1000000000000001 110.431 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 1.002 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 30.4 mt -90.8 148.72 22.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.989 0.423 . . . . 1.1499999999999999 109.965 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 103' ' ' GLN . 12.7 t -113.93 175.46 5.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.17 -0.678 . . . . 1.25 109.17 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.417 ' C ' ' H ' ' A' ' 120' ' ' ILE . 10.3 p -125.27 26.99 6.73 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.401 0.619 . . . . 1.52 110.274 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -78.15 44.45 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.547 1.165 . . . . 4.9900000000000002 109.141 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 101' ' ' ILE . 3.3 mp -128.46 161.73 36.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.839 -1.073 . . . . 1.4299999999999999 108.982 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.06 66.82 0.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.967 0.413 . . . . 1.53 111.301 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 101' ' ' ILE . 1.9 mt -116.25 173.31 6.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.112 -0.699 . . . . 2.1099999999999999 109.112 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.953 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.33 -0.258 0 O-C-N 123.92 0.762 . . . . 1.3700000000000001 110.622 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.614 -0.884 . . . . 1.3200000000000001 108.614 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -52.79 119.77 4.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.527 . . . . 3.1400000000000001 110.665 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.649 HD12 HG21 ' A' ' 101' ' ' ILE . 6.5 tp -89.52 138.62 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.218 -0.901 . . . . 1.47 110.326 -175.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -133.25 156.41 47.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.021 0.438 . . . . 1.6299999999999999 110.343 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.8 ttmt -118.49 121.66 40.82 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.795 -0.817 . . . . 1.96 108.795 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.82 166.95 25.78 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.675 -0.97 . . . . 0.31 110.675 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 90.4 mttt -100.21 156.88 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.41 0.624 . . . . 2.0499999999999998 111.114 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.994 HG22 HD13 ' A' ' 49' ' ' ILE . 1.7 mp -69.86 134.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.661 -1.154 . . . . 1.1100000000000001 109.822 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 59' ' ' ASP . 61.6 p -123.87 -18.41 6.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.357 0.599 . . . . 1.1499999999999999 111.314 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG2' ' HD2' ' A' ' 57' ' ' PHE . 7.2 ttm180 -150.6 131.3 14.02 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.361 -0.836 . . . . 2.2999999999999998 110.524 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.994 HD13 HG22 ' A' ' 46' ' ' ILE . 58.0 mt -139.81 101.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.657 -0.868 . . . . 1.0800000000000001 108.657 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -98.57 112.46 62.53 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.0 -0.545 . . . . 2.2400000000000002 110.015 -177.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.998 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 52.9 Cg_exo -57.12 -22.37 47.37 Favored 'Trans proline' 0 N--CA 1.467 -0.054 0 C-N-CA 122.953 2.435 . . . . 0.63 111.894 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -71.69 -20.09 61.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.8400000000000001 111.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -128.36 12.74 6.53 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.811 1.041 . . . . 1.22 113.811 -176.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER 47.73 40.78 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 2.5099999999999998 112.818 173.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.69 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.54 170.24 20.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 1.05 111.076 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 90' ' ' ILE . . . -137.63 149.12 46.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 1.03 112.032 -173.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.538 ' HD2' ' HG2' ' A' ' 48' ' ' ARG . 63.4 m-85 -98.38 137.64 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.66000000000000003 109.826 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.629 ' HB ' HD12 ' A' ' 116' ' ' LEU . 24.3 t -118.72 131.78 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.347 -0.842 . . . . 1.0800000000000001 109.832 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.622 ' HB2' HG22 ' A' ' 47' ' ' THR . 22.2 t70 -100.43 104.86 16.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.79000000000000004 110.649 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -127.11 65.4 1.3 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.973 -0.751 . . . . 1.28 108.973 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.41 52.18 19.6 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.336 -0.935 . . . . 0.82999999999999996 111.328 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 168.48 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 1.1499999999999999 111.193 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 7.4 tp10 -93.78 -53.54 3.98 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.905 -0.318 . . . . 2.4300000000000002 111.381 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.4 ptm180 -109.16 6.54 24.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.132 -0.627 . . . . 5.2199999999999998 110.778 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 15.7 m170 71.25 143.28 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.24 -0.891 . . . . 1.0600000000000001 111.511 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -74.53 117.33 5.46 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.829 -0.909 . . . . 0.52000000000000002 110.829 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.69 ' CZ ' ' HB2' ' A' ' 55' ' ' ALA . 21.6 t80 -99.83 98.73 9.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.166 0.508 . . . . 0.51000000000000001 110.375 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.897 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -87.34 117.54 68.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.506 -0.77 . . . . 1.04 111.05 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HD2' HD23 ' A' ' 68' ' ' LEU . 21.3 Cg_exo -67.65 141.85 56.37 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.821 2.347 . . . . 0.28000000000000003 111.721 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.692 HD12 ' HB ' ' A' ' 90' ' ' ILE . 18.0 tp -59.34 -35.09 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 1.04 112.035 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -67.83 -8.22 34.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.394 -0.366 . . . . 2.6200000000000001 111.786 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.44 ' C ' ' HG1' ' A' ' 118' ' ' THR . 8.0 mm-40 -96.31 -26.98 15.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.641 -0.254 . . . . 0.85999999999999999 110.349 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.538 HG21 HG11 ' A' ' 93' ' ' VAL . 33.9 mt -49.85 135.06 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.436 0.902 . . . . 1.3999999999999999 113.436 -167.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB2' ' HB1' ' A' ' 123' ' ' ALA . . . -91.07 148.99 22.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.394 -1.275 . . . . 1.1599999999999999 111.432 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.648 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 13.6 ttp180 -58.41 -14.49 7.8 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.937 -1.029 . . . . 3.4399999999999999 112.583 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.662 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 10.4 tp10 -54.36 -38.82 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 1.76 111.789 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 1.043 ' HH ' ' HA ' ' A' ' 100' ' ' VAL . 39.2 m-85 -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.581 0.586 . . . . 1.51 112.581 -168.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.648 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 12.5 p90 -97.91 88.58 0.65 Allowed Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 105.996 -1.853 . . . . 0.57999999999999996 105.996 158.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.08 143.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.876 3.717 . . . . 0.98999999999999999 114.216 -157.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.95 -7.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.907 -1.042 . . . . 1.5 112.65 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.7 -21.94 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.472 0.653 . . . . 2.6200000000000001 109.607 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -77.64 130.67 37.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.11 -0.95 . . . . 1.6499999999999999 109.466 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -68.57 100.35 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 2.4399999999999999 110.339 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.22 103.02 12.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.683 -0.69 . . . . 1.74 110.634 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -130.76 131.89 44.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.824 -0.625 . . . . 4.8300000000000001 109.856 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.15 -102.32 2.16 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.558 -0.829 . . . . 1.3600000000000001 111.84 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -136.94 133.12 18.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.138 -0.319 . . . . 5.0099999999999998 110.138 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -60.0 156.48 38.87 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.417 1.412 . . . . 0.35999999999999999 111.091 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.614 HD22 ' HG3' ' A' ' 91' ' ' LYS . 10.4 t30 -118.34 101.4 8.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.676 -0.49 . . . . 2.3300000000000001 109.676 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 70' ' ' LEU . 19.9 tt -54.79 -45.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.598 0.962 . . . . 1.1100000000000001 113.598 -164.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.998 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 17.0 ptmt -56.42 -16.54 5.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.838 0.681 . . . . 4.46 112.838 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.448 ' HB3' HD21 ' A' ' 89' ' ' ASN . 34.6 t70 -118.18 1.34 11.91 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.521 0.676 . . . . 1.9099999999999999 110.624 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 89' ' ' ASN . 45.3 t -105.58 -50.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.655 0.741 . . . . 1.1499999999999999 109.543 -175.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.674 ' HB3' HG12 ' A' ' 46' ' ' ILE . 81.6 mt -100.84 152.72 20.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.172 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 149.09 30.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.355 -0.839 . . . . 3.1000000000000001 109.389 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.535 ' HA ' HG23 ' A' ' 46' ' ' ILE . 31.0 mt-10 -56.24 123.93 16.24 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.722 0.639 . . . . 1.25 111.203 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.3 29.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.615 -0.721 . . . . 0.40999999999999998 112.151 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 8.4 tt0 -77.14 133.4 38.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.054 -0.35 . . . . 1.1799999999999999 110.054 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.43 158.1 24.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.714 . . . . 0.81000000000000005 110.97 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 1.043 ' HA ' ' HH ' ' A' ' 77' ' ' TYR . 27.5 m -137.41 146.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 1.02 110.549 170.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.969 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.6 mm -93.83 110.14 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.237 -1.023 . . . . 1.28 108.237 169.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.499 ' CG2' HD23 ' A' ' 116' ' ' LEU . 3.4 m -144.32 129.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.199 0.523 . . . . 1.0600000000000001 111.26 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.498 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 15.6 pt20 -93.53 138.87 31.37 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.507 -0.923 . . . . 2.0800000000000001 108.507 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.575 ' CD1' HD21 ' A' ' 116' ' ' LEU . 41.7 mm -80.54 96.21 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.615 0.721 . . . . 1.3400000000000001 109.338 176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.87 -29.49 63.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.727 -1.124 . . . . 1.3 109.852 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 115' ' ' ALA . 32.3 mttm -129.07 123.97 33.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 2.9700000000000002 109.578 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -79.26 158.71 27.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.95 -0.568 . . . . 2.5699999999999998 110.305 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.879 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 22.5 tt0 -70.63 90.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.56 0.695 . . . . 3.1400000000000001 110.717 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -111.26 6.98 20.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.862 -1.063 . . . . 3.9700000000000002 110.974 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.36 -46.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.643 -0.789 . . . . 1.74 113.432 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.65 -50.84 70.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.007 0.403 . . . . 3.25 111.064 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.619 ' HB2' ' HZ3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -121.8 -37.28 2.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.631 -0.877 . . . . 3.79 108.631 169.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.879 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 83.52 -133.4 11.85 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.823 -1.081 . . . . 1.02 111.098 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.47 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -73.02 96.87 2.22 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.155 0.502 . . . . 1.0800000000000001 110.309 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . . . -104.03 124.42 49.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 1.1000000000000001 111.528 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.897 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 31.4 mt -91.4 159.77 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.049 -0.723 . . . . 1.1499999999999999 109.049 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 102' ' ' VAL . 12.8 t -138.08 153.4 49.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.186 -0.672 . . . . 1.25 109.186 168.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 72' ' ' GLU . 0.7 OUTLIER -126.86 34.49 4.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.302 0.572 . . . . 1.52 111.015 172.143 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -80.25 45.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.357 -0.979 . . . . 4.9900000000000002 108.357 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.623 ' HB ' HD13 ' A' ' 122' ' ' LEU . 11.0 mt -121.36 168.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.471 -1.24 . . . . 1.4299999999999999 108.37 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.418 ' H ' HG21 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -85.03 33.48 0.54 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.947 0.721 . . . . 1.53 112.947 -172.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.969 ' HG ' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -117.2 100.19 7.54 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.684 0.754 . . . . 2.1099999999999999 109.882 175.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.662 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.712 -0.676 . . . . 1.3700000000000001 109.907 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.194 -0.669 . . . . 1.3200000000000001 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -55.69 124.03 16.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.084 0.469 . . . . 3.1400000000000001 110.948 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -95.33 144.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.881 -0.6 . . . . 1.47 109.663 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -125.22 135.45 52.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 1.6299999999999999 110.449 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 40.0 ttmt -98.75 103.67 15.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.911 -0.774 . . . . 1.96 108.911 167.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.94 161.89 19.35 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 110.691 -0.964 . . . . 0.31 110.691 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 84.6 mttt -94.45 158.06 15.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.171 0.51 . . . . 2.0499999999999998 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.761 HG22 ' CD1' ' A' ' 49' ' ' ILE . 1.8 mp -74.57 133.69 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.144 -1.058 . . . . 1.1100000000000001 108.144 169.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.61 HG21 ' CB ' ' A' ' 59' ' ' ASP . 57.5 p -117.57 -20.09 9.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.436 0.636 . . . . 1.1499999999999999 110.525 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 24.4 ttt180 -146.6 121.42 9.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.136 -0.938 . . . . 2.2999999999999998 109.677 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.761 ' CD1' HG22 ' A' ' 46' ' ' ILE . 75.4 mt -125.91 109.0 20.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.147 -0.686 . . . . 1.0800000000000001 109.147 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.547 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 7.0 tp10 -104.47 107.78 58.77 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.221 -0.9 . . . . 2.2400000000000002 109.488 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HB3' ' CD ' ' A' ' 91' ' ' LYS . 54.3 Cg_exo -53.95 -37.94 86.08 Favored 'Trans proline' 0 N--CA 1.467 -0.07 0 C-N-CA 123.309 2.673 . . . . 0.63 112.578 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -22.12 65.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.8400000000000001 112.158 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.0 pp -123.59 8.25 8.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.15 0.426 . . . . 1.22 112.15 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 39.23 60.23 1.55 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.705 0.802 . . . . 2.5099999999999998 112.197 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -165.67 158.47 15.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.248 -0.887 . . . . 1.05 110.405 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.508 ' HB3' HD12 ' A' ' 90' ' ' ILE . . . -122.91 144.49 49.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.546 0.572 . . . . 1.03 112.546 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.528 ' HD1' ' HB2' ' A' ' 65' ' ' HIS . 63.1 m-85 -97.02 137.09 36.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.417 -0.811 . . . . 0.66000000000000003 109.844 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HB ' HD13 ' A' ' 116' ' ' LEU . 38.4 t -120.47 129.67 75.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.019 -0.537 . . . . 1.0800000000000001 109.675 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.61 ' CB ' HG21 ' A' ' 47' ' ' THR . 29.2 t70 -102.41 112.68 25.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.319 -0.401 . . . . 0.79000000000000004 111.384 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.0 67.45 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.047 -0.723 . . . . 1.28 109.047 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.8 41.33 58.05 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.728 -0.669 . . . . 0.82999999999999996 112.153 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.21 147.61 44.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 1.1499999999999999 111.271 -172.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.66 -51.26 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 2.4300000000000002 108.803 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.882 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 26.7 mmm180 -96.23 106.61 18.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.224 -0.898 . . . . 5.2199999999999998 108.793 169.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 18.9 m170 -61.56 149.83 37.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 1.0600000000000001 111.51 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.08 110.31 3.14 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.771 -0.931 . . . . 0.52000000000000002 110.771 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 55' ' ' ALA . 9.5 t80 -98.87 100.58 11.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.326 0.584 . . . . 0.51000000000000001 110.827 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.912 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -92.15 115.09 64.06 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.09 -0.959 . . . . 1.04 110.94 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.627 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.0 Cg_exo -64.07 141.07 75.14 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.864 2.376 . . . . 0.28000000000000003 111.562 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.823 ' HA ' HG13 ' A' ' 73' ' ' ILE . 10.3 tp -63.07 -34.93 78.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.605 -0.725 . . . . 1.04 111.722 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.08 -14.8 52.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.982 0.42 . . . . 2.6200000000000001 111.083 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.627 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 1.6 mm-40 -99.19 -14.45 19.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.85999999999999999 110.534 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.823 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.8 mt -49.31 134.05 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.151 0.797 . . . . 1.3999999999999999 113.151 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -87.05 146.5 26.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.814 -1.084 . . . . 1.1599999999999999 110.922 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 18.2 ttm180 -62.19 -13.51 28.29 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.384 -0.825 . . . . 3.4399999999999999 111.806 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.689 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 15.0 tp10 -60.87 -27.22 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.468 . . . . 1.76 110.757 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.4 ' HD2' HG21 ' A' ' 73' ' ' ILE . 14.8 m-85 -87.45 -44.17 11.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.447 -0.797 . . . . 1.51 110.353 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.1 p90 -96.17 97.34 3.08 Favored Pre-proline 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 0.57999999999999996 107.098 166.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.1 Cg_endo -38.65 138.02 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.306 3.337 . . . . 0.98999999999999999 112.776 -163.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.69 -10.28 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.395 -0.821 . . . . 1.5 113.193 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -87.02 -12.6 46.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.349 0.595 . . . . 2.6200000000000001 110.317 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.88 143.5 41.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.782 -0.644 . . . . 1.6499999999999999 109.688 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -79.52 100.64 7.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.37 -0.377 . . . . 2.4399999999999999 110.957 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.448 ' HB3' ' HE2' ' A' ' 78' ' ' PHE . . . -87.04 123.4 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 1.74 110.182 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.57 -20.43 18.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.007 0.432 . . . . 4.8300000000000001 110.373 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -77.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.914 -0.66 . . . . 1.3600000000000001 111.572 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -104.84 132.57 20.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.043 -0.355 . . . . 5.0099999999999998 110.043 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.407 ' C ' HD13 ' A' ' 70' ' ' LEU . 11.5 Cg_endo -64.66 161.78 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.116 1.877 . . . . 0.35999999999999999 111.975 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.834 HD21 ' HB3' ' A' ' 92' ' ' ASP . 0.3 OUTLIER -122.11 102.62 8.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 2.3300000000000001 109.78 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 17.3 tt -54.85 -40.16 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.699 1.0 . . . . 1.1100000000000001 113.699 -162.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.608 ' CD ' ' HB3' ' A' ' 51' ' ' PRO . 43.2 pttt -67.65 -11.6 58.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.953 0.353 . . . . 4.46 111.953 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' ASN . 37.0 t70 -125.53 18.25 8.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.159 0.98 . . . . 1.9099999999999999 109.359 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.557 HG12 ' HB3' ' A' ' 78' ' ' PHE . 18.1 t -122.5 -54.77 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 1.1499999999999999 110.198 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.519 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 47.8 mt -101.09 153.34 19.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.55 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . 0.734 ' HD3' HE21 ' A' ' 98' ' ' GLN . 0.1 OUTLIER -125.43 150.53 47.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.106 -0.702 . . . . 3.1000000000000001 109.106 173.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.652 ' HA ' HG23 ' A' ' 46' ' ' ILE . 42.2 mt-10 -69.95 109.31 4.44 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.257 -1.016 . . . . 1.25 108.257 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.21 -11.46 19.81 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.438 -0.801 . . . . 0.40999999999999998 112.15 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.734 HE21 ' HD3' ' A' ' 95' ' ' ARG . 9.1 tt0 -80.29 144.71 32.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.206 0.503 . . . . 1.1799999999999999 109.966 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.69 153.71 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.32 0.581 . . . . 0.81000000000000005 111.612 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 27.3 m -136.29 146.4 29.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.088 -0.96 . . . . 1.02 109.018 169.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.863 ' HB ' HD13 ' A' ' 122' ' ' LEU . 4.3 mm -100.42 109.12 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.571 -1.27 . . . . 1.28 107.571 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.534 ' CG2' HD21 ' A' ' 116' ' ' LEU . 4.8 m -145.5 142.63 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.021 -0.536 . . . . 1.0600000000000001 110.717 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.415 ' HG3' HG21 ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.4 166.28 10.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.381 -0.6 . . . . 2.0800000000000001 109.381 175.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 106' ' ' LYS . 18.7 mm -108.53 98.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.629 0.728 . . . . 1.3400000000000001 110.072 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -83.71 -29.41 27.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.066 -0.97 . . . . 1.3 110.381 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 36.1 mmtm -117.65 136.35 53.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.449 . . . . 2.9700000000000002 109.895 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 28.2 mt-10 -97.56 158.25 15.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.417 -0.81 . . . . 2.5699999999999998 110.447 -166.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.882 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 24.8 tt0 -51.25 112.21 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.547 0.529 . . . . 3.1400000000000001 110.803 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.895 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 12.7 ptm180 -146.65 49.28 1.15 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.454 -0.794 . . . . 3.9700000000000002 110.382 -175.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.34 -96.25 1.0 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.788 -0.642 . . . . 1.74 113.991 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -60.66 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.004 0.742 . . . . 3.25 113.004 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -110.86 -40.28 4.58 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.143 -0.623 . . . . 3.79 110.144 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.895 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 60.88 -121.51 26.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.487 -0.778 . . . . 1.02 112.509 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -72.99 101.08 3.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.164 0.506 . . . . 1.0800000000000001 110.607 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -98.59 124.0 43.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.248 -0.433 . . . . 1.1000000000000001 110.907 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.912 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 46.9 mt -90.93 136.75 32.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 1.1499999999999999 109.732 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.415 HG21 ' HG3' ' A' ' 103' ' ' GLN . 5.0 t -96.82 168.17 10.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.635 . . . . 1.25 109.284 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.596 HG23 HD21 ' A' ' 68' ' ' LEU . 2.0 p -136.01 13.99 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.155 0.502 . . . . 1.52 111.159 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.91 57.52 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.246 -1.02 . . . . 4.9900000000000002 108.246 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.497 HG23 ' H ' ' A' ' 121' ' ' SER . 8.1 mt -127.9 175.5 9.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 113.975 -1.466 . . . . 1.4299999999999999 108.648 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.497 ' H ' HG23 ' A' ' 120' ' ' ILE . 14.6 m -75.61 33.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.448 0.536 . . . . 1.53 112.448 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.863 HD13 ' HB ' ' A' ' 101' ' ' ILE . 4.2 mp -116.34 124.22 49.56 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.349 -0.219 . . . . 2.1099999999999999 111.496 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.689 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.468 0.441 0 O-C-N 124.911 1.382 . . . . 1.3700000000000001 109.149 170.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 108.676 -0.861 . . . . 1.3200000000000001 108.676 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -61.66 124.95 22.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.378 0.609 . . . . 3.1400000000000001 110.783 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 103' ' ' GLN . 7.3 tp -94.18 143.96 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.194 -0.912 . . . . 1.47 110.098 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.22 144.09 51.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.05 0.452 . . . . 1.6299999999999999 110.968 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -112.42 117.61 32.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.307 -0.86 . . . . 1.96 109.389 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -153.11 177.63 30.64 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.629 -0.988 . . . . 0.31 110.629 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HD2' ' HA2' ' A' ' 97' ' ' GLY . 39.2 mtmt -116.52 159.11 22.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.64 0.733 . . . . 2.0499999999999998 111.88 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.812 HG23 HD12 ' A' ' 49' ' ' ILE . 1.7 mp -68.42 137.77 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.322 -1.308 . . . . 1.1100000000000001 110.089 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' ASP . 47.5 p -126.56 -20.18 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 1.1499999999999999 111.689 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.673 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 8.3 ttm180 -148.08 122.02 9.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.072 -0.513 . . . . 2.2999999999999998 110.09 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.812 HD12 HG23 ' A' ' 46' ' ' ILE . 88.2 mt -128.87 108.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.146 -0.687 . . . . 1.0800000000000001 109.146 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.583 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 17.3 tt0 -102.89 121.05 50.59 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.894 -0.594 . . . . 2.2400000000000002 109.688 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG3' ' CD ' ' A' ' 91' ' ' LYS . 12.2 Cg_exo -65.8 -31.25 48.71 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.977 2.451 . . . . 0.63 112.759 -171.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 t -77.03 -10.11 59.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 1.8400000000000001 111.657 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.583 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 3.1 pp -127.82 5.77 6.06 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.728 0.64 . . . . 1.22 112.728 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 43.47 55.55 4.81 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.352 0.596 . . . . 2.5099999999999998 112.095 170.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.0 158.98 22.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.461 -0.79 . . . . 1.05 110.365 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.508 ' HB2' HD12 ' A' ' 90' ' ' ILE . . . -129.1 140.26 51.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.873 0.694 . . . . 1.03 112.873 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.703 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 53.0 m-85 -92.43 128.61 38.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.134 -0.939 . . . . 0.66000000000000003 110.119 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.457 ' HB ' HD11 ' A' ' 116' ' ' LEU . 76.5 t -108.54 131.01 60.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.25 0.547 . . . . 1.0800000000000001 109.884 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.653 ' HB2' HG22 ' A' ' 47' ' ' THR . 10.6 t70 -101.49 96.49 7.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.715 -0.675 . . . . 0.79000000000000004 110.664 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.649 ' OH ' HD12 ' A' ' 104' ' ' ILE . 15.5 p90 -126.88 66.29 1.27 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.032 -0.729 . . . . 1.28 109.032 173.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.39 11.67 15.03 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.759 -0.734 . . . . 0.82999999999999996 112.533 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.61 110.71 18.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.843 0.354 . . . . 1.1499999999999999 110.305 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.63 -18.68 60.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 2.4300000000000002 110.637 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.699 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.9 mmp_? -95.63 -6.82 39.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.893 -0.594 . . . . 5.2199999999999998 110.371 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.703 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 59.18 107.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.238 -0.892 . . . . 1.0600000000000001 111.924 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -59.61 122.06 28.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.431 -0.89 . . . . 0.52000000000000002 111.151 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.7 t80 -111.28 107.67 17.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.283 0.563 . . . . 0.51000000000000001 110.524 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.733 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.3 118.58 67.71 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.326 -0.852 . . . . 1.04 110.84 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.555 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 27.5 Cg_exo -64.87 134.9 42.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.501 2.134 . . . . 0.28000000000000003 111.052 169.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.666 ' HA ' HG13 ' A' ' 73' ' ' ILE . 12.3 tp -57.19 -31.91 65.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.583 . . . . 1.04 111.961 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 21.3 pttp -70.2 -8.18 47.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.448 -0.342 . . . . 2.6200000000000001 111.529 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 6.1 mm-40 -103.65 -10.03 18.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 110.423 -0.214 . . . . 0.85999999999999999 110.423 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.666 HG13 ' HA ' ' A' ' 70' ' ' LEU . 18.5 mt -60.77 133.54 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.658 0.614 . . . . 1.3999999999999999 112.658 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 118' ' ' THR . . . -77.92 140.51 39.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.254 -0.884 . . . . 1.1599999999999999 111.208 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.755 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 29.6 ttp180 -58.62 -13.81 6.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.223 -0.899 . . . . 3.4399999999999999 112.397 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.886 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 25.3 tp10 -56.25 -29.94 61.73 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.437 -0.79 . . . . 1.76 111.351 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.531 ' CZ ' HD21 ' A' ' 122' ' ' LEU . 34.0 m-85 -85.32 -41.03 15.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 1.51 110.894 -172.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.755 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.4 p90 -102.0 96.73 7.15 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 106.963 -1.495 . . . . 0.57999999999999996 106.963 167.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_endo -32.01 138.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 1 C-N-CA 125.676 4.251 . . . . 0.98999999999999999 114.704 -162.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.634 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -51.13 -24.17 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.638 -1.164 . . . . 1.5 113.699 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -92.92 4.8 53.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.58 0.705 . . . . 2.6200000000000001 110.67 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -84.78 132.13 34.46 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.662 -0.866 . . . . 1.6499999999999999 108.662 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -65.81 99.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 2.4399999999999999 111.821 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -90.25 58.22 3.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.575 -0.738 . . . . 1.74 110.041 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -80.17 56.66 2.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.442 0.639 . . . . 4.8300000000000001 110.48 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.5 -120.82 1.29 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.732 -0.667 . . . . 1.3600000000000001 111.995 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -119.68 130.95 24.58 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.804 -0.443 . . . . 5.0099999999999998 109.804 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.524 ' HB2' HG21 ' A' ' 93' ' ' VAL . 8.5 Cg_endo -58.74 144.71 97.9 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.987 1.792 . . . . 0.35999999999999999 111.742 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.492 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.9 t30 -98.75 118.55 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.346 -0.612 . . . . 2.3300000000000001 109.346 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.7 tt -57.63 -47.54 85.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.863 1.06 . . . . 1.1100000000000001 113.863 -164.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CD ' ' HG3' ' A' ' 51' ' ' PRO . 15.1 mtpt -66.25 -6.52 14.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.076 0.769 . . . . 4.46 113.076 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.76 5.04 17.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.377 0.608 . . . . 1.9099999999999999 110.22 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 78' ' ' PHE . 69.0 t -117.62 -52.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.463 -0.789 . . . . 1.1499999999999999 109.852 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.465 ' HB2' HD11 ' A' ' 49' ' ' ILE . 80.6 mt -101.7 154.78 18.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 1.0 109.175 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.34 150.42 35.68 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.535 -0.543 . . . . 3.1000000000000001 109.535 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.631 ' HA ' HG21 ' A' ' 46' ' ' ILE . 48.3 mt-10 -57.0 110.97 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 1.25 109.991 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 45' ' ' LYS . . . 112.96 -1.05 25.7 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.857 -0.687 . . . . 0.40999999999999998 112.242 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.477 ' NE2' ' HB3' ' A' ' 77' ' ' TYR . 22.8 tt0 -95.96 135.53 37.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.832 -0.433 . . . . 1.1799999999999999 109.832 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 11.7 pt-20 -82.77 157.54 23.18 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.463 0.477 . . . . 0.81000000000000005 111.815 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.466 HG23 HG22 ' A' ' 102' ' ' VAL . 34.2 m -141.2 152.59 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.115 -0.948 . . . . 1.02 109.741 171.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.781 ' HB ' HD13 ' A' ' 122' ' ' LEU . 23.5 mm -103.35 110.66 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.356 -0.979 . . . . 1.28 108.356 168.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 100' ' ' VAL . 2.5 m -139.1 130.57 35.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.218 0.532 . . . . 1.0600000000000001 112.127 -170.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB3' HD13 ' A' ' 41' ' ' ILE . 10.1 pt20 -104.68 157.32 17.26 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.167 -1.049 . . . . 2.0800000000000001 108.167 170.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.649 HD12 ' OH ' ' A' ' 60' ' ' TYR . 20.6 mm -81.02 102.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.779 0.799 . . . . 1.3400000000000001 110.861 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.458 ' OD2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 t70 -71.44 -44.24 65.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.104 -1.407 . . . . 1.3 110.33 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HG3' ' OD2' ' A' ' 105' ' ' ASP . 63.0 mttp -125.37 156.76 38.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.48 0.657 . . . . 2.9700000000000002 111.183 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.3 155.88 17.64 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.597 -1.183 . . . . 2.5699999999999998 111.548 -162.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.595 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 19.1 mt-10 -69.17 89.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.113 -0.949 . . . . 3.1400000000000001 110.783 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.3 9.25 37.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.494 -1.23 . . . . 3.9700000000000002 110.497 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.27 -63.92 3.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.92 -0.657 . . . . 1.74 112.157 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.7 -31.85 73.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.503 0.192 . . . . 3.25 111.505 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -118.84 -39.68 2.94 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.388 0.614 . . . . 3.79 109.464 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 75.85 -140.05 25.3 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.726 -1.125 . . . . 1.02 112.858 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.45 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -81.72 91.71 6.5 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.944 0.402 . . . . 1.0800000000000001 110.821 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.15 123.66 27.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.208 -0.451 . . . . 1.1000000000000001 111.295 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.733 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 65.4 mt -91.91 161.06 14.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.08 -0.509 . . . . 1.1499999999999999 110.014 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.431 HG23 HD12 ' A' ' 120' ' ' ILE . 15.3 t -141.31 156.3 45.87 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.888 -0.782 . . . . 1.25 108.888 171.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -137.33 41.86 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.451 0.643 . . . . 1.52 112.507 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -96.53 33.17 1.86 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.148 -1.056 . . . . 4.9900000000000002 108.148 167.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.543 ' O ' HD11 ' A' ' 122' ' ' LEU . 0.8 OUTLIER -119.77 93.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.684 -1.143 . . . . 1.4299999999999999 111.06 -171.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 m 69.84 -30.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.602 1.334 . . . . 1.53 114.602 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.781 HD13 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -83.25 173.47 11.59 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.687 -0.633 . . . . 2.1099999999999999 111.264 -176.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.886 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 CA--C 1.514 -0.413 0 O-C-N 124.966 1.416 . . . . 1.3700000000000001 109.979 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.585 -0.895 . . . . 1.3200000000000001 108.585 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 39.7 m-80 -62.35 102.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.847 0.356 . . . . 3.1400000000000001 111.395 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.809 HD13 HG21 ' A' ' 101' ' ' ILE . 9.6 tp -82.71 134.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.958 -0.564 . . . . 1.47 110.365 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -132.02 145.58 51.54 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.226 0.536 . . . . 1.6299999999999999 110.72 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -109.65 107.27 17.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.184 -0.916 . . . . 1.96 108.81 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.34 166.25 27.69 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.153 -1.022 . . . . 0.31 111.855 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 30.9 mtmt -106.09 159.39 16.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.3 0.571 . . . . 2.0499999999999998 111.262 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.922 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -70.58 141.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.876 -1.056 . . . . 1.1100000000000001 110.436 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.604 HG21 ' CB ' ' A' ' 59' ' ' ASP . 65.3 p -131.22 -0.21 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.203 -0.453 . . . . 1.1499999999999999 111.501 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 31.3 ttt-85 -164.52 125.02 2.06 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.314 -0.403 . . . . 2.2999999999999998 110.409 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.922 HD11 HG21 ' A' ' 46' ' ' ILE . 88.5 mt -141.45 119.28 8.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.622 -0.51 . . . . 1.0800000000000001 109.622 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 3.5 mt-10 -117.86 130.1 24.93 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.205 -0.452 . . . . 2.2400000000000002 110.847 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.942 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 16.0 Cg_exo -68.95 -14.94 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.755 2.303 . . . . 0.63 111.324 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -73.09 -36.32 66.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 1.8400000000000001 110.817 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.24 5.8 11.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 1.22 112.157 -172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.43 57.35 2.54 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.953 0.783 . . . . 2.5099999999999998 111.537 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.493 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.16 166.63 16.87 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.303 -0.862 . . . . 1.05 110.568 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -136.34 148.08 47.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.642 0.608 . . . . 1.03 112.642 -172.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.609 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 45.1 m-85 -101.13 132.3 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.526 -0.761 . . . . 0.66000000000000003 110.09 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 116' ' ' LEU . 25.0 t -108.9 136.62 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.066 0.46 . . . . 1.0800000000000001 110.218 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.604 ' CB ' HG21 ' A' ' 47' ' ' THR . 27.4 t70 -108.88 107.72 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.812 -0.631 . . . . 0.79000000000000004 111.396 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -127.24 65.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.939 -0.763 . . . . 1.28 108.939 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.32 18.28 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.708 -0.758 . . . . 0.82999999999999996 112.054 -171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.9 141.81 37.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.408 0.283 . . . . 1.1499999999999999 110.873 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.79 -21.21 17.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 2.4300000000000002 110.994 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.595 ' HA ' ' NE ' ' A' ' 64' ' ' ARG . 2.6 mmp_? -106.38 -13.14 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 5.2199999999999998 110.802 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.609 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.5 OUTLIER 70.51 116.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.435 -0.802 . . . . 1.0600000000000001 111.755 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.88 118.19 12.66 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.518 -0.764 . . . . 0.52000000000000002 111.877 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.493 ' CZ ' ' HB1' ' A' ' 55' ' ' ALA . 15.8 t80 -105.16 112.25 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.169 0.509 . . . . 0.51000000000000001 110.806 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.962 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -101.31 117.69 61.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.517 -0.765 . . . . 1.04 111.137 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.1 Cg_exo -63.84 145.03 90.08 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.882 2.388 . . . . 0.28000000000000003 111.637 170.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.2 tp -65.87 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 1.04 111.649 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.51 -22.87 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.045 0.45 . . . . 2.6200000000000001 110.835 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 29.5 mm-40 -79.22 -29.78 42.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.914 -0.585 . . . . 0.85999999999999999 110.387 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.73 HG21 HG13 ' A' ' 93' ' ' VAL . 5.5 mt -48.03 125.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 113.386 0.884 . . . . 1.3999999999999999 113.386 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . . . -87.53 155.35 20.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.298 -1.319 . . . . 1.1599999999999999 110.369 176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.636 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 24.7 ttm180 -61.99 -13.72 28.36 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.003 -0.998 . . . . 3.4399999999999999 112.407 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.994 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 6.8 tp10 -60.79 -23.37 64.97 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.624 -0.673 . . . . 1.76 110.477 175.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.408 ' CD2' HG23 ' A' ' 73' ' ' ILE . 10.2 m-30 -84.88 -46.16 11.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.553 -0.749 . . . . 1.51 109.617 -175.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 3.5 p90 -103.64 94.71 6.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 107.895 -1.15 . . . . 0.57999999999999996 107.895 170.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -26.93 137.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 1 C-N-CA 125.67 4.246 . . . . 0.98999999999999999 115.468 -166.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . . . -50.36 -18.32 0.61 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.044 1.128 . . . . 1.5 114.044 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -95.9 -7.23 37.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.785 0.326 . . . . 2.6200000000000001 111.406 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -71.34 141.36 50.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.481 -0.563 . . . . 1.6499999999999999 109.481 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.84 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 2.4399999999999999 111.072 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.08 99.76 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 1.74 110.949 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -118.67 91.65 3.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.329 -0.396 . . . . 4.8300000000000001 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.79 -101.08 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.754 -0.736 . . . . 1.3600000000000001 112.794 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -132.23 131.96 22.7 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 5.0099999999999998 110.742 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -60.54 145.59 98.49 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.42 2.08 . . . . 0.35999999999999999 112.296 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.651 ' ND2' ' HB2' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -108.57 115.41 30.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 2.3300000000000001 109.925 173.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.683 ' HB ' HD13 ' A' ' 70' ' ' LEU . 15.9 tt -59.33 -35.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.882 0.697 . . . . 1.1100000000000001 112.882 -164.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.942 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 21.3 pttp -61.86 -21.84 65.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.095 0.406 . . . . 4.46 112.095 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.651 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 12.3 m-20 -117.04 18.07 14.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 1.9099999999999999 110.177 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.73 HG13 HG21 ' A' ' 73' ' ' ILE . 45.0 t -123.51 -47.27 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.332 0.587 . . . . 1.1499999999999999 110.364 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.503 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 95.8 mt -108.34 163.41 13.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.953 -0.567 . . . . 1.0 109.953 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 147.67 27.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.935 -0.765 . . . . 3.1000000000000001 108.935 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.629 ' HA ' HG22 ' A' ' 46' ' ' ILE . 49.1 mt-10 -59.85 113.27 2.19 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.465 0.478 . . . . 1.25 109.901 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.38 -0.16 26.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.632 -0.713 . . . . 0.40999999999999998 112.35 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 94' ' ' LEU . 6.8 tt0 -96.83 133.29 41.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.842 -0.429 . . . . 1.1799999999999999 109.842 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.56 156.99 28.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.134 0.492 . . . . 0.81000000000000005 111.439 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 102' ' ' VAL . 27.8 m -140.19 152.21 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.201 -0.908 . . . . 1.02 109.85 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.809 HG21 HD13 ' A' ' 41' ' ' ILE . 7.2 mm -96.99 110.06 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.544 -1.28 . . . . 1.28 107.544 169.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.518 ' HA ' ' CD1' ' A' ' 120' ' ' ILE . 2.4 m -140.98 123.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.537 . . . . 1.0600000000000001 111.954 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.707 HE21 HG12 ' A' ' 120' ' ' ILE . 10.3 pt20 -97.48 135.14 39.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.041 -1.096 . . . . 2.0800000000000001 108.041 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.486 ' CD1' HD21 ' A' ' 116' ' ' LEU . 20.4 mm -73.18 103.37 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 1.3400000000000001 110.772 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.64 -43.46 76.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.3 109.668 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.495 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . 37.4 mttp -119.59 121.95 40.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.187 -0.915 . . . . 2.9700000000000002 108.629 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 52.3 mt-10 -82.93 159.33 22.31 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.267 -0.424 . . . . 2.5699999999999998 110.13 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.564 ' HG2' ' HB2' ' A' ' 114' ' ' ALA . 31.1 mt-10 -62.68 91.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.468 0.651 . . . . 3.1400000000000001 109.601 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 3.6 ptp180 -129.83 41.12 3.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.85 -1.068 . . . . 3.9700000000000002 109.751 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.23 -82.04 1.58 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.234 -0.894 . . . . 1.74 113.84 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.1 -26.37 67.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.692 0.997 . . . . 3.25 113.692 -168.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HG2' ' HD3' ' A' ' 106' ' ' LYS . 9.9 mptt -116.5 -37.18 3.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.172 0.51 . . . . 3.79 110.028 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 74.89 -146.92 35.82 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.077 -0.965 . . . . 1.02 110.814 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.564 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . . . -88.82 104.62 17.09 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.934 0.397 . . . . 1.0800000000000001 110.558 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 106' ' ' LYS . . . -107.14 123.24 47.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.349 -0.387 . . . . 1.1000000000000001 111.09 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.962 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 17.4 mt -90.37 154.74 19.45 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.999 -0.741 . . . . 1.1499999999999999 108.999 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 103' ' ' GLN . 6.6 t -125.78 173.11 9.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.454 -0.339 . . . . 1.25 110.131 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.1 p -129.34 17.95 5.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 1.52 110.84 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -77.96 46.34 0.58 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.121 0.962 . . . . 4.9900000000000002 108.708 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.707 HG12 HE21 ' A' ' 103' ' ' GLN . 4.3 mt -129.56 173.34 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.492 -1.231 . . . . 1.4299999999999999 109.52 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 120' ' ' ILE . 13.0 m -74.81 67.73 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 1.53 110.902 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.557 HD11 ' O ' ' A' ' 101' ' ' ILE . 11.4 mt -116.15 172.15 7.35 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.453 -0.573 . . . . 2.1099999999999999 109.453 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.994 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.426 0 O-C-N 123.921 0.763 . . . . 1.3700000000000001 111.002 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.44 -0.578 . . . . 1.3200000000000001 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -49.02 118.75 2.79 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.557 0.536 . . . . 3.1400000000000001 110.202 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.695 HG12 HG23 ' A' ' 101' ' ' ILE . 5.0 tp -83.7 138.66 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.585 -0.524 . . . . 1.47 109.585 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -115.1 118.87 34.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.517 0.675 . . . . 1.6299999999999999 110.7 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.405 ' HD3' HD12 ' A' ' 101' ' ' ILE . 8.5 mmmm -89.64 102.67 15.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.858 -1.065 . . . . 1.96 109.671 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.25 163.78 26.32 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 110.555 -1.018 . . . . 0.31 110.555 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.14 161.97 18.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 2.0499999999999998 111.347 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.82 HG23 HD13 ' A' ' 49' ' ' ILE . 1.7 mp -65.05 146.09 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.299 -1.319 . . . . 1.1100000000000001 111.254 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.673 HG21 ' HB2' ' A' ' 59' ' ' ASP . 76.2 p -128.94 -32.05 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.009 0.433 . . . . 1.1499999999999999 111.854 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.656 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 13.9 ttm180 -140.27 126.12 19.45 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.351 -0.386 . . . . 2.2999999999999998 110.668 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.82 HD13 HG23 ' A' ' 46' ' ' ILE . 91.2 mt -133.8 120.36 36.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.652 -0.704 . . . . 1.0800000000000001 109.585 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.65 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 15.7 tp10 -111.94 111.21 53.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.896 -0.593 . . . . 2.2400000000000002 109.708 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.824 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 51.9 Cg_exo -54.0 -25.82 38.1 Favored 'Trans proline' 0 CA--C 1.521 -0.172 0 C-N-CA 123.361 2.707 . . . . 0.63 112.068 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.7 m -73.82 -22.48 59.78 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.503 -0.771 . . . . 1.8400000000000001 111.824 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.5 pp -123.78 7.48 8.76 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.598 0.962 . . . . 1.22 113.598 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 4.6 pt-20 48.56 49.76 17.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.408 1.083 . . . . 2.5099999999999998 112.824 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.98 162.67 31.95 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.081 -0.648 . . . . 1.05 112.208 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -131.22 138.06 49.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.669 -0.696 . . . . 1.03 112.167 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.656 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 65.7 m-85 -89.44 136.17 33.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.66000000000000003 109.818 171.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.521 ' HB ' HD12 ' A' ' 116' ' ' LEU . 2.2 t -112.74 139.49 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 1.0800000000000001 110.997 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.673 ' HB2' HG21 ' A' ' 47' ' ' THR . 17.9 t70 -103.14 102.3 12.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.79000000000000004 110.65 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -128.11 67.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.509 -0.552 . . . . 1.28 109.509 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 46.09 42.16 11.9 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.089 -0.577 . . . . 0.82999999999999996 111.899 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.72 160.01 14.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.171 0.51 . . . . 1.1499999999999999 111.092 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -87.83 -45.38 10.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.626 0.726 . . . . 2.4300000000000002 109.173 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 48.7 mtt180 -125.71 94.15 4.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.85 -1.068 . . . . 5.2199999999999998 108.403 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 15.4 m170 -35.9 131.22 0.56 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.147 1.165 . . . . 1.0600000000000001 114.147 -170.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.8 118.65 14.74 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.871 -1.059 . . . . 0.52000000000000002 111.498 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.639 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.2 t80 -104.79 97.73 7.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.138 0.494 . . . . 0.51000000000000001 111.282 -171.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 1.017 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -85.38 121.2 73.73 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.774 . . . . 1.04 111.365 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 19.6 Cg_exo -69.56 142.78 49.78 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.087 2.525 . . . . 0.28000000000000003 112.104 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.695 HD13 ' HB ' ' A' ' 90' ' ' ILE . 12.6 tp -60.8 -39.07 87.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.491 -0.777 . . . . 1.04 112.263 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -64.13 -13.34 47.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.644 0.259 . . . . 2.6200000000000001 111.651 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 7.2 mm-40 -96.09 -13.07 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.756 0.312 . . . . 0.85999999999999999 110.413 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.446 HG22 ' HE1' ' A' ' 78' ' ' PHE . 8.0 mt -57.86 138.48 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.636 0.731 . . . . 1.3999999999999999 112.823 -171.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . . . -102.25 153.53 19.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.836 -1.075 . . . . 1.1599999999999999 110.518 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.64 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 41.1 ttm180 -55.27 -14.68 1.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.522 -0.763 . . . . 3.4399999999999999 112.662 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . 0.947 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 24.3 tp10 -61.96 -19.71 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.487 -0.758 . . . . 1.76 110.759 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 73' ' ' ILE . 7.9 m-30 -92.65 -44.61 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.797 -0.638 . . . . 1.51 109.759 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.446 ' HE1' HG22 ' A' ' 73' ' ' ILE . 5.7 p90 -98.68 95.94 3.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.277 -1.379 . . . . 0.57999999999999996 107.277 168.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.3 Cg_endo -38.51 139.98 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.577 3.518 . . . . 0.98999999999999999 113.797 -162.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -55.55 -11.93 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 1.5 113.288 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -82.28 -21.11 36.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.235 0.54 . . . . 2.6200000000000001 109.97 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -78.2 146.14 35.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 1.6499999999999999 110.626 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -81.98 106.49 13.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.741 -0.663 . . . . 2.4399999999999999 111.566 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . 0.446 ' HB1' ' HE2' ' A' ' 78' ' ' PHE . . . -91.81 136.48 33.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 1.74 109.848 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -96.42 -40.61 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.136 0.493 . . . . 4.8300000000000001 110.225 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.11 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.504 -0.771 . . . . 1.3600000000000001 111.265 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -97.04 128.39 35.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.033 0.444 . . . . 5.0099999999999998 110.804 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.86 165.49 13.99 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.272 2.648 . . . . 0.35999999999999999 112.981 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -120.6 98.31 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.866 -0.606 . . . . 2.3300000000000001 109.951 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.695 ' HB ' HD13 ' A' ' 70' ' ' LEU . 21.2 tt -54.02 -39.7 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.497 0.925 . . . . 1.1100000000000001 113.497 -165.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.824 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 36.8 pttt -55.7 -21.78 20.13 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.009 0.744 . . . . 4.46 113.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -125.96 18.69 7.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.932 0.872 . . . . 1.9099999999999999 110.44 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 36.7 t -111.32 -50.03 6.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.693 0.759 . . . . 1.1499999999999999 109.278 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . 0.577 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.5 mt -103.04 150.86 23.16 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.206 -0.906 . . . . 1.0 110.231 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 147.93 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.171 -0.922 . . . . 3.1000000000000001 109.098 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 1.5 mp0 -58.29 122.5 13.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.864 0.364 . . . . 1.25 110.161 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.49 -18.15 23.03 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.786 -0.721 . . . . 0.40999999999999998 111.701 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 94' ' ' LEU . 6.6 tt0 -83.11 121.01 26.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.748 -0.464 . . . . 1.1799999999999999 109.748 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.65 155.2 36.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.81000000000000005 111.487 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.475 HG21 HG23 ' A' ' 102' ' ' VAL . 35.3 m -131.91 149.95 33.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.884 -1.053 . . . . 1.02 109.177 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.695 HG23 HG12 ' A' ' 41' ' ' ILE . 1.4 mm -98.95 107.48 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.072 -1.455 . . . . 1.28 107.072 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 117' ' ' THR . 4.4 m -145.54 135.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 1.0600000000000001 112.584 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . 0.53 ' O ' ' HB ' ' A' ' 117' ' ' THR . 18.4 pt20 -98.73 135.84 39.63 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.596 -0.891 . . . . 2.0800000000000001 108.596 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 106' ' ' LYS . 40.4 mm -80.95 99.57 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.256 0.55 . . . . 1.3400000000000001 109.71 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.32 -27.51 67.21 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 1.3 110.566 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 104' ' ' ILE . 55.0 mttp -113.63 -170.97 1.8 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 2.9700000000000002 111.411 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 50.4 mm-40 -129.6 145.79 51.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.294 -0.412 . . . . 2.5699999999999998 110.332 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.614 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 43.2 mt-10 -64.15 101.86 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.401 0.62 . . . . 3.1400000000000001 109.668 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 10.9 ptm180 -116.43 -61.63 1.7 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.237 -0.892 . . . . 3.9700000000000002 111.549 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -175.15 -63.9 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.466 -0.873 . . . . 1.74 112.519 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.88 -46.92 85.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.089 0.403 . . . . 3.25 112.089 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 115' ' ' ALA . 21.4 ttmm -116.19 -37.18 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.363 -0.535 . . . . 3.79 110.436 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 80.6 -122.47 5.73 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.652 -0.979 . . . . 1.02 110.652 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.29 127.5 33.7 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.99 -0.374 . . . . 1.0800000000000001 109.99 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.559 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . . . -118.4 126.99 53.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.729 0.3 . . . . 1.1000000000000001 110.88 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 1.017 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 14.6 mt -91.08 129.06 37.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.065 -0.516 . . . . 1.1499999999999999 110.177 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.592 ' O ' HG11 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -90.26 146.82 23.94 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.619 -0.719 . . . . 1.25 109.642 174.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.593 HG23 HD21 ' A' ' 68' ' ' LEU . 3.5 p -113.96 4.02 15.6 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.34 0.496 . . . . 1.52 112.34 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -78.34 57.36 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.695 0.76 . . . . 4.9900000000000002 110.451 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 121' ' ' SER . 2.9 mp -127.99 176.08 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.645 -1.242 . . . . 1.4299999999999999 107.645 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.0 t -69.4 69.62 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.296 0.569 . . . . 1.53 110.458 176.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 101' ' ' ILE . 12.0 mt -115.13 172.22 7.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.676 -0.861 . . . . 2.1099999999999999 108.676 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.947 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.447 0 O-C-N 123.683 0.615 . . . . 1.3700000000000001 110.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 107.657 -1.238 . . . . 1.3200000000000001 107.657 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -47.62 116.97 1.63 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.853 0.721 . . . . 3.1400000000000001 111.218 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.459 HD12 HG23 ' A' ' 101' ' ' ILE . 6.6 tp -84.65 139.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.107 -0.951 . . . . 1.47 110.128 -174.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -122.68 149.71 43.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.792 0.329 . . . . 1.6299999999999999 110.275 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.502 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 34.5 ttmt -115.78 94.08 4.53 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.984 -0.747 . . . . 1.96 108.984 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.17 166.69 13.15 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.271 -0.877 . . . . 0.31 111.073 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 1.6 mppt? -104.83 158.2 16.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.065 0.459 . . . . 2.0499999999999998 111.087 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -73.52 137.19 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.075 -0.966 . . . . 1.1100000000000001 109.628 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.533 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.7 p -124.33 -11.28 7.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.799 0.333 . . . . 1.1499999999999999 111.471 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ARG . . . . . 0.62 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 24.6 ttt85 -160.26 122.18 3.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.212 -0.449 . . . . 2.2999999999999998 110.462 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.949 HD11 HG21 ' A' ' 46' ' ' ILE . 47.5 mt -134.89 113.46 16.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.624 -0.509 . . . . 1.0800000000000001 109.624 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 31.6 mt-10 -118.01 122.54 30.37 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 121.505 0.669 . . . . 2.2400000000000002 111.475 -176.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' PRO . . . . . 0.854 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 31.9 Cg_exo -60.65 -27.41 84.79 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.112 2.541 . . . . 0.63 111.827 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.5 m -75.11 -21.43 58.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 1.8400000000000001 111.685 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.425 ' CG ' ' HB2' ' A' ' 50' ' ' GLU . 2.0 pp -118.38 8.85 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.964 -0.694 . . . . 1.22 112.792 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 43.52 48.36 6.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.493 0.717 . . . . 2.5099999999999998 111.917 169.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.27 171.15 12.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.474 -0.784 . . . . 1.05 110.974 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB1' HD11 ' A' ' 90' ' ' ILE . . . -135.56 139.48 43.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 1.03 111.539 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.62 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.9 m-85 -91.64 136.0 33.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.66000000000000003 109.633 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' VAL . . . . . 0.603 ' HB ' HD11 ' A' ' 116' ' ' LEU . 12.6 t -118.9 134.44 62.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.158 -0.682 . . . . 1.0800000000000001 109.158 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ASP . . . . . 0.533 ' CB ' HG21 ' A' ' 47' ' ' THR . 36.7 t70 -109.48 111.28 22.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.187 -0.46 . . . . 0.79000000000000004 112.027 -173.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -126.81 66.75 1.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.219 -1.03 . . . . 1.28 108.219 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.33 33.46 46.41 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.81 -0.71 . . . . 0.82999999999999996 112.46 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' A' ' 65' ' ' HIS . . . -93.79 147.72 22.79 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.645 -0.326 . . . . 1.1499999999999999 110.777 -175.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.93 -51.29 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 2.4300000000000002 111.272 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 8.8 mmt180 -94.36 -11.11 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.478 -0.489 . . . . 5.2199999999999998 109.796 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' HIS . . . . . 0.536 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 10.3 m170 76.49 145.07 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.423 1.077 . . . . 1.0600000000000001 110.854 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 102.14 1.08 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.666 -0.974 . . . . 0.52000000000000002 110.666 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PHE . . . . . 0.564 ' CZ ' ' HB1' ' A' ' 55' ' ' ALA . 2.9 t80 -88.98 104.25 16.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.842 0.353 . . . . 0.51000000000000001 110.541 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 1.113 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.72 113.35 60.15 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 1.04 110.307 178.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 68' ' ' LEU . 24.5 Cg_exo -65.27 141.72 69.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.787 2.325 . . . . 0.28000000000000003 111.607 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' A' ' 90' ' ' ILE . 17.8 tp -57.91 -33.46 68.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 1.04 111.819 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.59 -10.92 20.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 2.6200000000000001 111.482 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -97.44 -23.92 15.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.12 -0.491 . . . . 0.85999999999999999 110.856 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.703 HG23 HG12 ' A' ' 93' ' ' VAL . 6.1 mt -48.38 131.04 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 113.466 0.913 . . . . 1.3999999999999999 113.466 -166.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -100.22 156.67 17.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.64 -1.164 . . . . 1.1599999999999999 110.763 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.852 ' HG2' ' HA ' ' A' ' 80' ' ' ALA . 32.0 ttp180 -65.16 -12.7 53.9 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.55 0.944 . . . . 3.4399999999999999 113.55 -172.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.67 -25.76 68.36 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.795 -1.191 . . . . 1.76 110.208 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -75.84 -51.74 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.901 -0.59 . . . . 1.51 110.291 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.53 ' HB3' HG11 ' A' ' 93' ' ' VAL . 1.1 p90 -100.37 109.46 57.0 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.584 -1.265 . . . . 0.57999999999999996 107.584 169.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.43 133.6 0.33 Allowed 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 124.616 3.544 . . . . 0.98999999999999999 113.646 -162.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ALA . . . . . 0.852 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -57.03 -16.44 7.15 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.563 -1.199 . . . . 1.5 113.361 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -90.99 -0.89 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 2.6200000000000001 111.251 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -81.77 143.81 31.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 1.6499999999999999 109.976 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -71.09 100.9 2.12 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.397 -0.365 . . . . 2.4399999999999999 110.287 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.95 95.34 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.74 110.374 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -76.9 61.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.715 -0.675 . . . . 4.8300000000000001 110.928 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.47 -128.44 8.99 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.859 -0.686 . . . . 1.3600000000000001 111.631 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.85 135.41 45.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.809 0.338 . . . . 5.0099999999999998 110.32 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PRO . . . . . 0.445 ' O ' HD11 ' A' ' 70' ' ' LEU . 9.2 Cg_endo -58.41 154.7 39.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.916 2.411 . . . . 0.35999999999999999 113.161 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . 0.661 ' ND2' ' HB3' ' A' ' 92' ' ' ASP . 0.3 OUTLIER -119.41 111.42 18.13 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.248 -0.887 . . . . 2.3300000000000001 109.617 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ILE . . . . . 0.617 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.2 tt -62.13 -38.87 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.724 0.638 . . . . 1.1100000000000001 112.724 -163.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LYS . . . . . 0.854 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 7.8 ptmm? -60.07 -21.37 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.212 -0.449 . . . . 4.46 111.853 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASP . . . . . 0.661 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 34.6 t70 -119.62 12.01 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.817 0.818 . . . . 1.9099999999999999 110.343 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 73' ' ' ILE . 13.7 t -119.96 -50.57 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 1.1499999999999999 110.314 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -100.41 152.13 20.72 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.25 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 151.8 44.21 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.361 -0.836 . . . . 3.1000000000000001 110.319 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLU . . . . . 0.638 ' HA ' HG22 ' A' ' 46' ' ' ILE . 18.1 mt-10 -65.13 126.07 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.029 -0.987 . . . . 1.25 110.456 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.05 54.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.773 -0.727 . . . . 0.40999999999999998 112.055 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.9 tt0 -87.95 135.96 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.951 -0.389 . . . . 1.1799999999999999 109.951 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.92 157.22 20.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.81000000000000005 111.37 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 35.5 m -136.75 151.79 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.189 -0.914 . . . . 1.02 109.879 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.975 ' HB ' HD13 ' A' ' 122' ' ' LEU . 10.0 mm -97.03 110.45 25.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.004 -1.11 . . . . 1.28 108.004 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 100' ' ' VAL . 4.3 m -146.76 139.05 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.233 0.539 . . . . 1.0600000000000001 111.974 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -112.84 142.73 45.16 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.433 -0.951 . . . . 2.0800000000000001 108.433 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 116' ' ' LEU . 22.4 mm -71.89 102.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.76 0.79 . . . . 1.3400000000000001 110.771 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 35.0 t70 -83.76 -35.28 24.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.714 -1.13 . . . . 1.3 109.777 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LYS . . . . . 0.41 ' CB ' ' HB1' ' A' ' 115' ' ' ALA . 12.7 ttpp -112.03 137.99 49.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.605 -0.725 . . . . 2.9700000000000002 109.775 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' GLU . . . . . 0.411 ' HB3' HH21 ' A' ' 109' ' ' ARG . 1.8 tm-20 -87.2 133.79 33.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.26 -0.882 . . . . 2.5699999999999998 110.914 -163.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' A' ' 64' ' ' ARG . 42.6 tt0 -66.31 119.73 12.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 3.1400000000000001 110.208 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.557 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 6.6 ptp180 -139.72 -68.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.415 -0.811 . . . . 3.9700000000000002 111.115 -171.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -168.71 -66.99 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.553 -1.308 . . . . 1.74 113.722 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ASN . . . . . 0.462 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 25.6 t-20 -61.88 -50.91 70.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.958 0.379 . . . . 3.25 111.55 -172.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 98.6 mttt -122.92 -37.49 2.73 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.68 -0.408 . . . . 3.79 110.682 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLY . . . . . 0.557 ' HA2' ' HG2' ' A' ' 109' ' ' ARG . . . 63.79 -124.47 30.89 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.67 -0.695 . . . . 1.02 113.937 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.56 110.66 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.249 0.617 . . . . 1.0800000000000001 111.696 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' A' ' 106' ' ' LYS . . . -122.25 135.83 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.07 -0.514 . . . . 1.1000000000000001 110.566 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 1.113 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 43.2 mt -91.41 153.01 20.16 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.775 -0.648 . . . . 1.1499999999999999 109.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 8.2 t -116.69 171.47 7.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.241 -0.436 . . . . 1.25 110.292 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' THR . . . . . 0.48 ' C ' ' H ' ' A' ' 120' ' ' ILE . 26.1 p -138.27 20.93 2.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.78 0.659 . . . . 1.52 112.78 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' PHE . . . . . 0.414 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 3.2 p90 -78.45 42.42 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.499 1.142 . . . . 4.9900000000000002 109.385 170.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 118' ' ' THR . 4.4 mt -118.36 172.35 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 113.884 -1.507 . . . . 1.4299999999999999 108.015 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' SER . . . . . 0.461 ' H ' HG23 ' A' ' 120' ' ' ILE . 7.5 t -80.04 48.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.858 0.361 . . . . 1.53 111.93 -172.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LEU . . . . . 0.975 HD13 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -117.38 126.33 52.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.738 -0.21 . . . . 2.1099999999999999 111.257 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . . . . . . 0 N--CA 1.469 0.508 0 O-C-N 124.722 1.264 . . . . 1.3700000000000001 109.779 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.793 -0.523 . . . . 10.35 111.793 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.0 m -80.29 68.89 6.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.491 . . . . 7.9199999999999999 110.938 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -154.54 68.35 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 9.5399999999999991 109.929 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 52.6 ttm -104.37 91.88 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.922 -0.581 . . . . 7.4100000000000001 110.051 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt 61.81 -105.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.676 -0.693 . . . . 4.9100000000000001 110.959 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -173.16 -174.4 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.835 -0.802 . . . . 4.0700000000000003 108.835 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -115.74 82.36 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.671 -0.412 . . . . 4.9000000000000004 110.859 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm 58.96 20.78 8.51 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.651 0.594 . . . . 5.2999999999999998 112.385 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.493 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 41.3 pttt -131.66 -168.81 2.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 2.54 111.22 -175.866 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.493 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -63.37 159.8 17.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.56 -0.904 . . . . 1.3200000000000001 108.56 169.174 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.61 114.45 3.28 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.255 -0.578 . . . . 3.1400000000000001 110.82 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.603 HD11 ' HB3' ' A' ' 103' ' ' GLN . 8.7 tp -81.27 146.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.385 -0.825 . . . . 1.47 109.421 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.55 152.76 41.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.7 0.286 . . . . 1.6299999999999999 110.296 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.4 tttm -134.11 96.58 3.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.206 0.527 . . . . 1.96 109.716 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.46 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -140.46 175.67 21.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.952 -0.859 . . . . 0.31 110.952 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.507 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.34 159.47 15.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.648 0.737 . . . . 2.0499999999999998 112.054 -175.362 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 1.001 HG21 HD13 ' A' ' 49' ' ' ILE . 1.6 mp -67.64 138.47 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.363 -1.29 . . . . 1.1100000000000001 109.386 171.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.635 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.2 p -130.69 -7.17 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.763 0.316 . . . . 1.1499999999999999 111.725 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.59 ' HD3' ' HD2' ' A' ' 57' ' ' PHE . 29.9 ttt85 -158.43 123.02 4.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.326 -0.397 . . . . 2.2999999999999998 110.282 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 1.001 HD13 HG21 ' A' ' 46' ' ' ILE . 56.6 mt -136.76 109.04 7.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.096 0.474 . . . . 1.0800000000000001 109.877 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.32 113.2 65.38 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 2.2400000000000002 110.796 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.84 -19.56 55.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.012 2.475 . . . . 0.63 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.4 m -73.1 -26.01 61.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.208 -0.905 . . . . 1.8400000000000001 111.321 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.5 HD12 ' HZ ' ' A' ' 67' ' ' PHE . 2.5 pp -119.71 -8.91 9.85 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.212 0.819 . . . . 1.22 113.212 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 59.43 57.18 3.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.784 0.433 . . . . 2.5099999999999998 111.451 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.629 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -168.09 162.58 13.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.322 -0.399 . . . . 1.05 110.53 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.515 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -129.22 142.0 50.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.035 -0.529 . . . . 1.03 111.956 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.59 ' HD2' ' HD3' ' A' ' 48' ' ' ARG . 40.1 m-85 -94.3 142.07 27.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.691 -0.686 . . . . 0.66000000000000003 109.551 170.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.404 ' HB ' HD13 ' A' ' 116' ' ' LEU . 56.1 t -120.37 133.38 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 1.0800000000000001 109.947 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.635 ' CB ' HG21 ' A' ' 47' ' ' THR . 35.4 t70 -103.69 99.67 9.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.899 -0.591 . . . . 0.79000000000000004 110.716 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.4 p90 -126.8 66.59 1.26 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.703 -0.68 . . . . 1.28 109.337 175.454 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.1 21.95 26.82 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.733 -0.746 . . . . 0.82999999999999996 112.436 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 118.42 33.86 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.817 -0.225 . . . . 1.1499999999999999 110.53 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.99 -3.67 30.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 2.4300000000000002 111.453 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.454 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -117.11 -13.25 10.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.777 -0.647 . . . . 5.2199999999999998 110.189 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 63.84 141.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.039 -0.982 . . . . 1.0600000000000001 111.879 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.528 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -83.12 126.43 7.48 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.602 -0.808 . . . . 0.52000000000000002 111.193 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.629 ' CZ ' ' HB2' ' A' ' 55' ' ' ALA . 29.0 t80 -107.18 111.47 23.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.381 0.61 . . . . 0.51000000000000001 110.933 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -106.8 111.56 63.78 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.128 -0.942 . . . . 1.04 110.838 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.471 ' HA ' ' HB1' ' A' ' 55' ' ' ALA . 16.4 Cg_exo -69.23 145.03 58.91 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.155 2.57 . . . . 0.28000000000000003 111.981 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.636 HD12 ' HB ' ' A' ' 90' ' ' ILE . 13.4 tp -57.06 -39.69 75.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.804 -1.089 . . . . 1.04 113.102 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.735 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 19.9 pttp -67.54 -9.73 45.2 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.571 -0.451 . . . . 2.6200000000000001 111.174 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -92.84 -21.98 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.999 -0.371 . . . . 0.85999999999999999 109.999 178.507 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.589 HG22 HG13 ' A' ' 93' ' ' VAL . 8.0 mt -48.76 134.75 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.838 1.051 . . . . 1.3999999999999999 113.838 -168.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.76 156.32 16.74 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.717 -1.128 . . . . 1.1599999999999999 110.898 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.777 ' HB3' ' HB2' ' A' ' 123' ' ' ALA . 12.6 tpt180 -56.84 -16.86 7.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.153 -0.93 . . . . 3.4399999999999999 112.127 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 1.003 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 1.8 tp10 -65.06 -24.57 67.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.86 -0.525 . . . . 1.76 111.001 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.537 ' HH ' HD12 ' A' ' 122' ' ' LEU . 10.1 m-30 -82.37 -50.73 8.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.459 0.647 . . . . 1.51 110.141 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.543 ' HB3' HG12 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -97.77 101.11 9.73 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.044 -1.465 . . . . 0.57999999999999996 107.044 169.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -39.13 141.76 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 124.85 3.7 . . . . 0.98999999999999999 114.062 -161.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.71 -13.86 0.46 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.779 -1.1 . . . . 1.5 112.921 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.27 -11.05 53.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.3 0.571 . . . . 2.6200000000000001 110.524 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.66 139.56 30.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.682 -0.69 . . . . 1.6499999999999999 109.616 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -65.62 125.56 25.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 2.4399999999999999 111.161 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.433 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -130.01 114.68 16.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.162 -0.472 . . . . 1.74 110.986 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -139.62 77.25 1.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.286 -0.415 . . . . 4.8300000000000001 110.536 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.0 -113.58 1.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.691 -0.766 . . . . 1.3600000000000001 112.498 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.858 ' HD3' ' HD2' ' A' ' 88' ' ' PRO . 13.5 tpp180 -121.63 121.61 28.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.63 0.252 . . . . 5.0099999999999998 110.417 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.858 ' HD2' ' HD3' ' A' ' 87' ' ' ARG . 9.9 Cg_endo -59.84 166.23 8.81 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.999 2.466 . . . . 0.35999999999999999 112.733 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 107.24 13.65 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.923 0.392 . . . . 2.3300000000000001 110.445 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.636 ' HB ' HD12 ' A' ' 70' ' ' LEU . 20.2 tt -56.84 -37.69 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.115 0.783 . . . . 1.1100000000000001 113.115 -165.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . . . . . . . . . 5.4 pttt -56.1 -24.74 42.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.879 0.696 . . . . 4.46 112.879 178.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -125.29 20.92 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.845 0.831 . . . . 1.9099999999999999 110.173 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.589 HG13 HG22 ' A' ' 73' ' ' ILE . 14.2 t -117.09 -48.67 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.605 -0.725 . . . . 1.1499999999999999 109.893 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 42.6 mt -103.15 151.35 22.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.731 -0.668 . . . . 1.0 109.833 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 138.84 24.63 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.603 -0.726 . . . . 3.1000000000000001 109.643 176.104 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.688 ' HA ' HG22 ' A' ' 46' ' ' ILE . 13.1 mt-10 -54.15 121.37 8.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.538 -0.755 . . . . 1.25 110.773 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.2 -8.02 28.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.40999999999999998 111.791 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.526 ' OE1' ' HA ' ' A' ' 77' ' ' TYR . 9.1 tt0 -90.49 129.02 36.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.876 -0.416 . . . . 1.1799999999999999 109.876 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.507 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 13.8 pt-20 -84.95 157.03 20.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.981 0.419 . . . . 0.81000000000000005 111.025 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.501 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 32.8 m -139.33 155.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.539 -0.755 . . . . 1.02 110.416 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.535 ' O ' HD13 ' A' ' 120' ' ' ILE . 4.0 mm -102.66 110.38 29.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.038 -1.097 . . . . 1.28 108.038 172.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.49 ' CG2' HD21 ' A' ' 116' ' ' LEU . 3.5 m -147.3 147.55 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.104 0.409 . . . . 1.0600000000000001 112.104 -170.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.603 ' HB3' HD11 ' A' ' 41' ' ' ILE . 13.4 pt20 -128.07 158.72 37.18 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 2.0800000000000001 108.72 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.473 HD11 HD22 ' A' ' 116' ' ' LEU . 25.5 mm -83.94 109.66 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.441 0.639 . . . . 1.3400000000000001 111.638 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.644 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 13.5 t70 -85.4 -40.84 16.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.687 -1.142 . . . . 1.3 109.47 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.604 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . 2.3 mptp? -111.52 126.09 54.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.552 -0.749 . . . . 2.9700000000000002 109.239 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -85.67 158.38 20.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.012 -0.54 . . . . 2.5699999999999998 110.889 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.527 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -66.97 131.07 45.11 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.657 0.742 . . . . 3.1400000000000001 110.14 177.281 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -144.1 12.13 1.59 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.627 -1.169 . . . . 3.9700000000000002 108.833 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.71 84.72 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.974 -1.012 . . . . 1.74 112.499 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -130.5 -31.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.76 0.652 . . . . 3.25 112.76 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -120.25 -38.8 2.86 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.102 -0.639 . . . . 3.79 110.008 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.527 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . 99.48 -159.14 19.85 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.122 -1.037 . . . . 1.02 111.674 169.418 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.528 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.94 90.14 7.35 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.713 -0.847 . . . . 1.0800000000000001 108.713 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.604 ' HB1' ' HB2' ' A' ' 106' ' ' LYS . . . -85.66 126.02 33.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 1.1000000000000001 111.695 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.861 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 50.6 mt -90.27 135.42 33.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 1.1499999999999999 110.428 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.644 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 13.1 t -95.31 172.43 8.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.925 -0.58 . . . . 1.25 109.801 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.565 HG23 HD22 ' A' ' 68' ' ' LEU . 4.9 p -126.76 18.61 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.433 0.635 . . . . 1.52 110.191 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -81.07 46.93 0.95 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.962 0.887 . . . . 4.9900000000000002 109.304 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.557 HG12 HD13 ' A' ' 41' ' ' ILE . 1.8 mp -127.44 170.03 17.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.808 -1.087 . . . . 1.4299999999999999 108.898 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.452 ' N ' HG21 ' A' ' 120' ' ' ILE . 16.2 m -72.41 72.4 0.96 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.378 0.609 . . . . 1.53 110.92 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.537 HD12 ' HH ' ' A' ' 77' ' ' TYR . 26.3 mt -116.17 171.77 7.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.886 -0.783 . . . . 2.1099999999999999 108.886 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 1.003 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 72.29 80.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.012 0.82 . . . . 1.3700000000000001 109.854 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.62 49.36 3.06 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.552 -0.749 . . . . 2.7999999999999998 113.039 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.719 -0.658 . . . . 5.4100000000000001 109.493 176.836 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 112.327 -0.309 . . . . 10.35 112.327 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.5 ' C ' ' H ' ' A' ' 33' ' ' MET . 37.2 p -127.26 4.42 6.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.933 0.346 . . . . 7.9199999999999999 111.933 -173.962 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.409 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 m-70 69.85 -17.7 0.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.518 . . . . 9.5399999999999991 111.608 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.5 ' H ' ' C ' ' A' ' 31' ' ' SER . 86.3 mtp -77.09 -25.29 52.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.298 0.57 . . . . 7.4100000000000001 110.128 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.8 -48.31 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.183 -0.917 . . . . 4.9100000000000001 110.344 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.493 ' CA ' ' HG2' ' A' ' 38' ' ' LYS . 51.4 mp0 -78.23 -43.21 28.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.095 -0.957 . . . . 4.0700000000000003 112.235 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 69.65 -58.0 0.53 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.766 0.666 . . . . 4.9000000000000004 110.298 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -142.89 -17.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.016 -0.538 . . . . 5.2999999999999998 110.802 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.493 ' HG2' ' CA ' ' A' ' 35' ' ' GLU . 10.8 ptmt -76.59 179.96 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.255 0.55 . . . . 2.54 111.728 -171.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.476 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.06 156.84 22.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.637 -0.875 . . . . 1.3200000000000001 108.637 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.483 ' C ' HD21 ' A' ' 40' ' ' ASN . 0.2 OUTLIER -50.66 109.52 0.32 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.577 0.548 . . . . 3.1400000000000001 110.19 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.22 143.8 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.775 . . . . 1.47 109.961 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.79 144.99 49.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.079 -0.341 . . . . 1.6299999999999999 110.079 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -117.65 105.72 12.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.631 -1.248 . . . . 1.96 107.631 173.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.89 179.48 21.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.69 -0.767 . . . . 0.31 111.561 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.508 ' HD3' ' HA2' ' A' ' 97' ' ' GLY . 94.3 mttt -109.45 162.73 14.08 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.557 0.694 . . . . 2.0499999999999998 111.917 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.845 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -72.44 136.75 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.563 -1.199 . . . . 1.1100000000000001 108.893 170.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.697 HG21 ' CB ' ' A' ' 59' ' ' ASP . 73.2 p -127.1 -17.64 4.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.05 0.452 . . . . 1.1499999999999999 111.782 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.512 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 39.7 ttt180 -154.66 121.72 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.192 -0.67 . . . . 2.2999999999999998 109.192 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.845 HD11 HG21 ' A' ' 46' ' ' ILE . 96.7 mt -125.47 102.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.245 -0.65 . . . . 1.0800000000000001 109.245 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -99.17 108.0 47.4 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.005 -0.998 . . . . 2.2400000000000002 109.933 -176.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.784 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 45.0 Cg_exo -57.12 -29.8 84.64 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.96 2.44 . . . . 0.63 112.093 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -59.9 -29.76 68.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.81 -0.632 . . . . 1.8400000000000001 111.247 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.636 HD11 ' HZ ' ' A' ' 67' ' ' PHE . 2.2 pp -122.56 11.28 9.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.937 0.347 . . . . 1.22 111.937 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.87 58.01 2.18 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.656 0.782 . . . . 2.5099999999999998 112.034 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.595 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.99 160.75 25.03 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.387 -0.824 . . . . 1.05 110.846 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.505 ' HB2' HD13 ' A' ' 90' ' ' ILE . . . -120.59 140.79 51.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 1.03 112.285 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.512 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.8 m-85 -95.17 130.79 41.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.109 -0.95 . . . . 0.66000000000000003 110.106 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.16 132.46 58.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.208 -0.451 . . . . 1.0800000000000001 109.789 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.697 ' CB ' HG21 ' A' ' 47' ' ' THR . 13.8 t70 -100.81 103.32 14.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.95 0.405 . . . . 0.79000000000000004 111.223 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.433 ' HH ' ' HB1' ' A' ' 114' ' ' ALA . 16.5 p90 -126.17 66.71 1.21 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.688 -0.856 . . . . 1.28 108.688 172.052 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.04 31.71 56.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.823 -0.703 . . . . 0.82999999999999996 112.427 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.74 137.89 50.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.588 0.232 . . . . 1.1499999999999999 110.625 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.23 -44.24 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 2.4300000000000002 111.312 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -78.09 -16.55 57.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.778 -0.369 . . . . 5.2199999999999998 110.242 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.485 ' HD1' ' HB3' ' A' ' 57' ' ' PHE . 8.8 m170 68.59 146.77 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.044 -0.98 . . . . 1.0600000000000001 111.501 -177.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.9 106.07 1.94 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.426 -1.07 . . . . 0.52000000000000002 110.426 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.636 ' HZ ' HD11 ' A' ' 53' ' ' LEU . 2.7 t80 -96.19 106.3 18.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.097 0.475 . . . . 0.51000000000000001 110.709 -172.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.786 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -97.49 118.5 64.26 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 1.04 109.826 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.654 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 6.7 Cg_exo -69.91 141.04 43.57 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.128 1.885 . . . . 0.28000000000000003 111.344 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.795 ' HA ' HG13 ' A' ' 73' ' ' ILE . 9.3 tp -57.39 -32.85 67.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 1.04 111.184 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.654 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.9 ptmm? -59.76 -20.89 59.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.678 -0.692 . . . . 2.6200000000000001 111.624 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.58 -11.91 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.85999999999999999 110.738 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.795 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.6 mt -49.88 127.37 5.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 113.588 0.958 . . . . 1.3999999999999999 113.588 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.645 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -80.28 149.84 30.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.222 -1.354 . . . . 1.1599999999999999 111.211 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.632 ' HB3' ' H ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -66.33 -14.71 62.47 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.901 -0.59 . . . . 3.4399999999999999 111.243 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.676 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 7.0 tp10 -69.97 -17.63 63.3 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.324 -0.86 . . . . 1.76 109.912 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -81.01 -52.97 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.912 -0.586 . . . . 1.51 109.733 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HB3' HG11 ' A' ' 93' ' ' VAL . 5.2 p90 -100.82 110.19 60.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.412 -1.329 . . . . 0.57999999999999996 107.412 169.478 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.411 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.7 Cg_endo -37.97 135.45 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.454 0 C-N-CA 124.351 3.368 . . . . 0.98999999999999999 113.766 -165.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.51 -7.19 0.37 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.712 -1.131 . . . . 1.5 113.127 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.64 -14.68 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.631 0.729 . . . . 2.6200000000000001 109.391 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.874 ' HH ' ' HE2' ' A' ' 85' ' ' HIS . 78.9 t80 -92.43 119.37 31.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.281 -0.872 . . . . 1.6499999999999999 109.294 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.3 t -63.08 125.91 25.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.924 0.393 . . . . 2.4399999999999999 110.805 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.01 75.93 4.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.36 0.6 . . . . 1.74 110.634 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . 0.874 ' HE2' ' HH ' ' A' ' 82' ' ' TYR . 3.0 p80 -78.29 111.59 14.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 4.8300000000000001 110.452 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.87 -101.16 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.708 -0.678 . . . . 1.3600000000000001 111.651 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -138.21 150.78 68.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 5.0099999999999998 109.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.488 ' C ' HD12 ' A' ' 70' ' ' LEU . 5.6 Cg_endo -59.77 162.62 15.25 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.29 1.993 . . . . 0.35999999999999999 112.983 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.684 HD21 ' HB2' ' A' ' 92' ' ' ASP . 0.8 OUTLIER -121.26 103.66 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 2.3300000000000001 109.685 176.004 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.731 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 16.3 tt -57.02 -43.32 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 114.201 1.186 . . . . 1.1100000000000001 114.201 -161.444 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.784 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 18.5 pttp -62.74 -15.05 51.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.157 0.428 . . . . 4.46 112.157 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.684 ' HB2' HD21 ' A' ' 89' ' ' ASN . 24.6 m-20 -122.89 19.13 10.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.498 0.666 . . . . 1.9099999999999999 109.784 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.643 HG12 HG22 ' A' ' 73' ' ' ILE . 8.8 t -120.3 -51.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.814 . . . . 1.1499999999999999 109.555 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 46' ' ' ILE . 96.6 mt -101.35 164.6 11.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.545 -0.752 . . . . 1.0 109.404 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 152.66 32.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.99 -0.55 . . . . 3.1000000000000001 109.637 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.614 ' HA ' HG22 ' A' ' 46' ' ' ILE . 25.5 mt-10 -63.46 118.09 7.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 1.25 110.262 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.508 ' HA2' ' HD3' ' A' ' 45' ' ' LYS . . . 112.96 -11.84 24.75 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.707 -0.759 . . . . 0.40999999999999998 112.145 -174.592 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 17.6 tt0 -86.68 137.88 32.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 1.1799999999999999 109.785 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -86.95 157.13 19.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.81000000000000005 112.067 -175.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.465 HG23 HG22 ' A' ' 102' ' ' VAL . 32.9 m -143.47 156.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 1.02 109.833 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.567 ' O ' HD12 ' A' ' 120' ' ' ILE . 5.7 mm -104.92 110.83 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.083 -1.08 . . . . 1.28 108.083 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.465 HG22 HG23 ' A' ' 100' ' ' VAL . 3.2 m -144.84 136.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.225 0.535 . . . . 1.0600000000000001 112.384 -169.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -114.56 149.21 36.86 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.862 -0.792 . . . . 2.0800000000000001 108.862 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.494 HD13 HD23 ' A' ' 116' ' ' LEU . 23.2 mm -74.69 101.97 2.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 1.3400000000000001 110.447 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.73 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 32.8 t70 -83.5 -36.04 24.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.641 -1.163 . . . . 1.3 109.666 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.707 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . 12.7 mptt -111.99 121.84 46.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.809 -1.182 . . . . 2.9700000000000002 107.809 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.98 147.58 46.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.763 0.653 . . . . 2.5699999999999998 112.763 -164.044 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -66.85 90.87 0.18 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.852 -1.067 . . . . 3.1400000000000001 110.002 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -115.47 -61.94 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.238 -0.892 . . . . 3.9700000000000002 110.422 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.68 -21.9 0.92 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.603 -1.18 . . . . 1.74 110.72 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -63.05 -50.85 68.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.99 0.424 . . . . 3.25 110.161 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -124.56 -37.53 2.49 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.43 0.633 . . . . 3.79 109.486 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.1 -153.19 17.7 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.874 -1.057 . . . . 1.02 110.588 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.433 ' HB1' ' HH ' ' A' ' 60' ' ' TYR . . . -79.03 91.28 4.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.559 -0.534 . . . . 1.0800000000000001 109.559 178.344 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.707 ' HB1' ' HB2' ' A' ' 106' ' ' LYS . . . -95.1 133.3 39.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.134 0.492 . . . . 1.1000000000000001 111.553 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.786 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 68.8 mt -90.23 157.09 17.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.853 -0.612 . . . . 1.1499999999999999 110.133 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.73 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 14.0 t -116.72 170.06 8.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.301 -0.629 . . . . 1.25 109.301 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.591 HG22 HD22 ' A' ' 68' ' ' LEU . 15.8 p -126.39 25.67 6.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.271 0.558 . . . . 1.52 110.404 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.4 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.282 1.039 . . . . 4.9900000000000002 108.905 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.567 HD12 ' O ' ' A' ' 101' ' ' ILE . 2.7 mp -128.15 163.48 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.472 -1.24 . . . . 1.4299999999999999 108.029 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -74.15 53.81 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.335 0.588 . . . . 1.53 111.709 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.645 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 11.6 mt -116.91 109.44 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.481 -0.781 . . . . 2.1099999999999999 110.048 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.676 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . 158.34 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.469 1.106 . . . . 1.3700000000000001 109.783 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.632 ' H ' ' HB3' ' A' ' 75' ' ' ARG . . . -157.85 162.98 32.48 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.074 -0.81 . . . . 2.7999999999999998 111.074 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.767 -0.635 . . . . 5.4100000000000001 110.852 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 111.532 -0.627 . . . . 10.35 111.532 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -50.54 -74.33 0.03 OUTLIER 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.462 0.542 . . . . 7.9199999999999999 112.462 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -70.21 -16.75 63.1 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.98 -0.288 . . . . 9.5399999999999991 111.175 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -64.27 -39.01 93.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 7.4100000000000001 110.879 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.459 ' O ' ' HD2' ' A' ' 38' ' ' LYS . 4.6 mm? -79.38 -94.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.808 -0.633 . . . . 4.9100000000000001 111.217 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.533 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 8.7 pt-20 -143.94 16.89 1.77 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.61 0.243 . . . . 4.0700000000000003 111.593 -175.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -64.11 111.65 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.019 -0.363 . . . . 4.9000000000000004 110.019 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 65.59 24.44 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.782 0.801 . . . . 5.2999999999999998 109.479 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.636 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 37.7 ttmt -121.36 150.02 42.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.21 -0.905 . . . . 2.54 110.616 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.636 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -68.83 175.34 3.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.988 -0.551 . . . . 1.3200000000000001 109.705 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.415 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 43.2 m-80 -66.28 91.57 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.326 -0.397 . . . . 3.1400000000000001 110.982 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.595 ' HB ' ' HD3' ' A' ' 38' ' ' LYS . 9.5 tp -78.44 137.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.433 -0.349 . . . . 1.47 110.147 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.415 ' CE2' ' HB3' ' A' ' 40' ' ' ASN . 90.5 m-85 -138.25 138.45 38.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.216 0.531 . . . . 1.6299999999999999 110.49 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.01 104.94 14.78 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.549 -1.278 . . . . 1.96 107.549 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.464 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -137.45 -177.77 15.39 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.538 -0.839 . . . . 0.31 111.636 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.418 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 73.1 mttt -114.98 157.67 23.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.525 0.679 . . . . 2.0499999999999998 111.016 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 1.024 HG22 HD12 ' A' ' 49' ' ' ILE . 1.5 mp -69.63 139.57 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.604 -1.18 . . . . 1.1100000000000001 109.908 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.625 HG21 ' CB ' ' A' ' 59' ' ' ASP . 47.3 p -129.04 -23.26 3.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.096 0.474 . . . . 1.1499999999999999 111.938 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.594 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 40.1 ttm180 -146.2 124.61 12.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.338 -0.392 . . . . 2.2999999999999998 110.529 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 1.024 HD12 HG22 ' A' ' 46' ' ' ILE . 40.4 mt -140.29 112.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.408 -0.59 . . . . 1.0800000000000001 109.408 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.45 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -119.55 130.67 24.72 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.828 0.347 . . . . 2.2400000000000002 110.734 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.789 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 2.8 Cg_exo -71.04 -22.47 26.2 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.953 2.435 . . . . 0.63 111.409 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.89 -15.32 61.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.375 -0.83 . . . . 1.8400000000000001 111.315 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.515 HD11 ' HZ ' ' A' ' 67' ' ' PHE . 2.9 pp -128.3 -5.54 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 119.309 -0.377 . . . . 1.22 111.488 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 41.39 64.37 1.04 Allowed 'General case' 0 C--N 1.351 0.638 0 CA-C-O 121.772 0.796 . . . . 2.5099999999999998 111.616 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.593 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -169.25 167.92 10.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.052 -1.431 . . . . 1.05 109.069 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -135.82 142.71 44.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 1.03 112.547 -172.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.594 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 49.7 m-85 -96.59 134.72 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.66000000000000003 110.195 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 53.9 t -108.41 128.0 64.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.094 -0.957 . . . . 1.0800000000000001 109.372 174.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.625 ' CB ' HG21 ' A' ' 47' ' ' THR . 13.0 t0 -98.61 108.44 21.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.002 0.43 . . . . 0.79000000000000004 110.021 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' HH ' HG13 ' A' ' 104' ' ' ILE . 22.7 p90 -124.64 65.43 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.459 0.647 . . . . 1.28 109.434 177.464 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.08 34.6 52.88 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.336 -0.935 . . . . 0.82999999999999996 111.452 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.88 115.15 24.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.655 0.264 . . . . 1.1499999999999999 110.555 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.442 ' H ' ' CD ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -64.59 -27.06 68.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.911 -0.774 . . . . 2.4300000000000002 108.911 175.597 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.476 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 19.9 mtm-85 -84.06 -11.47 56.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.662 -1.154 . . . . 5.2199999999999998 110.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.413 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 61.28 -159.77 0.31 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.485 -0.779 . . . . 1.0600000000000001 109.998 -172.988 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.79 120.24 0.98 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 109.867 -1.293 . . . . 0.52000000000000002 109.867 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.593 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.1 t80 -103.78 113.22 26.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.192 0.52 . . . . 0.51000000000000001 111.169 -169.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.861 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -100.0 115.2 65.74 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.315 -0.857 . . . . 1.04 110.143 177.983 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.536 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 25.4 Cg_exo -64.66 143.61 81.54 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.752 2.301 . . . . 0.28000000000000003 111.803 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.843 HD13 ' HB ' ' A' ' 90' ' ' ILE . 24.3 tp -66.4 -26.5 67.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.959 -0.564 . . . . 1.04 111.514 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.538 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 20.9 pttp -73.05 -9.65 58.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.359 . . . . 2.6200000000000001 110.999 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.538 ' OE2' ' HG3' ' A' ' 71' ' ' LYS . 17.0 mm-40 -100.04 -14.93 18.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.85999999999999999 110.078 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.657 HG21 HG13 ' A' ' 93' ' ' VAL . 6.1 mm -49.04 133.57 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 113.47 0.915 . . . . 1.3999999999999999 113.47 -168.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.554 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -89.11 151.06 22.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.311 -1.313 . . . . 1.1599999999999999 111.864 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.884 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 3.0 tmm_? -65.24 -21.69 66.78 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.198 -0.91 . . . . 3.4399999999999999 111.1 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.527 ' HB3' HD21 ' A' ' 122' ' ' LEU . 4.5 tp10 -73.99 -14.95 61.11 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.446 -0.784 . . . . 1.76 110.852 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -81.76 -52.71 6.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.856 -0.611 . . . . 1.51 109.861 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.545 ' HB3' ' HA ' ' A' ' 93' ' ' VAL . 8.2 p90 -96.62 109.09 46.55 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.14 -1.43 . . . . 0.57999999999999996 107.14 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.2 Cg_endo -40.56 137.14 1.68 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 123.87 3.047 . . . . 0.98999999999999999 113.025 -166.674 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.884 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -48.99 -16.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.841 1.052 . . . . 1.5 113.841 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.52 -7.2 59.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 2.6200000000000001 110.786 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.424 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 69.6 t80 -84.89 144.01 28.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.099 -0.704 . . . . 1.6499999999999999 109.099 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -78.67 100.69 7.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 2.4399999999999999 111.777 -175.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.411 ' HB3' ' HE2' ' A' ' 78' ' ' PHE . . . -81.13 120.09 24.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 1.74 110.525 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -138.82 105.45 5.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.034 -0.53 . . . . 4.8300000000000001 110.647 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.87 -83.74 1.04 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.806 -0.711 . . . . 1.3600000000000001 111.824 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 133.49 17.3 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.791 0.329 . . . . 5.0099999999999998 110.252 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.45 ' HB2' HG22 ' A' ' 93' ' ' VAL . 11.6 Cg_endo -59.64 153.6 54.44 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.87 2.38 . . . . 0.35999999999999999 113.131 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.62 ' O ' HG21 ' A' ' 93' ' ' VAL . 6.9 t30 -106.28 111.26 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.644 -0.873 . . . . 2.3300000000000001 108.644 172.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.843 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.4 tt -62.78 -36.29 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.691 0.626 . . . . 1.1100000000000001 112.691 -164.861 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.789 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 32.4 mmmt -67.27 -5.59 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.482 0.549 . . . . 4.46 112.482 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 23.07 7.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 1.9099999999999999 109.58 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.657 HG13 HG21 ' A' ' 73' ' ' ILE . 48.0 t -121.94 -54.86 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.12 -0.945 . . . . 1.1499999999999999 109.833 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.757 ' HB3' HG12 ' A' ' 46' ' ' ILE . 93.5 mt -109.95 158.83 17.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.071 -0.968 . . . . 1.0 110.548 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 146.0 26.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.128 -0.942 . . . . 3.1000000000000001 109.352 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.585 ' HA ' HG23 ' A' ' 46' ' ' ILE . 47.8 mt-10 -55.6 119.48 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.25 110.893 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.47 -16.49 24.2 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.682 -0.69 . . . . 0.40999999999999998 112.129 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.418 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.2 tt0 -82.39 138.58 34.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.796 -0.446 . . . . 1.1799999999999999 109.796 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.464 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 12.5 pt-20 -87.54 156.73 19.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.256 0.55 . . . . 0.81000000000000005 111.936 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.452 HG22 HG21 ' A' ' 102' ' ' VAL . 33.5 m -141.02 147.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.973 -1.012 . . . . 1.02 109.397 171.484 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.589 ' O ' HD11 ' A' ' 120' ' ' ILE . 10.2 mm -99.57 110.29 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.26 -1.015 . . . . 1.28 108.26 171.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.452 HG21 HG22 ' A' ' 100' ' ' VAL . 3.4 m -144.64 132.5 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 1.0600000000000001 111.447 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.572 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 13.0 pt20 -107.02 133.13 52.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.249 -0.432 . . . . 2.0800000000000001 109.921 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.452 HD13 ' HA ' ' A' ' 104' ' ' ILE . 19.6 mm -67.14 102.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 1.3400000000000001 110.159 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.26 -38.63 24.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 1.3 109.531 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.525 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . 54.9 mttp -117.77 132.51 56.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.358 -0.837 . . . . 2.9700000000000002 110.09 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -102.34 158.57 16.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.908 -1.042 . . . . 2.5699999999999998 111.0 -168.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 1.044 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 0.2 OUTLIER -52.52 117.41 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 3.1400000000000001 111.298 -176.292 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -143.98 18.91 1.79 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.858 -1.064 . . . . 3.9700000000000002 109.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.65 -43.37 3.17 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.824 -0.626 . . . . 1.74 112.893 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.55 -51.28 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.853 0.316 . . . . 3.25 111.853 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -125.02 -38.93 2.29 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.378 0.609 . . . . 3.79 110.971 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 1.044 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 92.07 -126.79 8.65 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.469 -0.872 . . . . 1.02 111.687 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.07 94.19 7.16 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.812 0.339 . . . . 1.0800000000000001 110.747 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.525 ' HB1' ' HB2' ' A' ' 106' ' ' LYS . . . -94.52 124.96 38.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.474 -0.33 . . . . 1.1000000000000001 111.604 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.861 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 25.1 mt -90.8 135.66 33.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.729 -0.471 . . . . 1.1499999999999999 109.729 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 119' ' ' PHE . 7.1 t -97.38 167.57 10.92 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.446 -0.575 . . . . 1.25 109.446 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.597 HG23 HD22 ' A' ' 68' ' ' LEU . 11.9 p -125.32 19.83 8.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.165 0.507 . . . . 1.52 111.224 173.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 73.7 m-85 -80.89 54.13 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.826 0.822 . . . . 4.9900000000000002 109.918 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.589 HD11 ' O ' ' A' ' 101' ' ' ILE . 2.0 mp -127.63 175.85 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.579 -1.191 . . . . 1.4299999999999999 108.054 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.462 ' H ' HG23 ' A' ' 120' ' ' ILE . 1.5 m -66.85 19.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.425 0.898 . . . . 1.53 113.425 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.554 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 6.6 mp -115.9 106.5 13.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.22 -0.3 . . . . 2.1099999999999999 110.433 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.467 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . 158.44 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.727 1.211 . . . . 1.3700000000000001 109.254 169.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . 0.555 ' HA3' HH21 ' A' ' 75' ' ' ARG . . . -73.98 164.53 54.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 2.7999999999999998 112.757 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.875 -0.583 . . . . 5.4100000000000001 109.612 176.623 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.884 -0.487 . . . . 10.35 111.884 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.403 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 28.4 m -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.042 0.449 . . . . 7.9199999999999999 110.534 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -86.52 157.35 19.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.865 -0.607 . . . . 9.5399999999999991 110.516 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 63.4 mtt 71.72 23.33 3.72 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 124.056 0.848 . . . . 7.4100000000000001 111.434 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.403 ' CD1' ' HB2' ' A' ' 31' ' ' SER . 66.7 mt -101.38 -49.74 3.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.554 -0.906 . . . . 4.9100000000000001 108.554 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.513 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 1.8 mm-40 43.73 66.45 0.82 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.315 -1.311 . . . . 4.0700000000000003 110.106 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -79.47 -58.09 3.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.44 -0.8 . . . . 4.9000000000000004 112.942 -163.489 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -112.14 46.97 1.1 Allowed 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.82 -1.178 . . . . 5.2999999999999998 107.82 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 32.0 ttmt -131.63 148.43 52.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.055 -1.884 . . . . 2.54 109.896 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.595 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -72.3 150.35 43.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.459 -0.941 . . . . 1.3200000000000001 108.459 172.149 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -57.54 117.6 4.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 3.1400000000000001 110.447 -175.638 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.412 HD11 HG12 ' A' ' 120' ' ' ILE . 7.5 tp -84.39 146.74 6.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.294 -0.866 . . . . 1.47 111.292 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.78 147.29 40.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.409 -0.36 . . . . 1.6299999999999999 110.556 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.484 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 41.3 ttmt -108.37 116.63 32.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 1.96 109.045 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.21 23.85 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.83 -0.908 . . . . 0.31 110.83 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 68.4 mttt -102.33 161.37 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.27 0.557 . . . . 2.0499999999999998 110.814 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.814 HG12 ' HB3' ' A' ' 94' ' ' LEU . 1.8 mp -70.23 136.47 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.842 -1.072 . . . . 1.1100000000000001 109.239 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.718 HG22 ' HB2' ' A' ' 59' ' ' ASP . 1.9 p -121.52 -33.52 3.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.419 0.628 . . . . 1.1499999999999999 111.139 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.611 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 39.4 ttm180 -147.68 122.14 9.73 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.269 -0.878 . . . . 2.2999999999999998 110.384 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.805 HD11 HG23 ' A' ' 46' ' ' ILE . 51.1 mt -131.62 130.11 62.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.525 -0.546 . . . . 1.0800000000000001 109.525 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.846 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 22.6 tt0 -129.29 131.51 23.7 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.868 -0.606 . . . . 2.2400000000000002 109.461 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.736 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 9.4 Cg_exo -68.3 -24.92 36.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.475 2.117 . . . . 0.63 111.31 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.378 -0.828 . . . . 1.8400000000000001 111.079 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.846 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.1 pp -118.48 -1.85 11.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 119.086 -0.483 . . . . 1.22 111.758 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 41.04 54.22 3.3 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-O 121.979 0.895 . . . . 2.5099999999999998 111.396 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.597 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.37 166.52 27.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.269 -1.332 . . . . 1.05 109.499 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.499 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -133.47 134.24 43.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.406 -0.361 . . . . 1.03 111.55 -175.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.611 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 76.4 m-85 -85.86 133.1 33.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.387 -0.597 . . . . 0.66000000000000003 109.387 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.543 ' HB ' HD11 ' A' ' 116' ' ' LEU . 31.5 t -115.34 128.75 72.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.469 -0.787 . . . . 1.0800000000000001 109.626 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.718 ' HB2' HG22 ' A' ' 47' ' ' THR . 12.3 t0 -101.94 108.77 20.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.886 -0.597 . . . . 0.79000000000000004 110.321 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.14 65.49 1.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.369 -0.974 . . . . 1.28 108.369 171.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.48 30.5 50.04 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.525 -0.845 . . . . 0.82999999999999996 111.699 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.06 153.05 18.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 1.1499999999999999 111.552 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.77 -27.35 15.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.686 -0.688 . . . . 2.4300000000000002 110.52 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.601 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 2.4 mmp_? -113.57 -9.36 13.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.083 -0.508 . . . . 5.2199999999999998 110.532 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.517 ' HD1' ' HB3' ' A' ' 57' ' ' PHE . 9.7 m170 70.34 144.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.243 -0.889 . . . . 1.0600000000000001 111.221 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -78.78 104.23 2.07 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.413 -0.898 . . . . 0.52000000000000002 110.965 176.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.695 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 1.7 t80 -91.32 97.73 11.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.178 0.513 . . . . 0.51000000000000001 110.191 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 1.002 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -86.42 115.44 62.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.56 -0.746 . . . . 1.04 110.188 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.641 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 10.3 Cg_exo -69.52 141.33 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.245 1.963 . . . . 0.28000000000000003 111.471 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.569 HD11 ' HB ' ' A' ' 90' ' ' ILE . 21.2 tp -54.78 -30.62 57.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.335 -0.848 . . . . 1.04 112.144 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.641 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.0 ptmm? -61.76 -22.99 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 2.6200000000000001 111.768 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -93.57 -21.75 19.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.48 -0.327 . . . . 0.85999999999999999 111.256 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.682 HG21 HG11 ' A' ' 93' ' ' VAL . 17.0 mt -49.01 132.21 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.155 0.798 . . . . 1.3999999999999999 113.155 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.569 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -93.67 151.9 19.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.197 -0.91 . . . . 1.1599999999999999 111.363 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.49 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 10.0 tpt180 -54.38 -16.1 2.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.525 -1.216 . . . . 3.4399999999999999 112.777 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.953 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 29.7 tp10 -63.5 -29.89 71.09 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.788 -0.57 . . . . 1.76 110.823 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.645 ' CE1' HG12 ' A' ' 100' ' ' VAL . 26.1 m-85 -86.14 -41.61 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.317 -0.856 . . . . 1.51 110.733 -172.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.5 ' HB3' HG13 ' A' ' 93' ' ' VAL . 2.1 p90 -102.3 92.13 3.03 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 107.551 -1.277 . . . . 0.57999999999999996 107.551 166.896 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.503 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 23.4 Cg_exo -26.72 137.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.675 4.25 . . . . 0.98999999999999999 115.374 -167.504 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.6 -25.39 17.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.356 -1.293 . . . . 1.5 112.579 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.59 -6.57 59.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.196 0.522 . . . . 2.6200000000000001 111.253 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . 0.503 ' HB3' ' O ' ' A' ' 79' ' ' PRO . 58.1 t80 -87.85 135.38 33.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.313 -0.625 . . . . 1.6499999999999999 109.313 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -71.61 116.37 11.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.051 -0.722 . . . . 2.4399999999999999 109.051 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.486 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -63.73 -21.03 66.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.886 0.699 . . . . 1.74 112.886 -170.737 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 40.6 m80 65.55 23.93 11.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.284 0.564 . . . . 4.8300000000000001 110.412 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.41 -57.93 4.18 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.513 -0.767 . . . . 1.3600000000000001 111.953 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -137.3 130.27 17.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.864 0.364 . . . . 5.0099999999999998 110.46 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 6.5 Cg_endo -61.4 154.59 57.78 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.163 2.575 . . . . 0.35999999999999999 113.697 -178.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.516 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.3 t30 -114.98 110.7 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.24 -0.652 . . . . 2.3300000000000001 109.24 171.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.569 ' HB ' HD11 ' A' ' 70' ' ' LEU . 7.9 tt -55.63 -43.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 113.649 0.981 . . . . 1.1100000000000001 113.649 -164.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.736 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 4.7 mmmp? -56.7 -26.37 56.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.245 0.831 . . . . 4.46 113.245 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -110.18 9.38 23.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.145 0.497 . . . . 1.9099999999999999 111.079 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.682 HG11 HG21 ' A' ' 73' ' ' ILE . 53.2 t -115.21 -51.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.638 -0.71 . . . . 1.1499999999999999 109.849 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.814 ' HB3' HG12 ' A' ' 46' ' ' ILE . 83.1 mt -103.16 154.05 19.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.44 -0.8 . . . . 1.0 109.691 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.15 151.99 36.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.521 -0.763 . . . . 3.1000000000000001 108.95 174.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.561 ' HA ' HG21 ' A' ' 46' ' ' ILE . 36.6 mt-10 -62.06 118.69 7.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 1.25 110.237 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.35 -18.33 20.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.85 -0.614 . . . . 0.40999999999999998 112.209 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.459 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 tt0 -78.02 135.86 37.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.479 -0.563 . . . . 1.1799999999999999 109.479 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.9 157.37 19.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.136 0.493 . . . . 0.81000000000000005 111.361 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.645 HG12 ' CE1' ' A' ' 77' ' ' TYR . 35.0 m -138.07 151.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.169 -0.923 . . . . 1.02 109.959 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.576 HG12 HD23 ' A' ' 122' ' ' LEU . 3.5 mm -103.06 110.14 28.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.67 -1.233 . . . . 1.28 107.67 171.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.473 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -143.61 134.79 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.559 . . . . 1.0600000000000001 111.783 -170.215 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.403 ' O ' HG21 ' A' ' 117' ' ' THR . 10.7 pt20 -108.33 141.26 40.41 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.56 -0.904 . . . . 2.0800000000000001 108.56 174.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.426 ' CD1' HD21 ' A' ' 116' ' ' LEU . 18.3 mm -74.98 104.53 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.667 0.746 . . . . 1.3400000000000001 111.367 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.47 -43.33 32.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.686 -1.143 . . . . 1.3 109.776 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.609 ' HB2' ' HB2' ' A' ' 115' ' ' ALA . 60.4 mttp -118.04 137.42 52.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.66 -0.7 . . . . 2.9700000000000002 109.895 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.64 144.38 32.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.007 -0.997 . . . . 2.5699999999999998 112.547 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.601 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 40.8 tt0 -71.63 90.91 1.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.31 -0.859 . . . . 3.1400000000000001 110.321 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.594 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 17.8 mtt180 -105.53 -82.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.453 -0.794 . . . . 3.9700000000000002 110.665 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.93 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.561 -0.828 . . . . 1.74 112.569 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.412 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 21.6 t-20 -61.59 -49.71 75.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.579 0.214 . . . . 3.25 111.579 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.412 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 29.3 mtpp -123.55 -38.05 2.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.321 0.581 . . . . 3.79 109.812 171.719 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.594 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 85.64 -132.71 11.28 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.149 -0.932 . . . . 1.02 112.531 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.437 ' HB3' ' O ' ' A' ' 65' ' ' HIS . . . -75.57 108.01 8.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.148 -0.526 . . . . 1.0800000000000001 111.326 -171.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.609 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . . . -104.22 125.24 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.213 -0.449 . . . . 1.1000000000000001 110.431 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 1.002 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 30.4 mt -90.8 148.72 22.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.989 0.423 . . . . 1.1499999999999999 109.965 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 103' ' ' GLN . 12.7 t -113.93 175.46 5.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.17 -0.678 . . . . 1.25 109.17 175.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.417 ' C ' ' H ' ' A' ' 120' ' ' ILE . 10.3 p -125.27 26.99 6.73 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.401 0.619 . . . . 1.52 110.274 173.123 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -78.15 44.45 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.547 1.165 . . . . 4.9900000000000002 109.141 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.501 HD12 ' O ' ' A' ' 101' ' ' ILE . 3.3 mp -128.46 161.73 36.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.839 -1.073 . . . . 1.4299999999999999 108.982 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.06 66.82 0.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.967 0.413 . . . . 1.53 111.301 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.576 HD23 HG12 ' A' ' 101' ' ' ILE . 1.9 mt -116.25 173.31 6.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.112 -0.699 . . . . 2.1099999999999999 109.112 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.953 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 76.94 56.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.92 0.762 . . . . 1.3700000000000001 110.622 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.29 43.85 0.89 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.279 -0.873 . . . . 2.7999999999999998 111.967 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.335 -0.84 . . . . 5.4100000000000001 110.871 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 112.383 -0.287 . . . . 10.35 112.383 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -69.24 128.14 35.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.379 0.609 . . . . 7.9199999999999999 110.682 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -99.26 52.24 0.95 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.971 -0.559 . . . . 9.5399999999999991 110.945 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 72.8 mtm -87.06 -11.85 49.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.821 0.82 . . . . 7.4100000000000001 109.002 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.27 173.87 6.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.607 -1.179 . . . . 4.9100000000000001 108.782 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.451 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 33.8 mt-10 -61.78 -62.36 1.85 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.036 0.21 . . . . 4.0700000000000003 110.514 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 65.35 74.02 0.39 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.486 0.491 . . . . 4.9000000000000004 110.233 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 59.82 44.09 14.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.582 0.706 . . . . 5.2999999999999998 110.132 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.762 ' HB2' ' HZ2' ' A' ' 38' ' ' LYS . 4.3 ttmp? -130.72 143.16 50.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 2.54 110.925 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.67 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -71.19 158.26 36.72 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.614 -0.884 . . . . 1.3200000000000001 108.614 169.131 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -52.79 119.77 4.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.527 . . . . 3.1400000000000001 110.665 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.649 HD12 HG21 ' A' ' 101' ' ' ILE . 6.5 tp -89.52 138.62 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.218 -0.901 . . . . 1.47 110.326 -175.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -133.25 156.41 47.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.021 0.438 . . . . 1.6299999999999999 110.343 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.593 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.8 ttmt -118.49 121.66 40.82 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.795 -0.817 . . . . 1.96 108.795 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.82 166.95 25.78 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.675 -0.97 . . . . 0.31 110.675 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 90.4 mttt -100.21 156.88 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.41 0.624 . . . . 2.0499999999999998 111.114 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.994 HG22 HD13 ' A' ' 49' ' ' ILE . 1.7 mp -69.86 134.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.661 -1.154 . . . . 1.1100000000000001 109.822 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.622 HG22 ' HB2' ' A' ' 59' ' ' ASP . 61.6 p -123.87 -18.41 6.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.357 0.599 . . . . 1.1499999999999999 111.314 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.538 ' HG2' ' HD2' ' A' ' 57' ' ' PHE . 7.2 ttm180 -150.6 131.3 14.02 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.361 -0.836 . . . . 2.2999999999999998 110.524 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.994 HD13 HG22 ' A' ' 46' ' ' ILE . 58.0 mt -139.81 101.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.657 -0.868 . . . . 1.0800000000000001 108.657 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.581 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -98.57 112.46 62.53 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.0 -0.545 . . . . 2.2400000000000002 110.015 -177.06 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.998 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 52.9 Cg_exo -57.12 -22.37 47.37 Favored 'Trans proline' 0 N--CA 1.467 -0.054 0 C-N-CA 122.953 2.435 . . . . 0.63 111.894 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -71.69 -20.09 61.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.8400000000000001 111.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.581 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -128.36 12.74 6.53 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.811 1.041 . . . . 1.22 113.811 -176.056 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER 47.73 40.78 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 2.5099999999999998 112.818 173.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.69 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.54 170.24 20.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 1.05 111.076 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.467 ' HB2' HD12 ' A' ' 90' ' ' ILE . . . -137.63 149.12 46.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 1.03 112.032 -173.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.538 ' HD2' ' HG2' ' A' ' 48' ' ' ARG . 63.4 m-85 -98.38 137.64 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.66000000000000003 109.826 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.629 ' HB ' HD12 ' A' ' 116' ' ' LEU . 24.3 t -118.72 131.78 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.347 -0.842 . . . . 1.0800000000000001 109.832 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.622 ' HB2' HG22 ' A' ' 47' ' ' THR . 22.2 t70 -100.43 104.86 16.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.79000000000000004 110.649 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -127.11 65.4 1.3 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.973 -0.751 . . . . 1.28 108.973 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.41 52.18 19.6 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.336 -0.935 . . . . 0.82999999999999996 111.328 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 168.48 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 1.1499999999999999 111.193 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . 0.41 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 7.4 tp10 -93.78 -53.54 3.98 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.905 -0.318 . . . . 2.4300000000000002 111.381 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.45 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.4 ptm180 -109.16 6.54 24.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.132 -0.627 . . . . 5.2199999999999998 110.778 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 15.7 m170 71.25 143.28 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.24 -0.891 . . . . 1.0600000000000001 111.511 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.47 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -74.53 117.33 5.46 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.829 -0.909 . . . . 0.52000000000000002 110.829 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.69 ' CZ ' ' HB2' ' A' ' 55' ' ' ALA . 21.6 t80 -99.83 98.73 9.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.166 0.508 . . . . 0.51000000000000001 110.375 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.897 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -87.34 117.54 68.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.506 -0.77 . . . . 1.04 111.05 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.462 ' HD2' HD23 ' A' ' 68' ' ' LEU . 21.3 Cg_exo -67.65 141.85 56.37 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.821 2.347 . . . . 0.28000000000000003 111.721 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.692 HD12 ' HB ' ' A' ' 90' ' ' ILE . 18.0 tp -59.34 -35.09 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 1.04 112.035 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -67.83 -8.22 34.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.394 -0.366 . . . . 2.6200000000000001 111.786 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.44 ' C ' ' HG1' ' A' ' 118' ' ' THR . 8.0 mm-40 -96.31 -26.98 15.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.641 -0.254 . . . . 0.85999999999999999 110.349 176.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.538 HG21 HG11 ' A' ' 93' ' ' VAL . 33.9 mt -49.85 135.06 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.436 0.902 . . . . 1.3999999999999999 113.436 -167.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.417 ' HB2' ' HB1' ' A' ' 123' ' ' ALA . . . -91.07 148.99 22.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.394 -1.275 . . . . 1.1599999999999999 111.432 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.648 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 13.6 ttp180 -58.41 -14.49 7.8 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.937 -1.029 . . . . 3.4399999999999999 112.583 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.662 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 10.4 tp10 -54.36 -38.82 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 1.76 111.789 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 1.043 ' HH ' ' HA ' ' A' ' 100' ' ' VAL . 39.2 m-85 -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.581 0.586 . . . . 1.51 112.581 -168.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.648 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 12.5 p90 -97.91 88.58 0.65 Allowed Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 105.996 -1.853 . . . . 0.57999999999999996 105.996 158.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.08 143.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.876 3.717 . . . . 0.98999999999999999 114.216 -157.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.95 -7.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.907 -1.042 . . . . 1.5 112.65 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.7 -21.94 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.472 0.653 . . . . 2.6200000000000001 109.607 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -77.64 130.67 37.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.11 -0.95 . . . . 1.6499999999999999 109.466 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -68.57 100.35 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 2.4399999999999999 110.339 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -83.22 103.02 12.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.683 -0.69 . . . . 1.74 110.634 -178.901 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -130.76 131.89 44.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.824 -0.625 . . . . 4.8300000000000001 109.856 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.15 -102.32 2.16 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.558 -0.829 . . . . 1.3600000000000001 111.84 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -136.94 133.12 18.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.138 -0.319 . . . . 5.0099999999999998 110.138 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -60.0 156.48 38.87 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.417 1.412 . . . . 0.35999999999999999 111.091 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.614 HD22 ' HG3' ' A' ' 91' ' ' LYS . 10.4 t30 -118.34 101.4 8.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.676 -0.49 . . . . 2.3300000000000001 109.676 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.692 ' HB ' HD12 ' A' ' 70' ' ' LEU . 19.9 tt -54.79 -45.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.598 0.962 . . . . 1.1100000000000001 113.598 -164.219 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.998 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 17.0 ptmt -56.42 -16.54 5.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.838 0.681 . . . . 4.46 112.838 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.448 ' HB3' HD21 ' A' ' 89' ' ' ASN . 34.6 t70 -118.18 1.34 11.91 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.521 0.676 . . . . 1.9099999999999999 110.624 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 89' ' ' ASN . 45.3 t -105.58 -50.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.655 0.741 . . . . 1.1499999999999999 109.543 -175.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.674 ' HB3' HG12 ' A' ' 46' ' ' ILE . 81.6 mt -100.84 152.72 20.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.354 -0.839 . . . . 1.0 109.172 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 149.09 30.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.355 -0.839 . . . . 3.1000000000000001 109.389 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.535 ' HA ' HG23 ' A' ' 46' ' ' ILE . 31.0 mt-10 -56.24 123.93 16.24 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.722 0.639 . . . . 1.25 111.203 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.3 29.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.615 -0.721 . . . . 0.40999999999999998 112.151 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.51 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 8.4 tt0 -77.14 133.4 38.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.054 -0.35 . . . . 1.1799999999999999 110.054 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.43 158.1 24.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.714 . . . . 0.81000000000000005 110.97 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 1.043 ' HA ' ' HH ' ' A' ' 77' ' ' TYR . 27.5 m -137.41 146.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 1.02 110.549 170.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.969 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.6 mm -93.83 110.14 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.237 -1.023 . . . . 1.28 108.237 169.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.499 ' CG2' HD23 ' A' ' 116' ' ' LEU . 3.4 m -144.32 129.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.199 0.523 . . . . 1.0600000000000001 111.26 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.502 ' OE1' ' HG3' ' A' ' 38' ' ' LYS . 15.6 pt20 -93.53 138.87 31.37 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.507 -0.923 . . . . 2.0800000000000001 108.507 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.575 ' CD1' HD21 ' A' ' 116' ' ' LEU . 41.7 mm -80.54 96.21 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.615 0.721 . . . . 1.3400000000000001 109.338 176.654 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.87 -29.49 63.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.727 -1.124 . . . . 1.3 109.852 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.406 ' HB2' ' HB2' ' A' ' 115' ' ' ALA . 32.3 mttm -129.07 123.97 33.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 2.9700000000000002 109.578 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -79.26 158.71 27.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.95 -0.568 . . . . 2.5699999999999998 110.305 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.879 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 22.5 tt0 -70.63 90.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.56 0.695 . . . . 3.1400000000000001 110.717 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -111.26 6.98 20.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.862 -1.063 . . . . 3.9700000000000002 110.974 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.36 -46.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.643 -0.789 . . . . 1.74 113.432 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.65 -50.84 70.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.007 0.403 . . . . 3.25 111.064 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.619 ' HB2' ' HZ3' ' A' ' 112' ' ' LYS . 0.1 OUTLIER -121.8 -37.28 2.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.631 -0.877 . . . . 3.79 108.631 169.971 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.879 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 83.52 -133.4 11.85 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.823 -1.081 . . . . 1.02 111.098 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.47 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -73.02 96.87 2.22 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.155 0.502 . . . . 1.0800000000000001 110.309 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.406 ' HB2' ' HB2' ' A' ' 106' ' ' LYS . . . -104.03 124.42 49.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 1.1000000000000001 111.528 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.897 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 31.4 mt -91.4 159.77 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.049 -0.723 . . . . 1.1499999999999999 109.049 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.428 ' O ' HG13 ' A' ' 102' ' ' VAL . 12.8 t -138.08 153.4 49.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.186 -0.672 . . . . 1.25 109.186 168.001 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.44 ' HG1' ' C ' ' A' ' 72' ' ' GLU . 0.7 OUTLIER -126.86 34.49 4.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.302 0.572 . . . . 1.52 111.015 172.143 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -80.25 45.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.357 -0.979 . . . . 4.9900000000000002 108.357 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.623 ' HB ' HD13 ' A' ' 122' ' ' LEU . 11.0 mt -121.36 168.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.471 -1.24 . . . . 1.4299999999999999 108.37 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.418 ' H ' HG21 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -85.03 33.48 0.54 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.947 0.721 . . . . 1.53 112.947 -172.016 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.969 ' HG ' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -117.2 100.19 7.54 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.684 0.754 . . . . 2.1099999999999999 109.882 175.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.662 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . -161.66 37.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.712 -0.676 . . . . 1.3700000000000001 109.907 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.49 -162.19 29.64 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.052 -0.976 . . . . 2.7999999999999998 112.556 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.845 -0.598 . . . . 5.4100000000000001 109.831 176.569 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.985 -0.446 . . . . 10.35 111.985 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -129.73 67.07 1.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.981 0.419 . . . . 7.9199999999999999 109.972 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -152.02 47.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.39 0.614 . . . . 9.5399999999999991 110.269 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -88.7 -44.86 10.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.518 0.675 . . . . 7.4100000000000001 109.854 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.1 mt -128.48 -74.38 0.57 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.067 -0.969 . . . . 4.9100000000000001 110.497 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.444 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -139.34 -175.46 4.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.77 -0.65 . . . . 4.0700000000000003 110.555 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . 0.427 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 28.8 mt-30 -122.38 100.49 6.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 4.9000000000000004 110.362 -172.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 65.31 20.22 11.81 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.811 -0.631 . . . . 5.2999999999999998 110.19 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.567 ' HE3' HG21 ' A' ' 120' ' ' ILE . 23.8 ttmm -131.31 162.96 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.441 -0.8 . . . . 2.54 109.905 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.74 175.46 6.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.194 -0.669 . . . . 1.3200000000000001 109.194 171.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -55.69 124.03 16.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.084 0.469 . . . . 3.1400000000000001 110.948 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.549 HG12 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -95.33 144.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.881 -0.6 . . . . 1.47 109.663 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -125.22 135.45 52.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 1.6299999999999999 110.449 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.506 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 40.0 ttmt -98.75 103.67 15.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.911 -0.774 . . . . 1.96 108.911 167.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.94 161.89 19.35 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 110.691 -0.964 . . . . 0.31 110.691 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 84.6 mttt -94.45 158.06 15.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.171 0.51 . . . . 2.0499999999999998 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.761 HG22 ' CD1' ' A' ' 49' ' ' ILE . 1.8 mp -74.57 133.69 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.144 -1.058 . . . . 1.1100000000000001 108.144 169.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.61 HG21 ' CB ' ' A' ' 59' ' ' ASP . 57.5 p -117.57 -20.09 9.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.436 0.636 . . . . 1.1499999999999999 110.525 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.509 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 24.4 ttt180 -146.6 121.42 9.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.136 -0.938 . . . . 2.2999999999999998 109.677 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.761 ' CD1' HG22 ' A' ' 46' ' ' ILE . 75.4 mt -125.91 109.0 20.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.147 -0.686 . . . . 1.0800000000000001 109.147 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.547 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 7.0 tp10 -104.47 107.78 58.77 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.221 -0.9 . . . . 2.2400000000000002 109.488 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.608 ' HB3' ' CD ' ' A' ' 91' ' ' LYS . 54.3 Cg_exo -53.95 -37.94 86.08 Favored 'Trans proline' 0 N--CA 1.467 -0.07 0 C-N-CA 123.309 2.673 . . . . 0.63 112.578 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -22.12 65.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.8400000000000001 112.158 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.547 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.0 pp -123.59 8.25 8.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.15 0.426 . . . . 1.22 112.15 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 39.23 60.23 1.55 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.705 0.802 . . . . 2.5099999999999998 112.197 174.512 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.583 ' HB2' ' CZ ' ' A' ' 67' ' ' PHE . . . -165.67 158.47 15.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.248 -0.887 . . . . 1.05 110.405 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' HB3' HD12 ' A' ' 90' ' ' ILE . . . -122.91 144.49 49.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.546 0.572 . . . . 1.03 112.546 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.528 ' HD1' ' HB2' ' A' ' 65' ' ' HIS . 63.1 m-85 -97.02 137.09 36.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.417 -0.811 . . . . 0.66000000000000003 109.844 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.454 ' HB ' HD13 ' A' ' 116' ' ' LEU . 38.4 t -120.47 129.67 75.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.019 -0.537 . . . . 1.0800000000000001 109.675 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.61 ' CB ' HG21 ' A' ' 47' ' ' THR . 29.2 t70 -102.41 112.68 25.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.319 -0.401 . . . . 0.79000000000000004 111.384 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.0 67.45 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.047 -0.723 . . . . 1.28 109.047 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.8 41.33 58.05 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.728 -0.669 . . . . 0.82999999999999996 112.153 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.21 147.61 44.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 1.1499999999999999 111.271 -172.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.66 -51.26 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 2.4300000000000002 108.803 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.882 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 26.7 mmm180 -96.23 106.61 18.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.224 -0.898 . . . . 5.2199999999999998 108.793 169.258 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.582 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 18.9 m170 -61.56 149.83 37.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 1.0600000000000001 111.51 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.08 110.31 3.14 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.771 -0.931 . . . . 0.52000000000000002 110.771 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.583 ' CZ ' ' HB2' ' A' ' 55' ' ' ALA . 9.5 t80 -98.87 100.58 11.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.326 0.584 . . . . 0.51000000000000001 110.827 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.912 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -92.15 115.09 64.06 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.09 -0.959 . . . . 1.04 110.94 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.627 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.0 Cg_exo -64.07 141.07 75.14 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.864 2.376 . . . . 0.28000000000000003 111.562 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.823 ' HA ' HG13 ' A' ' 73' ' ' ILE . 10.3 tp -63.07 -34.93 78.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.605 -0.725 . . . . 1.04 111.722 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.08 -14.8 52.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.982 0.42 . . . . 2.6200000000000001 111.083 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.627 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 1.6 mm-40 -99.19 -14.45 19.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.85999999999999999 110.534 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.823 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.8 mt -49.31 134.05 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.151 0.797 . . . . 1.3999999999999999 113.151 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.538 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -87.05 146.5 26.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.814 -1.084 . . . . 1.1599999999999999 110.922 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.597 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 18.2 ttm180 -62.19 -13.51 28.29 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.384 -0.825 . . . . 3.4399999999999999 111.806 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.689 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 15.0 tp10 -60.87 -27.22 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.468 . . . . 1.76 110.757 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.4 ' HD2' HG21 ' A' ' 73' ' ' ILE . 14.8 m-85 -87.45 -44.17 11.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.447 -0.797 . . . . 1.51 110.353 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.597 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.1 p90 -96.17 97.34 3.08 Favored Pre-proline 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 0.57999999999999996 107.098 166.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.1 Cg_endo -38.65 138.02 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.306 3.337 . . . . 0.98999999999999999 112.776 -163.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.69 -10.28 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.395 -0.821 . . . . 1.5 113.193 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -87.02 -12.6 46.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.349 0.595 . . . . 2.6200000000000001 110.317 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.88 143.5 41.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.782 -0.644 . . . . 1.6499999999999999 109.688 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -79.52 100.64 7.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.37 -0.377 . . . . 2.4399999999999999 110.957 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.448 ' HB3' ' HE2' ' A' ' 78' ' ' PHE . . . -87.04 123.4 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 1.74 110.182 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.57 -20.43 18.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.007 0.432 . . . . 4.8300000000000001 110.373 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -77.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.914 -0.66 . . . . 1.3600000000000001 111.572 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -104.84 132.57 20.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.043 -0.355 . . . . 5.0099999999999998 110.043 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.407 ' C ' HD13 ' A' ' 70' ' ' LEU . 11.5 Cg_endo -64.66 161.78 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.116 1.877 . . . . 0.35999999999999999 111.975 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.834 HD21 ' HB3' ' A' ' 92' ' ' ASP . 0.3 OUTLIER -122.11 102.62 8.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 2.3300000000000001 109.78 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.675 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 17.3 tt -54.85 -40.16 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.699 1.0 . . . . 1.1100000000000001 113.699 -162.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.608 ' CD ' ' HB3' ' A' ' 51' ' ' PRO . 43.2 pttt -67.65 -11.6 58.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.953 0.353 . . . . 4.46 111.953 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.834 ' HB3' HD21 ' A' ' 89' ' ' ASN . 37.0 t70 -125.53 18.25 8.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.159 0.98 . . . . 1.9099999999999999 109.359 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.557 HG12 ' HB3' ' A' ' 78' ' ' PHE . 18.1 t -122.5 -54.77 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 1.1499999999999999 110.198 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.519 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 47.8 mt -101.09 153.34 19.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.429 -0.805 . . . . 1.0 109.55 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . 0.734 ' HD3' HE21 ' A' ' 98' ' ' GLN . 0.1 OUTLIER -125.43 150.53 47.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.106 -0.702 . . . . 3.1000000000000001 109.106 173.727 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.652 ' HA ' HG23 ' A' ' 46' ' ' ILE . 42.2 mt-10 -69.95 109.31 4.44 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.257 -1.016 . . . . 1.25 108.257 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.21 -11.46 19.81 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.438 -0.801 . . . . 0.40999999999999998 112.15 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.734 HE21 ' HD3' ' A' ' 95' ' ' ARG . 9.1 tt0 -80.29 144.71 32.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.206 0.503 . . . . 1.1799999999999999 109.966 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.69 153.71 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.32 0.581 . . . . 0.81000000000000005 111.612 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.506 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 27.3 m -136.29 146.4 29.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.088 -0.96 . . . . 1.02 109.018 169.473 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.863 ' HB ' HD13 ' A' ' 122' ' ' LEU . 4.3 mm -100.42 109.12 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.571 -1.27 . . . . 1.28 107.571 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.534 ' CG2' HD21 ' A' ' 116' ' ' LEU . 4.8 m -145.5 142.63 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.021 -0.536 . . . . 1.0600000000000001 110.717 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.415 ' HG3' HG21 ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.4 166.28 10.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.381 -0.6 . . . . 2.0800000000000001 109.381 175.807 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.42 HG22 ' O ' ' A' ' 106' ' ' LYS . 18.7 mm -108.53 98.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.629 0.728 . . . . 1.3400000000000001 110.072 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -83.71 -29.41 27.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.066 -0.97 . . . . 1.3 110.381 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.607 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 36.1 mmtm -117.65 136.35 53.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.449 . . . . 2.9700000000000002 109.895 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.528 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 28.2 mt-10 -97.56 158.25 15.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.417 -0.81 . . . . 2.5699999999999998 110.447 -166.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.882 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 24.8 tt0 -51.25 112.21 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.547 0.529 . . . . 3.1400000000000001 110.803 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.895 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 12.7 ptm180 -146.65 49.28 1.15 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.454 -0.794 . . . . 3.9700000000000002 110.382 -175.345 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.34 -96.25 1.0 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.788 -0.642 . . . . 1.74 113.991 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -60.66 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.004 0.742 . . . . 3.25 113.004 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -110.86 -40.28 4.58 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.143 -0.623 . . . . 3.79 110.144 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.895 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 60.88 -121.51 26.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.487 -0.778 . . . . 1.02 112.509 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -72.99 101.08 3.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.164 0.506 . . . . 1.0800000000000001 110.607 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.607 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -98.59 124.0 43.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.248 -0.433 . . . . 1.1000000000000001 110.907 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.912 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 46.9 mt -90.93 136.75 32.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 1.1499999999999999 109.732 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.415 HG21 ' HG3' ' A' ' 103' ' ' GLN . 5.0 t -96.82 168.17 10.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.635 . . . . 1.25 109.284 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.596 HG23 HD21 ' A' ' 68' ' ' LEU . 2.0 p -136.01 13.99 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.155 0.502 . . . . 1.52 111.159 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.91 57.52 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.246 -1.02 . . . . 4.9900000000000002 108.246 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.567 HG21 ' HE3' ' A' ' 38' ' ' LYS . 8.1 mt -127.9 175.5 9.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 113.975 -1.466 . . . . 1.4299999999999999 108.648 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.497 ' H ' HG23 ' A' ' 120' ' ' ILE . 14.6 m -75.61 33.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.448 0.536 . . . . 1.53 112.448 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.863 HD13 ' HB ' ' A' ' 101' ' ' ILE . 4.2 mp -116.34 124.22 49.56 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.349 -0.219 . . . . 2.1099999999999999 111.496 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.689 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . 159.07 34.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.911 1.382 . . . . 1.3700000000000001 109.149 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.09 -90.18 1.65 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.669 -0.972 . . . . 2.7999999999999998 110.669 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.667 -0.682 . . . . 5.4100000000000001 109.789 174.468 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.774 -0.531 . . . . 10.35 111.774 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -92.62 62.96 3.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.629 -0.508 . . . . 7.9199999999999999 109.629 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -56.95 -22.58 39.01 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.032 0.753 . . . . 9.5399999999999991 113.032 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.72 -27.31 66.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.317 0.58 . . . . 7.4100000000000001 110.454 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.6 mt -103.0 -46.37 4.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.459 -0.791 . . . . 4.9100000000000001 110.315 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.503 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 31.6 mt-10 -61.73 -64.04 1.07 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.25 -0.886 . . . . 4.0700000000000003 111.187 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 67.12 -69.06 0.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.918 0.761 . . . . 4.9000000000000004 111.011 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . 0.405 ' HE2' ' HB3' ' A' ' 37' ' ' LYS . 31.8 ttpt -122.5 -21.15 5.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 5.2999999999999998 109.954 178.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 15.1 pttm -87.58 175.56 7.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 2.54 110.597 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.11 173.59 8.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.676 -0.861 . . . . 1.3200000000000001 108.676 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -61.66 124.95 22.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.378 0.609 . . . . 3.1400000000000001 110.783 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.515 HD13 ' HB3' ' A' ' 103' ' ' GLN . 7.3 tp -94.18 143.96 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.194 -0.912 . . . . 1.47 110.098 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.22 144.09 51.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.05 0.452 . . . . 1.6299999999999999 110.968 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -112.42 117.61 32.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.307 -0.86 . . . . 1.96 109.389 173.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -153.11 177.63 30.64 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.629 -0.988 . . . . 0.31 110.629 -179.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.434 ' HD2' ' HA2' ' A' ' 97' ' ' GLY . 39.2 mtmt -116.52 159.11 22.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.64 0.733 . . . . 2.0499999999999998 111.88 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.812 HG23 HD12 ' A' ' 49' ' ' ILE . 1.7 mp -68.42 137.77 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.322 -1.308 . . . . 1.1100000000000001 110.089 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.653 HG22 ' HB2' ' A' ' 59' ' ' ASP . 47.5 p -126.56 -20.18 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 1.1499999999999999 111.689 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.673 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 8.3 ttm180 -148.08 122.02 9.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.072 -0.513 . . . . 2.2999999999999998 110.09 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.812 HD12 HG23 ' A' ' 46' ' ' ILE . 88.2 mt -128.87 108.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.146 -0.687 . . . . 1.0800000000000001 109.146 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.583 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 17.3 tt0 -102.89 121.05 50.59 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.894 -0.594 . . . . 2.2400000000000002 109.688 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG3' ' CD ' ' A' ' 91' ' ' LYS . 12.2 Cg_exo -65.8 -31.25 48.71 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.977 2.451 . . . . 0.63 112.759 -171.417 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 t -77.03 -10.11 59.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 1.8400000000000001 111.657 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.583 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 3.1 pp -127.82 5.77 6.06 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.728 0.64 . . . . 1.22 112.728 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 43.47 55.55 4.81 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.352 0.596 . . . . 2.5099999999999998 112.095 170.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.522 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.0 158.98 22.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.461 -0.79 . . . . 1.05 110.365 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.508 ' HB2' HD12 ' A' ' 90' ' ' ILE . . . -129.1 140.26 51.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.873 0.694 . . . . 1.03 112.873 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.703 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 53.0 m-85 -92.43 128.61 38.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.134 -0.939 . . . . 0.66000000000000003 110.119 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.457 ' HB ' HD11 ' A' ' 116' ' ' LEU . 76.5 t -108.54 131.01 60.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.25 0.547 . . . . 1.0800000000000001 109.884 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.653 ' HB2' HG22 ' A' ' 47' ' ' THR . 10.6 t70 -101.49 96.49 7.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.715 -0.675 . . . . 0.79000000000000004 110.664 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.649 ' OH ' HD12 ' A' ' 104' ' ' ILE . 15.5 p90 -126.88 66.29 1.27 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.032 -0.729 . . . . 1.28 109.032 173.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.39 11.67 15.03 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.759 -0.734 . . . . 0.82999999999999996 112.533 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.61 110.71 18.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.843 0.354 . . . . 1.1499999999999999 110.305 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.63 -18.68 60.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 2.4300000000000002 110.637 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.699 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.9 mmp_? -95.63 -6.82 39.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.893 -0.594 . . . . 5.2199999999999998 110.371 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.703 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 59.18 107.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.238 -0.892 . . . . 1.0600000000000001 111.924 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.45 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -59.61 122.06 28.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.431 -0.89 . . . . 0.52000000000000002 111.151 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.522 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.7 t80 -111.28 107.67 17.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.283 0.563 . . . . 0.51000000000000001 110.524 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.733 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.3 118.58 67.71 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.326 -0.852 . . . . 1.04 110.84 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.555 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 27.5 Cg_exo -64.87 134.9 42.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.501 2.134 . . . . 0.28000000000000003 111.052 169.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.666 ' HA ' HG13 ' A' ' 73' ' ' ILE . 12.3 tp -57.19 -31.91 65.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.583 . . . . 1.04 111.961 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.516 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 21.3 pttp -70.2 -8.18 47.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.448 -0.342 . . . . 2.6200000000000001 111.529 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 6.1 mm-40 -103.65 -10.03 18.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 110.423 -0.214 . . . . 0.85999999999999999 110.423 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.666 HG13 ' HA ' ' A' ' 70' ' ' LEU . 18.5 mt -60.77 133.54 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.658 0.614 . . . . 1.3999999999999999 112.658 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.454 ' HB2' ' HB ' ' A' ' 118' ' ' THR . . . -77.92 140.51 39.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.254 -0.884 . . . . 1.1599999999999999 111.208 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.755 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 29.6 ttp180 -58.62 -13.81 6.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.223 -0.899 . . . . 3.4399999999999999 112.397 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.886 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 25.3 tp10 -56.25 -29.94 61.73 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.437 -0.79 . . . . 1.76 111.351 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.531 ' CZ ' HD21 ' A' ' 122' ' ' LEU . 34.0 m-85 -85.32 -41.03 15.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 1.51 110.894 -172.002 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.755 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.4 p90 -102.0 96.73 7.15 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 106.963 -1.495 . . . . 0.57999999999999996 106.963 167.365 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_endo -32.01 138.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 1 C-N-CA 125.676 4.251 . . . . 0.98999999999999999 114.704 -162.186 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.634 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -51.13 -24.17 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.638 -1.164 . . . . 1.5 113.699 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -92.92 4.8 53.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.58 0.705 . . . . 2.6200000000000001 110.67 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -84.78 132.13 34.46 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.662 -0.866 . . . . 1.6499999999999999 108.662 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -65.81 99.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 2.4399999999999999 111.821 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.444 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -90.25 58.22 3.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.575 -0.738 . . . . 1.74 110.041 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -80.17 56.66 2.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.442 0.639 . . . . 4.8300000000000001 110.48 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.5 -120.82 1.29 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.732 -0.667 . . . . 1.3600000000000001 111.995 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -119.68 130.95 24.58 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.804 -0.443 . . . . 5.0099999999999998 109.804 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.524 ' HB2' HG21 ' A' ' 93' ' ' VAL . 8.5 Cg_endo -58.74 144.71 97.9 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.987 1.792 . . . . 0.35999999999999999 111.742 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.492 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.9 t30 -98.75 118.55 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.346 -0.612 . . . . 2.3300000000000001 109.346 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.563 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.7 tt -57.63 -47.54 85.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.863 1.06 . . . . 1.1100000000000001 113.863 -164.143 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CD ' ' HG3' ' A' ' 51' ' ' PRO . 15.1 mtpt -66.25 -6.52 14.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.076 0.769 . . . . 4.46 113.076 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.76 5.04 17.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.377 0.608 . . . . 1.9099999999999999 110.22 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.546 HG13 ' HB3' ' A' ' 78' ' ' PHE . 69.0 t -117.62 -52.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.463 -0.789 . . . . 1.1499999999999999 109.852 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.465 ' HB2' HD11 ' A' ' 49' ' ' ILE . 80.6 mt -101.7 154.78 18.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 1.0 109.175 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.34 150.42 35.68 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.535 -0.543 . . . . 3.1000000000000001 109.535 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.631 ' HA ' HG21 ' A' ' 46' ' ' ILE . 48.3 mt-10 -57.0 110.97 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 1.25 109.991 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . 0.434 ' HA2' ' HD2' ' A' ' 45' ' ' LYS . . . 112.96 -1.05 25.7 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.857 -0.687 . . . . 0.40999999999999998 112.242 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.477 ' NE2' ' HB3' ' A' ' 77' ' ' TYR . 22.8 tt0 -95.96 135.53 37.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.832 -0.433 . . . . 1.1799999999999999 109.832 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . 0.4 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 11.7 pt-20 -82.77 157.54 23.18 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.463 0.477 . . . . 0.81000000000000005 111.815 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.466 HG23 HG22 ' A' ' 102' ' ' VAL . 34.2 m -141.2 152.59 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.115 -0.948 . . . . 1.02 109.741 171.608 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.781 ' HB ' HD13 ' A' ' 122' ' ' LEU . 23.5 mm -103.35 110.66 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.356 -0.979 . . . . 1.28 108.356 168.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.466 HG22 HG23 ' A' ' 100' ' ' VAL . 2.5 m -139.1 130.57 35.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.218 0.532 . . . . 1.0600000000000001 112.127 -170.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.515 ' HB3' HD13 ' A' ' 41' ' ' ILE . 10.1 pt20 -104.68 157.32 17.26 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.167 -1.049 . . . . 2.0800000000000001 108.167 170.246 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.649 HD12 ' OH ' ' A' ' 60' ' ' TYR . 20.6 mm -81.02 102.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.779 0.799 . . . . 1.3400000000000001 110.861 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.458 ' OD2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 t70 -71.44 -44.24 65.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.104 -1.407 . . . . 1.3 110.33 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.458 ' HG3' ' OD2' ' A' ' 105' ' ' ASP . 63.0 mttp -125.37 156.76 38.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.48 0.657 . . . . 2.9700000000000002 111.183 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.3 155.88 17.64 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.597 -1.183 . . . . 2.5699999999999998 111.548 -162.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.595 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 19.1 mt-10 -69.17 89.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.113 -0.949 . . . . 3.1400000000000001 110.783 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.3 9.25 37.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.494 -1.23 . . . . 3.9700000000000002 110.497 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.27 -63.92 3.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.92 -0.657 . . . . 1.74 112.157 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.7 -31.85 73.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.503 0.192 . . . . 3.25 111.505 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -118.84 -39.68 2.94 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.388 0.614 . . . . 3.79 109.464 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.595 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 75.85 -140.05 25.3 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.726 -1.125 . . . . 1.02 112.858 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.45 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -81.72 91.71 6.5 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.944 0.402 . . . . 1.0800000000000001 110.821 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . . . . . . . . . . . -79.15 123.66 27.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.208 -0.451 . . . . 1.1000000000000001 111.295 -176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.733 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 65.4 mt -91.91 161.06 14.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.08 -0.509 . . . . 1.1499999999999999 110.014 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.431 HG23 HD12 ' A' ' 120' ' ' ILE . 15.3 t -141.31 156.3 45.87 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.888 -0.782 . . . . 1.25 108.888 171.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.454 ' HB ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -137.33 41.86 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.451 0.643 . . . . 1.52 112.507 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -96.53 33.17 1.86 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.148 -1.056 . . . . 4.9900000000000002 108.148 167.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.543 ' O ' HD11 ' A' ' 122' ' ' LEU . 0.8 OUTLIER -119.77 93.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.684 -1.143 . . . . 1.4299999999999999 111.06 -171.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 m 69.84 -30.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.602 1.334 . . . . 1.53 114.602 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.781 HD13 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -83.25 173.47 11.59 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.687 -0.633 . . . . 2.1099999999999999 111.264 -176.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.886 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 88.77 47.1 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 124.966 1.416 . . . . 1.3700000000000001 109.979 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.03 -122.29 7.46 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 114.911 -1.04 . . . . 2.7999999999999998 112.119 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.688 -0.672 . . . . 5.4100000000000001 109.958 179.098 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.882 -0.487 . . . . 10.35 111.882 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 m -127.9 21.6 6.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.47 0.176 . . . . 7.9199999999999999 110.838 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . 0.539 ' O ' ' HG3' ' A' ' 33' ' ' MET . 38.7 m80 61.0 -153.4 0.37 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.202 -0.666 . . . . 9.5399999999999991 109.202 -174.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.581 ' SD ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 ppp? 51.67 8.8 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.272 1.029 . . . . 7.4100000000000001 112.413 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . 0.581 ' HG ' ' SD ' ' A' ' 33' ' ' MET . 73.0 mt -137.21 -173.35 3.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.514 -0.921 . . . . 4.9100000000000001 108.514 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.27 105.17 16.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.018 0.747 . . . . 4.0700000000000003 113.018 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -81.77 67.37 7.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.21 -0.663 . . . . 4.9000000000000004 109.21 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.63 20.28 9.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.779 -0.646 . . . . 5.2999999999999998 110.901 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.51 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -115.24 -172.22 2.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.123 -0.49 . . . . 2.54 110.376 -178.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.51 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -81.38 171.85 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.585 -0.895 . . . . 1.3200000000000001 108.585 169.176 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.455 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 39.7 m-80 -62.35 102.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.847 0.356 . . . . 3.1400000000000001 111.395 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.809 HD13 HG21 ' A' ' 101' ' ' ILE . 9.6 tp -82.71 134.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.958 -0.564 . . . . 1.47 110.365 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -132.02 145.58 51.54 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.226 0.536 . . . . 1.6299999999999999 110.72 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -109.65 107.27 17.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.184 -0.916 . . . . 1.96 108.81 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.34 166.25 27.69 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.153 -1.022 . . . . 0.31 111.855 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.447 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 30.9 mtmt -106.09 159.39 16.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.3 0.571 . . . . 2.0499999999999998 111.262 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.922 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -70.58 141.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.876 -1.056 . . . . 1.1100000000000001 110.436 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.604 HG21 ' CB ' ' A' ' 59' ' ' ASP . 65.3 p -131.22 -0.21 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.203 -0.453 . . . . 1.1499999999999999 111.501 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.438 ' O ' ' HA ' ' A' ' 56' ' ' ALA . 31.3 ttt-85 -164.52 125.02 2.06 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.314 -0.403 . . . . 2.2999999999999998 110.409 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.922 HD11 HG21 ' A' ' 46' ' ' ILE . 88.5 mt -141.45 119.28 8.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.622 -0.51 . . . . 1.0800000000000001 109.622 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.47 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 3.5 mt-10 -117.86 130.1 24.93 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.205 -0.452 . . . . 2.2400000000000002 110.847 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.942 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 16.0 Cg_exo -68.95 -14.94 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.755 2.303 . . . . 0.63 111.324 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -73.09 -36.32 66.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 1.8400000000000001 110.817 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 pp -118.24 5.8 11.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 1.22 112.157 -172.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.43 57.35 2.54 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.953 0.783 . . . . 2.5099999999999998 111.537 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.493 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.16 166.63 16.87 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.303 -0.862 . . . . 1.05 110.568 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.468 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -136.34 148.08 47.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.642 0.608 . . . . 1.03 112.642 -172.819 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.609 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 45.1 m-85 -101.13 132.3 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.526 -0.761 . . . . 0.66000000000000003 110.09 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.487 ' HB ' HD11 ' A' ' 116' ' ' LEU . 25.0 t -108.9 136.62 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.066 0.46 . . . . 1.0800000000000001 110.218 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.604 ' CB ' HG21 ' A' ' 47' ' ' THR . 27.4 t70 -108.88 107.72 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.812 -0.631 . . . . 0.79000000000000004 111.396 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -127.24 65.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.939 -0.763 . . . . 1.28 108.939 171.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.32 18.28 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.708 -0.758 . . . . 0.82999999999999996 112.054 -171.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.9 141.81 37.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.408 0.283 . . . . 1.1499999999999999 110.873 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.79 -21.21 17.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 2.4300000000000002 110.994 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.595 ' HA ' ' NE ' ' A' ' 64' ' ' ARG . 2.6 mmp_? -106.38 -13.14 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 5.2199999999999998 110.802 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.609 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.5 OUTLIER 70.51 116.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.435 -0.802 . . . . 1.0600000000000001 111.755 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.88 118.19 12.66 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.518 -0.764 . . . . 0.52000000000000002 111.877 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.493 ' CZ ' ' HB1' ' A' ' 55' ' ' ALA . 15.8 t80 -105.16 112.25 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.169 0.509 . . . . 0.51000000000000001 110.806 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.962 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -101.31 117.69 61.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.517 -0.765 . . . . 1.04 111.137 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.461 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.1 Cg_exo -63.84 145.03 90.08 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.882 2.388 . . . . 0.28000000000000003 111.637 170.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.683 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.2 tp -65.87 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 1.04 111.649 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.51 -22.87 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.045 0.45 . . . . 2.6200000000000001 110.835 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.461 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 29.5 mm-40 -79.22 -29.78 42.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.914 -0.585 . . . . 0.85999999999999999 110.387 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.73 HG21 HG13 ' A' ' 93' ' ' VAL . 5.5 mt -48.03 125.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 113.386 0.884 . . . . 1.3999999999999999 113.386 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' HB3' ' A' ' 123' ' ' ALA . . . -87.53 155.35 20.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.298 -1.319 . . . . 1.1599999999999999 110.369 176.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.636 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 24.7 ttm180 -61.99 -13.72 28.36 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.003 -0.998 . . . . 3.4399999999999999 112.407 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.994 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 6.8 tp10 -60.79 -23.37 64.97 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.624 -0.673 . . . . 1.76 110.477 175.853 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.408 ' CD2' HG23 ' A' ' 73' ' ' ILE . 10.2 m-30 -84.88 -46.16 11.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.553 -0.749 . . . . 1.51 109.617 -175.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.636 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 3.5 p90 -103.64 94.71 6.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 107.895 -1.15 . . . . 0.57999999999999996 107.895 170.023 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -26.93 137.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 1 C-N-CA 125.67 4.246 . . . . 0.98999999999999999 115.468 -166.696 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.421 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . . . -50.36 -18.32 0.61 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.044 1.128 . . . . 1.5 114.044 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -95.9 -7.23 37.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.785 0.326 . . . . 2.6200000000000001 111.406 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -71.34 141.36 50.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.481 -0.563 . . . . 1.6499999999999999 109.481 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.84 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 2.4399999999999999 111.072 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.08 99.76 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 1.74 110.949 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -118.67 91.65 3.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.329 -0.396 . . . . 4.8300000000000001 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.79 -101.08 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.754 -0.736 . . . . 1.3600000000000001 112.794 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -132.23 131.96 22.7 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 5.0099999999999998 110.742 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -60.54 145.59 98.49 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.42 2.08 . . . . 0.35999999999999999 112.296 174.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.651 ' ND2' ' HB2' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -108.57 115.41 30.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 2.3300000000000001 109.925 173.232 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.683 ' HB ' HD13 ' A' ' 70' ' ' LEU . 15.9 tt -59.33 -35.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.882 0.697 . . . . 1.1100000000000001 112.882 -164.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.942 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 21.3 pttp -61.86 -21.84 65.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.095 0.406 . . . . 4.46 112.095 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.651 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 12.3 m-20 -117.04 18.07 14.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 1.9099999999999999 110.177 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.73 HG13 HG21 ' A' ' 73' ' ' ILE . 45.0 t -123.51 -47.27 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.332 0.587 . . . . 1.1499999999999999 110.364 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.503 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 95.8 mt -108.34 163.41 13.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.953 -0.567 . . . . 1.0 109.953 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 147.67 27.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.935 -0.765 . . . . 3.1000000000000001 108.935 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.629 ' HA ' HG22 ' A' ' 46' ' ' ILE . 49.1 mt-10 -59.85 113.27 2.19 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.465 0.478 . . . . 1.25 109.901 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.38 -0.16 26.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.632 -0.713 . . . . 0.40999999999999998 112.35 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.503 ' NE2' ' HA ' ' A' ' 94' ' ' LEU . 6.8 tt0 -96.83 133.29 41.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.842 -0.429 . . . . 1.1799999999999999 109.842 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.56 156.99 28.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.134 0.492 . . . . 0.81000000000000005 111.439 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.487 HG22 HG21 ' A' ' 102' ' ' VAL . 27.8 m -140.19 152.21 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.201 -0.908 . . . . 1.02 109.85 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.809 HG21 HD13 ' A' ' 41' ' ' ILE . 7.2 mm -96.99 110.06 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.544 -1.28 . . . . 1.28 107.544 169.886 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.518 ' HA ' ' CD1' ' A' ' 120' ' ' ILE . 2.4 m -140.98 123.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.537 . . . . 1.0600000000000001 111.954 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.707 HE21 HG12 ' A' ' 120' ' ' ILE . 10.3 pt20 -97.48 135.14 39.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.041 -1.096 . . . . 2.0800000000000001 108.041 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.486 ' CD1' HD21 ' A' ' 116' ' ' LEU . 20.4 mm -73.18 103.37 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 1.3400000000000001 110.772 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.64 -43.46 76.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.3 109.668 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.495 ' HB2' ' HB1' ' A' ' 115' ' ' ALA . 37.4 mttp -119.59 121.95 40.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.187 -0.915 . . . . 2.9700000000000002 108.629 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.678 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 52.3 mt-10 -82.93 159.33 22.31 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.267 -0.424 . . . . 2.5699999999999998 110.13 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.564 ' HG2' ' HB2' ' A' ' 114' ' ' ALA . 31.1 mt-10 -62.68 91.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.468 0.651 . . . . 3.1400000000000001 109.601 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.678 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 3.6 ptp180 -129.83 41.12 3.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.85 -1.068 . . . . 3.9700000000000002 109.751 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.23 -82.04 1.58 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.234 -0.894 . . . . 1.74 113.84 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.1 -26.37 67.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.692 0.997 . . . . 3.25 113.692 -168.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.424 ' HG2' ' HD3' ' A' ' 106' ' ' LYS . 9.9 mptt -116.5 -37.18 3.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.172 0.51 . . . . 3.79 110.028 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 74.89 -146.92 35.82 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.077 -0.965 . . . . 1.02 110.814 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.564 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . . . -88.82 104.62 17.09 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.934 0.397 . . . . 1.0800000000000001 110.558 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.495 ' HB1' ' HB2' ' A' ' 106' ' ' LYS . . . -107.14 123.24 47.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.349 -0.387 . . . . 1.1000000000000001 111.09 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.962 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 17.4 mt -90.37 154.74 19.45 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.999 -0.741 . . . . 1.1499999999999999 108.999 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.436 HG23 ' O ' ' A' ' 103' ' ' GLN . 6.6 t -125.78 173.11 9.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.454 -0.339 . . . . 1.25 110.131 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.1 p -129.34 17.95 5.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 1.52 110.84 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -77.96 46.34 0.58 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.121 0.962 . . . . 4.9900000000000002 108.708 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.707 HG12 HE21 ' A' ' 103' ' ' GLN . 4.3 mt -129.56 173.34 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.492 -1.231 . . . . 1.4299999999999999 109.52 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.457 ' H ' HG22 ' A' ' 120' ' ' ILE . 13.0 m -74.81 67.73 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 1.53 110.902 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.557 HD11 ' O ' ' A' ' 101' ' ' ILE . 11.4 mt -116.15 172.15 7.35 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.453 -0.573 . . . . 2.1099999999999999 109.453 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.994 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 77.34 59.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.921 0.763 . . . . 1.3700000000000001 111.002 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.15 34.79 22.8 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.488 -0.778 . . . . 2.7999999999999998 111.977 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.303 -0.856 . . . . 5.4100000000000001 110.288 -179.241 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.64 -0.584 . . . . 10.35 111.64 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.405 ' C ' ' H ' ' A' ' 33' ' ' MET . 10.9 p -125.54 8.26 7.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.943 0.371 . . . . 7.9199999999999999 111.646 -176.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -80.81 33.95 0.33 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.182 0.515 . . . . 9.5399999999999991 111.736 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' MET . . . . . 0.405 ' H ' ' C ' ' A' ' 31' ' ' SER . 3.3 mpp? -134.86 9.29 3.57 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.322 -0.992 . . . . 7.4100000000000001 108.322 174.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.4 mt -115.91 -59.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.044 -0.98 . . . . 4.9100000000000001 110.751 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' HB3' ' HZ2' ' A' ' 38' ' ' LYS . 0.5 OUTLIER 51.63 38.3 22.23 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.604 0.565 . . . . 4.0700000000000003 112.033 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 61.42 -118.16 0.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.243 -0.435 . . . . 4.9000000000000004 111.152 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -98.9 1.1 45.37 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.246 0.546 . . . . 5.2999999999999998 110.233 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.518 ' HZ2' ' HB3' ' A' ' 35' ' ' GLU . 19.9 ttpp -85.9 153.08 22.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.444 -0.798 . . . . 2.54 109.316 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.32 167.98 20.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.44 -0.578 . . . . 1.3200000000000001 109.44 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.478 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 t-20 -49.02 118.75 2.79 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.557 0.536 . . . . 3.1400000000000001 110.202 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.695 HG12 HG23 ' A' ' 101' ' ' ILE . 5.0 tp -83.7 138.66 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.585 -0.524 . . . . 1.47 109.585 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 87.1 m-85 -115.1 118.87 34.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.517 0.675 . . . . 1.6299999999999999 110.7 -176.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.405 ' HD3' HD12 ' A' ' 101' ' ' ILE . 8.5 mmmm -89.64 102.67 15.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.858 -1.065 . . . . 1.96 109.671 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.25 163.78 26.32 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 110.555 -1.018 . . . . 0.31 110.555 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.14 161.97 18.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 2.0499999999999998 111.347 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.82 HG23 HD13 ' A' ' 49' ' ' ILE . 1.7 mp -65.05 146.09 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.299 -1.319 . . . . 1.1100000000000001 111.254 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.673 HG21 ' HB2' ' A' ' 59' ' ' ASP . 76.2 p -128.94 -32.05 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.009 0.433 . . . . 1.1499999999999999 111.854 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.656 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 13.9 ttm180 -140.27 126.12 19.45 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.351 -0.386 . . . . 2.2999999999999998 110.668 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.82 HD13 HG23 ' A' ' 46' ' ' ILE . 91.2 mt -133.8 120.36 36.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.652 -0.704 . . . . 1.0800000000000001 109.585 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.65 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 15.7 tp10 -111.94 111.21 53.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.896 -0.593 . . . . 2.2400000000000002 109.708 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.824 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 51.9 Cg_exo -54.0 -25.82 38.1 Favored 'Trans proline' 0 CA--C 1.521 -0.172 0 C-N-CA 123.361 2.707 . . . . 0.63 112.068 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.7 m -73.82 -22.48 59.78 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.503 -0.771 . . . . 1.8400000000000001 111.824 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.65 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.5 pp -123.78 7.48 8.76 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.598 0.962 . . . . 1.22 113.598 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . 0.442 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 4.6 pt-20 48.56 49.76 17.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.408 1.083 . . . . 2.5099999999999998 112.824 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.639 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.98 162.67 31.95 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.081 -0.648 . . . . 1.05 112.208 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.548 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -131.22 138.06 49.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.669 -0.696 . . . . 1.03 112.167 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.656 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 65.7 m-85 -89.44 136.17 33.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.66000000000000003 109.818 171.594 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.521 ' HB ' HD12 ' A' ' 116' ' ' LEU . 2.2 t -112.74 139.49 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 1.0800000000000001 110.997 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.673 ' HB2' HG21 ' A' ' 47' ' ' THR . 17.9 t70 -103.14 102.3 12.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.79000000000000004 110.65 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -128.11 67.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.509 -0.552 . . . . 1.28 109.509 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 46.09 42.16 11.9 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.089 -0.577 . . . . 0.82999999999999996 111.899 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.72 160.01 14.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.171 0.51 . . . . 1.1499999999999999 111.092 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -87.83 -45.38 10.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.626 0.726 . . . . 2.4300000000000002 109.173 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 48.7 mtt180 -125.71 94.15 4.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.85 -1.068 . . . . 5.2199999999999998 108.403 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.464 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 15.4 m170 -35.9 131.22 0.56 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.147 1.165 . . . . 1.0600000000000001 114.147 -170.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.523 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.8 118.65 14.74 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.871 -1.059 . . . . 0.52000000000000002 111.498 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.639 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.2 t80 -104.79 97.73 7.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.138 0.494 . . . . 0.51000000000000001 111.282 -171.461 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 1.017 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -85.38 121.2 73.73 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.774 . . . . 1.04 111.365 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.566 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 19.6 Cg_exo -69.56 142.78 49.78 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.087 2.525 . . . . 0.28000000000000003 112.104 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.695 HD13 ' HB ' ' A' ' 90' ' ' ILE . 12.6 tp -60.8 -39.07 87.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.491 -0.777 . . . . 1.04 112.263 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -64.13 -13.34 47.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.644 0.259 . . . . 2.6200000000000001 111.651 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . 0.566 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 7.2 mm-40 -96.09 -13.07 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.756 0.312 . . . . 0.85999999999999999 110.413 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.446 HG22 ' HE1' ' A' ' 78' ' ' PHE . 8.0 mt -57.86 138.48 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.636 0.731 . . . . 1.3999999999999999 112.823 -171.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.573 ' HB2' ' HB2' ' A' ' 123' ' ' ALA . . . -102.25 153.53 19.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.836 -1.075 . . . . 1.1599999999999999 110.518 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.64 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 41.1 ttm180 -55.27 -14.68 1.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.522 -0.763 . . . . 3.4399999999999999 112.662 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . 0.947 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 24.3 tp10 -61.96 -19.71 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.487 -0.758 . . . . 1.76 110.759 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.438 ' CD2' HG23 ' A' ' 73' ' ' ILE . 7.9 m-30 -92.65 -44.61 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.797 -0.638 . . . . 1.51 109.759 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.446 ' HE1' HG22 ' A' ' 73' ' ' ILE . 5.7 p90 -98.68 95.94 3.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.277 -1.379 . . . . 0.57999999999999996 107.277 168.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . 0.415 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.3 Cg_endo -38.51 139.98 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.577 3.518 . . . . 0.98999999999999999 113.797 -162.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.64 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -55.55 -11.93 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 1.5 113.288 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -82.28 -21.11 36.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.235 0.54 . . . . 2.6200000000000001 109.97 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -78.2 146.14 35.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 1.6499999999999999 110.626 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -81.98 106.49 13.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.741 -0.663 . . . . 2.4399999999999999 111.566 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . 0.446 ' HB1' ' HE2' ' A' ' 78' ' ' PHE . . . -91.81 136.48 33.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 1.74 109.848 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -96.42 -40.61 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.136 0.493 . . . . 4.8300000000000001 110.225 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.11 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.504 -0.771 . . . . 1.3600000000000001 111.265 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -97.04 128.39 35.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.033 0.444 . . . . 5.0099999999999998 110.804 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.86 165.49 13.99 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.272 2.648 . . . . 0.35999999999999999 112.981 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -120.6 98.31 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.866 -0.606 . . . . 2.3300000000000001 109.951 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.695 ' HB ' HD13 ' A' ' 70' ' ' LEU . 21.2 tt -54.02 -39.7 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.497 0.925 . . . . 1.1100000000000001 113.497 -165.475 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.824 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 36.8 pttt -55.7 -21.78 20.13 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.009 0.744 . . . . 4.46 113.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -125.96 18.69 7.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.932 0.872 . . . . 1.9099999999999999 110.44 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.486 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 36.7 t -111.32 -50.03 6.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.693 0.759 . . . . 1.1499999999999999 109.278 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . 0.577 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.5 mt -103.04 150.86 23.16 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.206 -0.906 . . . . 1.0 110.231 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 147.93 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.171 -0.922 . . . . 3.1000000000000001 109.098 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.485 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 1.5 mp0 -58.29 122.5 13.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.864 0.364 . . . . 1.25 110.161 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.49 -18.15 23.03 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.786 -0.721 . . . . 0.40999999999999998 111.701 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.462 ' NE2' ' HA ' ' A' ' 94' ' ' LEU . 6.6 tt0 -83.11 121.01 26.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.748 -0.464 . . . . 1.1799999999999999 109.748 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.65 155.2 36.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.81000000000000005 111.487 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.475 HG21 HG23 ' A' ' 102' ' ' VAL . 35.3 m -131.91 149.95 33.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.884 -1.053 . . . . 1.02 109.177 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.695 HG23 HG12 ' A' ' 41' ' ' ILE . 1.4 mm -98.95 107.48 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.072 -1.455 . . . . 1.28 107.072 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.592 HG11 ' O ' ' A' ' 117' ' ' THR . 4.4 m -145.54 135.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 1.0600000000000001 112.584 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . 0.53 ' O ' ' HB ' ' A' ' 117' ' ' THR . 18.4 pt20 -98.73 135.84 39.63 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.596 -0.891 . . . . 2.0800000000000001 108.596 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.671 HG23 ' O ' ' A' ' 106' ' ' LYS . 40.4 mm -80.95 99.57 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.256 0.55 . . . . 1.3400000000000001 109.71 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.32 -27.51 67.21 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 1.3 110.566 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.671 ' O ' HG23 ' A' ' 104' ' ' ILE . 55.0 mttp -113.63 -170.97 1.8 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 2.9700000000000002 111.411 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 50.4 mm-40 -129.6 145.79 51.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.294 -0.412 . . . . 2.5699999999999998 110.332 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.614 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 43.2 mt-10 -64.15 101.86 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.401 0.62 . . . . 3.1400000000000001 109.668 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.494 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 10.9 ptm180 -116.43 -61.63 1.7 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.237 -0.892 . . . . 3.9700000000000002 111.549 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.455 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -175.15 -63.9 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.466 -0.873 . . . . 1.74 112.519 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.88 -46.92 85.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.089 0.403 . . . . 3.25 112.089 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.559 ' HD2' ' HB3' ' A' ' 115' ' ' ALA . 21.4 ttmm -116.19 -37.18 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.363 -0.535 . . . . 3.79 110.436 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 80.6 -122.47 5.73 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.652 -0.979 . . . . 1.02 110.652 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . 0.523 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.29 127.5 33.7 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.99 -0.374 . . . . 1.0800000000000001 109.99 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.559 ' HB3' ' HD2' ' A' ' 112' ' ' LYS . . . -118.4 126.99 53.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.729 0.3 . . . . 1.1000000000000001 110.88 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 1.017 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 14.6 mt -91.08 129.06 37.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.065 -0.516 . . . . 1.1499999999999999 110.177 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.592 ' O ' HG11 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -90.26 146.82 23.94 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.619 -0.719 . . . . 1.25 109.642 174.048 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.593 HG23 HD21 ' A' ' 68' ' ' LEU . 3.5 p -113.96 4.02 15.6 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.34 0.496 . . . . 1.52 112.34 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -78.34 57.36 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.695 0.76 . . . . 4.9900000000000002 110.451 176.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.516 HG23 ' HE2' ' A' ' 38' ' ' LYS . 2.9 mp -127.99 176.08 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.645 -1.242 . . . . 1.4299999999999999 107.645 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.0 t -69.4 69.62 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.296 0.569 . . . . 1.53 110.458 176.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.471 HD12 ' O ' ' A' ' 101' ' ' ILE . 12.0 mt -115.13 172.22 7.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.676 -0.861 . . . . 2.1099999999999999 108.676 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.947 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 73.95 37.33 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.683 0.615 . . . . 1.3700000000000001 110.609 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.43 44.76 0.28 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.278 -0.874 . . . . 2.7999999999999998 111.198 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.283 -0.865 . . . . 5.4100000000000001 109.7 179.228 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.017 -0.433 . . . . 10.35 112.017 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.2 t -131.98 -87.17 0.46 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.377 -0.231 . . . . 7.9199999999999999 110.377 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 m170 61.84 5.16 1.27 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.025 0.53 . . . . 9.5399999999999991 111.728 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 69.0 mtm -142.19 176.4 9.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.001 0.12 . . . . 7.4100000000000001 110.725 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.53 13.57 2.6 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.813 0.696 . . . . 4.9100000000000001 111.8 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.984 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 12.3 pt-20 40.47 38.03 0.53 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.408 1.083 . . . . 4.0700000000000003 112.423 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -78.86 -66.94 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.172 -0.467 . . . . 4.9000000000000004 109.845 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -102.0 36.27 2.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.658 -1.238 . . . . 5.2999999999999998 107.658 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' LYS . . . . . 0.984 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 32.8 tttp -130.39 137.9 50.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.156 -1.384 . . . . 2.54 110.13 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.473 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -65.43 138.4 58.09 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.657 -1.238 . . . . 1.3200000000000001 107.657 170.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -47.62 116.97 1.63 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.853 0.721 . . . . 3.1400000000000001 111.218 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.459 HD12 HG23 ' A' ' 101' ' ' ILE . 6.6 tp -84.65 139.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.107 -0.951 . . . . 1.47 110.128 -174.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -122.68 149.71 43.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.792 0.329 . . . . 1.6299999999999999 110.275 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.502 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 34.5 ttmt -115.78 94.08 4.53 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.984 -0.747 . . . . 1.96 108.984 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.17 166.69 13.15 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.271 -0.877 . . . . 0.31 111.073 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 1.6 mppt? -104.83 158.2 16.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.065 0.459 . . . . 2.0499999999999998 111.087 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.949 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -73.52 137.19 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.075 -0.966 . . . . 1.1100000000000001 109.628 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.533 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.7 p -124.33 -11.28 7.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.799 0.333 . . . . 1.1499999999999999 111.471 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ARG . . . . . 0.62 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 24.6 ttt85 -160.26 122.18 3.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.212 -0.449 . . . . 2.2999999999999998 110.462 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.949 HD11 HG21 ' A' ' 46' ' ' ILE . 47.5 mt -134.89 113.46 16.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.624 -0.509 . . . . 1.0800000000000001 109.624 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . 0.434 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 31.6 mt-10 -118.01 122.54 30.37 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 121.505 0.669 . . . . 2.2400000000000002 111.475 -176.047 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' PRO . . . . . 0.854 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 31.9 Cg_exo -60.65 -27.41 84.79 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.112 2.541 . . . . 0.63 111.827 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.5 m -75.11 -21.43 58.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 1.8400000000000001 111.685 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.425 ' CG ' ' HB2' ' A' ' 50' ' ' GLU . 2.0 pp -118.38 8.85 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.964 -0.694 . . . . 1.22 112.792 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 43.52 48.36 6.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.493 0.717 . . . . 2.5099999999999998 111.917 169.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ALA . . . . . 0.564 ' HB1' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.27 171.15 12.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.474 -0.784 . . . . 1.05 110.974 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ALA . . . . . 0.452 ' HB1' HD11 ' A' ' 90' ' ' ILE . . . -135.56 139.48 43.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 1.03 111.539 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.62 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.9 m-85 -91.64 136.0 33.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.66000000000000003 109.633 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' VAL . . . . . 0.603 ' HB ' HD11 ' A' ' 116' ' ' LEU . 12.6 t -118.9 134.44 62.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.158 -0.682 . . . . 1.0800000000000001 109.158 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ASP . . . . . 0.533 ' CB ' HG21 ' A' ' 47' ' ' THR . 36.7 t70 -109.48 111.28 22.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.187 -0.46 . . . . 0.79000000000000004 112.027 -173.783 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -126.81 66.75 1.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.219 -1.03 . . . . 1.28 108.219 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.33 33.46 46.41 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.81 -0.71 . . . . 0.82999999999999996 112.46 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . 0.427 ' HB1' ' HA ' ' A' ' 65' ' ' HIS . . . -93.79 147.72 22.79 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.645 -0.326 . . . . 1.1499999999999999 110.777 -175.227 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.93 -51.29 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 2.4300000000000002 111.272 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.536 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 8.8 mmt180 -94.36 -11.11 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.478 -0.489 . . . . 5.2199999999999998 109.796 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' HIS . . . . . 0.536 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 10.3 m170 76.49 145.07 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.423 1.077 . . . . 1.0600000000000001 110.854 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 102.14 1.08 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.666 -0.974 . . . . 0.52000000000000002 110.666 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PHE . . . . . 0.564 ' CZ ' ' HB1' ' A' ' 55' ' ' ALA . 2.9 t80 -88.98 104.25 16.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.842 0.353 . . . . 0.51000000000000001 110.541 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 1.113 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.72 113.35 60.15 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 1.04 110.307 178.135 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.412 ' HD2' HD22 ' A' ' 68' ' ' LEU . 24.5 Cg_exo -65.27 141.72 69.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.787 2.325 . . . . 0.28000000000000003 111.607 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.617 HD13 ' HB ' ' A' ' 90' ' ' ILE . 17.8 tp -57.91 -33.46 68.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 1.04 111.819 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.59 -10.92 20.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 2.6200000000000001 111.482 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -97.44 -23.92 15.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.12 -0.491 . . . . 0.85999999999999999 110.856 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.703 HG23 HG12 ' A' ' 93' ' ' VAL . 6.1 mt -48.38 131.04 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 113.466 0.913 . . . . 1.3999999999999999 113.466 -166.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.524 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -100.22 156.67 17.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.64 -1.164 . . . . 1.1599999999999999 110.763 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.852 ' HG2' ' HA ' ' A' ' 80' ' ' ALA . 32.0 ttp180 -65.16 -12.7 53.9 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.55 0.944 . . . . 3.4399999999999999 113.55 -172.478 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.67 -25.76 68.36 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.795 -1.191 . . . . 1.76 110.208 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -75.84 -51.74 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.901 -0.59 . . . . 1.51 110.291 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.53 ' HB3' HG11 ' A' ' 93' ' ' VAL . 1.1 p90 -100.37 109.46 57.0 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.584 -1.265 . . . . 0.57999999999999996 107.584 169.19 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.43 133.6 0.33 Allowed 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 124.616 3.544 . . . . 0.98999999999999999 113.646 -162.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ALA . . . . . 0.852 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -57.03 -16.44 7.15 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.563 -1.199 . . . . 1.5 113.361 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -90.99 -0.89 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 2.6200000000000001 111.251 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -81.77 143.81 31.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 1.6499999999999999 109.976 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -71.09 100.9 2.12 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.397 -0.365 . . . . 2.4399999999999999 110.287 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.95 95.34 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.74 110.374 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -76.9 61.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.715 -0.675 . . . . 4.8300000000000001 110.928 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.47 -128.44 8.99 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.859 -0.686 . . . . 1.3600000000000001 111.631 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.85 135.41 45.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.809 0.338 . . . . 5.0099999999999998 110.32 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PRO . . . . . 0.445 ' O ' HD11 ' A' ' 70' ' ' LEU . 9.2 Cg_endo -58.41 154.7 39.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.916 2.411 . . . . 0.35999999999999999 113.161 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . 0.661 ' ND2' ' HB3' ' A' ' 92' ' ' ASP . 0.3 OUTLIER -119.41 111.42 18.13 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.248 -0.887 . . . . 2.3300000000000001 109.617 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ILE . . . . . 0.617 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.2 tt -62.13 -38.87 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.724 0.638 . . . . 1.1100000000000001 112.724 -163.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LYS . . . . . 0.854 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 7.8 ptmm? -60.07 -21.37 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.212 -0.449 . . . . 4.46 111.853 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASP . . . . . 0.661 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 34.6 t70 -119.62 12.01 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.817 0.818 . . . . 1.9099999999999999 110.343 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.703 HG12 HG23 ' A' ' 73' ' ' ILE . 13.7 t -119.96 -50.57 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 1.1499999999999999 110.314 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -100.41 152.13 20.72 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.677 -0.692 . . . . 1.0 110.25 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 151.8 44.21 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.361 -0.836 . . . . 3.1000000000000001 110.319 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLU . . . . . 0.638 ' HA ' HG22 ' A' ' 46' ' ' ILE . 18.1 mt-10 -65.13 126.07 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.029 -0.987 . . . . 1.25 110.456 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.05 54.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.773 -0.727 . . . . 0.40999999999999998 112.055 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLN . . . . . 0.422 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.9 tt0 -87.95 135.96 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.951 -0.389 . . . . 1.1799999999999999 109.951 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.92 157.22 20.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.81000000000000005 111.37 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.484 ' O ' ' HA ' ' A' ' 43' ' ' LYS . 35.5 m -136.75 151.79 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.189 -0.914 . . . . 1.02 109.879 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.975 ' HB ' HD13 ' A' ' 122' ' ' LEU . 10.0 mm -97.03 110.45 25.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.004 -1.11 . . . . 1.28 108.004 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' VAL . . . . . 0.475 HG22 HG23 ' A' ' 100' ' ' VAL . 4.3 m -146.76 139.05 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.233 0.539 . . . . 1.0600000000000001 111.974 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -112.84 142.73 45.16 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.433 -0.951 . . . . 2.0800000000000001 108.433 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ILE . . . . . 0.496 HD13 HD23 ' A' ' 116' ' ' LEU . 22.4 mm -71.89 102.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.76 0.79 . . . . 1.3400000000000001 110.771 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ASP . . . . . 0.58 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 35.0 t70 -83.76 -35.28 24.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.714 -1.13 . . . . 1.3 109.777 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LYS . . . . . 0.41 ' CB ' ' HB1' ' A' ' 115' ' ' ALA . 12.7 ttpp -112.03 137.99 49.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.605 -0.725 . . . . 2.9700000000000002 109.775 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLU . . . . . 0.411 ' HB3' HH21 ' A' ' 109' ' ' ARG . 1.8 tm-20 -87.2 133.79 33.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.26 -0.882 . . . . 2.5699999999999998 110.914 -163.284 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.478 ' HG3' ' HG2' ' A' ' 64' ' ' ARG . 42.6 tt0 -66.31 119.73 12.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 3.1400000000000001 110.208 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.557 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 6.6 ptp180 -139.72 -68.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.415 -0.811 . . . . 3.9700000000000002 111.115 -171.255 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -168.71 -66.99 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.553 -1.308 . . . . 1.74 113.722 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ASN . . . . . 0.462 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 25.6 t-20 -61.88 -50.91 70.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.958 0.379 . . . . 3.25 111.55 -172.407 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.462 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 98.6 mttt -122.92 -37.49 2.73 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.68 -0.408 . . . . 3.79 110.682 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLY . . . . . 0.557 ' HA2' ' HG2' ' A' ' 109' ' ' ARG . . . 63.79 -124.47 30.89 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.67 -0.695 . . . . 1.02 113.937 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.56 110.66 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.249 0.617 . . . . 1.0800000000000001 111.696 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ALA . . . . . 0.41 ' HB1' ' CB ' ' A' ' 106' ' ' LYS . . . -122.25 135.83 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.07 -0.514 . . . . 1.1000000000000001 110.566 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 1.113 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 43.2 mt -91.41 153.01 20.16 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.775 -0.648 . . . . 1.1499999999999999 109.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' THR . . . . . 0.58 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 8.2 t -116.69 171.47 7.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.241 -0.436 . . . . 1.25 110.292 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . 0.48 ' C ' ' H ' ' A' ' 120' ' ' ILE . 26.1 p -138.27 20.93 2.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.78 0.659 . . . . 1.52 112.78 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' PHE . . . . . 0.414 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 3.2 p90 -78.45 42.42 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.499 1.142 . . . . 4.9900000000000002 109.385 170.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.48 ' H ' ' C ' ' A' ' 118' ' ' THR . 4.4 mt -118.36 172.35 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 113.884 -1.507 . . . . 1.4299999999999999 108.015 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' SER . . . . . 0.461 ' H ' HG23 ' A' ' 120' ' ' ILE . 7.5 t -80.04 48.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.858 0.361 . . . . 1.53 111.93 -172.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LEU . . . . . 0.975 HD13 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -117.38 126.33 52.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.738 -0.21 . . . . 2.1099999999999999 111.257 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ALA . . . . . 0.466 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . 163.62 25.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.722 1.264 . . . . 1.3700000000000001 109.779 166.368 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 168.75 58.35 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.983 -0.847 . . . . 2.7999999999999998 110.983 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.684 -0.674 . . . . 5.4100000000000001 110.379 -175.883 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 108.56 -0.904 . . . . 0.96 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.61 114.45 3.28 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.255 -0.578 . . . . 2.62 110.82 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 103' ' ' GLN . 8.7 tp -81.27 146.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.385 -0.825 . . . . 0.84 109.421 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.55 152.76 41.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.7 0.286 . . . . 1.02 110.296 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.4 tttm -134.11 96.58 3.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.206 0.527 . . . . 1.16 109.716 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -140.46 175.67 21.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.952 -0.859 . . . . 0.27 110.952 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.34 159.47 15.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.648 0.737 . . . . 1.54 112.054 -175.362 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.986 HG21 HD11 ' A' ' 49' ' ' ILE . 1.6 mp -67.64 138.47 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.363 -1.29 . . . . 0.25 109.386 171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.614 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.2 p -130.69 -7.17 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.763 0.316 . . . . 0.39 111.725 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.627 ' HD3' ' HD2' ' A' ' 57' ' ' PHE . 29.9 ttt85 -158.43 123.02 4.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.326 -0.397 . . . . 1.85 110.282 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.986 HD11 HG21 ' A' ' 46' ' ' ILE . 56.6 mt -136.76 109.04 7.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.096 0.474 . . . . 0.26 109.877 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.32 113.2 65.38 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 2.24 110.796 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.84 -19.56 55.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.012 2.475 . . . . 0.52 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.4 m -73.1 -26.01 61.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.208 -0.905 . . . . 1.23 111.321 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.5 pp -119.71 -8.91 9.85 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.212 0.819 . . . . 0.46 113.212 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 59.43 57.18 3.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.784 0.433 . . . . 2.51 111.451 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -168.09 162.58 13.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.322 -0.399 . . . . 0.19 110.53 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -129.22 142.0 50.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.035 -0.529 . . . . 0.18 111.956 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.627 ' HD2' ' HD3' ' A' ' 48' ' ' ARG . 40.1 m-85 -94.3 142.07 27.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.691 -0.686 . . . . 0.56 109.551 170.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.466 HG12 ' HD1' ' A' ' 60' ' ' TYR . 56.1 t -120.37 133.38 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.26 109.947 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.614 ' CB ' HG21 ' A' ' 47' ' ' THR . 35.4 t70 -103.69 99.67 9.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.899 -0.591 . . . . 0.79 110.716 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HD1' HG12 ' A' ' 58' ' ' VAL . 20.4 p90 -126.8 66.59 1.26 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.703 -0.68 . . . . 0.89 109.337 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.1 21.95 26.82 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.733 -0.746 . . . . 0.83 112.436 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 118.42 33.86 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.817 -0.225 . . . . 0.86 110.53 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.99 -3.67 30.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 2.43 111.453 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.468 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -117.11 -13.25 10.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.777 -0.647 . . . . 4.52 110.189 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 63.84 141.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.039 -0.982 . . . . 0.88 111.879 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -83.12 126.43 7.48 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.602 -0.808 . . . . 0.24 111.193 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 29.0 t80 -107.18 111.47 23.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.381 0.61 . . . . 0.41 110.933 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.884 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -106.8 111.56 63.78 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.128 -0.942 . . . . 0.16 110.838 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 16.4 Cg_exo -69.23 145.03 58.91 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.155 2.57 . . . . 0.23 111.981 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.612 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.4 tp -57.06 -39.69 75.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.804 -1.089 . . . . 0.19 113.102 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.755 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 19.9 pttp -67.54 -9.73 45.2 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.571 -0.451 . . . . 2.04 111.174 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.403 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 3.5 mm-40 -92.84 -21.98 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.999 -0.371 . . . . 0.86 109.999 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.603 HG21 HG11 ' A' ' 93' ' ' VAL . 8.0 mt -48.76 134.75 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.838 1.051 . . . . 0.56 113.838 -168.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.76 156.32 16.74 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.717 -1.128 . . . . 0.39 110.898 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.747 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 12.6 tpt180 -56.84 -16.86 7.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.153 -0.93 . . . . 3.01 112.127 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.07 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 1.8 tp10 -65.06 -24.57 67.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.86 -0.525 . . . . 1.76 111.001 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.542 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.1 m-30 -82.37 -50.73 8.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.459 0.647 . . . . 1.4 110.141 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HB3' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -97.77 101.11 9.73 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.044 -1.465 . . . . 0.46 107.044 169.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.9 Cg_endo -39.13 141.76 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 124.85 3.7 . . . . 0.71 114.062 -161.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.71 -13.86 0.46 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.779 -1.1 . . . . 0.93 112.921 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.27 -11.05 53.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.3 0.571 . . . . 2.62 110.524 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.66 139.56 30.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.682 -0.69 . . . . 1.33 109.616 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -65.62 125.56 25.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 2.18 111.161 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.433 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -130.01 114.68 16.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.162 -0.472 . . . . 1.74 110.986 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -139.62 77.25 1.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.286 -0.415 . . . . 3.99 110.536 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.0 -113.58 1.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.691 -0.766 . . . . 1.06 112.498 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.853 ' HD3' ' HD2' ' A' ' 88' ' ' PRO . 13.5 tpp180 -121.63 121.61 28.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.63 0.252 . . . . 4.37 110.417 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.853 ' HD2' ' HD3' ' A' ' 87' ' ' ARG . 9.9 Cg_endo -59.84 166.23 8.81 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.999 2.466 . . . . 0.31 112.733 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 107.24 13.65 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.923 0.392 . . . . 2.14 110.445 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' HD13 ' A' ' 70' ' ' LEU . 20.2 tt -56.84 -37.69 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.115 0.783 . . . . 0.21 113.115 -165.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 91' ' ' LYS . 5.4 pttt -56.1 -24.74 42.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.879 0.696 . . . . 3.82 112.879 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -125.29 20.92 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.845 0.831 . . . . 1.91 110.173 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 73' ' ' ILE . 14.2 t -117.09 -48.67 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.605 -0.725 . . . . 0.33 109.893 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.411 ' HB3' HG12 ' A' ' 46' ' ' ILE . 42.6 mt -103.15 151.35 22.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.731 -0.668 . . . . 0.3 109.833 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 138.84 24.63 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.603 -0.726 . . . . 2.67 109.643 176.104 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.682 ' HA ' HG22 ' A' ' 46' ' ' ILE . 13.1 mt-10 -54.15 121.37 8.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.538 -0.755 . . . . 1.25 110.773 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.2 -8.02 28.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.41 111.791 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.542 ' OE1' ' HA ' ' A' ' 77' ' ' TYR . 9.1 tt0 -90.49 129.02 36.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.876 -0.416 . . . . 1.18 109.876 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 13.8 pt-20 -84.95 157.03 20.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.981 0.419 . . . . 0.81 111.025 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 102' ' ' VAL . 32.8 m -139.33 155.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.539 -0.755 . . . . 0.18 110.416 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.548 ' O ' HD13 ' A' ' 120' ' ' ILE . 4.0 mm -102.66 110.38 29.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.038 -1.097 . . . . 0.51 108.038 172.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -147.3 147.55 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.104 0.409 . . . . 0.28 112.104 -170.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.582 ' HB3' HD12 ' A' ' 41' ' ' ILE . 13.4 pt20 -128.07 158.72 37.18 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 1.62 108.72 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.494 HD13 HD23 ' A' ' 116' ' ' LEU . 25.5 mm -83.94 109.66 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.441 0.639 . . . . 0.78 111.638 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 13.5 t70 -85.4 -40.84 16.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.687 -1.142 . . . . 1.3 109.47 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 2.3 mptp? -111.52 126.09 54.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.552 -0.749 . . . . 2.57 109.239 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -85.67 158.38 20.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.012 -0.54 . . . . 2.57 110.889 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.531 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -66.97 131.07 45.11 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.657 0.742 . . . . 3.14 110.14 177.281 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -144.1 12.13 1.59 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.627 -1.169 . . . . 3.49 108.833 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.71 84.72 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.974 -1.012 . . . . 1.74 112.499 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -130.5 -31.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.76 0.652 . . . . 2.88 112.76 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -120.25 -38.8 2.86 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.102 -0.639 . . . . 3.45 110.008 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . 99.48 -159.14 19.85 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.122 -1.037 . . . . 0.91 111.674 169.418 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.94 90.14 7.35 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.713 -0.847 . . . . 0.52 108.713 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -85.66 126.02 33.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.6 111.695 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.884 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 50.6 mt -90.27 135.42 33.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.35 110.428 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 13.1 t -95.31 172.43 8.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.925 -0.58 . . . . 0.99 109.801 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.568 HG23 HD21 ' A' ' 68' ' ' LEU . 4.9 p -126.76 18.61 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.433 0.635 . . . . 1.22 110.191 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -81.07 46.93 0.95 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.962 0.887 . . . . 4.11 109.304 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.572 HG12 HD11 ' A' ' 41' ' ' ILE . 1.8 mp -127.44 170.03 17.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.808 -1.087 . . . . 0.95 108.898 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.2 m -72.41 72.4 0.96 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.378 0.609 . . . . 1.25 110.92 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.526 HD11 ' O ' ' A' ' 101' ' ' ILE . 26.3 mt -116.17 171.77 7.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.886 -0.783 . . . . 1.38 108.886 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.07 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.012 0.82 . . . . 1.37 109.854 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 108.637 -0.875 . . . . 0.96 108.637 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -50.66 109.52 0.32 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.577 0.548 . . . . 2.62 110.19 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.22 143.8 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.775 . . . . 0.84 109.961 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.79 144.99 49.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.079 -0.341 . . . . 1.02 110.079 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -117.65 105.72 12.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.631 -1.248 . . . . 1.16 107.631 173.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.89 179.48 21.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.69 -0.767 . . . . 0.27 111.561 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HD3' ' HA2' ' A' ' 97' ' ' GLY . 94.3 mttt -109.45 162.73 14.08 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.557 0.694 . . . . 1.54 111.917 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.751 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -72.44 136.75 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.563 -1.199 . . . . 0.25 108.893 170.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.707 HG21 ' CB ' ' A' ' 59' ' ' ASP . 73.2 p -127.1 -17.64 4.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.05 0.452 . . . . 0.39 111.782 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 39.7 ttt180 -154.66 121.72 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.192 -0.67 . . . . 1.85 109.192 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.751 ' CD1' HG21 ' A' ' 46' ' ' ILE . 96.7 mt -125.47 102.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.245 -0.65 . . . . 0.26 109.245 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HB3' HD11 ' A' ' 53' ' ' LEU . 12.8 tp10 -99.17 108.0 47.4 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.005 -0.998 . . . . 2.24 109.933 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 45.0 Cg_exo -57.12 -29.8 84.64 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.96 2.44 . . . . 0.52 112.093 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -59.9 -29.76 68.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.81 -0.632 . . . . 1.23 111.247 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.669 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.2 pp -122.56 11.28 9.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.46 111.937 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.87 58.01 2.18 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.656 0.782 . . . . 2.51 112.034 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.99 160.75 25.03 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.387 -0.824 . . . . 0.19 110.846 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -120.59 140.79 51.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.18 112.285 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.8 m-85 -95.17 130.79 41.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.109 -0.95 . . . . 0.56 110.106 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.16 132.46 58.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.208 -0.451 . . . . 0.26 109.789 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.707 ' CB ' HG21 ' A' ' 47' ' ' THR . 13.8 t70 -100.81 103.32 14.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.95 0.405 . . . . 0.79 111.223 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -126.17 66.71 1.21 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.688 -0.856 . . . . 0.89 108.688 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.04 31.71 56.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.823 -0.703 . . . . 0.83 112.427 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.74 137.89 50.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.588 0.232 . . . . 0.86 110.625 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.23 -44.24 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 2.43 111.312 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -78.09 -16.55 57.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.778 -0.369 . . . . 4.52 110.242 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.8 m170 68.59 146.77 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.044 -0.98 . . . . 0.88 111.501 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.9 106.07 1.94 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.426 -1.07 . . . . 0.24 110.426 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.669 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 2.7 t80 -96.19 106.3 18.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.097 0.475 . . . . 0.41 110.709 -172.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.817 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -97.49 118.5 64.26 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.16 109.826 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.7 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 6.7 Cg_exo -69.91 141.04 43.57 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.128 1.885 . . . . 0.23 111.344 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.814 ' HA ' HG13 ' A' ' 73' ' ' ILE . 9.3 tp -57.39 -32.85 67.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.19 111.184 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.7 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.9 ptmm? -59.76 -20.89 59.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.678 -0.692 . . . . 2.04 111.624 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.58 -11.91 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.86 110.738 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.814 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.6 mt -49.88 127.37 5.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 113.588 0.958 . . . . 0.56 113.588 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -80.28 149.84 30.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.222 -1.354 . . . . 0.39 111.211 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 0.5 OUTLIER -66.33 -14.71 62.47 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.901 -0.59 . . . . 3.01 111.243 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.684 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 7.0 tp10 -69.97 -17.63 63.3 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.324 -0.86 . . . . 1.76 109.912 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -81.01 -52.97 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.912 -0.586 . . . . 1.4 109.733 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HB3' HG13 ' A' ' 93' ' ' VAL . 5.2 p90 -100.82 110.19 60.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.412 -1.329 . . . . 0.46 107.412 169.478 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.7 Cg_endo -37.97 135.45 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.454 0 C-N-CA 124.351 3.368 . . . . 0.71 113.766 -165.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.51 -7.19 0.37 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.712 -1.131 . . . . 0.93 113.127 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.64 -14.68 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.631 0.729 . . . . 2.62 109.391 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.435 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 78.9 t80 -92.43 119.37 31.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.281 -0.872 . . . . 1.33 109.294 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.3 t -63.08 125.91 25.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.924 0.393 . . . . 2.18 110.805 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.01 75.93 4.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.36 0.6 . . . . 1.74 110.634 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' HIS . . . . . 0.421 ' H ' ' CD2' ' A' ' 85' ' ' HIS . 3.0 p80 -78.29 111.59 14.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.99 110.452 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.87 -101.16 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.708 -0.678 . . . . 1.06 111.651 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -138.21 150.78 68.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 4.37 109.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' C ' HD11 ' A' ' 70' ' ' LEU . 5.6 Cg_endo -59.77 162.62 15.25 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.29 1.993 . . . . 0.31 112.983 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.528 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 0.7 OUTLIER -121.26 103.66 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 2.14 109.685 176.004 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 16.3 tt -57.02 -43.32 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 114.201 1.186 . . . . 0.21 114.201 -161.444 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.814 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 18.5 pttp -62.74 -15.05 51.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.157 0.428 . . . . 3.82 112.157 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.528 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 24.6 m-20 -122.89 19.13 10.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.498 0.666 . . . . 1.91 109.784 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.68 HG11 HG21 ' A' ' 73' ' ' ILE . 8.8 t -120.3 -51.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.814 . . . . 0.33 109.555 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.435 ' HB3' HG12 ' A' ' 46' ' ' ILE . 96.6 mt -101.35 164.6 11.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.545 -0.752 . . . . 0.3 109.404 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 152.66 32.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.99 -0.55 . . . . 2.67 109.637 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.6 ' HA ' HG22 ' A' ' 46' ' ' ILE . 25.5 mt-10 -63.46 118.09 7.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 1.25 110.262 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' HA2' ' HD3' ' A' ' 45' ' ' LYS . . . 112.96 -11.84 24.75 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.707 -0.759 . . . . 0.41 112.145 -174.592 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -86.68 137.88 32.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 1.18 109.785 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.404 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 12.6 pt-20 -86.95 157.13 19.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.81 112.067 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.544 HG23 HG22 ' A' ' 102' ' ' VAL . 32.9 m -143.47 156.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.18 109.833 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.573 ' H ' HD11 ' A' ' 122' ' ' LEU . 5.7 mm -104.92 110.83 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.083 -1.08 . . . . 0.51 108.083 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 100' ' ' VAL . 3.2 m -144.84 136.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.225 0.535 . . . . 0.28 112.384 -169.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -114.56 149.21 36.86 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.862 -0.792 . . . . 1.62 108.862 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.572 HD13 HD23 ' A' ' 116' ' ' LEU . 23.2 mm -74.69 101.97 2.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 0.78 110.447 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 32.8 t70 -83.5 -36.04 24.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.641 -1.163 . . . . 1.3 109.666 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.89 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 12.7 mptt -111.99 121.84 46.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.809 -1.182 . . . . 2.57 107.809 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.98 147.58 46.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.763 0.653 . . . . 2.57 112.763 -164.044 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -66.85 90.87 0.18 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.852 -1.067 . . . . 3.14 110.002 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -115.47 -61.94 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.238 -0.892 . . . . 3.49 110.422 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.68 -21.9 0.92 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.603 -1.18 . . . . 1.74 110.72 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -63.05 -50.85 68.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.99 0.424 . . . . 2.88 110.161 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -124.56 -37.53 2.49 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.43 0.633 . . . . 3.45 109.486 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.1 -153.19 17.7 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.874 -1.057 . . . . 0.91 110.588 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.03 91.28 4.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.559 -0.534 . . . . 0.52 109.559 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.89 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -95.1 133.3 39.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.134 0.492 . . . . 0.6 111.553 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.817 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 68.8 mt -90.23 157.09 17.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.853 -0.612 . . . . 0.35 110.133 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.75 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 14.0 t -116.72 170.06 8.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.301 -0.629 . . . . 0.99 109.301 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.606 HG23 HD21 ' A' ' 68' ' ' LEU . 15.8 p -126.39 25.67 6.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.271 0.558 . . . . 1.22 110.404 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.4 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.282 1.039 . . . . 4.11 108.905 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 101' ' ' ILE . 2.7 mp -128.15 163.48 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.472 -1.24 . . . . 0.95 108.029 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -74.15 53.81 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.335 0.588 . . . . 1.25 111.709 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 11.6 mt -116.91 109.44 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.481 -0.781 . . . . 1.38 110.048 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.755 0 O-C-N 124.469 1.106 . . . . 1.37 109.783 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.705 -0.48 . . . . 0.96 109.705 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 43.2 m-80 -66.28 91.57 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.326 -0.397 . . . . 2.62 110.982 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 9.5 tp -78.44 137.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.433 -0.349 . . . . 0.84 110.147 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 40' ' ' ASN . 90.5 m-85 -138.25 138.45 38.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.216 0.531 . . . . 1.02 110.49 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.01 104.94 14.78 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.549 -1.278 . . . . 1.16 107.549 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -137.45 -177.77 15.39 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.538 -0.839 . . . . 0.27 111.636 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 73.1 mttt -114.98 157.67 23.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.525 0.679 . . . . 1.54 111.016 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.999 HG21 HD11 ' A' ' 49' ' ' ILE . 1.5 mp -69.63 139.57 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.604 -1.18 . . . . 0.25 109.908 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.649 HG21 ' HB2' ' A' ' 59' ' ' ASP . 47.3 p -129.04 -23.26 3.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.096 0.474 . . . . 0.39 111.938 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.601 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 40.1 ttm180 -146.2 124.61 12.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.338 -0.392 . . . . 1.85 110.529 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.999 HD11 HG21 ' A' ' 46' ' ' ILE . 40.4 mt -140.29 112.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.408 -0.59 . . . . 0.26 109.408 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -119.55 130.67 24.72 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.828 0.347 . . . . 2.24 110.734 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.776 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 2.8 Cg_exo -71.04 -22.47 26.2 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.953 2.435 . . . . 0.52 111.409 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.89 -15.32 61.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.375 -0.83 . . . . 1.23 111.315 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.9 pp -128.3 -5.54 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 119.309 -0.377 . . . . 0.46 111.488 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 41.39 64.37 1.04 Allowed 'General case' 0 C--N 1.351 0.638 0 CA-C-O 121.772 0.796 . . . . 2.51 111.616 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -169.25 167.92 10.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.052 -1.431 . . . . 0.19 109.069 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -135.82 142.71 44.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.18 112.547 -172.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 49.7 m-85 -96.59 134.72 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.56 110.195 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 100' ' ' VAL . 53.9 t -108.41 128.0 64.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.094 -0.957 . . . . 0.26 109.372 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.649 ' HB2' HG21 ' A' ' 47' ' ' THR . 13.0 t0 -98.61 108.44 21.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.002 0.43 . . . . 0.79 110.021 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -124.64 65.43 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.459 0.647 . . . . 0.89 109.434 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.08 34.6 52.88 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.336 -0.935 . . . . 0.83 111.452 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.88 115.15 24.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.655 0.264 . . . . 0.86 110.555 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -64.59 -27.06 68.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.911 -0.774 . . . . 2.43 108.911 175.597 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.49 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 19.9 mtm-85 -84.06 -11.47 56.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.662 -1.154 . . . . 4.52 110.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.426 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 61.28 -159.77 0.31 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.485 -0.779 . . . . 0.88 109.998 -172.988 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.79 120.24 0.98 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 109.867 -1.293 . . . . 0.24 109.867 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.1 t80 -103.78 113.22 26.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.192 0.52 . . . . 0.41 111.169 -169.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.891 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -100.0 115.2 65.74 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.315 -0.857 . . . . 0.16 110.143 177.983 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 25.4 Cg_exo -64.66 143.61 81.54 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.752 2.301 . . . . 0.23 111.803 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.846 HD13 ' HB ' ' A' ' 90' ' ' ILE . 24.3 tp -66.4 -26.5 67.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.959 -0.564 . . . . 0.19 111.514 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.547 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 20.9 pttp -73.05 -9.65 58.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.359 . . . . 2.04 110.999 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 17.0 mm-40 -100.04 -14.93 18.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.86 110.078 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.654 HG21 HG11 ' A' ' 93' ' ' VAL . 6.1 mm -49.04 133.57 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 113.47 0.915 . . . . 0.56 113.47 -168.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -89.11 151.06 22.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.311 -1.313 . . . . 0.39 111.864 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.848 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 3.0 tmm_? -65.24 -21.69 66.78 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.198 -0.91 . . . . 3.01 111.1 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.53 ' HB3' HD23 ' A' ' 122' ' ' LEU . 4.5 tp10 -73.99 -14.95 61.11 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.446 -0.784 . . . . 1.76 110.852 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -81.76 -52.71 6.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.856 -0.611 . . . . 1.4 109.861 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 93' ' ' VAL . 8.2 p90 -96.62 109.09 46.55 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.14 -1.43 . . . . 0.46 107.14 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.2 Cg_endo -40.56 137.14 1.68 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 123.87 3.047 . . . . 0.71 113.025 -166.674 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -48.99 -16.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.841 1.052 . . . . 0.93 113.841 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.52 -7.2 59.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 2.62 110.786 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.42 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 69.6 t80 -84.89 144.01 28.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.099 -0.704 . . . . 1.33 109.099 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -78.67 100.69 7.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 2.18 111.777 -175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -81.13 120.09 24.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 1.74 110.525 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -138.82 105.45 5.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.034 -0.53 . . . . 3.99 110.647 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.87 -83.74 1.04 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.806 -0.711 . . . . 1.06 111.824 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 133.49 17.3 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.791 0.329 . . . . 4.37 110.252 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HB2' HG21 ' A' ' 93' ' ' VAL . 11.6 Cg_endo -59.64 153.6 54.44 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.87 2.38 . . . . 0.31 113.131 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.632 ' O ' HG23 ' A' ' 93' ' ' VAL . 26.6 t-20 -106.28 111.26 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.644 -0.873 . . . . 2.14 108.644 172.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.846 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.4 tt -62.78 -36.29 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.691 0.626 . . . . 0.21 112.691 -164.861 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.776 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 32.4 mmmt -67.27 -5.59 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.482 0.549 . . . . 3.82 112.482 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 23.07 7.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 1.91 109.58 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.654 HG11 HG21 ' A' ' 73' ' ' ILE . 48.0 t -121.94 -54.86 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.12 -0.945 . . . . 0.33 109.833 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.775 ' HB3' HG12 ' A' ' 46' ' ' ILE . 93.5 mt -109.95 158.83 17.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.071 -0.968 . . . . 0.3 110.548 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 146.0 26.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.128 -0.942 . . . . 2.67 109.352 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.608 ' HA ' HG22 ' A' ' 46' ' ' ILE . 47.8 mt-10 -55.6 119.48 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.25 110.893 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.47 -16.49 24.2 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.682 -0.69 . . . . 0.41 112.129 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.2 tt0 -82.39 138.58 34.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.796 -0.446 . . . . 1.18 109.796 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 12.5 pt-20 -87.54 156.73 19.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.256 0.55 . . . . 0.81 111.936 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 102' ' ' VAL . 33.5 m -141.02 147.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.973 -1.012 . . . . 0.18 109.397 171.484 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.598 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.2 mm -99.57 110.29 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.26 -1.015 . . . . 0.51 108.26 171.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 100' ' ' VAL . 3.4 m -144.64 132.5 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.28 111.447 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 7.7 pt20 -107.02 133.13 52.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.249 -0.432 . . . . 1.62 109.921 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.489 HD13 HD23 ' A' ' 116' ' ' LEU . 19.6 mm -67.14 102.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.78 110.159 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.26 -38.63 24.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 1.3 109.531 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 54.9 mttp -117.77 132.51 56.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.358 -0.837 . . . . 2.57 110.09 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -102.34 158.57 16.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.908 -1.042 . . . . 2.57 111.0 -168.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 1.06 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 0.2 OUTLIER -52.52 117.41 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 3.14 111.298 -176.292 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -143.98 18.91 1.79 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.858 -1.064 . . . . 3.49 109.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.65 -43.37 3.17 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.824 -0.626 . . . . 1.74 112.893 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.55 -51.28 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.853 0.316 . . . . 2.88 111.853 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -125.02 -38.93 2.29 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.378 0.609 . . . . 3.45 110.971 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 1.06 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 92.07 -126.79 8.65 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.469 -0.872 . . . . 0.91 111.687 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.07 94.19 7.16 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.812 0.339 . . . . 0.52 110.747 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -94.52 124.96 38.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.474 -0.33 . . . . 0.6 111.604 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.891 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 25.1 mt -90.8 135.66 33.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.729 -0.471 . . . . 0.35 109.729 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 119' ' ' PHE . 7.1 t -97.38 167.57 10.92 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.446 -0.575 . . . . 0.99 109.446 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.618 HG23 HD21 ' A' ' 68' ' ' LEU . 11.9 p -125.32 19.83 8.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.165 0.507 . . . . 1.22 111.224 173.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 73.7 m-85 -80.89 54.13 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.826 0.822 . . . . 4.11 109.918 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 121' ' ' SER . 2.0 mp -127.63 175.85 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.579 -1.191 . . . . 0.95 108.054 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.629 ' H ' HG22 ' A' ' 120' ' ' ILE . 1.5 m -66.85 19.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.425 0.898 . . . . 1.25 113.425 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 76' ' ' GLU . 6.6 mp -115.9 106.5 13.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.22 -0.3 . . . . 1.38 110.433 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 124.727 1.211 . . . . 1.37 109.254 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.459 -0.941 . . . . 0.96 108.459 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -57.54 117.6 4.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 2.62 110.447 -175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 HG12 ' A' ' 120' ' ' ILE . 7.5 tp -84.39 146.74 6.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.84 111.292 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.78 147.29 40.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.409 -0.36 . . . . 1.02 110.556 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 41.3 ttmt -108.37 116.63 32.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 1.16 109.045 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.21 23.85 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.83 -0.908 . . . . 0.27 110.83 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 68.4 mttt -102.33 161.37 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.27 0.557 . . . . 1.54 110.814 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.824 HG12 ' HB3' ' A' ' 94' ' ' LEU . 1.8 mp -70.23 136.47 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.842 -1.072 . . . . 0.25 109.239 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 59' ' ' ASP . 1.9 p -121.52 -33.52 3.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.419 0.628 . . . . 0.39 111.139 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.617 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 39.4 ttm180 -147.68 122.14 9.73 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.269 -0.878 . . . . 1.85 110.384 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.694 HD11 HG21 ' A' ' 46' ' ' ILE . 51.1 mt -131.62 130.11 62.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.525 -0.546 . . . . 0.26 109.525 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.861 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 22.6 tt0 -129.29 131.51 23.7 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.868 -0.606 . . . . 2.24 109.461 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.746 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 9.4 Cg_exo -68.3 -24.92 36.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.475 2.117 . . . . 0.52 111.31 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.378 -0.828 . . . . 1.23 111.079 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.861 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.1 pp -118.48 -1.85 11.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 119.086 -0.483 . . . . 0.46 111.758 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 41.04 54.22 3.3 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-O 121.979 0.895 . . . . 2.51 111.396 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.37 166.52 27.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.269 -1.332 . . . . 0.19 109.499 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -133.47 134.24 43.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.406 -0.361 . . . . 0.18 111.55 -175.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.617 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 76.4 m-85 -85.86 133.1 33.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.387 -0.597 . . . . 0.56 109.387 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.544 ' HB ' HD11 ' A' ' 116' ' ' LEU . 31.5 t -115.34 128.75 72.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.469 -0.787 . . . . 0.26 109.626 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.858 ' HB2' HG21 ' A' ' 47' ' ' THR . 12.3 t0 -101.94 108.77 20.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.886 -0.597 . . . . 0.79 110.321 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.14 65.49 1.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.369 -0.974 . . . . 0.89 108.369 171.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.48 30.5 50.04 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.525 -0.845 . . . . 0.83 111.699 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.06 153.05 18.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 0.86 111.552 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.77 -27.35 15.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.686 -0.688 . . . . 2.43 110.52 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 2.4 mmp_? -113.57 -9.36 13.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.083 -0.508 . . . . 4.52 110.532 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 9.7 m170 70.34 144.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.243 -0.889 . . . . 0.88 111.221 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA3' HD21 ' A' ' 116' ' ' LEU . . . -78.78 104.23 2.07 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.413 -0.898 . . . . 0.24 110.965 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.653 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 1.7 t80 -91.32 97.73 11.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.178 0.513 . . . . 0.41 110.191 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.025 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -86.42 115.44 62.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.56 -0.746 . . . . 0.16 110.188 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.672 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 10.3 Cg_exo -69.52 141.33 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.245 1.963 . . . . 0.23 111.471 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 21.2 tp -54.78 -30.62 57.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.335 -0.848 . . . . 0.19 112.144 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.672 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.0 ptmm? -61.76 -22.99 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 2.04 111.768 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -93.57 -21.75 19.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.48 -0.327 . . . . 0.86 111.256 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.717 HG21 HG11 ' A' ' 93' ' ' VAL . 17.0 mt -49.01 132.21 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.155 0.798 . . . . 0.56 113.155 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -93.67 151.9 19.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.197 -0.91 . . . . 0.39 111.363 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 10.0 tpt180 -54.38 -16.1 2.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.525 -1.216 . . . . 3.01 112.777 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.029 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 29.7 tp10 -63.5 -29.89 71.09 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.788 -0.57 . . . . 1.76 110.823 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.644 ' CE1' HG12 ' A' ' 100' ' ' VAL . 26.1 m-85 -86.14 -41.61 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.317 -0.856 . . . . 1.4 110.733 -172.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' HB3' HG22 ' A' ' 93' ' ' VAL . 2.1 p90 -102.3 92.13 3.03 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 107.551 -1.277 . . . . 0.46 107.551 166.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 23.4 Cg_exo -26.72 137.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.675 4.25 . . . . 0.71 115.374 -167.504 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.6 -25.39 17.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.356 -1.293 . . . . 0.93 112.579 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.59 -6.57 59.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.196 0.522 . . . . 2.62 111.253 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 79' ' ' PRO . 58.1 t80 -87.85 135.38 33.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.313 -0.625 . . . . 1.33 109.313 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -71.61 116.37 11.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.051 -0.722 . . . . 2.18 109.051 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.483 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -63.73 -21.03 66.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.886 0.699 . . . . 1.74 112.886 -170.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 40.6 m80 65.55 23.93 11.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.284 0.564 . . . . 3.99 110.412 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.41 -57.93 4.18 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.513 -0.767 . . . . 1.06 111.953 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -137.3 130.27 17.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.864 0.364 . . . . 4.37 110.46 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' O ' HD11 ' A' ' 70' ' ' LEU . 6.5 Cg_endo -61.4 154.59 57.78 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.163 2.575 . . . . 0.31 113.697 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.7 t-20 -114.98 110.7 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.24 -0.652 . . . . 2.14 109.24 171.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 tt -55.63 -43.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 113.649 0.981 . . . . 0.21 113.649 -164.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.746 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 4.7 mmmp? -56.7 -26.37 56.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.245 0.831 . . . . 3.82 113.245 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -110.18 9.38 23.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.145 0.497 . . . . 1.91 111.079 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.717 HG11 HG21 ' A' ' 73' ' ' ILE . 53.2 t -115.21 -51.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.638 -0.71 . . . . 0.33 109.849 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.824 ' HB3' HG12 ' A' ' 46' ' ' ILE . 83.1 mt -103.16 154.05 19.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.44 -0.8 . . . . 0.3 109.691 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -148.15 151.99 36.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.521 -0.763 . . . . 2.67 108.95 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HA ' HG22 ' A' ' 46' ' ' ILE . 36.6 mt-10 -62.06 118.69 7.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 1.25 110.237 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.35 -18.33 20.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.85 -0.614 . . . . 0.41 112.209 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 tt0 -78.02 135.86 37.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.479 -0.563 . . . . 1.18 109.479 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.9 157.37 19.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.136 0.493 . . . . 0.81 111.361 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG12 ' CE1' ' A' ' 77' ' ' TYR . 35.0 m -138.07 151.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.169 -0.923 . . . . 0.18 109.959 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 122' ' ' LEU . 3.5 mm -103.06 110.14 28.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.67 -1.233 . . . . 0.51 107.67 171.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -143.61 134.79 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.559 . . . . 0.28 111.783 -170.215 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -108.33 141.26 40.41 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.56 -0.904 . . . . 1.62 108.56 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 104' ' ' ILE . 18.3 mm -74.98 104.53 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.667 0.746 . . . . 0.78 111.367 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.47 -43.33 32.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.686 -1.143 . . . . 1.3 109.776 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.658 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 60.4 mttp -118.04 137.42 52.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.66 -0.7 . . . . 2.57 109.895 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.64 144.38 32.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.007 -0.997 . . . . 2.57 112.547 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 40.8 tt0 -71.63 90.91 1.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.31 -0.859 . . . . 3.14 110.321 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.599 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 17.8 mtt180 -105.53 -82.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.453 -0.794 . . . . 3.49 110.665 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.93 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.561 -0.828 . . . . 1.74 112.569 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.427 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 21.6 t-20 -61.59 -49.71 75.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.579 0.214 . . . . 2.88 111.579 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 29.3 mtpp -123.55 -38.05 2.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.321 0.581 . . . . 3.45 109.812 171.719 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.599 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 85.64 -132.71 11.28 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.149 -0.932 . . . . 0.91 112.531 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 65' ' ' HIS . . . -75.57 108.01 8.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.148 -0.526 . . . . 0.52 111.326 -171.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -104.22 125.24 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.213 -0.449 . . . . 0.6 110.431 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.025 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 30.4 mt -90.8 148.72 22.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.989 0.423 . . . . 0.35 109.965 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -113.93 175.46 5.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.17 -0.678 . . . . 0.99 109.17 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.27 26.99 6.73 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.401 0.619 . . . . 1.22 110.274 173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -78.15 44.45 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.547 1.165 . . . . 4.11 109.141 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 101' ' ' ILE . 3.3 mp -128.46 161.73 36.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.839 -1.073 . . . . 0.95 108.982 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.06 66.82 0.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.967 0.413 . . . . 1.25 111.301 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 101' ' ' ILE . 1.9 mt -116.25 173.31 6.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.112 -0.699 . . . . 1.38 109.112 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.029 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.33 -0.258 0 O-C-N 123.92 0.762 . . . . 1.37 110.622 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.614 -0.884 . . . . 0.96 108.614 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -52.79 119.77 4.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.527 . . . . 2.62 110.665 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.678 HD11 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -89.52 138.62 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.218 -0.901 . . . . 0.84 110.326 -175.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -133.25 156.41 47.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.021 0.438 . . . . 1.02 110.343 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.8 ttmt -118.49 121.66 40.82 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.795 -0.817 . . . . 1.16 108.795 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.82 166.95 25.78 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.675 -0.97 . . . . 0.27 110.675 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 90.4 mttt -100.21 156.88 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.41 0.624 . . . . 1.54 111.114 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.891 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -69.86 134.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.661 -1.154 . . . . 0.25 109.822 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 59' ' ' ASP . 61.6 p -123.87 -18.41 6.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.357 0.599 . . . . 0.39 111.314 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HG2' ' HD2' ' A' ' 57' ' ' PHE . 7.2 ttm180 -150.6 131.3 14.02 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.361 -0.836 . . . . 1.85 110.524 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 46' ' ' ILE . 58.0 mt -139.81 101.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.657 -0.868 . . . . 0.26 108.657 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.597 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -98.57 112.46 62.53 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.0 -0.545 . . . . 2.24 110.015 -177.06 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.996 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 52.9 Cg_exo -57.12 -22.37 47.37 Favored 'Trans proline' 0 N--CA 1.467 -0.054 0 C-N-CA 122.953 2.435 . . . . 0.52 111.894 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -71.69 -20.09 61.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.23 111.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -128.36 12.74 6.53 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.811 1.041 . . . . 0.46 113.811 -176.056 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER 47.73 40.78 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 2.51 112.818 173.973 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.54 170.24 20.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 0.19 111.076 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' PHE . . . -137.63 149.12 46.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.18 112.032 -173.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.526 ' HD2' ' HG2' ' A' ' 48' ' ' ARG . 63.4 m-85 -98.38 137.64 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.56 109.826 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.637 ' HB ' HD11 ' A' ' 116' ' ' LEU . 24.3 t -118.72 131.78 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.347 -0.842 . . . . 0.26 109.832 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.602 ' HB2' HG21 ' A' ' 47' ' ' THR . 22.2 t70 -100.43 104.86 16.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.79 110.649 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -127.11 65.4 1.3 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.973 -0.751 . . . . 0.89 108.973 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.41 52.18 19.6 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.336 -0.935 . . . . 0.83 111.328 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 168.48 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.86 111.193 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 7.4 tp10 -93.78 -53.54 3.98 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.905 -0.318 . . . . 2.43 111.381 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.4 ptm180 -109.16 6.54 24.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.132 -0.627 . . . . 4.52 110.778 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 15.7 m170 71.25 143.28 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.24 -0.891 . . . . 0.88 111.511 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -74.53 117.33 5.46 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.829 -0.909 . . . . 0.24 110.829 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 21.6 t80 -99.83 98.73 9.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.166 0.508 . . . . 0.41 110.375 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.925 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -87.34 117.54 68.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.506 -0.77 . . . . 0.16 111.05 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' HD23 ' A' ' 68' ' ' LEU . 21.3 Cg_exo -67.65 141.85 56.37 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.821 2.347 . . . . 0.23 111.721 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.699 HD13 ' HB ' ' A' ' 90' ' ' ILE . 18.0 tp -59.34 -35.09 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.19 112.035 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -67.83 -8.22 34.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.394 -0.366 . . . . 2.04 111.786 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -96.31 -26.98 15.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.641 -0.254 . . . . 0.86 110.349 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.545 HG21 HG11 ' A' ' 93' ' ' VAL . 33.9 mt -49.85 135.06 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.436 0.902 . . . . 0.56 113.436 -167.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -91.07 148.99 22.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.394 -1.275 . . . . 0.39 111.432 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.662 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 13.6 ttp180 -58.41 -14.49 7.8 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.937 -1.029 . . . . 3.01 112.583 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.673 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 10.4 tp10 -54.36 -38.82 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 1.76 111.789 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.92 ' OH ' ' HA ' ' A' ' 100' ' ' VAL . 39.2 m-85 -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.581 0.586 . . . . 1.4 112.581 -168.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.662 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 12.5 p90 -97.91 88.58 0.65 Allowed Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 105.996 -1.853 . . . . 0.46 105.996 158.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.08 143.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.876 3.717 . . . . 0.71 114.216 -157.706 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.95 -7.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.907 -1.042 . . . . 0.93 112.65 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.7 -21.94 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.472 0.653 . . . . 2.62 109.607 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -77.64 130.67 37.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.11 -0.95 . . . . 1.33 109.466 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -68.57 100.35 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 2.18 110.339 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -83.22 103.02 12.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.683 -0.69 . . . . 1.74 110.634 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -130.76 131.89 44.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.824 -0.625 . . . . 3.99 109.856 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.15 -102.32 2.16 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.558 -0.829 . . . . 1.06 111.84 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -136.94 133.12 18.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.138 -0.319 . . . . 4.37 110.138 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -60.0 156.48 38.87 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.417 1.412 . . . . 0.31 111.091 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.4 t-20 -118.34 101.4 8.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.676 -0.49 . . . . 2.14 109.676 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.699 ' HB ' HD13 ' A' ' 70' ' ' LEU . 19.9 tt -54.79 -45.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.598 0.962 . . . . 0.21 113.598 -164.219 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.996 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 17.0 ptmt -56.42 -16.54 5.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.838 0.681 . . . . 3.82 112.838 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -118.18 1.34 11.91 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.521 0.676 . . . . 1.91 110.624 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 78' ' ' PHE . 45.3 t -105.58 -50.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.655 0.741 . . . . 0.33 109.543 -175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.681 ' HB3' HG12 ' A' ' 46' ' ' ILE . 81.6 mt -100.84 152.72 20.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.354 -0.839 . . . . 0.3 109.172 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 149.09 30.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.355 -0.839 . . . . 2.67 109.389 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.538 ' HA ' HG22 ' A' ' 46' ' ' ILE . 31.0 mt-10 -56.24 123.93 16.24 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.722 0.639 . . . . 1.25 111.203 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.3 29.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.615 -0.721 . . . . 0.41 112.151 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 53.3 tt0 -77.14 133.4 38.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.054 -0.35 . . . . 1.18 110.054 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.43 158.1 24.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.714 . . . . 0.81 110.97 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.92 ' HA ' ' OH ' ' A' ' 77' ' ' TYR . 27.5 m -137.41 146.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.18 110.549 170.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.989 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.6 mm -93.83 110.14 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.237 -1.023 . . . . 0.51 108.237 169.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.539 ' CG2' HD22 ' A' ' 116' ' ' LEU . 3.4 m -144.32 129.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.199 0.523 . . . . 0.28 111.26 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 15.6 pt20 -93.53 138.87 31.37 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.507 -0.923 . . . . 1.62 108.507 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.569 ' CD1' HD23 ' A' ' 116' ' ' LEU . 41.7 mm -80.54 96.21 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.615 0.721 . . . . 0.78 109.338 176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.87 -29.49 63.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.727 -1.124 . . . . 1.3 109.852 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 32.3 mttm -129.07 123.97 33.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 2.57 109.578 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -79.26 158.71 27.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.95 -0.568 . . . . 2.57 110.305 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.898 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 22.5 tt0 -70.63 90.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.56 0.695 . . . . 3.14 110.717 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -111.26 6.98 20.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.862 -1.063 . . . . 3.49 110.974 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.36 -46.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.643 -0.789 . . . . 1.74 113.432 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.65 -50.84 70.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.007 0.403 . . . . 2.88 111.064 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 -37.28 2.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.631 -0.877 . . . . 3.45 108.631 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.898 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 83.52 -133.4 11.85 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.823 -1.081 . . . . 0.91 111.098 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.476 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -73.02 96.87 2.22 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.155 0.502 . . . . 0.52 110.309 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -104.03 124.42 49.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.6 111.528 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.925 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 31.4 mt -91.4 159.77 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.049 -0.723 . . . . 0.35 109.049 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.431 ' O ' HG12 ' A' ' 102' ' ' VAL . 12.8 t -138.08 153.4 49.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.186 -0.672 . . . . 0.99 109.186 168.001 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.413 HG23 HD11 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -126.86 34.49 4.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.302 0.572 . . . . 1.22 111.015 172.143 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -80.25 45.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.357 -0.979 . . . . 4.11 108.357 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.631 ' HB ' HD12 ' A' ' 122' ' ' LEU . 11.0 mt -121.36 168.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.471 -1.24 . . . . 0.95 108.37 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -85.03 33.48 0.54 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.947 0.721 . . . . 1.25 112.947 -172.016 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.989 ' HG ' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -117.2 100.19 7.54 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.684 0.754 . . . . 1.38 109.882 175.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.673 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.712 -0.676 . . . . 1.37 109.907 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.194 -0.669 . . . . 0.96 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -55.69 124.03 16.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.084 0.469 . . . . 2.62 110.948 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -95.33 144.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.881 -0.6 . . . . 0.84 109.663 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -125.22 135.45 52.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 1.02 110.449 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 40.0 ttmt -98.75 103.67 15.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.911 -0.774 . . . . 1.16 108.911 167.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.94 161.89 19.35 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 110.691 -0.964 . . . . 0.27 110.691 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 84.6 mttt -94.45 158.06 15.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.171 0.51 . . . . 1.54 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.769 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.8 mp -74.57 133.69 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.144 -1.058 . . . . 0.25 108.144 169.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.587 HG21 ' CB ' ' A' ' 59' ' ' ASP . 57.5 p -117.57 -20.09 9.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.436 0.636 . . . . 0.39 110.525 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 24.4 ttt180 -146.6 121.42 9.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.136 -0.938 . . . . 1.85 109.677 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.769 ' CD1' HG21 ' A' ' 46' ' ' ILE . 75.4 mt -125.91 109.0 20.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.147 -0.686 . . . . 0.26 109.147 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 7.0 tp10 -104.47 107.78 58.77 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.221 -0.9 . . . . 2.24 109.488 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HB3' ' CD ' ' A' ' 91' ' ' LYS . 54.3 Cg_exo -53.95 -37.94 86.08 Favored 'Trans proline' 0 N--CA 1.467 -0.07 0 C-N-CA 123.309 2.673 . . . . 0.52 112.578 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -22.12 65.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.23 112.158 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.0 pp -123.59 8.25 8.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.15 0.426 . . . . 0.46 112.15 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB2' HD23 ' A' ' 70' ' ' LEU . 8.0 pt-20 39.23 60.23 1.55 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.705 0.802 . . . . 2.51 112.197 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -165.67 158.47 15.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.248 -0.887 . . . . 0.19 110.405 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -122.91 144.49 49.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.546 0.572 . . . . 0.18 112.546 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.552 ' HD1' ' HB2' ' A' ' 65' ' ' HIS . 63.1 m-85 -97.02 137.09 36.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.417 -0.811 . . . . 0.56 109.844 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 116' ' ' LEU . 38.4 t -120.47 129.67 75.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.019 -0.537 . . . . 0.26 109.675 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.587 ' CB ' HG21 ' A' ' 47' ' ' THR . 29.2 t70 -102.41 112.68 25.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.319 -0.401 . . . . 0.79 111.384 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.0 67.45 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.047 -0.723 . . . . 0.89 109.047 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.8 41.33 58.05 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.728 -0.669 . . . . 0.83 112.153 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.21 147.61 44.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.86 111.271 -172.587 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.66 -51.26 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 2.43 108.803 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.911 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 26.7 mmm180 -96.23 106.61 18.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.224 -0.898 . . . . 4.52 108.793 169.258 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 18.9 m170 -61.56 149.83 37.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 0.88 111.51 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.08 110.31 3.14 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.771 -0.931 . . . . 0.24 110.771 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 9.5 t80 -98.87 100.58 11.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.326 0.584 . . . . 0.41 110.827 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.94 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -92.15 115.09 64.06 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.09 -0.959 . . . . 0.16 110.94 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.653 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.0 Cg_exo -64.07 141.07 75.14 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.864 2.376 . . . . 0.23 111.562 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.831 ' HA ' HG13 ' A' ' 73' ' ' ILE . 10.3 tp -63.07 -34.93 78.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.605 -0.725 . . . . 0.19 111.722 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.08 -14.8 52.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.982 0.42 . . . . 2.04 111.083 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 1.6 mm-40 -99.19 -14.45 19.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.86 110.534 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.831 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.8 mt -49.31 134.05 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.151 0.797 . . . . 0.56 113.151 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -87.05 146.5 26.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.814 -1.084 . . . . 0.39 110.922 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.604 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 18.2 ttm180 -62.19 -13.51 28.29 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.384 -0.825 . . . . 3.01 111.806 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.684 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 15.0 tp10 -60.87 -27.22 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.468 . . . . 1.76 110.757 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.429 ' HD2' HG23 ' A' ' 73' ' ' ILE . 14.8 m-85 -87.45 -44.17 11.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.447 -0.797 . . . . 1.4 110.353 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.1 p90 -96.17 97.34 3.08 Favored Pre-proline 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 0.46 107.098 166.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.1 Cg_endo -38.65 138.02 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.306 3.337 . . . . 0.71 112.776 -163.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.69 -10.28 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.395 -0.821 . . . . 0.93 113.193 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -87.02 -12.6 46.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.349 0.595 . . . . 2.62 110.317 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.88 143.5 41.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.782 -0.644 . . . . 1.33 109.688 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -79.52 100.64 7.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.37 -0.377 . . . . 2.18 110.957 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -87.04 123.4 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 1.74 110.182 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.57 -20.43 18.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.007 0.432 . . . . 3.99 110.373 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -77.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.914 -0.66 . . . . 1.06 111.572 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -104.84 132.57 20.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.043 -0.355 . . . . 4.37 110.043 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' C ' HD11 ' A' ' 70' ' ' LEU . 11.5 Cg_endo -64.66 161.78 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.116 1.877 . . . . 0.31 111.975 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.583 ' OD1' ' HB3' ' A' ' 92' ' ' ASP . 0.4 OUTLIER -122.11 102.62 8.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 2.14 109.78 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 17.3 tt -54.85 -40.16 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.699 1.0 . . . . 0.21 113.699 -162.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.605 ' CD ' ' HB3' ' A' ' 51' ' ' PRO . 43.2 pttt -67.65 -11.6 58.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.953 0.353 . . . . 3.82 111.953 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.583 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 37.0 t70 -125.53 18.25 8.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.159 0.98 . . . . 1.91 109.359 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 78' ' ' PHE . 18.1 t -122.5 -54.77 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.33 110.198 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 49' ' ' ILE . 47.8 mt -101.09 153.34 19.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.429 -0.805 . . . . 0.3 109.55 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.526 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -125.43 150.53 47.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.106 -0.702 . . . . 2.67 109.106 173.727 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.66 ' HA ' HG22 ' A' ' 46' ' ' ILE . 42.2 mt-10 -69.95 109.31 4.44 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.257 -1.016 . . . . 1.25 108.257 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.21 -11.46 19.81 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.438 -0.801 . . . . 0.41 112.15 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 46.8 tt0 -80.29 144.71 32.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.206 0.503 . . . . 1.18 109.966 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.69 153.71 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.32 0.581 . . . . 0.81 111.612 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 102' ' ' VAL . 27.3 m -136.29 146.4 29.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.088 -0.96 . . . . 0.18 109.018 169.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.896 ' HB ' HD11 ' A' ' 122' ' ' LEU . 4.3 mm -100.42 109.12 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.571 -1.27 . . . . 0.51 107.571 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.523 ' CG2' HD22 ' A' ' 116' ' ' LEU . 4.8 m -145.5 142.63 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.021 -0.536 . . . . 0.28 110.717 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.48 ' HG3' HG22 ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.4 166.28 10.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.381 -0.6 . . . . 1.62 109.381 175.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.477 ' CD1' HD23 ' A' ' 116' ' ' LEU . 18.7 mm -108.53 98.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.629 0.728 . . . . 0.78 110.072 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -83.71 -29.41 27.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.066 -0.97 . . . . 1.3 110.381 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 36.1 mmtm -117.65 136.35 53.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.449 . . . . 2.57 109.895 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 28.2 mt-10 -97.56 158.25 15.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.417 -0.81 . . . . 2.57 110.447 -166.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.911 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 24.8 tt0 -51.25 112.21 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.547 0.529 . . . . 3.14 110.803 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.917 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 12.7 ptm180 -146.65 49.28 1.15 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.454 -0.794 . . . . 3.49 110.382 -175.345 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.34 -96.25 1.0 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.788 -0.642 . . . . 1.74 113.991 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -60.66 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.004 0.742 . . . . 2.88 113.004 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -110.86 -40.28 4.58 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.143 -0.623 . . . . 3.45 110.144 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.917 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 60.88 -121.51 26.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.487 -0.778 . . . . 0.91 112.509 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.538 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -72.99 101.08 3.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.164 0.506 . . . . 0.52 110.607 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -98.59 124.0 43.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.248 -0.433 . . . . 0.6 110.907 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.94 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 46.9 mt -90.93 136.75 32.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 0.35 109.732 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' HG3' ' A' ' 103' ' ' GLN . 5.0 t -96.82 168.17 10.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.635 . . . . 0.99 109.284 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.61 HG23 HD21 ' A' ' 68' ' ' LEU . 2.0 p -136.01 13.99 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.155 0.502 . . . . 1.22 111.159 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.91 57.52 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.246 -1.02 . . . . 4.11 108.246 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 121' ' ' SER . 8.1 mt -127.9 175.5 9.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 113.975 -1.466 . . . . 0.95 108.648 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.586 ' H ' HG22 ' A' ' 120' ' ' ILE . 14.6 m -75.61 33.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.448 0.536 . . . . 1.25 112.448 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.896 HD11 ' HB ' ' A' ' 101' ' ' ILE . 4.2 mp -116.34 124.22 49.56 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.349 -0.219 . . . . 1.38 111.496 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.468 0.441 0 O-C-N 124.911 1.382 . . . . 1.37 109.149 170.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 108.676 -0.861 . . . . 0.96 108.676 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.8 t30 -61.66 124.95 22.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.378 0.609 . . . . 2.62 110.783 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 103' ' ' GLN . 7.3 tp -94.18 143.96 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.194 -0.912 . . . . 0.84 110.098 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.22 144.09 51.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.05 0.452 . . . . 1.02 110.968 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 99' ' ' GLU . 2.4 tppp? -112.42 117.61 32.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.307 -0.86 . . . . 1.16 109.389 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.63 30.64 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.629 -0.988 . . . . 0.27 110.629 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 97' ' ' GLY . 39.2 mtmt -116.52 159.11 22.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.64 0.733 . . . . 1.54 111.88 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.749 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -68.42 137.77 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.322 -1.308 . . . . 0.25 110.089 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 59' ' ' ASP . 47.5 p -126.56 -20.18 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.39 111.689 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.684 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 8.3 ttm180 -148.08 122.02 9.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.072 -0.513 . . . . 1.85 110.09 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.749 ' CD1' HG21 ' A' ' 46' ' ' ILE . 88.2 mt -128.87 108.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.146 -0.687 . . . . 0.26 109.146 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 17.3 tt0 -102.89 121.05 50.59 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.894 -0.594 . . . . 2.24 109.688 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG3' ' CD ' ' A' ' 91' ' ' LYS . 12.2 Cg_exo -65.8 -31.25 48.71 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.977 2.451 . . . . 0.52 112.759 -171.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 t -77.03 -10.11 59.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 1.23 111.657 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 3.1 pp -127.82 5.77 6.06 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.728 0.64 . . . . 0.46 112.728 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 70' ' ' LEU . 11.2 pt-20 43.47 55.55 4.81 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.352 0.596 . . . . 2.51 112.095 170.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.0 158.98 22.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.461 -0.79 . . . . 0.19 110.365 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -129.1 140.26 51.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.873 0.694 . . . . 0.18 112.873 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.711 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 53.0 m-85 -92.43 128.61 38.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.134 -0.939 . . . . 0.56 110.119 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.535 HG12 ' HD1' ' A' ' 60' ' ' TYR . 76.5 t -108.54 131.01 60.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.25 0.547 . . . . 0.26 109.884 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.689 ' HB2' HG21 ' A' ' 47' ' ' THR . 10.6 t70 -101.49 96.49 7.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.715 -0.675 . . . . 0.79 110.664 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.661 ' OH ' HD11 ' A' ' 104' ' ' ILE . 15.5 p90 -126.88 66.29 1.27 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.032 -0.729 . . . . 0.89 109.032 173.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.39 11.67 15.03 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.759 -0.734 . . . . 0.83 112.533 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.61 110.71 18.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.86 110.305 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.63 -18.68 60.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 2.43 110.637 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.677 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.9 mmp_? -95.63 -6.82 39.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.893 -0.594 . . . . 4.52 110.371 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.711 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 59.18 107.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.238 -0.892 . . . . 0.88 111.924 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -59.61 122.06 28.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.431 -0.89 . . . . 0.24 111.151 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 5.7 t80 -111.28 107.67 17.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.283 0.563 . . . . 0.41 110.524 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.762 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.3 118.58 67.71 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.326 -0.852 . . . . 0.16 110.84 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.57 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 27.5 Cg_exo -64.87 134.9 42.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.501 2.134 . . . . 0.23 111.052 169.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.691 ' HA ' HG13 ' A' ' 73' ' ' ILE . 12.3 tp -57.19 -31.91 65.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.583 . . . . 0.19 111.961 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 21.3 pttp -70.2 -8.18 47.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.448 -0.342 . . . . 2.04 111.529 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 6.1 mm-40 -103.65 -10.03 18.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 110.423 -0.214 . . . . 0.86 110.423 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.691 HG13 ' HA ' ' A' ' 70' ' ' LEU . 18.5 mt -60.77 133.54 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.658 0.614 . . . . 0.56 112.658 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' THR . . . -77.92 140.51 39.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.254 -0.884 . . . . 0.39 111.208 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.753 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 29.6 ttp180 -58.62 -13.81 6.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.223 -0.899 . . . . 3.01 112.397 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.927 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 25.3 tp10 -56.25 -29.94 61.73 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.437 -0.79 . . . . 1.76 111.351 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.543 ' CZ ' HD22 ' A' ' 122' ' ' LEU . 34.0 m-85 -85.32 -41.03 15.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 1.4 110.894 -172.002 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.753 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.4 p90 -102.0 96.73 7.15 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 106.963 -1.495 . . . . 0.46 106.963 167.365 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_endo -32.01 138.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 1 C-N-CA 125.676 4.251 . . . . 0.71 114.704 -162.186 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.634 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -51.13 -24.17 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.638 -1.164 . . . . 0.93 113.699 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -92.92 4.8 53.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.58 0.705 . . . . 2.62 110.67 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -84.78 132.13 34.46 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.662 -0.866 . . . . 1.33 108.662 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -65.81 99.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 2.18 111.821 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -90.25 58.22 3.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.575 -0.738 . . . . 1.74 110.041 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -80.17 56.66 2.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.442 0.639 . . . . 3.99 110.48 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.5 -120.82 1.29 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.732 -0.667 . . . . 1.06 111.995 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -119.68 130.95 24.58 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.804 -0.443 . . . . 4.37 109.804 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.569 ' HB2' HG21 ' A' ' 93' ' ' VAL . 8.5 Cg_endo -58.74 144.71 97.9 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.987 1.792 . . . . 0.31 111.742 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.9 t30 -98.75 118.55 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.346 -0.612 . . . . 2.14 109.346 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.7 tt -57.63 -47.54 85.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.863 1.06 . . . . 0.21 113.863 -164.143 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CD ' ' HG3' ' A' ' 51' ' ' PRO . 15.1 mtpt -66.25 -6.52 14.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.076 0.769 . . . . 3.82 113.076 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.76 5.04 17.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.377 0.608 . . . . 1.91 110.22 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 88' ' ' PRO . 69.0 t -117.62 -52.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.463 -0.789 . . . . 0.33 109.852 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.441 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.6 mt -101.7 154.78 18.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.3 109.175 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.34 150.42 35.68 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.535 -0.543 . . . . 2.67 109.535 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HA ' HG22 ' A' ' 46' ' ' ILE . 48.3 mt-10 -57.0 110.97 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 1.25 109.991 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 45' ' ' LYS . . . 112.96 -1.05 25.7 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.857 -0.687 . . . . 0.41 112.242 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.482 ' NE2' ' HB3' ' A' ' 77' ' ' TYR . 22.8 tt0 -95.96 135.53 37.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.832 -0.433 . . . . 1.18 109.832 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 11.7 pt-20 -82.77 157.54 23.18 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.463 0.477 . . . . 0.81 111.815 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.512 HG23 HG22 ' A' ' 102' ' ' VAL . 34.2 m -141.2 152.59 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.115 -0.948 . . . . 0.18 109.741 171.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.801 ' HB ' HD11 ' A' ' 122' ' ' LEU . 23.5 mm -103.35 110.66 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.356 -0.979 . . . . 0.51 108.356 168.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 100' ' ' VAL . 2.5 m -139.1 130.57 35.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.218 0.532 . . . . 0.28 112.127 -170.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.477 ' HB3' HD12 ' A' ' 41' ' ' ILE . 6.7 pt20 -104.68 157.32 17.26 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.167 -1.049 . . . . 1.62 108.167 170.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.661 HD11 ' OH ' ' A' ' 60' ' ' TYR . 20.6 mm -81.02 102.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.779 0.799 . . . . 0.78 110.861 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.467 ' OD2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 t70 -71.44 -44.24 65.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.104 -1.407 . . . . 1.3 110.33 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG3' ' OD2' ' A' ' 105' ' ' ASP . 63.0 mttp -125.37 156.76 38.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.48 0.657 . . . . 2.57 111.183 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.3 155.88 17.64 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.597 -1.183 . . . . 2.57 111.548 -162.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.613 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 19.1 mt-10 -69.17 89.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.113 -0.949 . . . . 3.14 110.783 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.3 9.25 37.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.494 -1.23 . . . . 3.49 110.497 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.27 -63.92 3.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.92 -0.657 . . . . 1.74 112.157 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.7 -31.85 73.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.503 0.192 . . . . 2.88 111.505 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -118.84 -39.68 2.94 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.388 0.614 . . . . 3.45 109.464 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 75.85 -140.05 25.3 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.726 -1.125 . . . . 0.91 112.858 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -81.72 91.71 6.5 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.944 0.402 . . . . 0.52 110.821 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' A' ' 106' ' ' LYS . . . -79.15 123.66 27.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.208 -0.451 . . . . 0.6 111.295 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.762 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 65.4 mt -91.91 161.06 14.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.08 -0.509 . . . . 0.35 110.014 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.595 HG23 HD11 ' A' ' 120' ' ' ILE . 15.3 t -141.31 156.3 45.87 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.888 -0.782 . . . . 0.99 108.888 171.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -137.33 41.86 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.451 0.643 . . . . 1.22 112.507 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -96.53 33.17 1.86 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.148 -1.056 . . . . 4.11 108.148 167.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.595 HD11 HG23 ' A' ' 117' ' ' THR . 0.8 OUTLIER -119.77 93.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.684 -1.143 . . . . 0.95 111.06 -171.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 m 69.84 -30.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.602 1.334 . . . . 1.25 114.602 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.801 HD11 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -83.25 173.47 11.59 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.687 -0.633 . . . . 1.38 111.264 -176.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.927 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 CA--C 1.514 -0.413 0 O-C-N 124.966 1.416 . . . . 1.37 109.979 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.585 -0.895 . . . . 0.96 108.585 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 39.7 m-80 -62.35 102.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.847 0.356 . . . . 2.62 111.395 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.831 HD11 HG22 ' A' ' 101' ' ' ILE . 9.6 tp -82.71 134.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.958 -0.564 . . . . 0.84 110.365 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -132.02 145.58 51.54 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.226 0.536 . . . . 1.02 110.72 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -109.65 107.27 17.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.184 -0.916 . . . . 1.16 108.81 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.34 166.25 27.69 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.153 -1.022 . . . . 0.27 111.855 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 30.9 mtmt -106.09 159.39 16.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.3 0.571 . . . . 1.54 111.262 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.828 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -70.58 141.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.876 -1.056 . . . . 0.25 110.436 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 59' ' ' ASP . 65.3 p -131.22 -0.21 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.203 -0.453 . . . . 0.39 111.501 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 31.3 ttt-85 -164.52 125.02 2.06 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.314 -0.403 . . . . 1.85 110.409 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.828 ' CD1' HG21 ' A' ' 46' ' ' ILE . 88.5 mt -141.45 119.28 8.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.622 -0.51 . . . . 0.26 109.622 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 3.5 mt-10 -117.86 130.1 24.93 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.205 -0.452 . . . . 2.24 110.847 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.956 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 16.0 Cg_exo -68.95 -14.94 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.755 2.303 . . . . 0.52 111.324 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -73.09 -36.32 66.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 1.23 110.817 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 50' ' ' GLU . 1.1 pp -118.24 5.8 11.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.46 112.157 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.43 57.35 2.54 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.953 0.783 . . . . 2.51 111.537 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.16 166.63 16.87 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.303 -0.862 . . . . 0.19 110.568 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -136.34 148.08 47.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.642 0.608 . . . . 0.18 112.642 -172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 45.1 m-85 -101.13 132.3 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.526 -0.761 . . . . 0.56 110.09 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 116' ' ' LEU . 25.0 t -108.9 136.62 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.066 0.46 . . . . 0.26 110.218 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.556 ' HB2' HG21 ' A' ' 47' ' ' THR . 27.4 t70 -108.88 107.72 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.812 -0.631 . . . . 0.79 111.396 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 58' ' ' VAL . 23.3 p90 -127.24 65.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.89 108.939 171.567 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.32 18.28 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.708 -0.758 . . . . 0.83 112.054 -171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.9 141.81 37.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.408 0.283 . . . . 0.86 110.873 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.79 -21.21 17.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 2.43 110.994 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.608 ' NE ' ' HA ' ' A' ' 64' ' ' ARG . 2.6 mmp_? -106.38 -13.14 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 4.52 110.802 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.624 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.5 OUTLIER 70.51 116.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.435 -0.802 . . . . 0.88 111.755 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.88 118.19 12.66 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.518 -0.764 . . . . 0.24 111.877 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 15.8 t80 -105.16 112.25 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.169 0.509 . . . . 0.41 110.806 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.983 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -101.31 117.69 61.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.517 -0.765 . . . . 0.16 111.137 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.1 Cg_exo -63.84 145.03 90.08 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.882 2.388 . . . . 0.23 111.637 170.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.684 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.2 tp -65.87 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.19 111.649 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.51 -22.87 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.045 0.45 . . . . 2.04 110.835 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 29.5 mm-40 -79.22 -29.78 42.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.914 -0.585 . . . . 0.86 110.387 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.749 HG21 HG11 ' A' ' 93' ' ' VAL . 5.5 mt -48.03 125.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 113.386 0.884 . . . . 0.56 113.386 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.53 155.35 20.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.298 -1.319 . . . . 0.39 110.369 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.639 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 24.7 ttm180 -61.99 -13.72 28.36 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.003 -0.998 . . . . 3.01 112.407 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 1.076 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 6.8 tp10 -60.79 -23.37 64.97 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.624 -0.673 . . . . 1.76 110.477 175.853 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CD2' HG23 ' A' ' 73' ' ' ILE . 10.2 m-30 -84.88 -46.16 11.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.553 -0.749 . . . . 1.4 109.617 -175.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.639 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 3.5 p90 -103.64 94.71 6.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 107.895 -1.15 . . . . 0.46 107.895 170.023 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -26.93 137.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 1 C-N-CA 125.67 4.246 . . . . 0.71 115.468 -166.696 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . . . -50.36 -18.32 0.61 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.044 1.128 . . . . 0.93 114.044 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -95.9 -7.23 37.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.785 0.326 . . . . 2.62 111.406 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -71.34 141.36 50.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.481 -0.563 . . . . 1.33 109.481 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.84 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 2.18 111.072 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.08 99.76 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 1.74 110.949 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -118.67 91.65 3.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.329 -0.396 . . . . 3.99 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.79 -101.08 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.754 -0.736 . . . . 1.06 112.794 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -132.23 131.96 22.7 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 4.37 110.742 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' O ' HD11 ' A' ' 70' ' ' LEU . 11.3 Cg_endo -60.54 145.59 98.49 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.42 2.08 . . . . 0.31 112.296 174.45 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.51 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 3.8 p30 -108.57 115.41 30.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 2.14 109.925 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.684 ' HB ' HD13 ' A' ' 70' ' ' LEU . 15.9 tt -59.33 -35.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.882 0.697 . . . . 0.21 112.882 -164.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.956 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 21.3 pttp -61.86 -21.84 65.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.095 0.406 . . . . 3.82 112.095 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.51 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 12.3 m-20 -117.04 18.07 14.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 1.91 110.177 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.749 HG11 HG21 ' A' ' 73' ' ' ILE . 45.0 t -123.51 -47.27 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.332 0.587 . . . . 0.33 110.364 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 46' ' ' ILE . 95.8 mt -108.34 163.41 13.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.953 -0.567 . . . . 0.3 109.953 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ARG . . . . . 0.492 HH11 ' NE2' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -151.17 147.67 27.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.935 -0.765 . . . . 2.67 108.935 174.416 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.646 ' HA ' HG22 ' A' ' 46' ' ' ILE . 49.1 mt-10 -59.85 113.27 2.19 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.465 0.478 . . . . 1.25 109.901 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.38 -0.16 26.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.632 -0.713 . . . . 0.41 112.35 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.492 ' NE2' HH11 ' A' ' 95' ' ' ARG . 41.0 tt0 -96.83 133.29 41.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.842 -0.429 . . . . 1.18 109.842 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.56 156.99 28.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.134 0.492 . . . . 0.81 111.439 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 102' ' ' VAL . 27.8 m -140.19 152.21 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.201 -0.908 . . . . 0.18 109.85 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 41' ' ' ILE . 7.2 mm -96.99 110.06 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.544 -1.28 . . . . 0.51 107.544 169.886 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 100' ' ' VAL . 2.4 m -140.98 123.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.537 . . . . 0.28 111.954 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.75 HE21 HG12 ' A' ' 120' ' ' ILE . 10.3 pt20 -97.48 135.14 39.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.041 -1.096 . . . . 1.62 108.041 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.547 ' CD1' HD23 ' A' ' 116' ' ' LEU . 20.4 mm -73.18 103.37 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 0.78 110.772 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.64 -43.46 76.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.3 109.668 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 37.4 mttp -119.59 121.95 40.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.187 -0.915 . . . . 2.57 108.629 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 52.3 mt-10 -82.93 159.33 22.31 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.267 -0.424 . . . . 2.57 110.13 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 114' ' ' ALA . 31.1 mt-10 -62.68 91.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.468 0.651 . . . . 3.14 109.601 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 3.6 ptp180 -129.83 41.12 3.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.85 -1.068 . . . . 3.49 109.751 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.23 -82.04 1.58 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.234 -0.894 . . . . 1.74 113.84 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.1 -26.37 67.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.692 0.997 . . . . 2.88 113.692 -168.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HG2' ' HD3' ' A' ' 106' ' ' LYS . 9.9 mptt -116.5 -37.18 3.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.172 0.51 . . . . 3.45 110.028 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 74.89 -146.92 35.82 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.077 -0.965 . . . . 0.91 110.814 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . . . -88.82 104.62 17.09 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.934 0.397 . . . . 0.52 110.558 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -107.14 123.24 47.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.349 -0.387 . . . . 0.6 111.09 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.983 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 17.4 mt -90.37 154.74 19.45 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.999 -0.741 . . . . 0.35 108.999 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 103' ' ' GLN . 6.6 t -125.78 173.11 9.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.99 110.131 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.1 p -129.34 17.95 5.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 1.22 110.84 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -77.96 46.34 0.58 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.121 0.962 . . . . 4.11 108.708 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.75 HG12 HE21 ' A' ' 103' ' ' GLN . 4.3 mt -129.56 173.34 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.492 -1.231 . . . . 0.95 109.52 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.494 ' H ' HG22 ' A' ' 120' ' ' ILE . 13.0 m -74.81 67.73 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 1.25 110.902 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 101' ' ' ILE . 11.4 mt -116.15 172.15 7.35 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.453 -0.573 . . . . 1.38 109.453 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 1.076 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.426 0 O-C-N 123.921 0.763 . . . . 1.37 111.002 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.44 -0.578 . . . . 0.96 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -49.02 118.75 2.79 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.557 0.536 . . . . 2.62 110.202 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.714 HG12 HG22 ' A' ' 101' ' ' ILE . 5.0 tp -83.7 138.66 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.585 -0.524 . . . . 0.84 109.585 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' A' ' 104' ' ' ILE . 87.1 m-85 -115.1 118.87 34.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.517 0.675 . . . . 1.02 110.7 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.438 ' HD3' HD12 ' A' ' 101' ' ' ILE . 8.5 mmmm -89.64 102.67 15.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.858 -1.065 . . . . 1.16 109.671 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.25 163.78 26.32 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 110.555 -1.018 . . . . 0.27 110.555 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.14 161.97 18.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 1.54 111.347 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -65.05 146.09 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.299 -1.319 . . . . 0.25 111.254 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 59' ' ' ASP . 76.2 p -128.94 -32.05 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.009 0.433 . . . . 0.39 111.854 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.655 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 13.9 ttm180 -140.27 126.12 19.45 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.351 -0.386 . . . . 1.85 110.668 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 46' ' ' ILE . 91.2 mt -133.8 120.36 36.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.652 -0.704 . . . . 0.26 109.585 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 15.7 tp10 -111.94 111.21 53.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.896 -0.593 . . . . 2.24 109.708 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 51.9 Cg_exo -54.0 -25.82 38.1 Favored 'Trans proline' 0 CA--C 1.521 -0.172 0 C-N-CA 123.361 2.707 . . . . 0.52 112.068 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.7 m -73.82 -22.48 59.78 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.503 -0.771 . . . . 1.23 111.824 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.5 pp -123.78 7.48 8.76 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.598 0.962 . . . . 0.46 113.598 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 4.6 pt-20 48.56 49.76 17.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.408 1.083 . . . . 2.51 112.824 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.98 162.67 31.95 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.081 -0.648 . . . . 0.19 112.208 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -131.22 138.06 49.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.669 -0.696 . . . . 0.18 112.167 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 65.7 m-85 -89.44 136.17 33.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.56 109.818 171.594 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' A' ' 116' ' ' LEU . 2.2 t -112.74 139.49 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.26 110.997 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.718 ' HB2' HG21 ' A' ' 47' ' ' THR . 17.9 t70 -103.14 102.3 12.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.79 110.65 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -128.11 67.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.509 -0.552 . . . . 0.89 109.509 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 46.09 42.16 11.9 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.089 -0.577 . . . . 0.83 111.899 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.72 160.01 14.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.171 0.51 . . . . 0.86 111.092 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -87.83 -45.38 10.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.626 0.726 . . . . 2.43 109.173 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 48.7 mtt180 -125.71 94.15 4.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.85 -1.068 . . . . 4.52 108.403 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 15.4 m170 -35.9 131.22 0.56 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.147 1.165 . . . . 0.88 114.147 -170.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.8 118.65 14.74 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.871 -1.059 . . . . 0.24 111.498 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.2 t80 -104.79 97.73 7.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.138 0.494 . . . . 0.41 111.282 -171.461 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.032 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -85.38 121.2 73.73 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.774 . . . . 0.16 111.365 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.59 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 19.6 Cg_exo -69.56 142.78 49.78 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.087 2.525 . . . . 0.23 112.104 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.717 HD13 ' HB ' ' A' ' 90' ' ' ILE . 12.6 tp -60.8 -39.07 87.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.491 -0.777 . . . . 0.19 112.263 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -64.13 -13.34 47.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.644 0.259 . . . . 2.04 111.651 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 7.2 mm-40 -96.09 -13.07 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.756 0.312 . . . . 0.86 110.413 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.501 HG23 ' CD2' ' A' ' 77' ' ' TYR . 8.0 mt -57.86 138.48 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.636 0.731 . . . . 0.56 112.823 -171.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -102.25 153.53 19.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.836 -1.075 . . . . 0.39 110.518 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.66 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 41.1 ttm180 -55.27 -14.68 1.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.522 -0.763 . . . . 3.01 112.662 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' GLU . . . . . 0.993 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 24.3 tp10 -61.96 -19.71 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.487 -0.758 . . . . 1.76 110.759 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.501 ' CD2' HG23 ' A' ' 73' ' ' ILE . 7.9 m-30 -92.65 -44.61 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.797 -0.638 . . . . 1.4 109.759 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 84' ' ' ALA . 5.7 p90 -98.68 95.94 3.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.277 -1.379 . . . . 0.46 107.277 168.742 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.3 Cg_endo -38.51 139.98 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.577 3.518 . . . . 0.71 113.797 -162.065 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.66 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -55.55 -11.93 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 0.93 113.288 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -82.28 -21.11 36.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.235 0.54 . . . . 2.62 109.97 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -78.2 146.14 35.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 1.33 110.626 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -81.98 106.49 13.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.741 -0.663 . . . . 2.18 111.566 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -91.81 136.48 33.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 1.74 109.848 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -96.42 -40.61 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.136 0.493 . . . . 3.99 110.225 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.11 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.504 -0.771 . . . . 1.06 111.265 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -97.04 128.39 35.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.033 0.444 . . . . 4.37 110.804 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.86 165.49 13.99 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.272 2.648 . . . . 0.31 112.981 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.6 98.31 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.866 -0.606 . . . . 2.14 109.951 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.717 ' HB ' HD13 ' A' ' 70' ' ' LEU . 21.2 tt -54.02 -39.7 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.497 0.925 . . . . 0.21 113.497 -165.475 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.845 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 36.8 pttt -55.7 -21.78 20.13 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.009 0.744 . . . . 3.82 113.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -125.96 18.69 7.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.932 0.872 . . . . 1.91 110.44 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 36.7 t -111.32 -50.03 6.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.693 0.759 . . . . 0.33 109.278 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.5 mt -103.04 150.86 23.16 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.206 -0.906 . . . . 0.3 110.231 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 147.93 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.171 -0.922 . . . . 2.67 109.098 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 1.5 mp0 -58.29 122.5 13.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.864 0.364 . . . . 1.25 110.161 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.49 -18.15 23.03 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.786 -0.721 . . . . 0.41 111.701 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -83.11 121.01 26.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.748 -0.464 . . . . 1.18 109.748 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.65 155.2 36.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.81 111.487 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.581 HG23 HG22 ' A' ' 102' ' ' VAL . 35.3 m -131.91 149.95 33.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.884 -1.053 . . . . 0.18 109.177 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 41' ' ' ILE . 1.4 mm -98.95 107.48 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.072 -1.455 . . . . 0.51 107.072 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.581 HG22 HG23 ' A' ' 100' ' ' VAL . 4.4 m -145.54 135.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 0.28 112.584 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLN . . . . . 0.535 ' O ' ' HB ' ' A' ' 117' ' ' THR . 18.4 pt20 -98.73 135.84 39.63 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.596 -0.891 . . . . 1.62 108.596 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 106' ' ' LYS . 40.4 mm -80.95 99.57 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.256 0.55 . . . . 0.78 109.71 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.32 -27.51 67.21 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 1.3 110.566 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 104' ' ' ILE . 55.0 mttp -113.63 -170.97 1.8 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 2.57 111.411 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 50.4 mm-40 -129.6 145.79 51.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.294 -0.412 . . . . 2.57 110.332 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.614 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 43.2 mt-10 -64.15 101.86 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.401 0.62 . . . . 3.14 109.668 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 10.9 ptm180 -116.43 -61.63 1.7 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.237 -0.892 . . . . 3.49 111.549 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -175.15 -63.9 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.466 -0.873 . . . . 1.74 112.519 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.88 -46.92 85.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.089 0.403 . . . . 2.88 112.089 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.583 ' HD2' ' HB2' ' A' ' 115' ' ' ALA . 21.4 ttmm -116.19 -37.18 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.363 -0.535 . . . . 3.45 110.436 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 80.6 -122.47 5.73 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.652 -0.979 . . . . 0.91 110.652 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.531 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.29 127.5 33.7 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.99 -0.374 . . . . 0.52 109.99 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.583 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . . . -118.4 126.99 53.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.729 0.3 . . . . 0.6 110.88 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.032 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 14.6 mt -91.08 129.06 37.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.065 -0.516 . . . . 0.35 110.177 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -90.26 146.82 23.94 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.99 109.642 174.048 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.646 HG23 HD21 ' A' ' 68' ' ' LEU . 3.5 p -113.96 4.02 15.6 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.34 0.496 . . . . 1.22 112.34 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.481 ' H ' HG23 ' A' ' 117' ' ' THR . 98.8 m-85 -78.34 57.36 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.695 0.76 . . . . 4.11 110.451 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 121' ' ' SER . 2.9 mp -127.99 176.08 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.645 -1.242 . . . . 0.95 107.645 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.0 t -69.4 69.62 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.296 0.569 . . . . 1.25 110.458 176.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 101' ' ' ILE . 12.0 mt -115.13 172.22 7.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.676 -0.861 . . . . 1.38 108.676 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.993 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.447 0 O-C-N 123.683 0.615 . . . . 1.37 110.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 107.657 -1.238 . . . . 0.96 107.657 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -47.62 116.97 1.63 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.853 0.721 . . . . 2.62 111.218 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 101' ' ' ILE . 6.6 tp -84.65 139.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.107 -0.951 . . . . 0.84 110.128 -174.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -122.68 149.71 43.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.792 0.329 . . . . 1.02 110.275 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 34.5 ttmt -115.78 94.08 4.53 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.984 -0.747 . . . . 1.16 108.984 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.17 166.69 13.15 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.271 -0.877 . . . . 0.27 111.073 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 1.6 mppt? -104.83 158.2 16.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.065 0.459 . . . . 1.54 111.087 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.886 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -73.52 137.19 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.075 -0.966 . . . . 0.25 109.628 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.483 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.7 p -124.33 -11.28 7.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.799 0.333 . . . . 0.39 111.471 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ARG . . . . . 0.641 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 24.6 ttt85 -160.26 122.18 3.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.212 -0.449 . . . . 1.85 110.462 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 46' ' ' ILE . 47.5 mt -134.89 113.46 16.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.624 -0.509 . . . . 0.26 109.624 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 31.6 mt-10 -118.01 122.54 30.37 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 121.505 0.669 . . . . 2.24 111.475 -176.047 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' PRO . . . . . 0.832 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 31.9 Cg_exo -60.65 -27.41 84.79 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.112 2.541 . . . . 0.52 111.827 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.5 m -75.11 -21.43 58.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 1.23 111.685 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 50' ' ' GLU . 2.0 pp -118.38 8.85 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.964 -0.694 . . . . 0.46 112.792 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 43.52 48.36 6.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.493 0.717 . . . . 2.51 111.917 169.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.27 171.15 12.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.474 -0.784 . . . . 0.19 110.974 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -135.56 139.48 43.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.18 111.539 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.641 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.9 m-85 -91.64 136.0 33.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.56 109.633 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HB ' HD11 ' A' ' 116' ' ' LEU . 12.6 t -118.9 134.44 62.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.158 -0.682 . . . . 0.26 109.158 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 47' ' ' THR . 36.7 t70 -109.48 111.28 22.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.187 -0.46 . . . . 0.79 112.027 -173.783 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -126.81 66.75 1.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.219 -1.03 . . . . 0.89 108.219 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.33 33.46 46.41 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.81 -0.71 . . . . 0.83 112.46 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 65' ' ' HIS . . . -93.79 147.72 22.79 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.645 -0.326 . . . . 0.86 110.777 -175.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.93 -51.29 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 2.43 111.272 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 8.8 mmt180 -94.36 -11.11 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.478 -0.489 . . . . 4.52 109.796 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 10.3 m170 76.49 145.07 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.423 1.077 . . . . 0.88 110.854 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 102.14 1.08 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.666 -0.974 . . . . 0.24 110.666 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 2.9 t80 -88.98 104.25 16.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.842 0.353 . . . . 0.41 110.541 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 1.133 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.72 113.35 60.15 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.16 110.307 178.135 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HD2' HD23 ' A' ' 68' ' ' LEU . 24.5 Cg_exo -65.27 141.72 69.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.787 2.325 . . . . 0.23 111.607 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.625 HD13 ' HB ' ' A' ' 90' ' ' ILE . 17.8 tp -57.91 -33.46 68.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.19 111.819 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.59 -10.92 20.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 2.04 111.482 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -97.44 -23.92 15.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.12 -0.491 . . . . 0.86 110.856 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 93' ' ' VAL . 6.1 mt -48.38 131.04 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 113.466 0.913 . . . . 0.56 113.466 -166.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -100.22 156.67 17.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.64 -1.164 . . . . 0.39 110.763 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.818 ' HG2' ' HA ' ' A' ' 80' ' ' ALA . 32.0 ttp180 -65.16 -12.7 53.9 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.55 0.944 . . . . 3.01 113.55 -172.478 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.67 -25.76 68.36 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.795 -1.191 . . . . 1.76 110.208 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -75.84 -51.74 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.901 -0.59 . . . . 1.4 110.291 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' HB3' HG13 ' A' ' 93' ' ' VAL . 1.1 p90 -100.37 109.46 57.0 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.584 -1.265 . . . . 0.46 107.584 169.19 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.43 133.6 0.33 Allowed 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 124.616 3.544 . . . . 0.71 113.646 -162.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -57.03 -16.44 7.15 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.563 -1.199 . . . . 0.93 113.361 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -90.99 -0.89 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 2.62 111.251 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -81.77 143.81 31.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 1.33 109.976 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -71.09 100.9 2.12 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.397 -0.365 . . . . 2.18 110.287 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.95 95.34 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.74 110.374 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -76.9 61.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.715 -0.675 . . . . 3.99 110.928 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.47 -128.44 8.99 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.859 -0.686 . . . . 1.06 111.631 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.85 135.41 45.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.809 0.338 . . . . 4.37 110.32 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' O ' HD11 ' A' ' 70' ' ' LEU . 9.2 Cg_endo -58.41 154.7 39.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.916 2.411 . . . . 0.31 113.161 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' A' ' 92' ' ' ASP . 4.0 p30 -119.41 111.42 18.13 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.248 -0.887 . . . . 2.14 109.617 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ILE . . . . . 0.625 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.2 tt -62.13 -38.87 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.724 0.638 . . . . 0.21 112.724 -163.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LYS . . . . . 0.832 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 7.8 ptmm? -60.07 -21.37 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.212 -0.449 . . . . 3.82 111.853 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASP . . . . . 0.508 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 34.6 t70 -119.62 12.01 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.817 0.818 . . . . 1.91 110.343 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 73' ' ' ILE . 13.7 t -119.96 -50.57 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.33 110.314 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -100.41 152.13 20.72 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.677 -0.692 . . . . 0.3 110.25 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 151.8 44.21 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.361 -0.836 . . . . 2.67 110.319 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 46' ' ' ILE . 18.1 mt-10 -65.13 126.07 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.029 -0.987 . . . . 1.25 110.456 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.05 54.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.773 -0.727 . . . . 0.41 112.055 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.9 tt0 -87.95 135.96 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.951 -0.389 . . . . 1.18 109.951 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.92 157.22 20.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.81 111.37 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.553 HG23 HG22 ' A' ' 102' ' ' VAL . 35.5 m -136.75 151.79 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.189 -0.914 . . . . 0.18 109.879 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.983 ' HB ' HD11 ' A' ' 122' ' ' LEU . 10.0 mm -97.03 110.45 25.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.004 -1.11 . . . . 0.51 108.004 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' VAL . . . . . 0.553 HG22 HG23 ' A' ' 100' ' ' VAL . 4.3 m -146.76 139.05 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.233 0.539 . . . . 0.28 111.974 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -112.84 142.73 45.16 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.433 -0.951 . . . . 1.62 108.433 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ILE . . . . . 0.539 HD13 HD23 ' A' ' 116' ' ' LEU . 22.4 mm -71.89 102.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.76 0.79 . . . . 0.78 110.771 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 35.0 t70 -83.76 -35.28 24.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.714 -1.13 . . . . 1.3 109.777 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 115' ' ' ALA . 12.7 ttpp -112.03 137.99 49.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.605 -0.725 . . . . 2.57 109.775 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' GLU . . . . . 0.444 ' HB3' HH21 ' A' ' 109' ' ' ARG . 1.8 tm-20 -87.2 133.79 33.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.26 -0.882 . . . . 2.57 110.914 -163.284 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HG3' ' HG2' ' A' ' 64' ' ' ARG . 42.6 tt0 -66.31 119.73 12.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 3.14 110.208 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.585 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 6.6 ptp180 -139.72 -68.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.415 -0.811 . . . . 3.49 111.115 -171.255 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -168.71 -66.99 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.553 -1.308 . . . . 1.74 113.722 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ASN . . . . . 0.474 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 25.6 t-20 -61.88 -50.91 70.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.958 0.379 . . . . 2.88 111.55 -172.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 98.6 mttt -122.92 -37.49 2.73 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.68 -0.408 . . . . 3.45 110.682 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLY . . . . . 0.585 ' HA2' ' HG2' ' A' ' 109' ' ' ARG . . . 63.79 -124.47 30.89 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.67 -0.695 . . . . 0.91 113.937 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.56 110.66 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.249 0.617 . . . . 0.52 111.696 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . -122.25 135.83 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.07 -0.514 . . . . 0.6 110.566 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 1.133 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 43.2 mt -91.41 153.01 20.16 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.775 -0.648 . . . . 0.35 109.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 8.2 t -116.69 171.47 7.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.241 -0.436 . . . . 0.99 110.292 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 120' ' ' ILE . 26.1 p -138.27 20.93 2.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.78 0.659 . . . . 1.22 112.78 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 119' ' ' PHE . 3.2 p90 -78.45 42.42 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.499 1.142 . . . . 4.11 109.385 170.86 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 121' ' ' SER . 4.4 mt -118.36 172.35 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 113.884 -1.507 . . . . 0.95 108.015 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' SER . . . . . 0.514 ' H ' HG22 ' A' ' 120' ' ' ILE . 7.5 t -80.04 48.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.858 0.361 . . . . 1.25 111.93 -172.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LEU . . . . . 0.983 HD11 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -117.38 126.33 52.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.738 -0.21 . . . . 1.38 111.257 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . . . . . . 0 N--CA 1.469 0.508 0 O-C-N 124.722 1.264 . . . . 1.37 109.779 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.793 -0.523 . . . . 9.91 111.793 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.0 m -80.29 68.89 6.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.491 . . . . 7.66 110.938 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -154.54 68.35 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 8.75 109.929 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 52.6 ttm -104.37 91.88 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.922 -0.581 . . . . 7.04 110.051 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt 61.81 -105.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.676 -0.693 . . . . 4.54 110.959 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -173.16 -174.4 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.835 -0.802 . . . . 4.07 108.835 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -115.74 82.36 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.671 -0.412 . . . . 4.36 110.859 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm 58.96 20.78 8.51 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.651 0.594 . . . . 4.85 112.385 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 41.3 pttt -131.66 -168.81 2.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 2.02 111.22 -175.866 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -63.37 159.8 17.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.56 -0.904 . . . . 0.96 108.56 169.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.61 114.45 3.28 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.255 -0.578 . . . . 2.62 110.82 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 103' ' ' GLN . 8.7 tp -81.27 146.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.385 -0.825 . . . . 0.84 109.421 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.55 152.76 41.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.7 0.286 . . . . 1.02 110.296 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.4 tttm -134.11 96.58 3.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.206 0.527 . . . . 1.16 109.716 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -140.46 175.67 21.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.952 -0.859 . . . . 0.27 110.952 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.34 159.47 15.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.648 0.737 . . . . 1.54 112.054 -175.362 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.986 HG21 HD11 ' A' ' 49' ' ' ILE . 1.6 mp -67.64 138.47 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.363 -1.29 . . . . 0.25 109.386 171.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.614 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.2 p -130.69 -7.17 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.763 0.316 . . . . 0.39 111.725 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.627 ' HD3' ' HD2' ' A' ' 57' ' ' PHE . 29.9 ttt85 -158.43 123.02 4.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.326 -0.397 . . . . 1.85 110.282 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.986 HD11 HG21 ' A' ' 46' ' ' ILE . 56.6 mt -136.76 109.04 7.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.096 0.474 . . . . 0.26 109.877 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.32 113.2 65.38 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 2.24 110.796 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.84 -19.56 55.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.012 2.475 . . . . 0.52 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.4 m -73.1 -26.01 61.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.208 -0.905 . . . . 1.23 111.321 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.5 pp -119.71 -8.91 9.85 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.212 0.819 . . . . 0.46 113.212 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 59.43 57.18 3.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.784 0.433 . . . . 2.51 111.451 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -168.09 162.58 13.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.322 -0.399 . . . . 0.19 110.53 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -129.22 142.0 50.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.035 -0.529 . . . . 0.18 111.956 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.627 ' HD2' ' HD3' ' A' ' 48' ' ' ARG . 40.1 m-85 -94.3 142.07 27.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.691 -0.686 . . . . 0.56 109.551 170.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.466 HG12 ' HD1' ' A' ' 60' ' ' TYR . 56.1 t -120.37 133.38 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.26 109.947 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.614 ' CB ' HG21 ' A' ' 47' ' ' THR . 35.4 t70 -103.69 99.67 9.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.899 -0.591 . . . . 0.79 110.716 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HD1' HG12 ' A' ' 58' ' ' VAL . 20.4 p90 -126.8 66.59 1.26 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.703 -0.68 . . . . 0.89 109.337 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.1 21.95 26.82 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.733 -0.746 . . . . 0.83 112.436 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 118.42 33.86 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.817 -0.225 . . . . 0.86 110.53 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.99 -3.67 30.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 2.43 111.453 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.468 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -117.11 -13.25 10.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.777 -0.647 . . . . 4.52 110.189 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 63.84 141.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.039 -0.982 . . . . 0.88 111.879 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -83.12 126.43 7.48 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.602 -0.808 . . . . 0.24 111.193 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 29.0 t80 -107.18 111.47 23.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.381 0.61 . . . . 0.41 110.933 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.884 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -106.8 111.56 63.78 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.128 -0.942 . . . . 0.16 110.838 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 16.4 Cg_exo -69.23 145.03 58.91 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.155 2.57 . . . . 0.23 111.981 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.612 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.4 tp -57.06 -39.69 75.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.804 -1.089 . . . . 0.19 113.102 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.755 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 19.9 pttp -67.54 -9.73 45.2 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.571 -0.451 . . . . 2.04 111.174 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.403 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 3.5 mm-40 -92.84 -21.98 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.999 -0.371 . . . . 0.86 109.999 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.603 HG21 HG11 ' A' ' 93' ' ' VAL . 8.0 mt -48.76 134.75 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.838 1.051 . . . . 0.56 113.838 -168.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.76 156.32 16.74 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.717 -1.128 . . . . 0.39 110.898 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.747 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 12.6 tpt180 -56.84 -16.86 7.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.153 -0.93 . . . . 3.01 112.127 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.07 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 1.8 tp10 -65.06 -24.57 67.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.86 -0.525 . . . . 1.76 111.001 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.542 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.1 m-30 -82.37 -50.73 8.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.459 0.647 . . . . 1.4 110.141 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HB3' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -97.77 101.11 9.73 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.044 -1.465 . . . . 0.46 107.044 169.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.9 Cg_endo -39.13 141.76 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 124.85 3.7 . . . . 0.71 114.062 -161.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.71 -13.86 0.46 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.779 -1.1 . . . . 0.93 112.921 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.27 -11.05 53.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.3 0.571 . . . . 2.62 110.524 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.66 139.56 30.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.682 -0.69 . . . . 1.33 109.616 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -65.62 125.56 25.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 2.18 111.161 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.433 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -130.01 114.68 16.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.162 -0.472 . . . . 1.74 110.986 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -139.62 77.25 1.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.286 -0.415 . . . . 3.99 110.536 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.0 -113.58 1.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.691 -0.766 . . . . 1.06 112.498 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.853 ' HD3' ' HD2' ' A' ' 88' ' ' PRO . 13.5 tpp180 -121.63 121.61 28.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.63 0.252 . . . . 4.37 110.417 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.853 ' HD2' ' HD3' ' A' ' 87' ' ' ARG . 9.9 Cg_endo -59.84 166.23 8.81 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.999 2.466 . . . . 0.31 112.733 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 107.24 13.65 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.923 0.392 . . . . 2.14 110.445 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' HD13 ' A' ' 70' ' ' LEU . 20.2 tt -56.84 -37.69 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.115 0.783 . . . . 0.21 113.115 -165.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 91' ' ' LYS . 5.4 pttt -56.1 -24.74 42.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.879 0.696 . . . . 3.82 112.879 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -125.29 20.92 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.845 0.831 . . . . 1.91 110.173 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 73' ' ' ILE . 14.2 t -117.09 -48.67 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.605 -0.725 . . . . 0.33 109.893 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.411 ' HB3' HG12 ' A' ' 46' ' ' ILE . 42.6 mt -103.15 151.35 22.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.731 -0.668 . . . . 0.3 109.833 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 138.84 24.63 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.603 -0.726 . . . . 2.67 109.643 176.104 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.682 ' HA ' HG22 ' A' ' 46' ' ' ILE . 13.1 mt-10 -54.15 121.37 8.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.538 -0.755 . . . . 1.25 110.773 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.2 -8.02 28.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.41 111.791 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.542 ' OE1' ' HA ' ' A' ' 77' ' ' TYR . 9.1 tt0 -90.49 129.02 36.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.876 -0.416 . . . . 1.18 109.876 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 13.8 pt-20 -84.95 157.03 20.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.981 0.419 . . . . 0.81 111.025 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 102' ' ' VAL . 32.8 m -139.33 155.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.539 -0.755 . . . . 0.18 110.416 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.548 ' O ' HD13 ' A' ' 120' ' ' ILE . 4.0 mm -102.66 110.38 29.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.038 -1.097 . . . . 0.51 108.038 172.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -147.3 147.55 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.104 0.409 . . . . 0.28 112.104 -170.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.582 ' HB3' HD12 ' A' ' 41' ' ' ILE . 13.4 pt20 -128.07 158.72 37.18 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 1.62 108.72 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.494 HD13 HD23 ' A' ' 116' ' ' LEU . 25.5 mm -83.94 109.66 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.441 0.639 . . . . 0.78 111.638 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 13.5 t70 -85.4 -40.84 16.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.687 -1.142 . . . . 1.3 109.47 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 2.3 mptp? -111.52 126.09 54.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.552 -0.749 . . . . 2.57 109.239 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -85.67 158.38 20.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.012 -0.54 . . . . 2.57 110.889 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.531 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -66.97 131.07 45.11 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.657 0.742 . . . . 3.14 110.14 177.281 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -144.1 12.13 1.59 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.627 -1.169 . . . . 3.49 108.833 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.71 84.72 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.974 -1.012 . . . . 1.74 112.499 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -130.5 -31.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.76 0.652 . . . . 2.88 112.76 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -120.25 -38.8 2.86 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.102 -0.639 . . . . 3.45 110.008 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . 99.48 -159.14 19.85 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.122 -1.037 . . . . 0.91 111.674 169.418 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.94 90.14 7.35 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.713 -0.847 . . . . 0.52 108.713 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -85.66 126.02 33.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.6 111.695 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.884 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 50.6 mt -90.27 135.42 33.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.35 110.428 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 13.1 t -95.31 172.43 8.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.925 -0.58 . . . . 0.99 109.801 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.568 HG23 HD21 ' A' ' 68' ' ' LEU . 4.9 p -126.76 18.61 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.433 0.635 . . . . 1.22 110.191 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -81.07 46.93 0.95 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.962 0.887 . . . . 4.11 109.304 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.572 HG12 HD11 ' A' ' 41' ' ' ILE . 1.8 mp -127.44 170.03 17.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.808 -1.087 . . . . 0.95 108.898 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.2 m -72.41 72.4 0.96 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.378 0.609 . . . . 1.25 110.92 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.526 HD11 ' O ' ' A' ' 101' ' ' ILE . 26.3 mt -116.17 171.77 7.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.886 -0.783 . . . . 1.38 108.886 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.07 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 72.29 80.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.012 0.82 . . . . 1.37 109.854 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.62 49.36 3.06 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.552 -0.749 . . . . 2.8 113.039 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.719 -0.658 . . . . 5.11 109.493 176.836 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 112.327 -0.309 . . . . 9.91 112.327 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 33' ' ' MET . 37.2 p -127.26 4.42 6.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.933 0.346 . . . . 7.66 111.933 -173.962 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 m-70 69.85 -17.7 0.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.518 . . . . 8.75 111.608 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' SER . 86.3 mtp -77.09 -25.29 52.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.298 0.57 . . . . 7.04 110.128 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.8 -48.31 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.183 -0.917 . . . . 4.54 110.344 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' CB ' ' HG2' ' A' ' 38' ' ' LYS . 51.4 mp0 -78.23 -43.21 28.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.095 -0.957 . . . . 4.07 112.235 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 69.65 -58.0 0.53 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.766 0.666 . . . . 4.36 110.298 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -142.89 -17.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.016 -0.538 . . . . 4.85 110.802 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' HG2' ' CB ' ' A' ' 35' ' ' GLU . 10.8 ptmt -76.59 179.96 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.255 0.55 . . . . 2.02 111.728 -171.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.06 156.84 22.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.637 -0.875 . . . . 0.96 108.637 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 41.0 t-20 -50.66 109.52 0.32 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.577 0.548 . . . . 2.62 110.19 -178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.22 143.8 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.775 . . . . 0.84 109.961 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.79 144.99 49.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.079 -0.341 . . . . 1.02 110.079 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -117.65 105.72 12.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.631 -1.248 . . . . 1.16 107.631 173.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.89 179.48 21.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.69 -0.767 . . . . 0.27 111.561 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HD3' ' HA2' ' A' ' 97' ' ' GLY . 94.3 mttt -109.45 162.73 14.08 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.557 0.694 . . . . 1.54 111.917 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.751 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -72.44 136.75 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.563 -1.199 . . . . 0.25 108.893 170.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.707 HG21 ' CB ' ' A' ' 59' ' ' ASP . 73.2 p -127.1 -17.64 4.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.05 0.452 . . . . 0.39 111.782 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 39.7 ttt180 -154.66 121.72 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.192 -0.67 . . . . 1.85 109.192 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.751 ' CD1' HG21 ' A' ' 46' ' ' ILE . 96.7 mt -125.47 102.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.245 -0.65 . . . . 0.26 109.245 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HB3' HD11 ' A' ' 53' ' ' LEU . 12.8 tp10 -99.17 108.0 47.4 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.005 -0.998 . . . . 2.24 109.933 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 45.0 Cg_exo -57.12 -29.8 84.64 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.96 2.44 . . . . 0.52 112.093 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -59.9 -29.76 68.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.81 -0.632 . . . . 1.23 111.247 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.669 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.2 pp -122.56 11.28 9.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.46 111.937 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.87 58.01 2.18 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.656 0.782 . . . . 2.51 112.034 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.99 160.75 25.03 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.387 -0.824 . . . . 0.19 110.846 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -120.59 140.79 51.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.18 112.285 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.8 m-85 -95.17 130.79 41.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.109 -0.95 . . . . 0.56 110.106 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.16 132.46 58.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.208 -0.451 . . . . 0.26 109.789 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.707 ' CB ' HG21 ' A' ' 47' ' ' THR . 13.8 t70 -100.81 103.32 14.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.95 0.405 . . . . 0.79 111.223 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -126.17 66.71 1.21 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.688 -0.856 . . . . 0.89 108.688 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.04 31.71 56.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.823 -0.703 . . . . 0.83 112.427 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.74 137.89 50.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.588 0.232 . . . . 0.86 110.625 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.23 -44.24 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 2.43 111.312 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -78.09 -16.55 57.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.778 -0.369 . . . . 4.52 110.242 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.8 m170 68.59 146.77 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.044 -0.98 . . . . 0.88 111.501 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.9 106.07 1.94 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.426 -1.07 . . . . 0.24 110.426 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.669 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 2.7 t80 -96.19 106.3 18.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.097 0.475 . . . . 0.41 110.709 -172.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.817 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -97.49 118.5 64.26 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.16 109.826 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.7 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 6.7 Cg_exo -69.91 141.04 43.57 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.128 1.885 . . . . 0.23 111.344 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.814 ' HA ' HG13 ' A' ' 73' ' ' ILE . 9.3 tp -57.39 -32.85 67.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.19 111.184 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.7 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.9 ptmm? -59.76 -20.89 59.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.678 -0.692 . . . . 2.04 111.624 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.58 -11.91 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.86 110.738 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.814 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.6 mt -49.88 127.37 5.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 113.588 0.958 . . . . 0.56 113.588 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -80.28 149.84 30.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.222 -1.354 . . . . 0.39 111.211 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.637 ' HB3' ' H ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -66.33 -14.71 62.47 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.901 -0.59 . . . . 3.01 111.243 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.684 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 7.0 tp10 -69.97 -17.63 63.3 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.324 -0.86 . . . . 1.76 109.912 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -81.01 -52.97 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.912 -0.586 . . . . 1.4 109.733 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HB3' HG13 ' A' ' 93' ' ' VAL . 5.2 p90 -100.82 110.19 60.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.412 -1.329 . . . . 0.46 107.412 169.478 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.7 Cg_endo -37.97 135.45 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.454 0 C-N-CA 124.351 3.368 . . . . 0.71 113.766 -165.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.51 -7.19 0.37 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.712 -1.131 . . . . 0.93 113.127 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.64 -14.68 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.631 0.729 . . . . 2.62 109.391 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.435 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 78.9 t80 -92.43 119.37 31.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.281 -0.872 . . . . 1.33 109.294 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.3 t -63.08 125.91 25.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.924 0.393 . . . . 2.18 110.805 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.01 75.93 4.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.36 0.6 . . . . 1.74 110.634 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' HIS . . . . . 0.421 ' H ' ' CD2' ' A' ' 85' ' ' HIS . 3.0 p80 -78.29 111.59 14.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.99 110.452 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.87 -101.16 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.708 -0.678 . . . . 1.06 111.651 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -138.21 150.78 68.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 4.37 109.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' C ' HD11 ' A' ' 70' ' ' LEU . 5.6 Cg_endo -59.77 162.62 15.25 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.29 1.993 . . . . 0.31 112.983 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.528 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 0.7 OUTLIER -121.26 103.66 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 2.14 109.685 176.004 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 16.3 tt -57.02 -43.32 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 114.201 1.186 . . . . 0.21 114.201 -161.444 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.814 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 18.5 pttp -62.74 -15.05 51.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.157 0.428 . . . . 3.82 112.157 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.528 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 24.6 m-20 -122.89 19.13 10.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.498 0.666 . . . . 1.91 109.784 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.68 HG11 HG21 ' A' ' 73' ' ' ILE . 8.8 t -120.3 -51.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.814 . . . . 0.33 109.555 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.435 ' HB3' HG12 ' A' ' 46' ' ' ILE . 96.6 mt -101.35 164.6 11.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.545 -0.752 . . . . 0.3 109.404 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 152.66 32.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.99 -0.55 . . . . 2.67 109.637 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.6 ' HA ' HG22 ' A' ' 46' ' ' ILE . 25.5 mt-10 -63.46 118.09 7.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 1.25 110.262 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' HA2' ' HD3' ' A' ' 45' ' ' LYS . . . 112.96 -11.84 24.75 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.707 -0.759 . . . . 0.41 112.145 -174.592 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -86.68 137.88 32.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 1.18 109.785 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 12.6 pt-20 -86.95 157.13 19.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.81 112.067 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.544 HG23 HG22 ' A' ' 102' ' ' VAL . 32.9 m -143.47 156.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.18 109.833 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.573 ' H ' HD11 ' A' ' 122' ' ' LEU . 5.7 mm -104.92 110.83 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.083 -1.08 . . . . 0.51 108.083 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 100' ' ' VAL . 3.2 m -144.84 136.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.225 0.535 . . . . 0.28 112.384 -169.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -114.56 149.21 36.86 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.862 -0.792 . . . . 1.62 108.862 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.572 HD13 HD23 ' A' ' 116' ' ' LEU . 23.2 mm -74.69 101.97 2.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 0.78 110.447 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 32.8 t70 -83.5 -36.04 24.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.641 -1.163 . . . . 1.3 109.666 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.89 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 12.7 mptt -111.99 121.84 46.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.809 -1.182 . . . . 2.57 107.809 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.98 147.58 46.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.763 0.653 . . . . 2.57 112.763 -164.044 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -66.85 90.87 0.18 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.852 -1.067 . . . . 3.14 110.002 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -115.47 -61.94 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.238 -0.892 . . . . 3.49 110.422 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.68 -21.9 0.92 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.603 -1.18 . . . . 1.74 110.72 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -63.05 -50.85 68.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.99 0.424 . . . . 2.88 110.161 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -124.56 -37.53 2.49 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.43 0.633 . . . . 3.45 109.486 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.1 -153.19 17.7 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.874 -1.057 . . . . 0.91 110.588 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.03 91.28 4.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.559 -0.534 . . . . 0.52 109.559 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.89 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -95.1 133.3 39.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.134 0.492 . . . . 0.6 111.553 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.817 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 68.8 mt -90.23 157.09 17.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.853 -0.612 . . . . 0.35 110.133 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.75 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 14.0 t -116.72 170.06 8.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.301 -0.629 . . . . 0.99 109.301 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.606 HG23 HD21 ' A' ' 68' ' ' LEU . 15.8 p -126.39 25.67 6.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.271 0.558 . . . . 1.22 110.404 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.4 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.282 1.039 . . . . 4.11 108.905 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 101' ' ' ILE . 2.7 mp -128.15 163.48 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.472 -1.24 . . . . 0.95 108.029 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -74.15 53.81 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.335 0.588 . . . . 1.25 111.709 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 11.6 mt -116.91 109.44 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.481 -0.781 . . . . 1.38 110.048 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . 158.34 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.469 1.106 . . . . 1.37 109.783 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.637 ' H ' ' HB3' ' A' ' 75' ' ' ARG . . . -157.85 162.98 32.48 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.074 -0.81 . . . . 2.8 111.074 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.767 -0.635 . . . . 5.11 110.852 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 111.532 -0.627 . . . . 9.91 111.532 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -50.54 -74.33 0.03 OUTLIER 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.462 0.542 . . . . 7.66 112.462 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -70.21 -16.75 63.1 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.98 -0.288 . . . . 8.75 111.175 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -64.27 -39.01 93.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 7.04 110.879 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.471 ' O ' ' HD2' ' A' ' 38' ' ' LYS . 4.6 mm? -79.38 -94.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.808 -0.633 . . . . 4.54 111.217 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 8.7 pt-20 -143.94 16.89 1.77 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.61 0.243 . . . . 4.07 111.593 -175.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 60.2 tp60 -64.11 111.65 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.019 -0.363 . . . . 4.36 110.019 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 65.59 24.44 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.782 0.801 . . . . 4.85 109.479 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 37.7 ttmt -121.36 150.02 42.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.21 -0.905 . . . . 2.02 110.616 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -68.83 175.34 3.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.988 -0.551 . . . . 0.96 109.705 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 43.2 m-80 -66.28 91.57 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.326 -0.397 . . . . 2.62 110.982 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.606 ' HB ' ' HD3' ' A' ' 38' ' ' LYS . 9.5 tp -78.44 137.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.433 -0.349 . . . . 0.84 110.147 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 40' ' ' ASN . 90.5 m-85 -138.25 138.45 38.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.216 0.531 . . . . 1.02 110.49 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.01 104.94 14.78 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.549 -1.278 . . . . 1.16 107.549 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -137.45 -177.77 15.39 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.538 -0.839 . . . . 0.27 111.636 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 73.1 mttt -114.98 157.67 23.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.525 0.679 . . . . 1.54 111.016 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.999 HG21 HD11 ' A' ' 49' ' ' ILE . 1.5 mp -69.63 139.57 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.604 -1.18 . . . . 0.25 109.908 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.649 HG21 ' HB2' ' A' ' 59' ' ' ASP . 47.3 p -129.04 -23.26 3.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.096 0.474 . . . . 0.39 111.938 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.601 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 40.1 ttm180 -146.2 124.61 12.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.338 -0.392 . . . . 1.85 110.529 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.999 HD11 HG21 ' A' ' 46' ' ' ILE . 40.4 mt -140.29 112.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.408 -0.59 . . . . 0.26 109.408 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -119.55 130.67 24.72 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.828 0.347 . . . . 2.24 110.734 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.776 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 2.8 Cg_exo -71.04 -22.47 26.2 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.953 2.435 . . . . 0.52 111.409 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.89 -15.32 61.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.375 -0.83 . . . . 1.23 111.315 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.9 pp -128.3 -5.54 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 119.309 -0.377 . . . . 0.46 111.488 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 41.39 64.37 1.04 Allowed 'General case' 0 C--N 1.351 0.638 0 CA-C-O 121.772 0.796 . . . . 2.51 111.616 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -169.25 167.92 10.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.052 -1.431 . . . . 0.19 109.069 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -135.82 142.71 44.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.18 112.547 -172.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 49.7 m-85 -96.59 134.72 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.56 110.195 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 100' ' ' VAL . 53.9 t -108.41 128.0 64.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.094 -0.957 . . . . 0.26 109.372 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.649 ' HB2' HG21 ' A' ' 47' ' ' THR . 13.0 t0 -98.61 108.44 21.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.002 0.43 . . . . 0.79 110.021 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -124.64 65.43 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.459 0.647 . . . . 0.89 109.434 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.08 34.6 52.88 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.336 -0.935 . . . . 0.83 111.452 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.88 115.15 24.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.655 0.264 . . . . 0.86 110.555 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -64.59 -27.06 68.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.911 -0.774 . . . . 2.43 108.911 175.597 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.49 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 19.9 mtm-85 -84.06 -11.47 56.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.662 -1.154 . . . . 4.52 110.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.426 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 61.28 -159.77 0.31 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.485 -0.779 . . . . 0.88 109.998 -172.988 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.79 120.24 0.98 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 109.867 -1.293 . . . . 0.24 109.867 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.1 t80 -103.78 113.22 26.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.192 0.52 . . . . 0.41 111.169 -169.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.891 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -100.0 115.2 65.74 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.315 -0.857 . . . . 0.16 110.143 177.983 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 25.4 Cg_exo -64.66 143.61 81.54 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.752 2.301 . . . . 0.23 111.803 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.846 HD13 ' HB ' ' A' ' 90' ' ' ILE . 24.3 tp -66.4 -26.5 67.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.959 -0.564 . . . . 0.19 111.514 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 20.9 pttp -73.05 -9.65 58.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.359 . . . . 2.04 110.999 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 17.0 mm-40 -100.04 -14.93 18.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.86 110.078 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.654 HG21 HG11 ' A' ' 93' ' ' VAL . 6.1 mm -49.04 133.57 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 113.47 0.915 . . . . 0.56 113.47 -168.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -89.11 151.06 22.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.311 -1.313 . . . . 0.39 111.864 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.848 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 3.0 tmm_? -65.24 -21.69 66.78 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.198 -0.91 . . . . 3.01 111.1 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.53 ' HB3' HD23 ' A' ' 122' ' ' LEU . 4.5 tp10 -73.99 -14.95 61.11 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.446 -0.784 . . . . 1.76 110.852 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -81.76 -52.71 6.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.856 -0.611 . . . . 1.4 109.861 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 93' ' ' VAL . 8.2 p90 -96.62 109.09 46.55 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.14 -1.43 . . . . 0.46 107.14 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.2 Cg_endo -40.56 137.14 1.68 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 123.87 3.047 . . . . 0.71 113.025 -166.674 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -48.99 -16.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.841 1.052 . . . . 0.93 113.841 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.52 -7.2 59.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 2.62 110.786 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.42 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 69.6 t80 -84.89 144.01 28.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.099 -0.704 . . . . 1.33 109.099 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -78.67 100.69 7.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 2.18 111.777 -175.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -81.13 120.09 24.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 1.74 110.525 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -138.82 105.45 5.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.034 -0.53 . . . . 3.99 110.647 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.87 -83.74 1.04 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.806 -0.711 . . . . 1.06 111.824 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 133.49 17.3 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.791 0.329 . . . . 4.37 110.252 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HB2' HG21 ' A' ' 93' ' ' VAL . 11.6 Cg_endo -59.64 153.6 54.44 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.87 2.38 . . . . 0.31 113.131 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.632 ' O ' HG23 ' A' ' 93' ' ' VAL . 26.6 t-20 -106.28 111.26 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.644 -0.873 . . . . 2.14 108.644 172.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.846 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.4 tt -62.78 -36.29 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.691 0.626 . . . . 0.21 112.691 -164.861 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.776 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 32.4 mmmt -67.27 -5.59 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.482 0.549 . . . . 3.82 112.482 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 23.07 7.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 1.91 109.58 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.654 HG11 HG21 ' A' ' 73' ' ' ILE . 48.0 t -121.94 -54.86 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.12 -0.945 . . . . 0.33 109.833 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.775 ' HB3' HG12 ' A' ' 46' ' ' ILE . 93.5 mt -109.95 158.83 17.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.071 -0.968 . . . . 0.3 110.548 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 146.0 26.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.128 -0.942 . . . . 2.67 109.352 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.608 ' HA ' HG22 ' A' ' 46' ' ' ILE . 47.8 mt-10 -55.6 119.48 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.25 110.893 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.47 -16.49 24.2 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.682 -0.69 . . . . 0.41 112.129 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.2 tt0 -82.39 138.58 34.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.796 -0.446 . . . . 1.18 109.796 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 12.5 pt-20 -87.54 156.73 19.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.256 0.55 . . . . 0.81 111.936 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 102' ' ' VAL . 33.5 m -141.02 147.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.973 -1.012 . . . . 0.18 109.397 171.484 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.598 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.2 mm -99.57 110.29 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.26 -1.015 . . . . 0.51 108.26 171.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 100' ' ' VAL . 3.4 m -144.64 132.5 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.28 111.447 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 7.7 pt20 -107.02 133.13 52.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.249 -0.432 . . . . 1.62 109.921 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.489 HD13 HD23 ' A' ' 116' ' ' LEU . 19.6 mm -67.14 102.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.78 110.159 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.26 -38.63 24.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 1.3 109.531 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 54.9 mttp -117.77 132.51 56.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.358 -0.837 . . . . 2.57 110.09 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -102.34 158.57 16.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.908 -1.042 . . . . 2.57 111.0 -168.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 1.06 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 0.2 OUTLIER -52.52 117.41 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 3.14 111.298 -176.292 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -143.98 18.91 1.79 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.858 -1.064 . . . . 3.49 109.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.65 -43.37 3.17 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.824 -0.626 . . . . 1.74 112.893 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.55 -51.28 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.853 0.316 . . . . 2.88 111.853 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -125.02 -38.93 2.29 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.378 0.609 . . . . 3.45 110.971 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 1.06 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 92.07 -126.79 8.65 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.469 -0.872 . . . . 0.91 111.687 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.07 94.19 7.16 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.812 0.339 . . . . 0.52 110.747 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -94.52 124.96 38.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.474 -0.33 . . . . 0.6 111.604 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.891 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 25.1 mt -90.8 135.66 33.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.729 -0.471 . . . . 0.35 109.729 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 119' ' ' PHE . 7.1 t -97.38 167.57 10.92 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.446 -0.575 . . . . 0.99 109.446 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.618 HG23 HD21 ' A' ' 68' ' ' LEU . 11.9 p -125.32 19.83 8.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.165 0.507 . . . . 1.22 111.224 173.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 73.7 m-85 -80.89 54.13 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.826 0.822 . . . . 4.11 109.918 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 121' ' ' SER . 2.0 mp -127.63 175.85 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.579 -1.191 . . . . 0.95 108.054 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.629 ' H ' HG22 ' A' ' 120' ' ' ILE . 1.5 m -66.85 19.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.425 0.898 . . . . 1.25 113.425 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 76' ' ' GLU . 6.6 mp -115.9 106.5 13.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.22 -0.3 . . . . 1.38 110.433 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . 158.44 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.727 1.211 . . . . 1.37 109.254 169.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . 0.565 ' HA3' HH21 ' A' ' 75' ' ' ARG . . . -73.98 164.53 54.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 2.8 112.757 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.875 -0.583 . . . . 5.11 109.612 176.623 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.884 -0.487 . . . . 9.91 111.884 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 28.4 m -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.042 0.449 . . . . 7.66 110.534 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -86.52 157.35 19.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.865 -0.607 . . . . 8.75 110.516 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 63.4 mtt 71.72 23.33 3.72 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 124.056 0.848 . . . . 7.04 111.434 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 31' ' ' SER . 66.7 mt -101.38 -49.74 3.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.554 -0.906 . . . . 4.54 108.554 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 1.8 mm-40 43.73 66.45 0.82 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.315 -1.311 . . . . 4.07 110.106 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.426 ' CD ' ' H ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -79.47 -58.09 3.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.44 -0.8 . . . . 4.36 112.942 -163.489 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -112.14 46.97 1.1 Allowed 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.82 -1.178 . . . . 4.85 107.82 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 32.0 ttmt -131.63 148.43 52.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.055 -1.884 . . . . 2.02 109.896 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -72.3 150.35 43.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.459 -0.941 . . . . 0.96 108.459 172.149 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -57.54 117.6 4.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 2.62 110.447 -175.638 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 HG12 ' A' ' 120' ' ' ILE . 7.5 tp -84.39 146.74 6.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.84 111.292 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.78 147.29 40.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.409 -0.36 . . . . 1.02 110.556 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 41.3 ttmt -108.37 116.63 32.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 1.16 109.045 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.21 23.85 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.83 -0.908 . . . . 0.27 110.83 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 68.4 mttt -102.33 161.37 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.27 0.557 . . . . 1.54 110.814 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.824 HG12 ' HB3' ' A' ' 94' ' ' LEU . 1.8 mp -70.23 136.47 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.842 -1.072 . . . . 0.25 109.239 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 59' ' ' ASP . 1.9 p -121.52 -33.52 3.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.419 0.628 . . . . 0.39 111.139 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.617 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 39.4 ttm180 -147.68 122.14 9.73 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.269 -0.878 . . . . 1.85 110.384 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.694 HD11 HG21 ' A' ' 46' ' ' ILE . 51.1 mt -131.62 130.11 62.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.525 -0.546 . . . . 0.26 109.525 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.861 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 22.6 tt0 -129.29 131.51 23.7 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.868 -0.606 . . . . 2.24 109.461 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.746 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 9.4 Cg_exo -68.3 -24.92 36.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.475 2.117 . . . . 0.52 111.31 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.378 -0.828 . . . . 1.23 111.079 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.861 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.1 pp -118.48 -1.85 11.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 119.086 -0.483 . . . . 0.46 111.758 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 41.04 54.22 3.3 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-O 121.979 0.895 . . . . 2.51 111.396 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.37 166.52 27.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.269 -1.332 . . . . 0.19 109.499 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -133.47 134.24 43.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.406 -0.361 . . . . 0.18 111.55 -175.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.617 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 76.4 m-85 -85.86 133.1 33.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.387 -0.597 . . . . 0.56 109.387 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.544 ' HB ' HD11 ' A' ' 116' ' ' LEU . 31.5 t -115.34 128.75 72.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.469 -0.787 . . . . 0.26 109.626 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.858 ' HB2' HG21 ' A' ' 47' ' ' THR . 12.3 t0 -101.94 108.77 20.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.886 -0.597 . . . . 0.79 110.321 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.14 65.49 1.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.369 -0.974 . . . . 0.89 108.369 171.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.48 30.5 50.04 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.525 -0.845 . . . . 0.83 111.699 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.06 153.05 18.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 0.86 111.552 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.77 -27.35 15.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.686 -0.688 . . . . 2.43 110.52 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 2.4 mmp_? -113.57 -9.36 13.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.083 -0.508 . . . . 4.52 110.532 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 9.7 m170 70.34 144.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.243 -0.889 . . . . 0.88 111.221 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA3' HD21 ' A' ' 116' ' ' LEU . . . -78.78 104.23 2.07 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.413 -0.898 . . . . 0.24 110.965 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.653 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 1.7 t80 -91.32 97.73 11.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.178 0.513 . . . . 0.41 110.191 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.025 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -86.42 115.44 62.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.56 -0.746 . . . . 0.16 110.188 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.672 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 10.3 Cg_exo -69.52 141.33 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.245 1.963 . . . . 0.23 111.471 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 21.2 tp -54.78 -30.62 57.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.335 -0.848 . . . . 0.19 112.144 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.672 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.0 ptmm? -61.76 -22.99 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 2.04 111.768 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -93.57 -21.75 19.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.48 -0.327 . . . . 0.86 111.256 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.717 HG21 HG11 ' A' ' 93' ' ' VAL . 17.0 mt -49.01 132.21 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.155 0.798 . . . . 0.56 113.155 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -93.67 151.9 19.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.197 -0.91 . . . . 0.39 111.363 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 10.0 tpt180 -54.38 -16.1 2.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.525 -1.216 . . . . 3.01 112.777 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.029 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 29.7 tp10 -63.5 -29.89 71.09 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.788 -0.57 . . . . 1.76 110.823 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.644 ' CE1' HG12 ' A' ' 100' ' ' VAL . 26.1 m-85 -86.14 -41.61 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.317 -0.856 . . . . 1.4 110.733 -172.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' HB3' HG22 ' A' ' 93' ' ' VAL . 2.1 p90 -102.3 92.13 3.03 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 107.551 -1.277 . . . . 0.46 107.551 166.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 23.4 Cg_exo -26.72 137.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.675 4.25 . . . . 0.71 115.374 -167.504 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.6 -25.39 17.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.356 -1.293 . . . . 0.93 112.579 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.59 -6.57 59.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.196 0.522 . . . . 2.62 111.253 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 79' ' ' PRO . 58.1 t80 -87.85 135.38 33.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.313 -0.625 . . . . 1.33 109.313 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -71.61 116.37 11.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.051 -0.722 . . . . 2.18 109.051 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.483 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -63.73 -21.03 66.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.886 0.699 . . . . 1.74 112.886 -170.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 40.6 m80 65.55 23.93 11.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.284 0.564 . . . . 3.99 110.412 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.41 -57.93 4.18 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.513 -0.767 . . . . 1.06 111.953 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -137.3 130.27 17.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.864 0.364 . . . . 4.37 110.46 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' O ' HD11 ' A' ' 70' ' ' LEU . 6.5 Cg_endo -61.4 154.59 57.78 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.163 2.575 . . . . 0.31 113.697 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.7 t-20 -114.98 110.7 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.24 -0.652 . . . . 2.14 109.24 171.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 tt -55.63 -43.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 113.649 0.981 . . . . 0.21 113.649 -164.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.746 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 4.7 mmmp? -56.7 -26.37 56.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.245 0.831 . . . . 3.82 113.245 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -110.18 9.38 23.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.145 0.497 . . . . 1.91 111.079 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.717 HG11 HG21 ' A' ' 73' ' ' ILE . 53.2 t -115.21 -51.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.638 -0.71 . . . . 0.33 109.849 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.824 ' HB3' HG12 ' A' ' 46' ' ' ILE . 83.1 mt -103.16 154.05 19.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.44 -0.8 . . . . 0.3 109.691 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -148.15 151.99 36.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.521 -0.763 . . . . 2.67 108.95 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HA ' HG22 ' A' ' 46' ' ' ILE . 36.6 mt-10 -62.06 118.69 7.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 1.25 110.237 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.35 -18.33 20.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.85 -0.614 . . . . 0.41 112.209 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 tt0 -78.02 135.86 37.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.479 -0.563 . . . . 1.18 109.479 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.9 157.37 19.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.136 0.493 . . . . 0.81 111.361 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG12 ' CE1' ' A' ' 77' ' ' TYR . 35.0 m -138.07 151.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.169 -0.923 . . . . 0.18 109.959 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 122' ' ' LEU . 3.5 mm -103.06 110.14 28.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.67 -1.233 . . . . 0.51 107.67 171.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -143.61 134.79 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.559 . . . . 0.28 111.783 -170.215 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -108.33 141.26 40.41 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.56 -0.904 . . . . 1.62 108.56 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 104' ' ' ILE . 18.3 mm -74.98 104.53 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.667 0.746 . . . . 0.78 111.367 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.47 -43.33 32.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.686 -1.143 . . . . 1.3 109.776 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.658 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 60.4 mttp -118.04 137.42 52.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.66 -0.7 . . . . 2.57 109.895 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.64 144.38 32.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.007 -0.997 . . . . 2.57 112.547 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 40.8 tt0 -71.63 90.91 1.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.31 -0.859 . . . . 3.14 110.321 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.599 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 17.8 mtt180 -105.53 -82.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.453 -0.794 . . . . 3.49 110.665 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.93 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.561 -0.828 . . . . 1.74 112.569 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.427 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 21.6 t-20 -61.59 -49.71 75.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.579 0.214 . . . . 2.88 111.579 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 29.3 mtpp -123.55 -38.05 2.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.321 0.581 . . . . 3.45 109.812 171.719 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.599 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 85.64 -132.71 11.28 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.149 -0.932 . . . . 0.91 112.531 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 65' ' ' HIS . . . -75.57 108.01 8.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.148 -0.526 . . . . 0.52 111.326 -171.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -104.22 125.24 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.213 -0.449 . . . . 0.6 110.431 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.025 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 30.4 mt -90.8 148.72 22.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.989 0.423 . . . . 0.35 109.965 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -113.93 175.46 5.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.17 -0.678 . . . . 0.99 109.17 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.27 26.99 6.73 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.401 0.619 . . . . 1.22 110.274 173.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -78.15 44.45 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.547 1.165 . . . . 4.11 109.141 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 101' ' ' ILE . 3.3 mp -128.46 161.73 36.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.839 -1.073 . . . . 0.95 108.982 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.06 66.82 0.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.967 0.413 . . . . 1.25 111.301 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 101' ' ' ILE . 1.9 mt -116.25 173.31 6.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.112 -0.699 . . . . 1.38 109.112 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.029 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 76.94 56.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.92 0.762 . . . . 1.37 110.622 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.29 43.85 0.89 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.279 -0.873 . . . . 2.8 111.967 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.335 -0.84 . . . . 5.11 110.871 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 112.383 -0.287 . . . . 9.91 112.383 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -69.24 128.14 35.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.379 0.609 . . . . 7.66 110.682 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -99.26 52.24 0.95 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.971 -0.559 . . . . 8.75 110.945 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 72.8 mtm -87.06 -11.85 49.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.821 0.82 . . . . 7.04 109.002 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.27 173.87 6.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.607 -1.179 . . . . 4.54 108.782 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 33.8 mt-10 -61.78 -62.36 1.85 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.036 0.21 . . . . 4.07 110.514 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 65.35 74.02 0.39 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.486 0.491 . . . . 4.36 110.233 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 59.82 44.09 14.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.582 0.706 . . . . 4.85 110.132 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 4.3 ttmp? -130.72 143.16 50.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 2.02 110.925 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.681 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -71.19 158.26 36.72 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.614 -0.884 . . . . 0.96 108.614 169.131 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -52.79 119.77 4.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.527 . . . . 2.62 110.665 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.678 HD11 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -89.52 138.62 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.218 -0.901 . . . . 0.84 110.326 -175.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -133.25 156.41 47.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.021 0.438 . . . . 1.02 110.343 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.8 ttmt -118.49 121.66 40.82 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.795 -0.817 . . . . 1.16 108.795 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.82 166.95 25.78 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.675 -0.97 . . . . 0.27 110.675 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 90.4 mttt -100.21 156.88 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.41 0.624 . . . . 1.54 111.114 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.891 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -69.86 134.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.661 -1.154 . . . . 0.25 109.822 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 59' ' ' ASP . 61.6 p -123.87 -18.41 6.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.357 0.599 . . . . 0.39 111.314 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HG2' ' HD2' ' A' ' 57' ' ' PHE . 7.2 ttm180 -150.6 131.3 14.02 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.361 -0.836 . . . . 1.85 110.524 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 46' ' ' ILE . 58.0 mt -139.81 101.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.657 -0.868 . . . . 0.26 108.657 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.597 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -98.57 112.46 62.53 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.0 -0.545 . . . . 2.24 110.015 -177.06 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.996 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 52.9 Cg_exo -57.12 -22.37 47.37 Favored 'Trans proline' 0 N--CA 1.467 -0.054 0 C-N-CA 122.953 2.435 . . . . 0.52 111.894 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -71.69 -20.09 61.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.23 111.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -128.36 12.74 6.53 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.811 1.041 . . . . 0.46 113.811 -176.056 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER 47.73 40.78 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 2.51 112.818 173.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.54 170.24 20.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 0.19 111.076 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' PHE . . . -137.63 149.12 46.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.18 112.032 -173.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.526 ' HD2' ' HG2' ' A' ' 48' ' ' ARG . 63.4 m-85 -98.38 137.64 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.56 109.826 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.637 ' HB ' HD11 ' A' ' 116' ' ' LEU . 24.3 t -118.72 131.78 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.347 -0.842 . . . . 0.26 109.832 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.602 ' HB2' HG21 ' A' ' 47' ' ' THR . 22.2 t70 -100.43 104.86 16.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.79 110.649 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -127.11 65.4 1.3 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.973 -0.751 . . . . 0.89 108.973 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.41 52.18 19.6 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.336 -0.935 . . . . 0.83 111.328 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 168.48 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.86 111.193 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 7.4 tp10 -93.78 -53.54 3.98 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.905 -0.318 . . . . 2.43 111.381 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.4 ptm180 -109.16 6.54 24.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.132 -0.627 . . . . 4.52 110.778 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 15.7 m170 71.25 143.28 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.24 -0.891 . . . . 0.88 111.511 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -74.53 117.33 5.46 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.829 -0.909 . . . . 0.24 110.829 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 21.6 t80 -99.83 98.73 9.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.166 0.508 . . . . 0.41 110.375 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.925 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -87.34 117.54 68.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.506 -0.77 . . . . 0.16 111.05 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' HD23 ' A' ' 68' ' ' LEU . 21.3 Cg_exo -67.65 141.85 56.37 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.821 2.347 . . . . 0.23 111.721 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.699 HD13 ' HB ' ' A' ' 90' ' ' ILE . 18.0 tp -59.34 -35.09 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.19 112.035 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -67.83 -8.22 34.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.394 -0.366 . . . . 2.04 111.786 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -96.31 -26.98 15.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.641 -0.254 . . . . 0.86 110.349 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.545 HG21 HG11 ' A' ' 93' ' ' VAL . 33.9 mt -49.85 135.06 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.436 0.902 . . . . 0.56 113.436 -167.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -91.07 148.99 22.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.394 -1.275 . . . . 0.39 111.432 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.662 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 13.6 ttp180 -58.41 -14.49 7.8 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.937 -1.029 . . . . 3.01 112.583 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.673 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 10.4 tp10 -54.36 -38.82 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 1.76 111.789 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.92 ' OH ' ' HA ' ' A' ' 100' ' ' VAL . 39.2 m-85 -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.581 0.586 . . . . 1.4 112.581 -168.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.662 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 12.5 p90 -97.91 88.58 0.65 Allowed Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 105.996 -1.853 . . . . 0.46 105.996 158.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.08 143.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.876 3.717 . . . . 0.71 114.216 -157.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.95 -7.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.907 -1.042 . . . . 0.93 112.65 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.7 -21.94 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.472 0.653 . . . . 2.62 109.607 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -77.64 130.67 37.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.11 -0.95 . . . . 1.33 109.466 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -68.57 100.35 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 2.18 110.339 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -83.22 103.02 12.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.683 -0.69 . . . . 1.74 110.634 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -130.76 131.89 44.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.824 -0.625 . . . . 3.99 109.856 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.15 -102.32 2.16 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.558 -0.829 . . . . 1.06 111.84 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -136.94 133.12 18.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.138 -0.319 . . . . 4.37 110.138 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -60.0 156.48 38.87 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.417 1.412 . . . . 0.31 111.091 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.515 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.4 t-20 -118.34 101.4 8.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.676 -0.49 . . . . 2.14 109.676 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.699 ' HB ' HD13 ' A' ' 70' ' ' LEU . 19.9 tt -54.79 -45.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.598 0.962 . . . . 0.21 113.598 -164.219 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.996 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 17.0 ptmt -56.42 -16.54 5.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.838 0.681 . . . . 3.82 112.838 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 34.6 t70 -118.18 1.34 11.91 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.521 0.676 . . . . 1.91 110.624 179.314 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 78' ' ' PHE . 45.3 t -105.58 -50.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.655 0.741 . . . . 0.33 109.543 -175.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.681 ' HB3' HG12 ' A' ' 46' ' ' ILE . 81.6 mt -100.84 152.72 20.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.354 -0.839 . . . . 0.3 109.172 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 149.09 30.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.355 -0.839 . . . . 2.67 109.389 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.538 ' HA ' HG22 ' A' ' 46' ' ' ILE . 31.0 mt-10 -56.24 123.93 16.24 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.722 0.639 . . . . 1.25 111.203 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.3 29.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.615 -0.721 . . . . 0.41 112.151 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 53.3 tt0 -77.14 133.4 38.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.054 -0.35 . . . . 1.18 110.054 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.43 158.1 24.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.714 . . . . 0.81 110.97 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.92 ' HA ' ' OH ' ' A' ' 77' ' ' TYR . 27.5 m -137.41 146.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.18 110.549 170.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.989 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.6 mm -93.83 110.14 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.237 -1.023 . . . . 0.51 108.237 169.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.539 ' CG2' HD22 ' A' ' 116' ' ' LEU . 3.4 m -144.32 129.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.199 0.523 . . . . 0.28 111.26 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 15.6 pt20 -93.53 138.87 31.37 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.507 -0.923 . . . . 1.62 108.507 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.569 ' CD1' HD23 ' A' ' 116' ' ' LEU . 41.7 mm -80.54 96.21 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.615 0.721 . . . . 0.78 109.338 176.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.87 -29.49 63.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.727 -1.124 . . . . 1.3 109.852 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 32.3 mttm -129.07 123.97 33.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 2.57 109.578 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -79.26 158.71 27.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.95 -0.568 . . . . 2.57 110.305 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.898 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 22.5 tt0 -70.63 90.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.56 0.695 . . . . 3.14 110.717 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -111.26 6.98 20.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.862 -1.063 . . . . 3.49 110.974 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.36 -46.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.643 -0.789 . . . . 1.74 113.432 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.65 -50.84 70.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.007 0.403 . . . . 2.88 111.064 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 -37.28 2.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.631 -0.877 . . . . 3.45 108.631 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.898 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 83.52 -133.4 11.85 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.823 -1.081 . . . . 0.91 111.098 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.476 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -73.02 96.87 2.22 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.155 0.502 . . . . 0.52 110.309 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -104.03 124.42 49.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.6 111.528 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.925 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 31.4 mt -91.4 159.77 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.049 -0.723 . . . . 0.35 109.049 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.431 ' O ' HG12 ' A' ' 102' ' ' VAL . 12.8 t -138.08 153.4 49.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.186 -0.672 . . . . 0.99 109.186 168.001 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.413 HG23 HD11 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -126.86 34.49 4.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.302 0.572 . . . . 1.22 111.015 172.143 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -80.25 45.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.357 -0.979 . . . . 4.11 108.357 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.631 ' HB ' HD12 ' A' ' 122' ' ' LEU . 11.0 mt -121.36 168.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.471 -1.24 . . . . 0.95 108.37 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -85.03 33.48 0.54 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.947 0.721 . . . . 1.25 112.947 -172.016 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.989 ' HG ' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -117.2 100.19 7.54 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.684 0.754 . . . . 1.38 109.882 175.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.673 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . -161.66 37.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.712 -0.676 . . . . 1.37 109.907 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.49 -162.19 29.64 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.052 -0.976 . . . . 2.8 112.556 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.845 -0.598 . . . . 5.11 109.831 176.569 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.985 -0.446 . . . . 9.91 111.985 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -129.73 67.07 1.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.981 0.419 . . . . 7.66 109.972 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -152.02 47.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.39 0.614 . . . . 8.75 110.269 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -88.7 -44.86 10.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.518 0.675 . . . . 7.04 109.854 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.1 mt -128.48 -74.38 0.57 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.067 -0.969 . . . . 4.54 110.497 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -139.34 -175.46 4.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.77 -0.65 . . . . 4.07 110.555 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 28.8 mt-30 -122.38 100.49 6.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 4.36 110.362 -172.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 65.31 20.22 11.81 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.811 -0.631 . . . . 4.85 110.19 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.57 ' HE3' HG23 ' A' ' 120' ' ' ILE . 23.8 ttmm -131.31 162.96 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.441 -0.8 . . . . 2.02 109.905 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.74 175.46 6.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.194 -0.669 . . . . 0.96 109.194 171.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -55.69 124.03 16.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.084 0.469 . . . . 2.62 110.948 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -95.33 144.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.881 -0.6 . . . . 0.84 109.663 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -125.22 135.45 52.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 1.02 110.449 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 40.0 ttmt -98.75 103.67 15.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.911 -0.774 . . . . 1.16 108.911 167.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.94 161.89 19.35 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 110.691 -0.964 . . . . 0.27 110.691 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 84.6 mttt -94.45 158.06 15.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.171 0.51 . . . . 1.54 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.769 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.8 mp -74.57 133.69 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.144 -1.058 . . . . 0.25 108.144 169.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.587 HG21 ' CB ' ' A' ' 59' ' ' ASP . 57.5 p -117.57 -20.09 9.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.436 0.636 . . . . 0.39 110.525 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 24.4 ttt180 -146.6 121.42 9.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.136 -0.938 . . . . 1.85 109.677 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.769 ' CD1' HG21 ' A' ' 46' ' ' ILE . 75.4 mt -125.91 109.0 20.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.147 -0.686 . . . . 0.26 109.147 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 7.0 tp10 -104.47 107.78 58.77 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.221 -0.9 . . . . 2.24 109.488 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HB3' ' CD ' ' A' ' 91' ' ' LYS . 54.3 Cg_exo -53.95 -37.94 86.08 Favored 'Trans proline' 0 N--CA 1.467 -0.07 0 C-N-CA 123.309 2.673 . . . . 0.52 112.578 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -22.12 65.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.23 112.158 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.0 pp -123.59 8.25 8.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.15 0.426 . . . . 0.46 112.15 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB2' HD23 ' A' ' 70' ' ' LEU . 8.0 pt-20 39.23 60.23 1.55 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.705 0.802 . . . . 2.51 112.197 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -165.67 158.47 15.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.248 -0.887 . . . . 0.19 110.405 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -122.91 144.49 49.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.546 0.572 . . . . 0.18 112.546 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.552 ' HD1' ' HB2' ' A' ' 65' ' ' HIS . 63.1 m-85 -97.02 137.09 36.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.417 -0.811 . . . . 0.56 109.844 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 116' ' ' LEU . 38.4 t -120.47 129.67 75.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.019 -0.537 . . . . 0.26 109.675 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.587 ' CB ' HG21 ' A' ' 47' ' ' THR . 29.2 t70 -102.41 112.68 25.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.319 -0.401 . . . . 0.79 111.384 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.0 67.45 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.047 -0.723 . . . . 0.89 109.047 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.8 41.33 58.05 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.728 -0.669 . . . . 0.83 112.153 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.21 147.61 44.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.86 111.271 -172.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.66 -51.26 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 2.43 108.803 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.911 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 26.7 mmm180 -96.23 106.61 18.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.224 -0.898 . . . . 4.52 108.793 169.258 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 18.9 m170 -61.56 149.83 37.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 0.88 111.51 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.08 110.31 3.14 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.771 -0.931 . . . . 0.24 110.771 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 9.5 t80 -98.87 100.58 11.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.326 0.584 . . . . 0.41 110.827 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.94 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -92.15 115.09 64.06 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.09 -0.959 . . . . 0.16 110.94 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.653 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.0 Cg_exo -64.07 141.07 75.14 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.864 2.376 . . . . 0.23 111.562 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.831 ' HA ' HG13 ' A' ' 73' ' ' ILE . 10.3 tp -63.07 -34.93 78.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.605 -0.725 . . . . 0.19 111.722 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.08 -14.8 52.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.982 0.42 . . . . 2.04 111.083 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 1.6 mm-40 -99.19 -14.45 19.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.86 110.534 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.831 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.8 mt -49.31 134.05 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.151 0.797 . . . . 0.56 113.151 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -87.05 146.5 26.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.814 -1.084 . . . . 0.39 110.922 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.604 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 18.2 ttm180 -62.19 -13.51 28.29 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.384 -0.825 . . . . 3.01 111.806 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.684 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 15.0 tp10 -60.87 -27.22 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.468 . . . . 1.76 110.757 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.429 ' HD2' HG23 ' A' ' 73' ' ' ILE . 14.8 m-85 -87.45 -44.17 11.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.447 -0.797 . . . . 1.4 110.353 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.1 p90 -96.17 97.34 3.08 Favored Pre-proline 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 0.46 107.098 166.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.1 Cg_endo -38.65 138.02 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.306 3.337 . . . . 0.71 112.776 -163.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.69 -10.28 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.395 -0.821 . . . . 0.93 113.193 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -87.02 -12.6 46.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.349 0.595 . . . . 2.62 110.317 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.88 143.5 41.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.782 -0.644 . . . . 1.33 109.688 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -79.52 100.64 7.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.37 -0.377 . . . . 2.18 110.957 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -87.04 123.4 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 1.74 110.182 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.57 -20.43 18.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.007 0.432 . . . . 3.99 110.373 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -77.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.914 -0.66 . . . . 1.06 111.572 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -104.84 132.57 20.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.043 -0.355 . . . . 4.37 110.043 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' C ' HD11 ' A' ' 70' ' ' LEU . 11.5 Cg_endo -64.66 161.78 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.116 1.877 . . . . 0.31 111.975 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.583 ' OD1' ' HB3' ' A' ' 92' ' ' ASP . 0.4 OUTLIER -122.11 102.62 8.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 2.14 109.78 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 17.3 tt -54.85 -40.16 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.699 1.0 . . . . 0.21 113.699 -162.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.605 ' CD ' ' HB3' ' A' ' 51' ' ' PRO . 43.2 pttt -67.65 -11.6 58.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.953 0.353 . . . . 3.82 111.953 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.583 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 37.0 t70 -125.53 18.25 8.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.159 0.98 . . . . 1.91 109.359 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 78' ' ' PHE . 18.1 t -122.5 -54.77 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.33 110.198 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.431 ' HB3' HD11 ' A' ' 49' ' ' ILE . 47.8 mt -101.09 153.34 19.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.429 -0.805 . . . . 0.3 109.55 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.526 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -125.43 150.53 47.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.106 -0.702 . . . . 2.67 109.106 173.727 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.66 ' HA ' HG22 ' A' ' 46' ' ' ILE . 42.2 mt-10 -69.95 109.31 4.44 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.257 -1.016 . . . . 1.25 108.257 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.21 -11.46 19.81 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.438 -0.801 . . . . 0.41 112.15 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 46.8 tt0 -80.29 144.71 32.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.206 0.503 . . . . 1.18 109.966 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.69 153.71 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.32 0.581 . . . . 0.81 111.612 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 102' ' ' VAL . 27.3 m -136.29 146.4 29.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.088 -0.96 . . . . 0.18 109.018 169.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.896 ' HB ' HD11 ' A' ' 122' ' ' LEU . 4.3 mm -100.42 109.12 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.571 -1.27 . . . . 0.51 107.571 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.523 ' CG2' HD22 ' A' ' 116' ' ' LEU . 4.8 m -145.5 142.63 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.021 -0.536 . . . . 0.28 110.717 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.48 ' HG3' HG22 ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.4 166.28 10.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.381 -0.6 . . . . 1.62 109.381 175.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.477 ' CD1' HD23 ' A' ' 116' ' ' LEU . 18.7 mm -108.53 98.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.629 0.728 . . . . 0.78 110.072 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -83.71 -29.41 27.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.066 -0.97 . . . . 1.3 110.381 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 36.1 mmtm -117.65 136.35 53.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.449 . . . . 2.57 109.895 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 28.2 mt-10 -97.56 158.25 15.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.417 -0.81 . . . . 2.57 110.447 -166.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.911 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 24.8 tt0 -51.25 112.21 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.547 0.529 . . . . 3.14 110.803 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.917 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 12.7 ptm180 -146.65 49.28 1.15 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.454 -0.794 . . . . 3.49 110.382 -175.345 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.34 -96.25 1.0 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.788 -0.642 . . . . 1.74 113.991 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -60.66 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.004 0.742 . . . . 2.88 113.004 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -110.86 -40.28 4.58 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.143 -0.623 . . . . 3.45 110.144 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.917 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 60.88 -121.51 26.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.487 -0.778 . . . . 0.91 112.509 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.538 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -72.99 101.08 3.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.164 0.506 . . . . 0.52 110.607 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -98.59 124.0 43.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.248 -0.433 . . . . 0.6 110.907 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.94 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 46.9 mt -90.93 136.75 32.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 0.35 109.732 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' HG3' ' A' ' 103' ' ' GLN . 5.0 t -96.82 168.17 10.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.635 . . . . 0.99 109.284 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.61 HG23 HD21 ' A' ' 68' ' ' LEU . 2.0 p -136.01 13.99 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.155 0.502 . . . . 1.22 111.159 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.91 57.52 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.246 -1.02 . . . . 4.11 108.246 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 121' ' ' SER . 8.1 mt -127.9 175.5 9.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 113.975 -1.466 . . . . 0.95 108.648 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.586 ' H ' HG22 ' A' ' 120' ' ' ILE . 14.6 m -75.61 33.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.448 0.536 . . . . 1.25 112.448 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.896 HD11 ' HB ' ' A' ' 101' ' ' ILE . 4.2 mp -116.34 124.22 49.56 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.349 -0.219 . . . . 1.38 111.496 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . 159.07 34.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.911 1.382 . . . . 1.37 109.149 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.09 -90.18 1.65 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.669 -0.972 . . . . 2.8 110.669 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.667 -0.682 . . . . 5.11 109.789 174.468 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.774 -0.531 . . . . 9.91 111.774 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -92.62 62.96 3.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.629 -0.508 . . . . 7.66 109.629 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -56.95 -22.58 39.01 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.032 0.753 . . . . 8.75 113.032 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.72 -27.31 66.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.317 0.58 . . . . 7.04 110.454 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.6 mt -103.0 -46.37 4.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.459 -0.791 . . . . 4.54 110.315 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 31.6 mt-10 -61.73 -64.04 1.07 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.25 -0.886 . . . . 4.07 111.187 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 67.12 -69.06 0.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.918 0.761 . . . . 4.36 111.011 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -122.5 -21.15 5.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 4.85 109.954 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 15.1 pttm -87.58 175.56 7.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 2.02 110.597 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.11 173.59 8.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.676 -0.861 . . . . 0.96 108.676 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -61.66 124.95 22.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.378 0.609 . . . . 2.62 110.783 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 103' ' ' GLN . 7.3 tp -94.18 143.96 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.194 -0.912 . . . . 0.84 110.098 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.22 144.09 51.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.05 0.452 . . . . 1.02 110.968 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 99' ' ' GLU . 2.4 tppp? -112.42 117.61 32.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.307 -0.86 . . . . 1.16 109.389 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.63 30.64 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.629 -0.988 . . . . 0.27 110.629 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 97' ' ' GLY . 39.2 mtmt -116.52 159.11 22.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.64 0.733 . . . . 1.54 111.88 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.749 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -68.42 137.77 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.322 -1.308 . . . . 0.25 110.089 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 59' ' ' ASP . 47.5 p -126.56 -20.18 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.39 111.689 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.684 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 8.3 ttm180 -148.08 122.02 9.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.072 -0.513 . . . . 1.85 110.09 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.749 ' CD1' HG21 ' A' ' 46' ' ' ILE . 88.2 mt -128.87 108.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.146 -0.687 . . . . 0.26 109.146 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 17.3 tt0 -102.89 121.05 50.59 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.894 -0.594 . . . . 2.24 109.688 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG3' ' CD ' ' A' ' 91' ' ' LYS . 12.2 Cg_exo -65.8 -31.25 48.71 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.977 2.451 . . . . 0.52 112.759 -171.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 t -77.03 -10.11 59.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 1.23 111.657 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 3.1 pp -127.82 5.77 6.06 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.728 0.64 . . . . 0.46 112.728 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 70' ' ' LEU . 11.2 pt-20 43.47 55.55 4.81 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.352 0.596 . . . . 2.51 112.095 170.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.0 158.98 22.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.461 -0.79 . . . . 0.19 110.365 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -129.1 140.26 51.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.873 0.694 . . . . 0.18 112.873 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.711 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 53.0 m-85 -92.43 128.61 38.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.134 -0.939 . . . . 0.56 110.119 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.535 HG12 ' HD1' ' A' ' 60' ' ' TYR . 76.5 t -108.54 131.01 60.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.25 0.547 . . . . 0.26 109.884 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.689 ' HB2' HG21 ' A' ' 47' ' ' THR . 10.6 t70 -101.49 96.49 7.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.715 -0.675 . . . . 0.79 110.664 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.661 ' OH ' HD11 ' A' ' 104' ' ' ILE . 15.5 p90 -126.88 66.29 1.27 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.032 -0.729 . . . . 0.89 109.032 173.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.39 11.67 15.03 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.759 -0.734 . . . . 0.83 112.533 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.61 110.71 18.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.86 110.305 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.63 -18.68 60.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 2.43 110.637 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.677 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.9 mmp_? -95.63 -6.82 39.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.893 -0.594 . . . . 4.52 110.371 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.711 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 59.18 107.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.238 -0.892 . . . . 0.88 111.924 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -59.61 122.06 28.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.431 -0.89 . . . . 0.24 111.151 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 5.7 t80 -111.28 107.67 17.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.283 0.563 . . . . 0.41 110.524 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.762 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.3 118.58 67.71 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.326 -0.852 . . . . 0.16 110.84 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.57 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 27.5 Cg_exo -64.87 134.9 42.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.501 2.134 . . . . 0.23 111.052 169.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.691 ' HA ' HG13 ' A' ' 73' ' ' ILE . 12.3 tp -57.19 -31.91 65.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.583 . . . . 0.19 111.961 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 21.3 pttp -70.2 -8.18 47.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.448 -0.342 . . . . 2.04 111.529 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 6.1 mm-40 -103.65 -10.03 18.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 110.423 -0.214 . . . . 0.86 110.423 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.691 HG13 ' HA ' ' A' ' 70' ' ' LEU . 18.5 mt -60.77 133.54 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.658 0.614 . . . . 0.56 112.658 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' THR . . . -77.92 140.51 39.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.254 -0.884 . . . . 0.39 111.208 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.753 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 29.6 ttp180 -58.62 -13.81 6.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.223 -0.899 . . . . 3.01 112.397 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.927 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 25.3 tp10 -56.25 -29.94 61.73 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.437 -0.79 . . . . 1.76 111.351 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.543 ' CZ ' HD22 ' A' ' 122' ' ' LEU . 34.0 m-85 -85.32 -41.03 15.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 1.4 110.894 -172.002 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.753 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.4 p90 -102.0 96.73 7.15 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 106.963 -1.495 . . . . 0.46 106.963 167.365 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_endo -32.01 138.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 1 C-N-CA 125.676 4.251 . . . . 0.71 114.704 -162.186 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.634 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -51.13 -24.17 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.638 -1.164 . . . . 0.93 113.699 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -92.92 4.8 53.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.58 0.705 . . . . 2.62 110.67 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -84.78 132.13 34.46 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.662 -0.866 . . . . 1.33 108.662 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -65.81 99.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 2.18 111.821 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -90.25 58.22 3.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.575 -0.738 . . . . 1.74 110.041 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -80.17 56.66 2.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.442 0.639 . . . . 3.99 110.48 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.5 -120.82 1.29 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.732 -0.667 . . . . 1.06 111.995 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -119.68 130.95 24.58 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.804 -0.443 . . . . 4.37 109.804 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.569 ' HB2' HG21 ' A' ' 93' ' ' VAL . 8.5 Cg_endo -58.74 144.71 97.9 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.987 1.792 . . . . 0.31 111.742 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.9 t30 -98.75 118.55 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.346 -0.612 . . . . 2.14 109.346 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.7 tt -57.63 -47.54 85.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.863 1.06 . . . . 0.21 113.863 -164.143 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CD ' ' HG3' ' A' ' 51' ' ' PRO . 15.1 mtpt -66.25 -6.52 14.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.076 0.769 . . . . 3.82 113.076 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.76 5.04 17.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.377 0.608 . . . . 1.91 110.22 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 88' ' ' PRO . 69.0 t -117.62 -52.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.463 -0.789 . . . . 0.33 109.852 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.441 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.6 mt -101.7 154.78 18.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.3 109.175 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.34 150.42 35.68 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.535 -0.543 . . . . 2.67 109.535 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HA ' HG22 ' A' ' 46' ' ' ILE . 48.3 mt-10 -57.0 110.97 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 1.25 109.991 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 45' ' ' LYS . . . 112.96 -1.05 25.7 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.857 -0.687 . . . . 0.41 112.242 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.482 ' NE2' ' HB3' ' A' ' 77' ' ' TYR . 22.8 tt0 -95.96 135.53 37.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.832 -0.433 . . . . 1.18 109.832 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 11.7 pt-20 -82.77 157.54 23.18 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.463 0.477 . . . . 0.81 111.815 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.512 HG23 HG22 ' A' ' 102' ' ' VAL . 34.2 m -141.2 152.59 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.115 -0.948 . . . . 0.18 109.741 171.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.801 ' HB ' HD11 ' A' ' 122' ' ' LEU . 23.5 mm -103.35 110.66 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.356 -0.979 . . . . 0.51 108.356 168.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 100' ' ' VAL . 2.5 m -139.1 130.57 35.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.218 0.532 . . . . 0.28 112.127 -170.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' OE1' ' HB2' ' A' ' 38' ' ' LYS . 10.1 pt20 -104.68 157.32 17.26 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.167 -1.049 . . . . 1.62 108.167 170.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.661 HD11 ' OH ' ' A' ' 60' ' ' TYR . 20.6 mm -81.02 102.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.779 0.799 . . . . 0.78 110.861 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.467 ' OD2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 t70 -71.44 -44.24 65.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.104 -1.407 . . . . 1.3 110.33 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG3' ' OD2' ' A' ' 105' ' ' ASP . 63.0 mttp -125.37 156.76 38.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.48 0.657 . . . . 2.57 111.183 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.3 155.88 17.64 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.597 -1.183 . . . . 2.57 111.548 -162.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.613 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 19.1 mt-10 -69.17 89.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.113 -0.949 . . . . 3.14 110.783 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.3 9.25 37.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.494 -1.23 . . . . 3.49 110.497 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.27 -63.92 3.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.92 -0.657 . . . . 1.74 112.157 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.7 -31.85 73.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.503 0.192 . . . . 2.88 111.505 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -118.84 -39.68 2.94 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.388 0.614 . . . . 3.45 109.464 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 75.85 -140.05 25.3 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.726 -1.125 . . . . 0.91 112.858 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -81.72 91.71 6.5 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.944 0.402 . . . . 0.52 110.821 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' A' ' 106' ' ' LYS . . . -79.15 123.66 27.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.208 -0.451 . . . . 0.6 111.295 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.762 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 65.4 mt -91.91 161.06 14.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.08 -0.509 . . . . 0.35 110.014 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.595 HG23 HD11 ' A' ' 120' ' ' ILE . 15.3 t -141.31 156.3 45.87 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.888 -0.782 . . . . 0.99 108.888 171.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -137.33 41.86 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.451 0.643 . . . . 1.22 112.507 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -96.53 33.17 1.86 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.148 -1.056 . . . . 4.11 108.148 167.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.595 HD11 HG23 ' A' ' 117' ' ' THR . 0.8 OUTLIER -119.77 93.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.684 -1.143 . . . . 0.95 111.06 -171.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 m 69.84 -30.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.602 1.334 . . . . 1.25 114.602 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.801 HD11 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -83.25 173.47 11.59 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.687 -0.633 . . . . 1.38 111.264 -176.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.927 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 88.77 47.1 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 124.966 1.416 . . . . 1.37 109.979 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.03 -122.29 7.46 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 114.911 -1.04 . . . . 2.8 112.119 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.688 -0.672 . . . . 5.11 109.958 179.098 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.882 -0.487 . . . . 9.91 111.882 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 m -127.9 21.6 6.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.47 0.176 . . . . 7.66 110.838 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' HIS . . . . . 0.534 ' O ' ' HG3' ' A' ' 33' ' ' MET . 92.1 m-70 61.0 -153.4 0.37 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.202 -0.666 . . . . 8.75 109.202 -174.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' MET . . . . . 0.585 ' SD ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 ppp? 51.67 8.8 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.272 1.029 . . . . 7.04 112.413 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.585 ' HG ' ' SD ' ' A' ' 33' ' ' MET . 73.0 mt -137.21 -173.35 3.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.514 -0.921 . . . . 4.54 108.514 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.27 105.17 16.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.018 0.747 . . . . 4.07 113.018 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -81.77 67.37 7.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.21 -0.663 . . . . 4.36 109.21 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.63 20.28 9.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.779 -0.646 . . . . 4.85 110.901 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -115.24 -172.22 2.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.123 -0.49 . . . . 2.02 110.376 -178.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -81.38 171.85 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.585 -0.895 . . . . 0.96 108.585 169.176 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 39.7 m-80 -62.35 102.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.847 0.356 . . . . 2.62 111.395 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.831 HD11 HG22 ' A' ' 101' ' ' ILE . 9.6 tp -82.71 134.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.958 -0.564 . . . . 0.84 110.365 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -132.02 145.58 51.54 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.226 0.536 . . . . 1.02 110.72 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -109.65 107.27 17.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.184 -0.916 . . . . 1.16 108.81 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.34 166.25 27.69 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.153 -1.022 . . . . 0.27 111.855 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 30.9 mtmt -106.09 159.39 16.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.3 0.571 . . . . 1.54 111.262 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.828 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -70.58 141.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.876 -1.056 . . . . 0.25 110.436 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 59' ' ' ASP . 65.3 p -131.22 -0.21 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.203 -0.453 . . . . 0.39 111.501 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 31.3 ttt-85 -164.52 125.02 2.06 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.314 -0.403 . . . . 1.85 110.409 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.828 ' CD1' HG21 ' A' ' 46' ' ' ILE . 88.5 mt -141.45 119.28 8.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.622 -0.51 . . . . 0.26 109.622 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 3.5 mt-10 -117.86 130.1 24.93 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.205 -0.452 . . . . 2.24 110.847 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.956 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 16.0 Cg_exo -68.95 -14.94 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.755 2.303 . . . . 0.52 111.324 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -73.09 -36.32 66.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 1.23 110.817 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 50' ' ' GLU . 1.1 pp -118.24 5.8 11.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.46 112.157 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.43 57.35 2.54 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.953 0.783 . . . . 2.51 111.537 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.16 166.63 16.87 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.303 -0.862 . . . . 0.19 110.568 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -136.34 148.08 47.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.642 0.608 . . . . 0.18 112.642 -172.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 45.1 m-85 -101.13 132.3 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.526 -0.761 . . . . 0.56 110.09 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 116' ' ' LEU . 25.0 t -108.9 136.62 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.066 0.46 . . . . 0.26 110.218 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.556 ' HB2' HG21 ' A' ' 47' ' ' THR . 27.4 t70 -108.88 107.72 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.812 -0.631 . . . . 0.79 111.396 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 58' ' ' VAL . 23.3 p90 -127.24 65.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.89 108.939 171.567 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.32 18.28 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.708 -0.758 . . . . 0.83 112.054 -171.191 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.9 141.81 37.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.408 0.283 . . . . 0.86 110.873 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.79 -21.21 17.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 2.43 110.994 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.608 ' NE ' ' HA ' ' A' ' 64' ' ' ARG . 2.6 mmp_? -106.38 -13.14 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 4.52 110.802 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.624 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.5 OUTLIER 70.51 116.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.435 -0.802 . . . . 0.88 111.755 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.88 118.19 12.66 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.518 -0.764 . . . . 0.24 111.877 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 15.8 t80 -105.16 112.25 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.169 0.509 . . . . 0.41 110.806 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.983 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -101.31 117.69 61.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.517 -0.765 . . . . 0.16 111.137 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.1 Cg_exo -63.84 145.03 90.08 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.882 2.388 . . . . 0.23 111.637 170.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.684 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.2 tp -65.87 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.19 111.649 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.51 -22.87 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.045 0.45 . . . . 2.04 110.835 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 29.5 mm-40 -79.22 -29.78 42.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.914 -0.585 . . . . 0.86 110.387 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.749 HG21 HG11 ' A' ' 93' ' ' VAL . 5.5 mt -48.03 125.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 113.386 0.884 . . . . 0.56 113.386 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.53 155.35 20.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.298 -1.319 . . . . 0.39 110.369 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.639 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 24.7 ttm180 -61.99 -13.72 28.36 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.003 -0.998 . . . . 3.01 112.407 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 1.076 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 6.8 tp10 -60.79 -23.37 64.97 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.624 -0.673 . . . . 1.76 110.477 175.853 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CD2' HG23 ' A' ' 73' ' ' ILE . 10.2 m-30 -84.88 -46.16 11.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.553 -0.749 . . . . 1.4 109.617 -175.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.639 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 3.5 p90 -103.64 94.71 6.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 107.895 -1.15 . . . . 0.46 107.895 170.023 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -26.93 137.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 1 C-N-CA 125.67 4.246 . . . . 0.71 115.468 -166.696 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . . . -50.36 -18.32 0.61 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.044 1.128 . . . . 0.93 114.044 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -95.9 -7.23 37.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.785 0.326 . . . . 2.62 111.406 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -71.34 141.36 50.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.481 -0.563 . . . . 1.33 109.481 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.84 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 2.18 111.072 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.08 99.76 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 1.74 110.949 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -118.67 91.65 3.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.329 -0.396 . . . . 3.99 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.79 -101.08 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.754 -0.736 . . . . 1.06 112.794 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -132.23 131.96 22.7 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 4.37 110.742 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' O ' HD11 ' A' ' 70' ' ' LEU . 11.3 Cg_endo -60.54 145.59 98.49 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.42 2.08 . . . . 0.31 112.296 174.45 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.51 ' OD1' ' HB2' ' A' ' 92' ' ' ASP . 3.8 p30 -108.57 115.41 30.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 2.14 109.925 173.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.684 ' HB ' HD13 ' A' ' 70' ' ' LEU . 15.9 tt -59.33 -35.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.882 0.697 . . . . 0.21 112.882 -164.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.956 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 21.3 pttp -61.86 -21.84 65.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.095 0.406 . . . . 3.82 112.095 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.51 ' HB2' ' OD1' ' A' ' 89' ' ' ASN . 12.3 m-20 -117.04 18.07 14.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 1.91 110.177 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.749 HG11 HG21 ' A' ' 73' ' ' ILE . 45.0 t -123.51 -47.27 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.332 0.587 . . . . 0.33 110.364 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.402 ' HB3' HG12 ' A' ' 46' ' ' ILE . 95.8 mt -108.34 163.41 13.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.953 -0.567 . . . . 0.3 109.953 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ARG . . . . . 0.492 HH11 ' NE2' ' A' ' 98' ' ' GLN . 0.0 OUTLIER -151.17 147.67 27.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.935 -0.765 . . . . 2.67 108.935 174.416 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.646 ' HA ' HG22 ' A' ' 46' ' ' ILE . 49.1 mt-10 -59.85 113.27 2.19 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.465 0.478 . . . . 1.25 109.901 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.38 -0.16 26.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.632 -0.713 . . . . 0.41 112.35 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.492 ' NE2' HH11 ' A' ' 95' ' ' ARG . 41.0 tt0 -96.83 133.29 41.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.842 -0.429 . . . . 1.18 109.842 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.56 156.99 28.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.134 0.492 . . . . 0.81 111.439 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 102' ' ' VAL . 27.8 m -140.19 152.21 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.201 -0.908 . . . . 0.18 109.85 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 41' ' ' ILE . 7.2 mm -96.99 110.06 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.544 -1.28 . . . . 0.51 107.544 169.886 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 100' ' ' VAL . 2.4 m -140.98 123.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.537 . . . . 0.28 111.954 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.75 HE21 HG12 ' A' ' 120' ' ' ILE . 10.3 pt20 -97.48 135.14 39.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.041 -1.096 . . . . 1.62 108.041 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.547 ' CD1' HD23 ' A' ' 116' ' ' LEU . 20.4 mm -73.18 103.37 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 0.78 110.772 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.64 -43.46 76.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.3 109.668 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 37.4 mttp -119.59 121.95 40.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.187 -0.915 . . . . 2.57 108.629 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 52.3 mt-10 -82.93 159.33 22.31 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.267 -0.424 . . . . 2.57 110.13 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 114' ' ' ALA . 31.1 mt-10 -62.68 91.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.468 0.651 . . . . 3.14 109.601 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 3.6 ptp180 -129.83 41.12 3.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.85 -1.068 . . . . 3.49 109.751 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.23 -82.04 1.58 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.234 -0.894 . . . . 1.74 113.84 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.1 -26.37 67.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.692 0.997 . . . . 2.88 113.692 -168.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HG2' ' HD3' ' A' ' 106' ' ' LYS . 9.9 mptt -116.5 -37.18 3.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.172 0.51 . . . . 3.45 110.028 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 74.89 -146.92 35.82 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.077 -0.965 . . . . 0.91 110.814 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . . . -88.82 104.62 17.09 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.934 0.397 . . . . 0.52 110.558 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -107.14 123.24 47.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.349 -0.387 . . . . 0.6 111.09 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.983 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 17.4 mt -90.37 154.74 19.45 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.999 -0.741 . . . . 0.35 108.999 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 103' ' ' GLN . 6.6 t -125.78 173.11 9.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.99 110.131 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.1 p -129.34 17.95 5.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 1.22 110.84 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -77.96 46.34 0.58 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.121 0.962 . . . . 4.11 108.708 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.75 HG12 HE21 ' A' ' 103' ' ' GLN . 4.3 mt -129.56 173.34 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.492 -1.231 . . . . 0.95 109.52 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.494 ' H ' HG22 ' A' ' 120' ' ' ILE . 13.0 m -74.81 67.73 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 1.25 110.902 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 101' ' ' ILE . 11.4 mt -116.15 172.15 7.35 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.453 -0.573 . . . . 1.38 109.453 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 1.076 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 77.34 59.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.921 0.763 . . . . 1.37 111.002 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.15 34.79 22.8 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.488 -0.778 . . . . 2.8 111.977 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.303 -0.856 . . . . 5.11 110.288 -179.241 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.64 -0.584 . . . . 9.91 111.64 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.9 p -125.54 8.26 7.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.943 0.371 . . . . 7.66 111.646 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -80.81 33.95 0.33 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.182 0.515 . . . . 8.75 111.736 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -134.86 9.29 3.57 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.322 -0.992 . . . . 7.04 108.322 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.4 mt -115.91 -59.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.044 -0.98 . . . . 4.54 110.751 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER 51.63 38.3 22.23 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.604 0.565 . . . . 4.07 112.033 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 61.42 -118.16 0.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.243 -0.435 . . . . 4.36 111.152 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -98.9 1.1 45.37 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.246 0.546 . . . . 4.85 110.233 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 120' ' ' ILE . 19.9 ttpp -85.9 153.08 22.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.444 -0.798 . . . . 2.02 109.316 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.32 167.98 20.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.44 -0.578 . . . . 0.96 109.44 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.491 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 t-20 -49.02 118.75 2.79 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.557 0.536 . . . . 2.62 110.202 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.714 HG12 HG22 ' A' ' 101' ' ' ILE . 5.0 tp -83.7 138.66 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.585 -0.524 . . . . 0.84 109.585 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' A' ' 104' ' ' ILE . 87.1 m-85 -115.1 118.87 34.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.517 0.675 . . . . 1.02 110.7 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.438 ' HD3' HD12 ' A' ' 101' ' ' ILE . 8.5 mmmm -89.64 102.67 15.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.858 -1.065 . . . . 1.16 109.671 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.25 163.78 26.32 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 110.555 -1.018 . . . . 0.27 110.555 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.14 161.97 18.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 1.54 111.347 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -65.05 146.09 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.299 -1.319 . . . . 0.25 111.254 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 59' ' ' ASP . 76.2 p -128.94 -32.05 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.009 0.433 . . . . 0.39 111.854 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.655 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 13.9 ttm180 -140.27 126.12 19.45 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.351 -0.386 . . . . 1.85 110.668 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 46' ' ' ILE . 91.2 mt -133.8 120.36 36.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.652 -0.704 . . . . 0.26 109.585 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 15.7 tp10 -111.94 111.21 53.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.896 -0.593 . . . . 2.24 109.708 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 51.9 Cg_exo -54.0 -25.82 38.1 Favored 'Trans proline' 0 CA--C 1.521 -0.172 0 C-N-CA 123.361 2.707 . . . . 0.52 112.068 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.7 m -73.82 -22.48 59.78 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.503 -0.771 . . . . 1.23 111.824 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.5 pp -123.78 7.48 8.76 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.598 0.962 . . . . 0.46 113.598 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 4.6 pt-20 48.56 49.76 17.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.408 1.083 . . . . 2.51 112.824 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.98 162.67 31.95 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.081 -0.648 . . . . 0.19 112.208 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -131.22 138.06 49.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.669 -0.696 . . . . 0.18 112.167 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 65.7 m-85 -89.44 136.17 33.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.56 109.818 171.594 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' A' ' 116' ' ' LEU . 2.2 t -112.74 139.49 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.26 110.997 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.718 ' HB2' HG21 ' A' ' 47' ' ' THR . 17.9 t70 -103.14 102.3 12.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.79 110.65 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -128.11 67.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.509 -0.552 . . . . 0.89 109.509 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 46.09 42.16 11.9 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.089 -0.577 . . . . 0.83 111.899 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.72 160.01 14.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.171 0.51 . . . . 0.86 111.092 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -87.83 -45.38 10.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.626 0.726 . . . . 2.43 109.173 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 48.7 mtt180 -125.71 94.15 4.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.85 -1.068 . . . . 4.52 108.403 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 15.4 m170 -35.9 131.22 0.56 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.147 1.165 . . . . 0.88 114.147 -170.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.8 118.65 14.74 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.871 -1.059 . . . . 0.24 111.498 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.2 t80 -104.79 97.73 7.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.138 0.494 . . . . 0.41 111.282 -171.461 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.032 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -85.38 121.2 73.73 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.774 . . . . 0.16 111.365 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.59 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 19.6 Cg_exo -69.56 142.78 49.78 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.087 2.525 . . . . 0.23 112.104 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.717 HD13 ' HB ' ' A' ' 90' ' ' ILE . 12.6 tp -60.8 -39.07 87.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.491 -0.777 . . . . 0.19 112.263 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -64.13 -13.34 47.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.644 0.259 . . . . 2.04 111.651 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 7.2 mm-40 -96.09 -13.07 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.756 0.312 . . . . 0.86 110.413 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.501 HG23 ' CD2' ' A' ' 77' ' ' TYR . 8.0 mt -57.86 138.48 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.636 0.731 . . . . 0.56 112.823 -171.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -102.25 153.53 19.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.836 -1.075 . . . . 0.39 110.518 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.66 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 41.1 ttm180 -55.27 -14.68 1.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.522 -0.763 . . . . 3.01 112.662 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' GLU . . . . . 0.993 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 24.3 tp10 -61.96 -19.71 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.487 -0.758 . . . . 1.76 110.759 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.501 ' CD2' HG23 ' A' ' 73' ' ' ILE . 7.9 m-30 -92.65 -44.61 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.797 -0.638 . . . . 1.4 109.759 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 84' ' ' ALA . 5.7 p90 -98.68 95.94 3.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.277 -1.379 . . . . 0.46 107.277 168.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.3 Cg_endo -38.51 139.98 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.577 3.518 . . . . 0.71 113.797 -162.065 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.66 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -55.55 -11.93 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 0.93 113.288 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -82.28 -21.11 36.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.235 0.54 . . . . 2.62 109.97 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -78.2 146.14 35.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 1.33 110.626 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -81.98 106.49 13.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.741 -0.663 . . . . 2.18 111.566 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -91.81 136.48 33.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 1.74 109.848 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -96.42 -40.61 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.136 0.493 . . . . 3.99 110.225 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.11 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.504 -0.771 . . . . 1.06 111.265 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -97.04 128.39 35.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.033 0.444 . . . . 4.37 110.804 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.86 165.49 13.99 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.272 2.648 . . . . 0.31 112.981 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -120.6 98.31 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.866 -0.606 . . . . 2.14 109.951 175.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.717 ' HB ' HD13 ' A' ' 70' ' ' LEU . 21.2 tt -54.02 -39.7 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.497 0.925 . . . . 0.21 113.497 -165.475 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.845 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 36.8 pttt -55.7 -21.78 20.13 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.009 0.744 . . . . 3.82 113.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -125.96 18.69 7.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.932 0.872 . . . . 1.91 110.44 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 36.7 t -111.32 -50.03 6.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.693 0.759 . . . . 0.33 109.278 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.5 mt -103.04 150.86 23.16 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.206 -0.906 . . . . 0.3 110.231 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 147.93 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.171 -0.922 . . . . 2.67 109.098 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 1.5 mp0 -58.29 122.5 13.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.864 0.364 . . . . 1.25 110.161 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.49 -18.15 23.03 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.786 -0.721 . . . . 0.41 111.701 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -83.11 121.01 26.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.748 -0.464 . . . . 1.18 109.748 177.14 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.65 155.2 36.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.81 111.487 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.581 HG23 HG22 ' A' ' 102' ' ' VAL . 35.3 m -131.91 149.95 33.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.884 -1.053 . . . . 0.18 109.177 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 41' ' ' ILE . 1.4 mm -98.95 107.48 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.072 -1.455 . . . . 0.51 107.072 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG22 HG23 ' A' ' 100' ' ' VAL . 4.4 m -145.54 135.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 0.28 112.584 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLN . . . . . 0.535 ' O ' ' HB ' ' A' ' 117' ' ' THR . 18.4 pt20 -98.73 135.84 39.63 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.596 -0.891 . . . . 1.62 108.596 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 106' ' ' LYS . 40.4 mm -80.95 99.57 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.256 0.55 . . . . 0.78 109.71 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.32 -27.51 67.21 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 1.3 110.566 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 104' ' ' ILE . 55.0 mttp -113.63 -170.97 1.8 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 2.57 111.411 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 50.4 mm-40 -129.6 145.79 51.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.294 -0.412 . . . . 2.57 110.332 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.614 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 43.2 mt-10 -64.15 101.86 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.401 0.62 . . . . 3.14 109.668 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 10.9 ptm180 -116.43 -61.63 1.7 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.237 -0.892 . . . . 3.49 111.549 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -175.15 -63.9 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.466 -0.873 . . . . 1.74 112.519 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.88 -46.92 85.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.089 0.403 . . . . 2.88 112.089 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.583 ' HD2' ' HB2' ' A' ' 115' ' ' ALA . 21.4 ttmm -116.19 -37.18 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.363 -0.535 . . . . 3.45 110.436 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 80.6 -122.47 5.73 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.652 -0.979 . . . . 0.91 110.652 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.531 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.29 127.5 33.7 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.99 -0.374 . . . . 0.52 109.99 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.583 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . . . -118.4 126.99 53.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.729 0.3 . . . . 0.6 110.88 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.032 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 14.6 mt -91.08 129.06 37.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.065 -0.516 . . . . 0.35 110.177 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -90.26 146.82 23.94 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.99 109.642 174.048 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.646 HG23 HD21 ' A' ' 68' ' ' LEU . 3.5 p -113.96 4.02 15.6 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.34 0.496 . . . . 1.22 112.34 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.481 ' H ' HG23 ' A' ' 117' ' ' THR . 98.8 m-85 -78.34 57.36 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.695 0.76 . . . . 4.11 110.451 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.536 HG23 ' HE2' ' A' ' 38' ' ' LYS . 2.9 mp -127.99 176.08 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.645 -1.242 . . . . 0.95 107.645 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.0 t -69.4 69.62 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.296 0.569 . . . . 1.25 110.458 176.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 101' ' ' ILE . 12.0 mt -115.13 172.22 7.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.676 -0.861 . . . . 1.38 108.676 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.993 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 73.95 37.33 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.683 0.615 . . . . 1.37 110.609 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.43 44.76 0.28 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.278 -0.874 . . . . 2.8 111.198 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.283 -0.865 . . . . 5.11 109.7 179.228 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.017 -0.433 . . . . 9.91 112.017 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.2 t -131.98 -87.17 0.46 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.377 -0.231 . . . . 7.66 110.377 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 m170 61.84 5.16 1.27 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.025 0.53 . . . . 8.75 111.728 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 69.0 mtm -142.19 176.4 9.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.001 0.12 . . . . 7.04 110.725 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.53 13.57 2.6 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.813 0.696 . . . . 4.54 111.8 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.999 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 12.3 pt-20 40.47 38.03 0.53 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.408 1.083 . . . . 4.07 112.423 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -78.86 -66.94 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.172 -0.467 . . . . 4.36 109.845 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -102.0 36.27 2.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.658 -1.238 . . . . 4.85 107.658 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' LYS . . . . . 0.999 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 32.8 tttp -130.39 137.9 50.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.156 -1.384 . . . . 2.02 110.13 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -65.43 138.4 58.09 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.657 -1.238 . . . . 0.96 107.657 170.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -47.62 116.97 1.63 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.853 0.721 . . . . 2.62 111.218 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 101' ' ' ILE . 6.6 tp -84.65 139.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.107 -0.951 . . . . 0.84 110.128 -174.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -122.68 149.71 43.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.792 0.329 . . . . 1.02 110.275 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 34.5 ttmt -115.78 94.08 4.53 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.984 -0.747 . . . . 1.16 108.984 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.17 166.69 13.15 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.271 -0.877 . . . . 0.27 111.073 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 1.6 mppt? -104.83 158.2 16.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.065 0.459 . . . . 1.54 111.087 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.886 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -73.52 137.19 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.075 -0.966 . . . . 0.25 109.628 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.483 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.7 p -124.33 -11.28 7.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.799 0.333 . . . . 0.39 111.471 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ARG . . . . . 0.641 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 24.6 ttt85 -160.26 122.18 3.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.212 -0.449 . . . . 1.85 110.462 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 46' ' ' ILE . 47.5 mt -134.89 113.46 16.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.624 -0.509 . . . . 0.26 109.624 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 31.6 mt-10 -118.01 122.54 30.37 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 121.505 0.669 . . . . 2.24 111.475 -176.047 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' PRO . . . . . 0.832 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 31.9 Cg_exo -60.65 -27.41 84.79 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.112 2.541 . . . . 0.52 111.827 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.5 m -75.11 -21.43 58.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 1.23 111.685 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 50' ' ' GLU . 2.0 pp -118.38 8.85 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.964 -0.694 . . . . 0.46 112.792 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 43.52 48.36 6.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.493 0.717 . . . . 2.51 111.917 169.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.27 171.15 12.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.474 -0.784 . . . . 0.19 110.974 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -135.56 139.48 43.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.18 111.539 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.641 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.9 m-85 -91.64 136.0 33.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.56 109.633 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HB ' HD11 ' A' ' 116' ' ' LEU . 12.6 t -118.9 134.44 62.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.158 -0.682 . . . . 0.26 109.158 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 47' ' ' THR . 36.7 t70 -109.48 111.28 22.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.187 -0.46 . . . . 0.79 112.027 -173.783 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -126.81 66.75 1.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.219 -1.03 . . . . 0.89 108.219 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.33 33.46 46.41 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.81 -0.71 . . . . 0.83 112.46 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 65' ' ' HIS . . . -93.79 147.72 22.79 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.645 -0.326 . . . . 0.86 110.777 -175.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.93 -51.29 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 2.43 111.272 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 8.8 mmt180 -94.36 -11.11 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.478 -0.489 . . . . 4.52 109.796 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 10.3 m170 76.49 145.07 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.423 1.077 . . . . 0.88 110.854 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 102.14 1.08 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.666 -0.974 . . . . 0.24 110.666 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 2.9 t80 -88.98 104.25 16.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.842 0.353 . . . . 0.41 110.541 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 1.133 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.72 113.35 60.15 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.16 110.307 178.135 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HD2' HD23 ' A' ' 68' ' ' LEU . 24.5 Cg_exo -65.27 141.72 69.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.787 2.325 . . . . 0.23 111.607 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.625 HD13 ' HB ' ' A' ' 90' ' ' ILE . 17.8 tp -57.91 -33.46 68.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.19 111.819 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.59 -10.92 20.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 2.04 111.482 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -97.44 -23.92 15.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.12 -0.491 . . . . 0.86 110.856 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 93' ' ' VAL . 6.1 mt -48.38 131.04 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 113.466 0.913 . . . . 0.56 113.466 -166.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -100.22 156.67 17.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.64 -1.164 . . . . 0.39 110.763 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.818 ' HG2' ' HA ' ' A' ' 80' ' ' ALA . 32.0 ttp180 -65.16 -12.7 53.9 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.55 0.944 . . . . 3.01 113.55 -172.478 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.67 -25.76 68.36 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.795 -1.191 . . . . 1.76 110.208 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -75.84 -51.74 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.901 -0.59 . . . . 1.4 110.291 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' HB3' HG13 ' A' ' 93' ' ' VAL . 1.1 p90 -100.37 109.46 57.0 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.584 -1.265 . . . . 0.46 107.584 169.19 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.43 133.6 0.33 Allowed 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 124.616 3.544 . . . . 0.71 113.646 -162.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -57.03 -16.44 7.15 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.563 -1.199 . . . . 0.93 113.361 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -90.99 -0.89 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 2.62 111.251 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -81.77 143.81 31.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 1.33 109.976 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -71.09 100.9 2.12 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.397 -0.365 . . . . 2.18 110.287 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.95 95.34 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.74 110.374 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -76.9 61.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.715 -0.675 . . . . 3.99 110.928 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.47 -128.44 8.99 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.859 -0.686 . . . . 1.06 111.631 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.85 135.41 45.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.809 0.338 . . . . 4.37 110.32 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' O ' HD11 ' A' ' 70' ' ' LEU . 9.2 Cg_endo -58.41 154.7 39.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.916 2.411 . . . . 0.31 113.161 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . 0.508 ' OD1' ' HB3' ' A' ' 92' ' ' ASP . 4.0 p30 -119.41 111.42 18.13 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.248 -0.887 . . . . 2.14 109.617 176.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ILE . . . . . 0.625 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.2 tt -62.13 -38.87 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.724 0.638 . . . . 0.21 112.724 -163.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LYS . . . . . 0.832 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 7.8 ptmm? -60.07 -21.37 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.212 -0.449 . . . . 3.82 111.853 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASP . . . . . 0.508 ' HB3' ' OD1' ' A' ' 89' ' ' ASN . 34.6 t70 -119.62 12.01 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.817 0.818 . . . . 1.91 110.343 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 73' ' ' ILE . 13.7 t -119.96 -50.57 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.33 110.314 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -100.41 152.13 20.72 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.677 -0.692 . . . . 0.3 110.25 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 151.8 44.21 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.361 -0.836 . . . . 2.67 110.319 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 46' ' ' ILE . 18.1 mt-10 -65.13 126.07 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.029 -0.987 . . . . 1.25 110.456 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.05 54.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.773 -0.727 . . . . 0.41 112.055 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.9 tt0 -87.95 135.96 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.951 -0.389 . . . . 1.18 109.951 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.92 157.22 20.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.81 111.37 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.553 HG23 HG22 ' A' ' 102' ' ' VAL . 35.5 m -136.75 151.79 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.189 -0.914 . . . . 0.18 109.879 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.983 ' HB ' HD11 ' A' ' 122' ' ' LEU . 10.0 mm -97.03 110.45 25.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.004 -1.11 . . . . 0.51 108.004 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' VAL . . . . . 0.553 HG22 HG23 ' A' ' 100' ' ' VAL . 4.3 m -146.76 139.05 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.233 0.539 . . . . 0.28 111.974 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -112.84 142.73 45.16 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.433 -0.951 . . . . 1.62 108.433 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ILE . . . . . 0.539 HD13 HD23 ' A' ' 116' ' ' LEU . 22.4 mm -71.89 102.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.76 0.79 . . . . 0.78 110.771 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 35.0 t70 -83.76 -35.28 24.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.714 -1.13 . . . . 1.3 109.777 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 115' ' ' ALA . 12.7 ttpp -112.03 137.99 49.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.605 -0.725 . . . . 2.57 109.775 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLU . . . . . 0.444 ' HB3' HH21 ' A' ' 109' ' ' ARG . 1.8 tm-20 -87.2 133.79 33.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.26 -0.882 . . . . 2.57 110.914 -163.284 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HG3' ' HG2' ' A' ' 64' ' ' ARG . 42.6 tt0 -66.31 119.73 12.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 3.14 110.208 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.585 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 6.6 ptp180 -139.72 -68.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.415 -0.811 . . . . 3.49 111.115 -171.255 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -168.71 -66.99 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.553 -1.308 . . . . 1.74 113.722 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ASN . . . . . 0.474 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 25.6 t-20 -61.88 -50.91 70.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.958 0.379 . . . . 2.88 111.55 -172.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 98.6 mttt -122.92 -37.49 2.73 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.68 -0.408 . . . . 3.45 110.682 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLY . . . . . 0.585 ' HA2' ' HG2' ' A' ' 109' ' ' ARG . . . 63.79 -124.47 30.89 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.67 -0.695 . . . . 0.91 113.937 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.56 110.66 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.249 0.617 . . . . 0.52 111.696 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . -122.25 135.83 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.07 -0.514 . . . . 0.6 110.566 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 1.133 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 43.2 mt -91.41 153.01 20.16 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.775 -0.648 . . . . 0.35 109.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 8.2 t -116.69 171.47 7.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.241 -0.436 . . . . 0.99 110.292 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 120' ' ' ILE . 26.1 p -138.27 20.93 2.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.78 0.659 . . . . 1.22 112.78 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' PHE . . . . . 0.411 ' HD1' ' O ' ' A' ' 119' ' ' PHE . 3.2 p90 -78.45 42.42 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.499 1.142 . . . . 4.11 109.385 170.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 121' ' ' SER . 4.4 mt -118.36 172.35 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 113.884 -1.507 . . . . 0.95 108.015 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' SER . . . . . 0.514 ' H ' HG22 ' A' ' 120' ' ' ILE . 7.5 t -80.04 48.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.858 0.361 . . . . 1.25 111.93 -172.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LEU . . . . . 0.983 HD11 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -117.38 126.33 52.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.738 -0.21 . . . . 1.38 111.257 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . 163.62 25.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.722 1.264 . . . . 1.37 109.779 166.368 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 168.75 58.35 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.983 -0.847 . . . . 2.8 110.983 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.684 -0.674 . . . . 5.11 110.379 -175.883 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.613 0 N-CA-C 108.56 -0.904 . . . . 0.95999999999999996 108.56 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.61 114.45 3.28 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.255 -0.578 . . . . 2.6200000000000001 110.82 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 103' ' ' GLN . 8.7 tp -81.27 146.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.385 -0.825 . . . . 0.83999999999999997 109.421 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.55 152.76 41.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.7 0.286 . . . . 1.02 110.296 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.4 tttm -134.11 96.58 3.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.206 0.527 . . . . 1.1599999999999999 109.716 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -140.46 175.67 21.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.952 -0.859 . . . . 0.27000000000000002 110.952 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.34 159.47 15.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.648 0.737 . . . . 1.54 112.054 -175.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.986 HG21 HD11 ' A' ' 49' ' ' ILE . 1.6 mp -67.64 138.47 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.363 -1.29 . . . . 0.25 109.386 171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.614 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.2 p -130.69 -7.17 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.763 0.316 . . . . 0.39000000000000001 111.725 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.627 ' HD3' ' HD2' ' A' ' 57' ' ' PHE . 29.9 ttt85 -158.43 123.02 4.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.326 -0.397 . . . . 1.8500000000000001 110.282 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.986 HD11 HG21 ' A' ' 46' ' ' ILE . 56.6 mt -136.76 109.04 7.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.096 0.474 . . . . 0.26000000000000001 109.877 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.32 113.2 65.38 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 2.2400000000000002 110.796 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.84 -19.56 55.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.012 2.475 . . . . 0.52000000000000002 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.4 m -73.1 -26.01 61.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.208 -0.905 . . . . 1.23 111.321 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.485 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.5 pp -119.71 -8.91 9.85 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.212 0.819 . . . . 0.46000000000000002 113.212 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 59.43 57.18 3.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.784 0.433 . . . . 2.5099999999999998 111.451 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -168.09 162.58 13.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.322 -0.399 . . . . 0.19 110.53 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -129.22 142.0 50.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.035 -0.529 . . . . 0.17999999999999999 111.956 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.627 ' HD2' ' HD3' ' A' ' 48' ' ' ARG . 40.1 m-85 -94.3 142.07 27.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.691 -0.686 . . . . 0.56000000000000005 109.551 170.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.466 HG12 ' HD1' ' A' ' 60' ' ' TYR . 56.1 t -120.37 133.38 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.26000000000000001 109.947 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.614 ' CB ' HG21 ' A' ' 47' ' ' THR . 35.4 t70 -103.69 99.67 9.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.899 -0.591 . . . . 0.79000000000000004 110.716 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HD1' HG12 ' A' ' 58' ' ' VAL . 20.4 p90 -126.8 66.59 1.26 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.703 -0.68 . . . . 0.89000000000000001 109.337 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.1 21.95 26.82 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.733 -0.746 . . . . 0.82999999999999996 112.436 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 118.42 33.86 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.817 -0.225 . . . . 0.85999999999999999 110.53 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.99 -3.67 30.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 2.4300000000000002 111.453 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.468 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -117.11 -13.25 10.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.777 -0.647 . . . . 4.5199999999999996 110.189 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 63.84 141.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.039 -0.982 . . . . 0.88 111.879 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -83.12 126.43 7.48 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.602 -0.808 . . . . 0.23999999999999999 111.193 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 29.0 t80 -107.18 111.47 23.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.381 0.61 . . . . 0.40999999999999998 110.933 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.884 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -106.8 111.56 63.78 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.128 -0.942 . . . . 0.16 110.838 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 16.4 Cg_exo -69.23 145.03 58.91 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.155 2.57 . . . . 0.23000000000000001 111.981 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.612 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.4 tp -57.06 -39.69 75.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.804 -1.089 . . . . 0.19 113.102 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.755 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 19.9 pttp -67.54 -9.73 45.2 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.571 -0.451 . . . . 2.04 111.174 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.403 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 3.5 mm-40 -92.84 -21.98 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.999 -0.371 . . . . 0.85999999999999999 109.999 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.603 HG21 HG11 ' A' ' 93' ' ' VAL . 8.0 mt -48.76 134.75 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.838 1.051 . . . . 0.56000000000000005 113.838 -168.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.76 156.32 16.74 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.717 -1.128 . . . . 0.39000000000000001 110.898 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.747 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 12.6 tpt180 -56.84 -16.86 7.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.153 -0.93 . . . . 3.0099999999999998 112.127 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.07 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 1.8 tp10 -65.06 -24.57 67.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.86 -0.525 . . . . 1.76 111.001 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.542 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.1 m-30 -82.37 -50.73 8.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.459 0.647 . . . . 1.3999999999999999 110.141 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HB3' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -97.77 101.11 9.73 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.044 -1.465 . . . . 0.46000000000000002 107.044 169.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.9 Cg_endo -39.13 141.76 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 124.85 3.7 . . . . 0.70999999999999996 114.062 -161.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.71 -13.86 0.46 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.779 -1.1 . . . . 0.93000000000000005 112.921 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.27 -11.05 53.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.3 0.571 . . . . 2.6200000000000001 110.524 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.66 139.56 30.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.682 -0.69 . . . . 1.3300000000000001 109.616 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -65.62 125.56 25.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 2.1800000000000002 111.161 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.433 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -130.01 114.68 16.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.162 -0.472 . . . . 1.74 110.986 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -139.62 77.25 1.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.286 -0.415 . . . . 3.9900000000000002 110.536 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.0 -113.58 1.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.691 -0.766 . . . . 1.0600000000000001 112.498 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.853 ' HD3' ' HD2' ' A' ' 88' ' ' PRO . 13.5 tpp180 -121.63 121.61 28.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.63 0.252 . . . . 4.3700000000000001 110.417 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.853 ' HD2' ' HD3' ' A' ' 87' ' ' ARG . 9.9 Cg_endo -59.84 166.23 8.81 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.999 2.466 . . . . 0.31 112.733 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 107.24 13.65 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.923 0.392 . . . . 2.1400000000000001 110.445 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' HD13 ' A' ' 70' ' ' LEU . 20.2 tt -56.84 -37.69 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.115 0.783 . . . . 0.20999999999999999 113.115 -165.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 91' ' ' LYS . 5.4 pttt -56.1 -24.74 42.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.879 0.696 . . . . 3.8199999999999998 112.879 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -125.29 20.92 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.845 0.831 . . . . 1.9099999999999999 110.173 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 73' ' ' ILE . 14.2 t -117.09 -48.67 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.605 -0.725 . . . . 0.33000000000000002 109.893 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.411 ' HB3' HG12 ' A' ' 46' ' ' ILE . 42.6 mt -103.15 151.35 22.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.731 -0.668 . . . . 0.29999999999999999 109.833 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 138.84 24.63 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.603 -0.726 . . . . 2.6699999999999999 109.643 176.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.682 ' HA ' HG22 ' A' ' 46' ' ' ILE . 13.1 mt-10 -54.15 121.37 8.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.538 -0.755 . . . . 1.25 110.773 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.2 -8.02 28.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.40999999999999998 111.791 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.542 ' OE1' ' HA ' ' A' ' 77' ' ' TYR . 9.1 tt0 -90.49 129.02 36.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.876 -0.416 . . . . 1.1799999999999999 109.876 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 13.8 pt-20 -84.95 157.03 20.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.981 0.419 . . . . 0.81000000000000005 111.025 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 102' ' ' VAL . 32.8 m -139.33 155.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.539 -0.755 . . . . 0.17999999999999999 110.416 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.548 ' O ' HD13 ' A' ' 120' ' ' ILE . 4.0 mm -102.66 110.38 29.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.038 -1.097 . . . . 0.51000000000000001 108.038 172.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -147.3 147.55 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.104 0.409 . . . . 0.28000000000000003 112.104 -170.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.582 ' HB3' HD12 ' A' ' 41' ' ' ILE . 13.4 pt20 -128.07 158.72 37.18 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 1.6200000000000001 108.72 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.494 HD13 HD23 ' A' ' 116' ' ' LEU . 25.5 mm -83.94 109.66 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.441 0.639 . . . . 0.78000000000000003 111.638 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 13.5 t70 -85.4 -40.84 16.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.687 -1.142 . . . . 1.3 109.47 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 2.3 mptp? -111.52 126.09 54.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.552 -0.749 . . . . 2.5699999999999998 109.239 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -85.67 158.38 20.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.012 -0.54 . . . . 2.5699999999999998 110.889 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.531 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -66.97 131.07 45.11 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.657 0.742 . . . . 3.1400000000000001 110.14 177.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -144.1 12.13 1.59 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.627 -1.169 . . . . 3.4900000000000002 108.833 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.71 84.72 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.974 -1.012 . . . . 1.74 112.499 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -130.5 -31.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.76 0.652 . . . . 2.8799999999999999 112.76 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -120.25 -38.8 2.86 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.102 -0.639 . . . . 3.4500000000000002 110.008 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . 99.48 -159.14 19.85 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.122 -1.037 . . . . 0.91000000000000003 111.674 169.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.94 90.14 7.35 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.713 -0.847 . . . . 0.52000000000000002 108.713 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -85.66 126.02 33.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.59999999999999998 111.695 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.884 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 50.6 mt -90.27 135.42 33.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.34999999999999998 110.428 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 13.1 t -95.31 172.43 8.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.925 -0.58 . . . . 0.98999999999999999 109.801 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.568 HG23 HD21 ' A' ' 68' ' ' LEU . 4.9 p -126.76 18.61 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.433 0.635 . . . . 1.22 110.191 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -81.07 46.93 0.95 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.962 0.887 . . . . 4.1100000000000003 109.304 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.572 HG12 HD11 ' A' ' 41' ' ' ILE . 1.8 mp -127.44 170.03 17.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.808 -1.087 . . . . 0.94999999999999996 108.898 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.2 m -72.41 72.4 0.96 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.378 0.609 . . . . 1.25 110.92 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.526 HD11 ' O ' ' A' ' 101' ' ' ILE . 26.3 mt -116.17 171.77 7.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.886 -0.783 . . . . 1.3799999999999999 108.886 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.07 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.325 -0.459 0 O-C-N 124.012 0.82 . . . . 1.3700000000000001 109.854 -179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.601 0 N-CA-C 108.637 -0.875 . . . . 0.95999999999999996 108.637 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.5 HD22 ' C ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -50.66 109.52 0.32 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.577 0.548 . . . . 2.6200000000000001 110.19 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.22 143.8 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.775 . . . . 0.83999999999999997 109.961 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.79 144.99 49.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.079 -0.341 . . . . 1.02 110.079 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -117.65 105.72 12.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.631 -1.248 . . . . 1.1599999999999999 107.631 173.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.89 179.48 21.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.69 -0.767 . . . . 0.27000000000000002 111.561 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HD3' ' HA2' ' A' ' 97' ' ' GLY . 94.3 mttt -109.45 162.73 14.08 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.557 0.694 . . . . 1.54 111.917 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.751 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -72.44 136.75 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.563 -1.199 . . . . 0.25 108.893 170.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.707 HG21 ' CB ' ' A' ' 59' ' ' ASP . 73.2 p -127.1 -17.64 4.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.05 0.452 . . . . 0.39000000000000001 111.782 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 39.7 ttt180 -154.66 121.72 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.192 -0.67 . . . . 1.8500000000000001 109.192 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.751 ' CD1' HG21 ' A' ' 46' ' ' ILE . 96.7 mt -125.47 102.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.245 -0.65 . . . . 0.26000000000000001 109.245 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HB3' HD11 ' A' ' 53' ' ' LEU . 12.8 tp10 -99.17 108.0 47.4 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.005 -0.998 . . . . 2.2400000000000002 109.933 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 45.0 Cg_exo -57.12 -29.8 84.64 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.96 2.44 . . . . 0.52000000000000002 112.093 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -59.9 -29.76 68.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.81 -0.632 . . . . 1.23 111.247 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.669 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.2 pp -122.56 11.28 9.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.46000000000000002 111.937 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.87 58.01 2.18 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.656 0.782 . . . . 2.5099999999999998 112.034 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.99 160.75 25.03 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.387 -0.824 . . . . 0.19 110.846 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -120.59 140.79 51.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.17999999999999999 112.285 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.8 m-85 -95.17 130.79 41.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.109 -0.95 . . . . 0.56000000000000005 110.106 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.16 132.46 58.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.208 -0.451 . . . . 0.26000000000000001 109.789 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.707 ' CB ' HG21 ' A' ' 47' ' ' THR . 13.8 t70 -100.81 103.32 14.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.95 0.405 . . . . 0.79000000000000004 111.223 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -126.17 66.71 1.21 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.688 -0.856 . . . . 0.89000000000000001 108.688 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.04 31.71 56.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.823 -0.703 . . . . 0.82999999999999996 112.427 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.74 137.89 50.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.588 0.232 . . . . 0.85999999999999999 110.625 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.23 -44.24 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 2.4300000000000002 111.312 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -78.09 -16.55 57.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.778 -0.369 . . . . 4.5199999999999996 110.242 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.8 m170 68.59 146.77 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.044 -0.98 . . . . 0.88 111.501 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.9 106.07 1.94 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.426 -1.07 . . . . 0.23999999999999999 110.426 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.669 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 2.7 t80 -96.19 106.3 18.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.097 0.475 . . . . 0.40999999999999998 110.709 -172.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.817 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -97.49 118.5 64.26 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.16 109.826 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.7 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 6.7 Cg_exo -69.91 141.04 43.57 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.128 1.885 . . . . 0.23000000000000001 111.344 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.814 ' HA ' HG13 ' A' ' 73' ' ' ILE . 9.3 tp -57.39 -32.85 67.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.19 111.184 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.7 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.9 ptmm? -59.76 -20.89 59.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.678 -0.692 . . . . 2.04 111.624 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.58 -11.91 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.85999999999999999 110.738 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.814 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.6 mt -49.88 127.37 5.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 113.588 0.958 . . . . 0.56000000000000005 113.588 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -80.28 149.84 30.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.222 -1.354 . . . . 0.39000000000000001 111.211 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.458 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 0.5 OUTLIER -66.33 -14.71 62.47 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.901 -0.59 . . . . 3.0099999999999998 111.243 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.684 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 7.0 tp10 -69.97 -17.63 63.3 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.324 -0.86 . . . . 1.76 109.912 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -81.01 -52.97 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.912 -0.586 . . . . 1.3999999999999999 109.733 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HB3' HG13 ' A' ' 93' ' ' VAL . 5.2 p90 -100.82 110.19 60.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.412 -1.329 . . . . 0.46000000000000002 107.412 169.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.7 Cg_endo -37.97 135.45 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.454 0 C-N-CA 124.351 3.368 . . . . 0.70999999999999996 113.766 -165.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.51 -7.19 0.37 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.712 -1.131 . . . . 0.93000000000000005 113.127 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.64 -14.68 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.631 0.729 . . . . 2.6200000000000001 109.391 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.435 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 78.9 t80 -92.43 119.37 31.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.281 -0.872 . . . . 1.3300000000000001 109.294 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.3 t -63.08 125.91 25.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.924 0.393 . . . . 2.1800000000000002 110.805 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.01 75.93 4.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.36 0.6 . . . . 1.74 110.634 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . 0.421 ' H ' ' CD2' ' A' ' 85' ' ' HIS . 3.0 p80 -78.29 111.59 14.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.9900000000000002 110.452 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.87 -101.16 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.708 -0.678 . . . . 1.0600000000000001 111.651 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -138.21 150.78 68.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 4.3700000000000001 109.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.499 ' C ' HD11 ' A' ' 70' ' ' LEU . 5.6 Cg_endo -59.77 162.62 15.25 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.29 1.993 . . . . 0.31 112.983 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.726 HD22 ' HB2' ' A' ' 92' ' ' ASP . 0.8 OUTLIER -121.26 103.66 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 2.1400000000000001 109.685 176.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 16.3 tt -57.02 -43.32 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 114.201 1.186 . . . . 0.20999999999999999 114.201 -161.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.814 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 18.5 pttp -62.74 -15.05 51.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.157 0.428 . . . . 3.8199999999999998 112.157 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.726 ' HB2' HD22 ' A' ' 89' ' ' ASN . 24.6 m-20 -122.89 19.13 10.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.498 0.666 . . . . 1.9099999999999999 109.784 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.68 HG11 HG21 ' A' ' 73' ' ' ILE . 8.8 t -120.3 -51.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.814 . . . . 0.33000000000000002 109.555 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.435 ' HB3' HG12 ' A' ' 46' ' ' ILE . 96.6 mt -101.35 164.6 11.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.545 -0.752 . . . . 0.29999999999999999 109.404 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 152.66 32.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.99 -0.55 . . . . 2.6699999999999999 109.637 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.6 ' HA ' HG22 ' A' ' 46' ' ' ILE . 25.5 mt-10 -63.46 118.09 7.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 1.25 110.262 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.521 ' HA2' ' HD3' ' A' ' 45' ' ' LYS . . . 112.96 -11.84 24.75 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.707 -0.759 . . . . 0.40999999999999998 112.145 -174.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -86.68 137.88 32.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 1.1799999999999999 109.785 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.404 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 12.6 pt-20 -86.95 157.13 19.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.81000000000000005 112.067 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.544 HG23 HG22 ' A' ' 102' ' ' VAL . 32.9 m -143.47 156.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.17999999999999999 109.833 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.573 ' H ' HD11 ' A' ' 122' ' ' LEU . 5.7 mm -104.92 110.83 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.083 -1.08 . . . . 0.51000000000000001 108.083 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 100' ' ' VAL . 3.2 m -144.84 136.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.225 0.535 . . . . 0.28000000000000003 112.384 -169.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -114.56 149.21 36.86 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.862 -0.792 . . . . 1.6200000000000001 108.862 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.572 HD13 HD23 ' A' ' 116' ' ' LEU . 23.2 mm -74.69 101.97 2.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 0.78000000000000003 110.447 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 32.8 t70 -83.5 -36.04 24.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.641 -1.163 . . . . 1.3 109.666 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.89 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 12.7 mptt -111.99 121.84 46.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.809 -1.182 . . . . 2.5699999999999998 107.809 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.98 147.58 46.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.763 0.653 . . . . 2.5699999999999998 112.763 -164.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -66.85 90.87 0.18 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.852 -1.067 . . . . 3.1400000000000001 110.002 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -115.47 -61.94 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.238 -0.892 . . . . 3.4900000000000002 110.422 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.68 -21.9 0.92 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.603 -1.18 . . . . 1.74 110.72 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -63.05 -50.85 68.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.99 0.424 . . . . 2.8799999999999999 110.161 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -124.56 -37.53 2.49 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.43 0.633 . . . . 3.4500000000000002 109.486 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.1 -153.19 17.7 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.874 -1.057 . . . . 0.91000000000000003 110.588 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.03 91.28 4.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.559 -0.534 . . . . 0.52000000000000002 109.559 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.89 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -95.1 133.3 39.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.134 0.492 . . . . 0.59999999999999998 111.553 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.817 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 68.8 mt -90.23 157.09 17.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.853 -0.612 . . . . 0.34999999999999998 110.133 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.75 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 14.0 t -116.72 170.06 8.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.301 -0.629 . . . . 0.98999999999999999 109.301 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.606 HG23 HD21 ' A' ' 68' ' ' LEU . 15.8 p -126.39 25.67 6.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.271 0.558 . . . . 1.22 110.404 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.4 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.282 1.039 . . . . 4.1100000000000003 108.905 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 101' ' ' ILE . 2.7 mp -128.15 163.48 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.472 -1.24 . . . . 0.94999999999999996 108.029 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -74.15 53.81 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.335 0.588 . . . . 1.25 111.709 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 11.6 mt -116.91 109.44 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.481 -0.781 . . . . 1.3799999999999999 110.048 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.474 0.755 0 O-C-N 124.469 1.106 . . . . 1.3700000000000001 109.783 170.045 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.237 0 N-CA-C 109.705 -0.48 . . . . 0.95999999999999996 109.705 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 43.2 m-80 -66.28 91.57 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.326 -0.397 . . . . 2.6200000000000001 110.982 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.597 ' HA ' ' HA ' ' A' ' 103' ' ' GLN . 9.5 tp -78.44 137.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.433 -0.349 . . . . 0.83999999999999997 110.147 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 40' ' ' ASN . 90.5 m-85 -138.25 138.45 38.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.216 0.531 . . . . 1.02 110.49 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.01 104.94 14.78 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.549 -1.278 . . . . 1.1599999999999999 107.549 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -137.45 -177.77 15.39 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.538 -0.839 . . . . 0.27000000000000002 111.636 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 73.1 mttt -114.98 157.67 23.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.525 0.679 . . . . 1.54 111.016 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.999 HG21 HD11 ' A' ' 49' ' ' ILE . 1.5 mp -69.63 139.57 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.604 -1.18 . . . . 0.25 109.908 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.649 HG21 ' HB2' ' A' ' 59' ' ' ASP . 47.3 p -129.04 -23.26 3.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.096 0.474 . . . . 0.39000000000000001 111.938 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.601 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 40.1 ttm180 -146.2 124.61 12.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.338 -0.392 . . . . 1.8500000000000001 110.529 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.999 HD11 HG21 ' A' ' 46' ' ' ILE . 40.4 mt -140.29 112.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.408 -0.59 . . . . 0.26000000000000001 109.408 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -119.55 130.67 24.72 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.828 0.347 . . . . 2.2400000000000002 110.734 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.776 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 2.8 Cg_exo -71.04 -22.47 26.2 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.953 2.435 . . . . 0.52000000000000002 111.409 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.89 -15.32 61.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.375 -0.83 . . . . 1.23 111.315 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.452 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.9 pp -128.3 -5.54 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 119.309 -0.377 . . . . 0.46000000000000002 111.488 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 41.39 64.37 1.04 Allowed 'General case' 0 C--N 1.351 0.638 0 CA-C-O 121.772 0.796 . . . . 2.5099999999999998 111.616 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -169.25 167.92 10.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.052 -1.431 . . . . 0.19 109.069 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -135.82 142.71 44.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.17999999999999999 112.547 -172.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 49.7 m-85 -96.59 134.72 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.56000000000000005 110.195 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 100' ' ' VAL . 53.9 t -108.41 128.0 64.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.094 -0.957 . . . . 0.26000000000000001 109.372 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.649 ' HB2' HG21 ' A' ' 47' ' ' THR . 13.0 t0 -98.61 108.44 21.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.002 0.43 . . . . 0.79000000000000004 110.021 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -124.64 65.43 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.459 0.647 . . . . 0.89000000000000001 109.434 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.08 34.6 52.88 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.336 -0.935 . . . . 0.82999999999999996 111.452 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.88 115.15 24.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.655 0.264 . . . . 0.85999999999999999 110.555 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -64.59 -27.06 68.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.911 -0.774 . . . . 2.4300000000000002 108.911 175.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.49 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 19.9 mtm-85 -84.06 -11.47 56.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.662 -1.154 . . . . 4.5199999999999996 110.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.426 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 61.28 -159.77 0.31 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.485 -0.779 . . . . 0.88 109.998 -172.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.79 120.24 0.98 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 109.867 -1.293 . . . . 0.23999999999999999 109.867 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.1 t80 -103.78 113.22 26.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.192 0.52 . . . . 0.40999999999999998 111.169 -169.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.891 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -100.0 115.2 65.74 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.315 -0.857 . . . . 0.16 110.143 177.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 25.4 Cg_exo -64.66 143.61 81.54 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.752 2.301 . . . . 0.23000000000000001 111.803 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.846 HD13 ' HB ' ' A' ' 90' ' ' ILE . 24.3 tp -66.4 -26.5 67.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.959 -0.564 . . . . 0.19 111.514 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.547 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 20.9 pttp -73.05 -9.65 58.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.359 . . . . 2.04 110.999 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 17.0 mm-40 -100.04 -14.93 18.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.85999999999999999 110.078 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.654 HG21 HG11 ' A' ' 93' ' ' VAL . 6.1 mm -49.04 133.57 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 113.47 0.915 . . . . 0.56000000000000005 113.47 -168.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -89.11 151.06 22.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.311 -1.313 . . . . 0.39000000000000001 111.864 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.848 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 3.0 tmm_? -65.24 -21.69 66.78 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.198 -0.91 . . . . 3.0099999999999998 111.1 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.53 ' HB3' HD23 ' A' ' 122' ' ' LEU . 4.5 tp10 -73.99 -14.95 61.11 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.446 -0.784 . . . . 1.76 110.852 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -81.76 -52.71 6.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.856 -0.611 . . . . 1.3999999999999999 109.861 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 93' ' ' VAL . 8.2 p90 -96.62 109.09 46.55 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.14 -1.43 . . . . 0.46000000000000002 107.14 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.2 Cg_endo -40.56 137.14 1.68 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 123.87 3.047 . . . . 0.70999999999999996 113.025 -166.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -48.99 -16.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.841 1.052 . . . . 0.93000000000000005 113.841 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.52 -7.2 59.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 2.6200000000000001 110.786 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.42 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 69.6 t80 -84.89 144.01 28.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.099 -0.704 . . . . 1.3300000000000001 109.099 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -78.67 100.69 7.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 2.1800000000000002 111.777 -175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -81.13 120.09 24.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 1.74 110.525 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -138.82 105.45 5.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.034 -0.53 . . . . 3.9900000000000002 110.647 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.87 -83.74 1.04 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.806 -0.711 . . . . 1.0600000000000001 111.824 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 133.49 17.3 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.791 0.329 . . . . 4.3700000000000001 110.252 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HB2' HG21 ' A' ' 93' ' ' VAL . 11.6 Cg_endo -59.64 153.6 54.44 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.87 2.38 . . . . 0.31 113.131 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.632 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.9 t30 -106.28 111.26 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.644 -0.873 . . . . 2.1400000000000001 108.644 172.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.846 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.4 tt -62.78 -36.29 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.691 0.626 . . . . 0.20999999999999999 112.691 -164.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.776 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 32.4 mmmt -67.27 -5.59 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.482 0.549 . . . . 3.8199999999999998 112.482 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 23.07 7.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 1.9099999999999999 109.58 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.654 HG11 HG21 ' A' ' 73' ' ' ILE . 48.0 t -121.94 -54.86 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.12 -0.945 . . . . 0.33000000000000002 109.833 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.775 ' HB3' HG12 ' A' ' 46' ' ' ILE . 93.5 mt -109.95 158.83 17.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.071 -0.968 . . . . 0.29999999999999999 110.548 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 146.0 26.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.128 -0.942 . . . . 2.6699999999999999 109.352 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.608 ' HA ' HG22 ' A' ' 46' ' ' ILE . 47.8 mt-10 -55.6 119.48 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.25 110.893 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.47 -16.49 24.2 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.682 -0.69 . . . . 0.40999999999999998 112.129 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.2 tt0 -82.39 138.58 34.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.796 -0.446 . . . . 1.1799999999999999 109.796 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 12.5 pt-20 -87.54 156.73 19.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.256 0.55 . . . . 0.81000000000000005 111.936 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 102' ' ' VAL . 33.5 m -141.02 147.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.973 -1.012 . . . . 0.17999999999999999 109.397 171.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.598 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.2 mm -99.57 110.29 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.26 -1.015 . . . . 0.51000000000000001 108.26 171.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 100' ' ' VAL . 3.4 m -144.64 132.5 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.28000000000000003 111.447 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 13.0 pt20 -107.02 133.13 52.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.249 -0.432 . . . . 1.6200000000000001 109.921 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.489 HD13 HD23 ' A' ' 116' ' ' LEU . 19.6 mm -67.14 102.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.78000000000000003 110.159 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.26 -38.63 24.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 1.3 109.531 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 54.9 mttp -117.77 132.51 56.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.358 -0.837 . . . . 2.5699999999999998 110.09 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -102.34 158.57 16.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.908 -1.042 . . . . 2.5699999999999998 111.0 -168.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 1.06 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 0.2 OUTLIER -52.52 117.41 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 3.1400000000000001 111.298 -176.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -143.98 18.91 1.79 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.858 -1.064 . . . . 3.4900000000000002 109.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.65 -43.37 3.17 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.824 -0.626 . . . . 1.74 112.893 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.55 -51.28 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.853 0.316 . . . . 2.8799999999999999 111.853 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -125.02 -38.93 2.29 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.378 0.609 . . . . 3.4500000000000002 110.971 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 1.06 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 92.07 -126.79 8.65 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.469 -0.872 . . . . 0.91000000000000003 111.687 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.07 94.19 7.16 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.812 0.339 . . . . 0.52000000000000002 110.747 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -94.52 124.96 38.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.474 -0.33 . . . . 0.59999999999999998 111.604 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.891 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 25.1 mt -90.8 135.66 33.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.729 -0.471 . . . . 0.34999999999999998 109.729 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 119' ' ' PHE . 7.1 t -97.38 167.57 10.92 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.446 -0.575 . . . . 0.98999999999999999 109.446 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.618 HG23 HD21 ' A' ' 68' ' ' LEU . 11.9 p -125.32 19.83 8.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.165 0.507 . . . . 1.22 111.224 173.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.416 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 73.7 m-85 -80.89 54.13 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.826 0.822 . . . . 4.1100000000000003 109.918 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 121' ' ' SER . 2.0 mp -127.63 175.85 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.579 -1.191 . . . . 0.94999999999999996 108.054 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.629 ' H ' HG22 ' A' ' 120' ' ' ILE . 1.5 m -66.85 19.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.425 0.898 . . . . 1.25 113.425 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 76' ' ' GLU . 6.6 mp -115.9 106.5 13.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.22 -0.3 . . . . 1.3799999999999999 110.433 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . . . . . . 0 N--CA 1.474 0.73 0 C-N-CA 124.727 1.211 . . . . 1.3700000000000001 109.254 169.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.557 0 N-CA-C 108.459 -0.941 . . . . 0.95999999999999996 108.459 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -57.54 117.6 4.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 2.6200000000000001 110.447 -175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 HG12 ' A' ' 120' ' ' ILE . 7.5 tp -84.39 146.74 6.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.83999999999999997 111.292 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.78 147.29 40.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.409 -0.36 . . . . 1.02 110.556 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 41.3 ttmt -108.37 116.63 32.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 1.1599999999999999 109.045 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.21 23.85 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.83 -0.908 . . . . 0.27000000000000002 110.83 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 68.4 mttt -102.33 161.37 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.27 0.557 . . . . 1.54 110.814 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.824 HG12 ' HB3' ' A' ' 94' ' ' LEU . 1.8 mp -70.23 136.47 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.842 -1.072 . . . . 0.25 109.239 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 59' ' ' ASP . 1.9 p -121.52 -33.52 3.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.419 0.628 . . . . 0.39000000000000001 111.139 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.617 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 39.4 ttm180 -147.68 122.14 9.73 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.269 -0.878 . . . . 1.8500000000000001 110.384 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.694 HD11 HG21 ' A' ' 46' ' ' ILE . 51.1 mt -131.62 130.11 62.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.525 -0.546 . . . . 0.26000000000000001 109.525 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.861 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 22.6 tt0 -129.29 131.51 23.7 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.868 -0.606 . . . . 2.2400000000000002 109.461 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.746 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 9.4 Cg_exo -68.3 -24.92 36.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.475 2.117 . . . . 0.52000000000000002 111.31 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.378 -0.828 . . . . 1.23 111.079 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.861 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.1 pp -118.48 -1.85 11.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 119.086 -0.483 . . . . 0.46000000000000002 111.758 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 41.04 54.22 3.3 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-O 121.979 0.895 . . . . 2.5099999999999998 111.396 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.37 166.52 27.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.269 -1.332 . . . . 0.19 109.499 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -133.47 134.24 43.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.406 -0.361 . . . . 0.17999999999999999 111.55 -175.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.617 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 76.4 m-85 -85.86 133.1 33.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.387 -0.597 . . . . 0.56000000000000005 109.387 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.544 ' HB ' HD11 ' A' ' 116' ' ' LEU . 31.5 t -115.34 128.75 72.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.469 -0.787 . . . . 0.26000000000000001 109.626 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.858 ' HB2' HG21 ' A' ' 47' ' ' THR . 12.3 t0 -101.94 108.77 20.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.886 -0.597 . . . . 0.79000000000000004 110.321 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.14 65.49 1.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.369 -0.974 . . . . 0.89000000000000001 108.369 171.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.48 30.5 50.04 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.525 -0.845 . . . . 0.82999999999999996 111.699 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.06 153.05 18.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 0.85999999999999999 111.552 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.77 -27.35 15.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.686 -0.688 . . . . 2.4300000000000002 110.52 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 2.4 mmp_? -113.57 -9.36 13.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.083 -0.508 . . . . 4.5199999999999996 110.532 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 9.7 m170 70.34 144.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.243 -0.889 . . . . 0.88 111.221 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA3' HD21 ' A' ' 116' ' ' LEU . . . -78.78 104.23 2.07 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.413 -0.898 . . . . 0.23999999999999999 110.965 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.653 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 1.7 t80 -91.32 97.73 11.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.178 0.513 . . . . 0.40999999999999998 110.191 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.025 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -86.42 115.44 62.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.56 -0.746 . . . . 0.16 110.188 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.672 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 10.3 Cg_exo -69.52 141.33 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.245 1.963 . . . . 0.23000000000000001 111.471 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 21.2 tp -54.78 -30.62 57.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.335 -0.848 . . . . 0.19 112.144 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.672 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.0 ptmm? -61.76 -22.99 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 2.04 111.768 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -93.57 -21.75 19.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.48 -0.327 . . . . 0.85999999999999999 111.256 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.717 HG21 HG11 ' A' ' 93' ' ' VAL . 17.0 mt -49.01 132.21 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.155 0.798 . . . . 0.56000000000000005 113.155 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -93.67 151.9 19.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.197 -0.91 . . . . 0.39000000000000001 111.363 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 10.0 tpt180 -54.38 -16.1 2.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.525 -1.216 . . . . 3.0099999999999998 112.777 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.029 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 29.7 tp10 -63.5 -29.89 71.09 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.788 -0.57 . . . . 1.76 110.823 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.644 ' CE1' HG12 ' A' ' 100' ' ' VAL . 26.1 m-85 -86.14 -41.61 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.317 -0.856 . . . . 1.3999999999999999 110.733 -172.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.531 ' HB3' HG22 ' A' ' 93' ' ' VAL . 2.1 p90 -102.3 92.13 3.03 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 107.551 -1.277 . . . . 0.46000000000000002 107.551 166.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 23.4 Cg_exo -26.72 137.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.675 4.25 . . . . 0.70999999999999996 115.374 -167.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.6 -25.39 17.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.356 -1.293 . . . . 0.93000000000000005 112.579 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.59 -6.57 59.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.196 0.522 . . . . 2.6200000000000001 111.253 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 79' ' ' PRO . 58.1 t80 -87.85 135.38 33.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.313 -0.625 . . . . 1.3300000000000001 109.313 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -71.61 116.37 11.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.051 -0.722 . . . . 2.1800000000000002 109.051 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.483 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -63.73 -21.03 66.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.886 0.699 . . . . 1.74 112.886 -170.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 40.6 m80 65.55 23.93 11.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.284 0.564 . . . . 3.9900000000000002 110.412 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.41 -57.93 4.18 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.513 -0.767 . . . . 1.0600000000000001 111.953 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -137.3 130.27 17.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.864 0.364 . . . . 4.3700000000000001 110.46 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.406 ' O ' HD11 ' A' ' 70' ' ' LEU . 6.5 Cg_endo -61.4 154.59 57.78 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.163 2.575 . . . . 0.31 113.697 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.3 t30 -114.98 110.7 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.24 -0.652 . . . . 2.1400000000000001 109.24 171.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 tt -55.63 -43.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 113.649 0.981 . . . . 0.20999999999999999 113.649 -164.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.746 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 4.7 mmmp? -56.7 -26.37 56.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.245 0.831 . . . . 3.8199999999999998 113.245 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -110.18 9.38 23.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.145 0.497 . . . . 1.9099999999999999 111.079 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.717 HG11 HG21 ' A' ' 73' ' ' ILE . 53.2 t -115.21 -51.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.638 -0.71 . . . . 0.33000000000000002 109.849 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.824 ' HB3' HG12 ' A' ' 46' ' ' ILE . 83.1 mt -103.16 154.05 19.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.44 -0.8 . . . . 0.29999999999999999 109.691 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -148.15 151.99 36.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.521 -0.763 . . . . 2.6699999999999999 108.95 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HA ' HG22 ' A' ' 46' ' ' ILE . 36.6 mt-10 -62.06 118.69 7.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 1.25 110.237 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.35 -18.33 20.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.85 -0.614 . . . . 0.40999999999999998 112.209 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 tt0 -78.02 135.86 37.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.479 -0.563 . . . . 1.1799999999999999 109.479 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.9 157.37 19.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.136 0.493 . . . . 0.81000000000000005 111.361 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.644 HG12 ' CE1' ' A' ' 77' ' ' TYR . 35.0 m -138.07 151.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.169 -0.923 . . . . 0.17999999999999999 109.959 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 122' ' ' LEU . 3.5 mm -103.06 110.14 28.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.67 -1.233 . . . . 0.51000000000000001 107.67 171.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -143.61 134.79 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.559 . . . . 0.28000000000000003 111.783 -170.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -108.33 141.26 40.41 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.56 -0.904 . . . . 1.6200000000000001 108.56 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 104' ' ' ILE . 18.3 mm -74.98 104.53 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.667 0.746 . . . . 0.78000000000000003 111.367 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.47 -43.33 32.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.686 -1.143 . . . . 1.3 109.776 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.658 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 60.4 mttp -118.04 137.42 52.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.66 -0.7 . . . . 2.5699999999999998 109.895 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.64 144.38 32.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.007 -0.997 . . . . 2.5699999999999998 112.547 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 40.8 tt0 -71.63 90.91 1.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.31 -0.859 . . . . 3.1400000000000001 110.321 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.599 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 17.8 mtt180 -105.53 -82.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.453 -0.794 . . . . 3.4900000000000002 110.665 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.93 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.561 -0.828 . . . . 1.74 112.569 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.427 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 21.6 t-20 -61.59 -49.71 75.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.579 0.214 . . . . 2.8799999999999999 111.579 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 29.3 mtpp -123.55 -38.05 2.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.321 0.581 . . . . 3.4500000000000002 109.812 171.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.599 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 85.64 -132.71 11.28 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.149 -0.932 . . . . 0.91000000000000003 112.531 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 65' ' ' HIS . . . -75.57 108.01 8.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.148 -0.526 . . . . 0.52000000000000002 111.326 -171.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -104.22 125.24 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.213 -0.449 . . . . 0.59999999999999998 110.431 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.025 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 30.4 mt -90.8 148.72 22.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.989 0.423 . . . . 0.34999999999999998 109.965 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -113.93 175.46 5.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.17 -0.678 . . . . 0.98999999999999999 109.17 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.27 26.99 6.73 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.401 0.619 . . . . 1.22 110.274 173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -78.15 44.45 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.547 1.165 . . . . 4.1100000000000003 109.141 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 101' ' ' ILE . 3.3 mp -128.46 161.73 36.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.839 -1.073 . . . . 0.94999999999999996 108.982 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.06 66.82 0.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.967 0.413 . . . . 1.25 111.301 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 101' ' ' ILE . 1.9 mt -116.25 173.31 6.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.112 -0.699 . . . . 1.3799999999999999 109.112 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.029 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.33 -0.258 0 O-C-N 123.92 0.762 . . . . 1.3700000000000001 110.622 174.164 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.512 0 N-CA-C 108.614 -0.884 . . . . 0.95999999999999996 108.614 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -52.79 119.77 4.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.527 . . . . 2.6200000000000001 110.665 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.678 HD11 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -89.52 138.62 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.218 -0.901 . . . . 0.83999999999999997 110.326 -175.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -133.25 156.41 47.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.021 0.438 . . . . 1.02 110.343 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.8 ttmt -118.49 121.66 40.82 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.795 -0.817 . . . . 1.1599999999999999 108.795 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.82 166.95 25.78 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.675 -0.97 . . . . 0.27000000000000002 110.675 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 90.4 mttt -100.21 156.88 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.41 0.624 . . . . 1.54 111.114 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.891 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -69.86 134.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.661 -1.154 . . . . 0.25 109.822 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 59' ' ' ASP . 61.6 p -123.87 -18.41 6.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.357 0.599 . . . . 0.39000000000000001 111.314 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HG2' ' HD2' ' A' ' 57' ' ' PHE . 7.2 ttm180 -150.6 131.3 14.02 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.361 -0.836 . . . . 1.8500000000000001 110.524 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 46' ' ' ILE . 58.0 mt -139.81 101.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.657 -0.868 . . . . 0.26000000000000001 108.657 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.597 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -98.57 112.46 62.53 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.0 -0.545 . . . . 2.2400000000000002 110.015 -177.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.996 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 52.9 Cg_exo -57.12 -22.37 47.37 Favored 'Trans proline' 0 N--CA 1.467 -0.054 0 C-N-CA 122.953 2.435 . . . . 0.52000000000000002 111.894 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -71.69 -20.09 61.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.23 111.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -128.36 12.74 6.53 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.811 1.041 . . . . 0.46000000000000002 113.811 -176.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER 47.73 40.78 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 2.5099999999999998 112.818 173.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.54 170.24 20.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 0.19 111.076 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' PHE . . . -137.63 149.12 46.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.17999999999999999 112.032 -173.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.526 ' HD2' ' HG2' ' A' ' 48' ' ' ARG . 63.4 m-85 -98.38 137.64 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.56000000000000005 109.826 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.637 ' HB ' HD11 ' A' ' 116' ' ' LEU . 24.3 t -118.72 131.78 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.347 -0.842 . . . . 0.26000000000000001 109.832 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.602 ' HB2' HG21 ' A' ' 47' ' ' THR . 22.2 t70 -100.43 104.86 16.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.79000000000000004 110.649 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -127.11 65.4 1.3 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.973 -0.751 . . . . 0.89000000000000001 108.973 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.41 52.18 19.6 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.336 -0.935 . . . . 0.82999999999999996 111.328 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 168.48 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.85999999999999999 111.193 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 7.4 tp10 -93.78 -53.54 3.98 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.905 -0.318 . . . . 2.4300000000000002 111.381 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.4 ptm180 -109.16 6.54 24.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.132 -0.627 . . . . 4.5199999999999996 110.778 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 15.7 m170 71.25 143.28 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.24 -0.891 . . . . 0.88 111.511 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -74.53 117.33 5.46 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.829 -0.909 . . . . 0.23999999999999999 110.829 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 21.6 t80 -99.83 98.73 9.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.166 0.508 . . . . 0.40999999999999998 110.375 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.925 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -87.34 117.54 68.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.506 -0.77 . . . . 0.16 111.05 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' HD23 ' A' ' 68' ' ' LEU . 21.3 Cg_exo -67.65 141.85 56.37 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.821 2.347 . . . . 0.23000000000000001 111.721 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.699 HD13 ' HB ' ' A' ' 90' ' ' ILE . 18.0 tp -59.34 -35.09 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.19 112.035 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -67.83 -8.22 34.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.394 -0.366 . . . . 2.04 111.786 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -96.31 -26.98 15.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.641 -0.254 . . . . 0.85999999999999999 110.349 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.545 HG21 HG11 ' A' ' 93' ' ' VAL . 33.9 mt -49.85 135.06 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.436 0.902 . . . . 0.56000000000000005 113.436 -167.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -91.07 148.99 22.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.394 -1.275 . . . . 0.39000000000000001 111.432 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.662 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 13.6 ttp180 -58.41 -14.49 7.8 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.937 -1.029 . . . . 3.0099999999999998 112.583 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.673 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 10.4 tp10 -54.36 -38.82 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 1.76 111.789 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.92 ' OH ' ' HA ' ' A' ' 100' ' ' VAL . 39.2 m-85 -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.581 0.586 . . . . 1.3999999999999999 112.581 -168.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.662 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 12.5 p90 -97.91 88.58 0.65 Allowed Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 105.996 -1.853 . . . . 0.46000000000000002 105.996 158.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.08 143.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.876 3.717 . . . . 0.70999999999999996 114.216 -157.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.95 -7.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.907 -1.042 . . . . 0.93000000000000005 112.65 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.7 -21.94 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.472 0.653 . . . . 2.6200000000000001 109.607 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -77.64 130.67 37.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.11 -0.95 . . . . 1.3300000000000001 109.466 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -68.57 100.35 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 2.1800000000000002 110.339 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -83.22 103.02 12.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.683 -0.69 . . . . 1.74 110.634 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -130.76 131.89 44.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.824 -0.625 . . . . 3.9900000000000002 109.856 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.15 -102.32 2.16 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.558 -0.829 . . . . 1.0600000000000001 111.84 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -136.94 133.12 18.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.138 -0.319 . . . . 4.3700000000000001 110.138 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -60.0 156.48 38.87 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.417 1.412 . . . . 0.31 111.091 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.642 HD21 ' HG3' ' A' ' 91' ' ' LYS . 10.4 t30 -118.34 101.4 8.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.676 -0.49 . . . . 2.1400000000000001 109.676 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.699 ' HB ' HD13 ' A' ' 70' ' ' LEU . 19.9 tt -54.79 -45.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.598 0.962 . . . . 0.20999999999999999 113.598 -164.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.996 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 17.0 ptmt -56.42 -16.54 5.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.838 0.681 . . . . 3.8199999999999998 112.838 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.503 ' HB3' HD22 ' A' ' 89' ' ' ASN . 34.6 t70 -118.18 1.34 11.91 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.521 0.676 . . . . 1.9099999999999999 110.624 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 78' ' ' PHE . 45.3 t -105.58 -50.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.655 0.741 . . . . 0.33000000000000002 109.543 -175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.681 ' HB3' HG12 ' A' ' 46' ' ' ILE . 81.6 mt -100.84 152.72 20.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.354 -0.839 . . . . 0.29999999999999999 109.172 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 149.09 30.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.355 -0.839 . . . . 2.6699999999999999 109.389 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.538 ' HA ' HG22 ' A' ' 46' ' ' ILE . 31.0 mt-10 -56.24 123.93 16.24 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.722 0.639 . . . . 1.25 111.203 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.3 29.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.615 -0.721 . . . . 0.40999999999999998 112.151 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 8.4 tt0 -77.14 133.4 38.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.054 -0.35 . . . . 1.1799999999999999 110.054 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.43 158.1 24.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.714 . . . . 0.81000000000000005 110.97 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.92 ' HA ' ' OH ' ' A' ' 77' ' ' TYR . 27.5 m -137.41 146.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.17999999999999999 110.549 170.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.989 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.6 mm -93.83 110.14 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.237 -1.023 . . . . 0.51000000000000001 108.237 169.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.539 ' CG2' HD22 ' A' ' 116' ' ' LEU . 3.4 m -144.32 129.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.199 0.523 . . . . 0.28000000000000003 111.26 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 15.6 pt20 -93.53 138.87 31.37 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.507 -0.923 . . . . 1.6200000000000001 108.507 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.569 ' CD1' HD23 ' A' ' 116' ' ' LEU . 41.7 mm -80.54 96.21 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.615 0.721 . . . . 0.78000000000000003 109.338 176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.87 -29.49 63.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.727 -1.124 . . . . 1.3 109.852 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 32.3 mttm -129.07 123.97 33.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 2.5699999999999998 109.578 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -79.26 158.71 27.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.95 -0.568 . . . . 2.5699999999999998 110.305 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.898 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 22.5 tt0 -70.63 90.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.56 0.695 . . . . 3.1400000000000001 110.717 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -111.26 6.98 20.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.862 -1.063 . . . . 3.4900000000000002 110.974 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.36 -46.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.643 -0.789 . . . . 1.74 113.432 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.65 -50.84 70.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.007 0.403 . . . . 2.8799999999999999 111.064 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 -37.28 2.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.631 -0.877 . . . . 3.4500000000000002 108.631 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.898 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 83.52 -133.4 11.85 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.823 -1.081 . . . . 0.91000000000000003 111.098 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.476 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -73.02 96.87 2.22 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.155 0.502 . . . . 0.52000000000000002 110.309 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -104.03 124.42 49.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.59999999999999998 111.528 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.925 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 31.4 mt -91.4 159.77 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.049 -0.723 . . . . 0.34999999999999998 109.049 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.431 ' O ' HG12 ' A' ' 102' ' ' VAL . 12.8 t -138.08 153.4 49.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.186 -0.672 . . . . 0.98999999999999999 109.186 168.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.413 HG23 HD11 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -126.86 34.49 4.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.302 0.572 . . . . 1.22 111.015 172.143 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -80.25 45.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.357 -0.979 . . . . 4.1100000000000003 108.357 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.631 ' HB ' HD12 ' A' ' 122' ' ' LEU . 11.0 mt -121.36 168.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.471 -1.24 . . . . 0.94999999999999996 108.37 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -85.03 33.48 0.54 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.947 0.721 . . . . 1.25 112.947 -172.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.989 ' HG ' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -117.2 100.19 7.54 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.684 0.754 . . . . 1.3799999999999999 109.882 175.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.673 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.324 -0.539 0 CA-C-N 115.712 -0.676 . . . . 1.3700000000000001 109.907 -179.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.534 0 N-CA-C 109.194 -0.669 . . . . 0.95999999999999996 109.194 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -55.69 124.03 16.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.084 0.469 . . . . 2.6200000000000001 110.948 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -95.33 144.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.881 -0.6 . . . . 0.83999999999999997 109.663 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -125.22 135.45 52.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 1.02 110.449 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 40.0 ttmt -98.75 103.67 15.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.911 -0.774 . . . . 1.1599999999999999 108.911 167.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.94 161.89 19.35 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 110.691 -0.964 . . . . 0.27000000000000002 110.691 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 84.6 mttt -94.45 158.06 15.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.171 0.51 . . . . 1.54 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.769 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.8 mp -74.57 133.69 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.144 -1.058 . . . . 0.25 108.144 169.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.587 HG21 ' CB ' ' A' ' 59' ' ' ASP . 57.5 p -117.57 -20.09 9.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.436 0.636 . . . . 0.39000000000000001 110.525 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 24.4 ttt180 -146.6 121.42 9.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.136 -0.938 . . . . 1.8500000000000001 109.677 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.769 ' CD1' HG21 ' A' ' 46' ' ' ILE . 75.4 mt -125.91 109.0 20.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.147 -0.686 . . . . 0.26000000000000001 109.147 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 7.0 tp10 -104.47 107.78 58.77 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.221 -0.9 . . . . 2.2400000000000002 109.488 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HB3' ' CD ' ' A' ' 91' ' ' LYS . 54.3 Cg_exo -53.95 -37.94 86.08 Favored 'Trans proline' 0 N--CA 1.467 -0.07 0 C-N-CA 123.309 2.673 . . . . 0.52000000000000002 112.578 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -22.12 65.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.23 112.158 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.0 pp -123.59 8.25 8.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.15 0.426 . . . . 0.46000000000000002 112.15 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB2' HD23 ' A' ' 70' ' ' LEU . 8.0 pt-20 39.23 60.23 1.55 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.705 0.802 . . . . 2.5099999999999998 112.197 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -165.67 158.47 15.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.248 -0.887 . . . . 0.19 110.405 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -122.91 144.49 49.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.546 0.572 . . . . 0.17999999999999999 112.546 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.552 ' HD1' ' HB2' ' A' ' 65' ' ' HIS . 63.1 m-85 -97.02 137.09 36.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.417 -0.811 . . . . 0.56000000000000005 109.844 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 116' ' ' LEU . 38.4 t -120.47 129.67 75.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.019 -0.537 . . . . 0.26000000000000001 109.675 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.587 ' CB ' HG21 ' A' ' 47' ' ' THR . 29.2 t70 -102.41 112.68 25.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.319 -0.401 . . . . 0.79000000000000004 111.384 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.0 67.45 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.047 -0.723 . . . . 0.89000000000000001 109.047 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.8 41.33 58.05 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.728 -0.669 . . . . 0.82999999999999996 112.153 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.21 147.61 44.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.85999999999999999 111.271 -172.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.66 -51.26 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 2.4300000000000002 108.803 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.911 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 26.7 mmm180 -96.23 106.61 18.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.224 -0.898 . . . . 4.5199999999999996 108.793 169.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 18.9 m170 -61.56 149.83 37.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 0.88 111.51 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.08 110.31 3.14 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.771 -0.931 . . . . 0.23999999999999999 110.771 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 9.5 t80 -98.87 100.58 11.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.326 0.584 . . . . 0.40999999999999998 110.827 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.94 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -92.15 115.09 64.06 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.09 -0.959 . . . . 0.16 110.94 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.653 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.0 Cg_exo -64.07 141.07 75.14 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.864 2.376 . . . . 0.23000000000000001 111.562 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.831 ' HA ' HG13 ' A' ' 73' ' ' ILE . 10.3 tp -63.07 -34.93 78.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.605 -0.725 . . . . 0.19 111.722 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.08 -14.8 52.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.982 0.42 . . . . 2.04 111.083 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 1.6 mm-40 -99.19 -14.45 19.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.85999999999999999 110.534 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.831 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.8 mt -49.31 134.05 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.151 0.797 . . . . 0.56000000000000005 113.151 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -87.05 146.5 26.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.814 -1.084 . . . . 0.39000000000000001 110.922 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.604 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 18.2 ttm180 -62.19 -13.51 28.29 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.384 -0.825 . . . . 3.0099999999999998 111.806 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.684 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 15.0 tp10 -60.87 -27.22 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.468 . . . . 1.76 110.757 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.429 ' HD2' HG23 ' A' ' 73' ' ' ILE . 14.8 m-85 -87.45 -44.17 11.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.447 -0.797 . . . . 1.3999999999999999 110.353 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.1 p90 -96.17 97.34 3.08 Favored Pre-proline 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 0.46000000000000002 107.098 166.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.1 Cg_endo -38.65 138.02 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.306 3.337 . . . . 0.70999999999999996 112.776 -163.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.69 -10.28 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.395 -0.821 . . . . 0.93000000000000005 113.193 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -87.02 -12.6 46.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.349 0.595 . . . . 2.6200000000000001 110.317 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.88 143.5 41.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.782 -0.644 . . . . 1.3300000000000001 109.688 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -79.52 100.64 7.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.37 -0.377 . . . . 2.1800000000000002 110.957 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -87.04 123.4 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 1.74 110.182 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.57 -20.43 18.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.007 0.432 . . . . 3.9900000000000002 110.373 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -77.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.914 -0.66 . . . . 1.0600000000000001 111.572 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -104.84 132.57 20.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.043 -0.355 . . . . 4.3700000000000001 110.043 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.417 ' C ' HD11 ' A' ' 70' ' ' LEU . 11.5 Cg_endo -64.66 161.78 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.116 1.877 . . . . 0.31 111.975 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.894 HD22 ' HB3' ' A' ' 92' ' ' ASP . 0.3 OUTLIER -122.11 102.62 8.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 2.1400000000000001 109.78 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 17.3 tt -54.85 -40.16 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.699 1.0 . . . . 0.20999999999999999 113.699 -162.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.605 ' CD ' ' HB3' ' A' ' 51' ' ' PRO . 43.2 pttt -67.65 -11.6 58.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.953 0.353 . . . . 3.8199999999999998 111.953 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.894 ' HB3' HD22 ' A' ' 89' ' ' ASN . 37.0 t70 -125.53 18.25 8.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.159 0.98 . . . . 1.9099999999999999 109.359 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 78' ' ' PHE . 18.1 t -122.5 -54.77 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.33000000000000002 110.198 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 47.8 mt -101.09 153.34 19.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.429 -0.805 . . . . 0.29999999999999999 109.55 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . 0.768 ' HD3' HE21 ' A' ' 98' ' ' GLN . 0.1 OUTLIER -125.43 150.53 47.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.106 -0.702 . . . . 2.6699999999999999 109.106 173.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.66 ' HA ' HG22 ' A' ' 46' ' ' ILE . 42.2 mt-10 -69.95 109.31 4.44 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.257 -1.016 . . . . 1.25 108.257 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.21 -11.46 19.81 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.438 -0.801 . . . . 0.40999999999999998 112.15 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.768 HE21 ' HD3' ' A' ' 95' ' ' ARG . 9.1 tt0 -80.29 144.71 32.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.206 0.503 . . . . 1.1799999999999999 109.966 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.69 153.71 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.32 0.581 . . . . 0.81000000000000005 111.612 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 102' ' ' VAL . 27.3 m -136.29 146.4 29.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.088 -0.96 . . . . 0.17999999999999999 109.018 169.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.896 ' HB ' HD11 ' A' ' 122' ' ' LEU . 4.3 mm -100.42 109.12 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.571 -1.27 . . . . 0.51000000000000001 107.571 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.523 ' CG2' HD22 ' A' ' 116' ' ' LEU . 4.8 m -145.5 142.63 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.021 -0.536 . . . . 0.28000000000000003 110.717 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.48 ' HG3' HG22 ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.4 166.28 10.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.381 -0.6 . . . . 1.6200000000000001 109.381 175.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.477 ' CD1' HD23 ' A' ' 116' ' ' LEU . 18.7 mm -108.53 98.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.629 0.728 . . . . 0.78000000000000003 110.072 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -83.71 -29.41 27.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.066 -0.97 . . . . 1.3 110.381 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 36.1 mmtm -117.65 136.35 53.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.449 . . . . 2.5699999999999998 109.895 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 28.2 mt-10 -97.56 158.25 15.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.417 -0.81 . . . . 2.5699999999999998 110.447 -166.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.911 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 24.8 tt0 -51.25 112.21 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.547 0.529 . . . . 3.1400000000000001 110.803 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.917 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 12.7 ptm180 -146.65 49.28 1.15 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.454 -0.794 . . . . 3.4900000000000002 110.382 -175.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.34 -96.25 1.0 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.788 -0.642 . . . . 1.74 113.991 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -60.66 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.004 0.742 . . . . 2.8799999999999999 113.004 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -110.86 -40.28 4.58 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.143 -0.623 . . . . 3.4500000000000002 110.144 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.917 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 60.88 -121.51 26.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.487 -0.778 . . . . 0.91000000000000003 112.509 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.538 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -72.99 101.08 3.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.164 0.506 . . . . 0.52000000000000002 110.607 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -98.59 124.0 43.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.248 -0.433 . . . . 0.59999999999999998 110.907 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.94 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 46.9 mt -90.93 136.75 32.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 0.34999999999999998 109.732 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' HG3' ' A' ' 103' ' ' GLN . 5.0 t -96.82 168.17 10.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.635 . . . . 0.98999999999999999 109.284 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.61 HG23 HD21 ' A' ' 68' ' ' LEU . 2.0 p -136.01 13.99 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.155 0.502 . . . . 1.22 111.159 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.91 57.52 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.246 -1.02 . . . . 4.1100000000000003 108.246 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 121' ' ' SER . 8.1 mt -127.9 175.5 9.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 113.975 -1.466 . . . . 0.94999999999999996 108.648 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.586 ' H ' HG22 ' A' ' 120' ' ' ILE . 14.6 m -75.61 33.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.448 0.536 . . . . 1.25 112.448 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.896 HD11 ' HB ' ' A' ' 101' ' ' ILE . 4.2 mp -116.34 124.22 49.56 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.349 -0.219 . . . . 1.3799999999999999 111.496 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . . . . . . 0 N--CA 1.468 0.441 0 O-C-N 124.911 1.382 . . . . 1.3700000000000001 109.149 170.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.633 0 N-CA-C 108.676 -0.861 . . . . 0.95999999999999996 108.676 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -61.66 124.95 22.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.378 0.609 . . . . 2.6200000000000001 110.783 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 103' ' ' GLN . 7.3 tp -94.18 143.96 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.194 -0.912 . . . . 0.83999999999999997 110.098 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.22 144.09 51.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.05 0.452 . . . . 1.02 110.968 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 99' ' ' GLU . 2.4 tppp? -112.42 117.61 32.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.307 -0.86 . . . . 1.1599999999999999 109.389 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.63 30.64 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.629 -0.988 . . . . 0.27000000000000002 110.629 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 97' ' ' GLY . 39.2 mtmt -116.52 159.11 22.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.64 0.733 . . . . 1.54 111.88 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.749 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -68.42 137.77 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.322 -1.308 . . . . 0.25 110.089 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 59' ' ' ASP . 47.5 p -126.56 -20.18 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.39000000000000001 111.689 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.684 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 8.3 ttm180 -148.08 122.02 9.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.072 -0.513 . . . . 1.8500000000000001 110.09 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.749 ' CD1' HG21 ' A' ' 46' ' ' ILE . 88.2 mt -128.87 108.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.146 -0.687 . . . . 0.26000000000000001 109.146 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 17.3 tt0 -102.89 121.05 50.59 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.894 -0.594 . . . . 2.2400000000000002 109.688 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG3' ' CD ' ' A' ' 91' ' ' LYS . 12.2 Cg_exo -65.8 -31.25 48.71 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.977 2.451 . . . . 0.52000000000000002 112.759 -171.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 t -77.03 -10.11 59.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 1.23 111.657 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 3.1 pp -127.82 5.77 6.06 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.728 0.64 . . . . 0.46000000000000002 112.728 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 70' ' ' LEU . 11.2 pt-20 43.47 55.55 4.81 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.352 0.596 . . . . 2.5099999999999998 112.095 170.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.0 158.98 22.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.461 -0.79 . . . . 0.19 110.365 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -129.1 140.26 51.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.873 0.694 . . . . 0.17999999999999999 112.873 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.711 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 53.0 m-85 -92.43 128.61 38.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.134 -0.939 . . . . 0.56000000000000005 110.119 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.535 HG12 ' HD1' ' A' ' 60' ' ' TYR . 76.5 t -108.54 131.01 60.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.25 0.547 . . . . 0.26000000000000001 109.884 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.689 ' HB2' HG21 ' A' ' 47' ' ' THR . 10.6 t70 -101.49 96.49 7.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.715 -0.675 . . . . 0.79000000000000004 110.664 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.661 ' OH ' HD11 ' A' ' 104' ' ' ILE . 15.5 p90 -126.88 66.29 1.27 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.032 -0.729 . . . . 0.89000000000000001 109.032 173.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.39 11.67 15.03 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.759 -0.734 . . . . 0.82999999999999996 112.533 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.61 110.71 18.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.85999999999999999 110.305 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.63 -18.68 60.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 2.4300000000000002 110.637 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.677 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.9 mmp_? -95.63 -6.82 39.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.893 -0.594 . . . . 4.5199999999999996 110.371 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.711 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 59.18 107.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.238 -0.892 . . . . 0.88 111.924 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -59.61 122.06 28.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.431 -0.89 . . . . 0.23999999999999999 111.151 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 5.7 t80 -111.28 107.67 17.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.283 0.563 . . . . 0.40999999999999998 110.524 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.762 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.3 118.58 67.71 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.326 -0.852 . . . . 0.16 110.84 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.57 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 27.5 Cg_exo -64.87 134.9 42.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.501 2.134 . . . . 0.23000000000000001 111.052 169.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.691 ' HA ' HG13 ' A' ' 73' ' ' ILE . 12.3 tp -57.19 -31.91 65.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.583 . . . . 0.19 111.961 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 21.3 pttp -70.2 -8.18 47.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.448 -0.342 . . . . 2.04 111.529 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 6.1 mm-40 -103.65 -10.03 18.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 110.423 -0.214 . . . . 0.85999999999999999 110.423 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.691 HG13 ' HA ' ' A' ' 70' ' ' LEU . 18.5 mt -60.77 133.54 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.658 0.614 . . . . 0.56000000000000005 112.658 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' THR . . . -77.92 140.51 39.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.254 -0.884 . . . . 0.39000000000000001 111.208 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.753 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 29.6 ttp180 -58.62 -13.81 6.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.223 -0.899 . . . . 3.0099999999999998 112.397 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.927 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 25.3 tp10 -56.25 -29.94 61.73 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.437 -0.79 . . . . 1.76 111.351 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.543 ' CZ ' HD22 ' A' ' 122' ' ' LEU . 34.0 m-85 -85.32 -41.03 15.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 1.3999999999999999 110.894 -172.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.753 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.4 p90 -102.0 96.73 7.15 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 106.963 -1.495 . . . . 0.46000000000000002 106.963 167.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_endo -32.01 138.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 1 C-N-CA 125.676 4.251 . . . . 0.70999999999999996 114.704 -162.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.634 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -51.13 -24.17 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.638 -1.164 . . . . 0.93000000000000005 113.699 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -92.92 4.8 53.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.58 0.705 . . . . 2.6200000000000001 110.67 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -84.78 132.13 34.46 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.662 -0.866 . . . . 1.3300000000000001 108.662 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -65.81 99.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 2.1800000000000002 111.821 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -90.25 58.22 3.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.575 -0.738 . . . . 1.74 110.041 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -80.17 56.66 2.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.442 0.639 . . . . 3.9900000000000002 110.48 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.5 -120.82 1.29 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.732 -0.667 . . . . 1.0600000000000001 111.995 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -119.68 130.95 24.58 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.804 -0.443 . . . . 4.3700000000000001 109.804 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.569 ' HB2' HG21 ' A' ' 93' ' ' VAL . 8.5 Cg_endo -58.74 144.71 97.9 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.987 1.792 . . . . 0.31 111.742 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.9 t30 -98.75 118.55 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.346 -0.612 . . . . 2.1400000000000001 109.346 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.7 tt -57.63 -47.54 85.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.863 1.06 . . . . 0.20999999999999999 113.863 -164.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CD ' ' HG3' ' A' ' 51' ' ' PRO . 15.1 mtpt -66.25 -6.52 14.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.076 0.769 . . . . 3.8199999999999998 113.076 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.76 5.04 17.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.377 0.608 . . . . 1.9099999999999999 110.22 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 88' ' ' PRO . 69.0 t -117.62 -52.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.463 -0.789 . . . . 0.33000000000000002 109.852 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.441 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.6 mt -101.7 154.78 18.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.29999999999999999 109.175 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.34 150.42 35.68 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.535 -0.543 . . . . 2.6699999999999999 109.535 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HA ' HG22 ' A' ' 46' ' ' ILE . 48.3 mt-10 -57.0 110.97 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 1.25 109.991 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 45' ' ' LYS . . . 112.96 -1.05 25.7 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.857 -0.687 . . . . 0.40999999999999998 112.242 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.482 ' NE2' ' HB3' ' A' ' 77' ' ' TYR . 22.8 tt0 -95.96 135.53 37.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.832 -0.433 . . . . 1.1799999999999999 109.832 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 11.7 pt-20 -82.77 157.54 23.18 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.463 0.477 . . . . 0.81000000000000005 111.815 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.512 HG23 HG22 ' A' ' 102' ' ' VAL . 34.2 m -141.2 152.59 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.115 -0.948 . . . . 0.17999999999999999 109.741 171.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.801 ' HB ' HD11 ' A' ' 122' ' ' LEU . 23.5 mm -103.35 110.66 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.356 -0.979 . . . . 0.51000000000000001 108.356 168.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 100' ' ' VAL . 2.5 m -139.1 130.57 35.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.218 0.532 . . . . 0.28000000000000003 112.127 -170.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.477 ' HB3' HD12 ' A' ' 41' ' ' ILE . 10.1 pt20 -104.68 157.32 17.26 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.167 -1.049 . . . . 1.6200000000000001 108.167 170.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.661 HD11 ' OH ' ' A' ' 60' ' ' TYR . 20.6 mm -81.02 102.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.779 0.799 . . . . 0.78000000000000003 110.861 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.467 ' OD2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 t70 -71.44 -44.24 65.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.104 -1.407 . . . . 1.3 110.33 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG3' ' OD2' ' A' ' 105' ' ' ASP . 63.0 mttp -125.37 156.76 38.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.48 0.657 . . . . 2.5699999999999998 111.183 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.3 155.88 17.64 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.597 -1.183 . . . . 2.5699999999999998 111.548 -162.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.613 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 19.1 mt-10 -69.17 89.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.113 -0.949 . . . . 3.1400000000000001 110.783 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.3 9.25 37.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.494 -1.23 . . . . 3.4900000000000002 110.497 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.27 -63.92 3.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.92 -0.657 . . . . 1.74 112.157 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.7 -31.85 73.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.503 0.192 . . . . 2.8799999999999999 111.505 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -118.84 -39.68 2.94 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.388 0.614 . . . . 3.4500000000000002 109.464 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 75.85 -140.05 25.3 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.726 -1.125 . . . . 0.91000000000000003 112.858 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -81.72 91.71 6.5 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.944 0.402 . . . . 0.52000000000000002 110.821 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' A' ' 106' ' ' LYS . . . -79.15 123.66 27.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.208 -0.451 . . . . 0.59999999999999998 111.295 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.762 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 65.4 mt -91.91 161.06 14.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.08 -0.509 . . . . 0.34999999999999998 110.014 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.595 HG23 HD11 ' A' ' 120' ' ' ILE . 15.3 t -141.31 156.3 45.87 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.888 -0.782 . . . . 0.98999999999999999 108.888 171.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -137.33 41.86 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.451 0.643 . . . . 1.22 112.507 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -96.53 33.17 1.86 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.148 -1.056 . . . . 4.1100000000000003 108.148 167.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.595 HD11 HG23 ' A' ' 117' ' ' THR . 0.8 OUTLIER -119.77 93.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.684 -1.143 . . . . 0.94999999999999996 111.06 -171.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 m 69.84 -30.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.602 1.334 . . . . 1.25 114.602 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.801 HD11 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -83.25 173.47 11.59 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.687 -0.633 . . . . 1.3799999999999999 111.264 -176.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.927 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 CA--C 1.514 -0.413 0 O-C-N 124.966 1.416 . . . . 1.3700000000000001 109.979 -178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.397 0 N-CA-C 108.585 -0.895 . . . . 0.95999999999999996 108.585 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 39.7 m-80 -62.35 102.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.847 0.356 . . . . 2.6200000000000001 111.395 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.831 HD11 HG22 ' A' ' 101' ' ' ILE . 9.6 tp -82.71 134.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.958 -0.564 . . . . 0.83999999999999997 110.365 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -132.02 145.58 51.54 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.226 0.536 . . . . 1.02 110.72 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -109.65 107.27 17.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.184 -0.916 . . . . 1.1599999999999999 108.81 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.34 166.25 27.69 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.153 -1.022 . . . . 0.27000000000000002 111.855 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 30.9 mtmt -106.09 159.39 16.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.3 0.571 . . . . 1.54 111.262 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.828 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -70.58 141.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.876 -1.056 . . . . 0.25 110.436 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 59' ' ' ASP . 65.3 p -131.22 -0.21 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.203 -0.453 . . . . 0.39000000000000001 111.501 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 31.3 ttt-85 -164.52 125.02 2.06 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.314 -0.403 . . . . 1.8500000000000001 110.409 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.828 ' CD1' HG21 ' A' ' 46' ' ' ILE . 88.5 mt -141.45 119.28 8.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.622 -0.51 . . . . 0.26000000000000001 109.622 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 3.5 mt-10 -117.86 130.1 24.93 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.205 -0.452 . . . . 2.2400000000000002 110.847 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.956 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 16.0 Cg_exo -68.95 -14.94 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.755 2.303 . . . . 0.52000000000000002 111.324 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -73.09 -36.32 66.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 1.23 110.817 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 50' ' ' GLU . 1.1 pp -118.24 5.8 11.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.46000000000000002 112.157 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.43 57.35 2.54 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.953 0.783 . . . . 2.5099999999999998 111.537 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.16 166.63 16.87 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.303 -0.862 . . . . 0.19 110.568 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -136.34 148.08 47.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.642 0.608 . . . . 0.17999999999999999 112.642 -172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 45.1 m-85 -101.13 132.3 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.526 -0.761 . . . . 0.56000000000000005 110.09 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 116' ' ' LEU . 25.0 t -108.9 136.62 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.066 0.46 . . . . 0.26000000000000001 110.218 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.556 ' HB2' HG21 ' A' ' 47' ' ' THR . 27.4 t70 -108.88 107.72 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.812 -0.631 . . . . 0.79000000000000004 111.396 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 58' ' ' VAL . 23.3 p90 -127.24 65.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.89000000000000001 108.939 171.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.32 18.28 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.708 -0.758 . . . . 0.82999999999999996 112.054 -171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.9 141.81 37.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.408 0.283 . . . . 0.85999999999999999 110.873 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.79 -21.21 17.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 2.4300000000000002 110.994 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.608 ' HA ' ' NE ' ' A' ' 64' ' ' ARG . 2.6 mmp_? -106.38 -13.14 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 4.5199999999999996 110.802 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.624 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.5 OUTLIER 70.51 116.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.435 -0.802 . . . . 0.88 111.755 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.88 118.19 12.66 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.518 -0.764 . . . . 0.23999999999999999 111.877 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 15.8 t80 -105.16 112.25 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.169 0.509 . . . . 0.40999999999999998 110.806 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.983 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -101.31 117.69 61.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.517 -0.765 . . . . 0.16 111.137 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.1 Cg_exo -63.84 145.03 90.08 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.882 2.388 . . . . 0.23000000000000001 111.637 170.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.684 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.2 tp -65.87 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.19 111.649 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.51 -22.87 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.045 0.45 . . . . 2.04 110.835 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 29.5 mm-40 -79.22 -29.78 42.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.914 -0.585 . . . . 0.85999999999999999 110.387 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.749 HG21 HG11 ' A' ' 93' ' ' VAL . 5.5 mt -48.03 125.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 113.386 0.884 . . . . 0.56000000000000005 113.386 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.53 155.35 20.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.298 -1.319 . . . . 0.39000000000000001 110.369 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.639 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 24.7 ttm180 -61.99 -13.72 28.36 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.003 -0.998 . . . . 3.0099999999999998 112.407 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 1.076 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 6.8 tp10 -60.79 -23.37 64.97 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.624 -0.673 . . . . 1.76 110.477 175.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CD2' HG23 ' A' ' 73' ' ' ILE . 10.2 m-30 -84.88 -46.16 11.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.553 -0.749 . . . . 1.3999999999999999 109.617 -175.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.639 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 3.5 p90 -103.64 94.71 6.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 107.895 -1.15 . . . . 0.46000000000000002 107.895 170.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -26.93 137.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 1 C-N-CA 125.67 4.246 . . . . 0.70999999999999996 115.468 -166.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . . . -50.36 -18.32 0.61 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.044 1.128 . . . . 0.93000000000000005 114.044 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -95.9 -7.23 37.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.785 0.326 . . . . 2.6200000000000001 111.406 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -71.34 141.36 50.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.481 -0.563 . . . . 1.3300000000000001 109.481 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.84 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 2.1800000000000002 111.072 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.08 99.76 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 1.74 110.949 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -118.67 91.65 3.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.329 -0.396 . . . . 3.9900000000000002 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.79 -101.08 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.754 -0.736 . . . . 1.0600000000000001 112.794 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -132.23 131.96 22.7 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 4.3700000000000001 110.742 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.4 ' O ' HD11 ' A' ' 70' ' ' LEU . 11.3 Cg_endo -60.54 145.59 98.49 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.42 2.08 . . . . 0.31 112.296 174.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.66 ' ND2' ' HB2' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -108.57 115.41 30.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 2.1400000000000001 109.925 173.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.684 ' HB ' HD13 ' A' ' 70' ' ' LEU . 15.9 tt -59.33 -35.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.882 0.697 . . . . 0.20999999999999999 112.882 -164.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.956 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 21.3 pttp -61.86 -21.84 65.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.095 0.406 . . . . 3.8199999999999998 112.095 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.66 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 12.3 m-20 -117.04 18.07 14.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 1.9099999999999999 110.177 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.749 HG11 HG21 ' A' ' 73' ' ' ILE . 45.0 t -123.51 -47.27 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.332 0.587 . . . . 0.33000000000000002 110.364 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.516 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 95.8 mt -108.34 163.41 13.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.953 -0.567 . . . . 0.29999999999999999 109.953 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 147.67 27.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.935 -0.765 . . . . 2.6699999999999999 108.935 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.646 ' HA ' HG22 ' A' ' 46' ' ' ILE . 49.1 mt-10 -59.85 113.27 2.19 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.465 0.478 . . . . 1.25 109.901 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.38 -0.16 26.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.632 -0.713 . . . . 0.40999999999999998 112.35 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 94' ' ' LEU . 6.8 tt0 -96.83 133.29 41.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.842 -0.429 . . . . 1.1799999999999999 109.842 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.56 156.99 28.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.134 0.492 . . . . 0.81000000000000005 111.439 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 102' ' ' VAL . 27.8 m -140.19 152.21 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.201 -0.908 . . . . 0.17999999999999999 109.85 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 41' ' ' ILE . 7.2 mm -96.99 110.06 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.544 -1.28 . . . . 0.51000000000000001 107.544 169.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 100' ' ' VAL . 2.4 m -140.98 123.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.537 . . . . 0.28000000000000003 111.954 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.75 HE21 HG12 ' A' ' 120' ' ' ILE . 10.3 pt20 -97.48 135.14 39.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.041 -1.096 . . . . 1.6200000000000001 108.041 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.547 ' CD1' HD23 ' A' ' 116' ' ' LEU . 20.4 mm -73.18 103.37 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 0.78000000000000003 110.772 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.64 -43.46 76.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.3 109.668 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 37.4 mttp -119.59 121.95 40.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.187 -0.915 . . . . 2.5699999999999998 108.629 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 52.3 mt-10 -82.93 159.33 22.31 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.267 -0.424 . . . . 2.5699999999999998 110.13 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 114' ' ' ALA . 31.1 mt-10 -62.68 91.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.468 0.651 . . . . 3.1400000000000001 109.601 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 3.6 ptp180 -129.83 41.12 3.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.85 -1.068 . . . . 3.4900000000000002 109.751 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.23 -82.04 1.58 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.234 -0.894 . . . . 1.74 113.84 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.1 -26.37 67.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.692 0.997 . . . . 2.8799999999999999 113.692 -168.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HG2' ' HD3' ' A' ' 106' ' ' LYS . 9.9 mptt -116.5 -37.18 3.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.172 0.51 . . . . 3.4500000000000002 110.028 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 74.89 -146.92 35.82 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.077 -0.965 . . . . 0.91000000000000003 110.814 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . . . -88.82 104.62 17.09 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.934 0.397 . . . . 0.52000000000000002 110.558 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -107.14 123.24 47.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.349 -0.387 . . . . 0.59999999999999998 111.09 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.983 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 17.4 mt -90.37 154.74 19.45 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.999 -0.741 . . . . 0.34999999999999998 108.999 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 103' ' ' GLN . 6.6 t -125.78 173.11 9.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.98999999999999999 110.131 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.1 p -129.34 17.95 5.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 1.22 110.84 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -77.96 46.34 0.58 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.121 0.962 . . . . 4.1100000000000003 108.708 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.75 HG12 HE21 ' A' ' 103' ' ' GLN . 4.3 mt -129.56 173.34 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.492 -1.231 . . . . 0.94999999999999996 109.52 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.494 ' H ' HG22 ' A' ' 120' ' ' ILE . 13.0 m -74.81 67.73 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 1.25 110.902 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 101' ' ' ILE . 11.4 mt -116.15 172.15 7.35 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.453 -0.573 . . . . 1.3799999999999999 109.453 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 1.076 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.426 0 O-C-N 123.921 0.763 . . . . 1.3700000000000001 111.002 176.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.514 0 N-CA-C 109.44 -0.578 . . . . 0.95999999999999996 109.44 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -49.02 118.75 2.79 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.557 0.536 . . . . 2.6200000000000001 110.202 178.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.714 HG12 HG22 ' A' ' 101' ' ' ILE . 5.0 tp -83.7 138.66 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.585 -0.524 . . . . 0.83999999999999997 109.585 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' A' ' 104' ' ' ILE . 87.1 m-85 -115.1 118.87 34.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.517 0.675 . . . . 1.02 110.7 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.438 ' HD3' HD12 ' A' ' 101' ' ' ILE . 8.5 mmmm -89.64 102.67 15.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.858 -1.065 . . . . 1.1599999999999999 109.671 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.25 163.78 26.32 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 110.555 -1.018 . . . . 0.27000000000000002 110.555 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.14 161.97 18.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 1.54 111.347 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -65.05 146.09 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.299 -1.319 . . . . 0.25 111.254 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 59' ' ' ASP . 76.2 p -128.94 -32.05 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.009 0.433 . . . . 0.39000000000000001 111.854 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.655 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 13.9 ttm180 -140.27 126.12 19.45 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.351 -0.386 . . . . 1.8500000000000001 110.668 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 46' ' ' ILE . 91.2 mt -133.8 120.36 36.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.652 -0.704 . . . . 0.26000000000000001 109.585 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 15.7 tp10 -111.94 111.21 53.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.896 -0.593 . . . . 2.2400000000000002 109.708 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 51.9 Cg_exo -54.0 -25.82 38.1 Favored 'Trans proline' 0 CA--C 1.521 -0.172 0 C-N-CA 123.361 2.707 . . . . 0.52000000000000002 112.068 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.7 m -73.82 -22.48 59.78 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.503 -0.771 . . . . 1.23 111.824 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.5 pp -123.78 7.48 8.76 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.598 0.962 . . . . 0.46000000000000002 113.598 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 4.6 pt-20 48.56 49.76 17.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.408 1.083 . . . . 2.5099999999999998 112.824 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.98 162.67 31.95 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.081 -0.648 . . . . 0.19 112.208 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -131.22 138.06 49.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.669 -0.696 . . . . 0.17999999999999999 112.167 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 65.7 m-85 -89.44 136.17 33.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.56000000000000005 109.818 171.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' A' ' 116' ' ' LEU . 2.2 t -112.74 139.49 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.26000000000000001 110.997 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.718 ' HB2' HG21 ' A' ' 47' ' ' THR . 17.9 t70 -103.14 102.3 12.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.79000000000000004 110.65 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -128.11 67.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.509 -0.552 . . . . 0.89000000000000001 109.509 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 46.09 42.16 11.9 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.089 -0.577 . . . . 0.82999999999999996 111.899 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.72 160.01 14.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.171 0.51 . . . . 0.85999999999999999 111.092 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -87.83 -45.38 10.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.626 0.726 . . . . 2.4300000000000002 109.173 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 48.7 mtt180 -125.71 94.15 4.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.85 -1.068 . . . . 4.5199999999999996 108.403 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 15.4 m170 -35.9 131.22 0.56 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.147 1.165 . . . . 0.88 114.147 -170.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.8 118.65 14.74 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.871 -1.059 . . . . 0.23999999999999999 111.498 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.2 t80 -104.79 97.73 7.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.138 0.494 . . . . 0.40999999999999998 111.282 -171.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.032 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -85.38 121.2 73.73 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.774 . . . . 0.16 111.365 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.59 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 19.6 Cg_exo -69.56 142.78 49.78 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.087 2.525 . . . . 0.23000000000000001 112.104 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.717 HD13 ' HB ' ' A' ' 90' ' ' ILE . 12.6 tp -60.8 -39.07 87.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.491 -0.777 . . . . 0.19 112.263 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -64.13 -13.34 47.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.644 0.259 . . . . 2.04 111.651 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 7.2 mm-40 -96.09 -13.07 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.756 0.312 . . . . 0.85999999999999999 110.413 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.501 HG23 ' CD2' ' A' ' 77' ' ' TYR . 8.0 mt -57.86 138.48 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.636 0.731 . . . . 0.56000000000000005 112.823 -171.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -102.25 153.53 19.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.836 -1.075 . . . . 0.39000000000000001 110.518 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.66 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 41.1 ttm180 -55.27 -14.68 1.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.522 -0.763 . . . . 3.0099999999999998 112.662 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . 0.993 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 24.3 tp10 -61.96 -19.71 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.487 -0.758 . . . . 1.76 110.759 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.501 ' CD2' HG23 ' A' ' 73' ' ' ILE . 7.9 m-30 -92.65 -44.61 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.797 -0.638 . . . . 1.3999999999999999 109.759 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 84' ' ' ALA . 5.7 p90 -98.68 95.94 3.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.277 -1.379 . . . . 0.46000000000000002 107.277 168.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.3 Cg_endo -38.51 139.98 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.577 3.518 . . . . 0.70999999999999996 113.797 -162.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.66 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -55.55 -11.93 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 0.93000000000000005 113.288 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -82.28 -21.11 36.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.235 0.54 . . . . 2.6200000000000001 109.97 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -78.2 146.14 35.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 1.3300000000000001 110.626 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -81.98 106.49 13.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.741 -0.663 . . . . 2.1800000000000002 111.566 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -91.81 136.48 33.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 1.74 109.848 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -96.42 -40.61 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.136 0.493 . . . . 3.9900000000000002 110.225 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.11 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.504 -0.771 . . . . 1.0600000000000001 111.265 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -97.04 128.39 35.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.033 0.444 . . . . 4.3700000000000001 110.804 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.86 165.49 13.99 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.272 2.648 . . . . 0.31 112.981 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -120.6 98.31 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.866 -0.606 . . . . 2.1400000000000001 109.951 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.717 ' HB ' HD13 ' A' ' 70' ' ' LEU . 21.2 tt -54.02 -39.7 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.497 0.925 . . . . 0.20999999999999999 113.497 -165.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.845 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 36.8 pttt -55.7 -21.78 20.13 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.009 0.744 . . . . 3.8199999999999998 113.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -125.96 18.69 7.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.932 0.872 . . . . 1.9099999999999999 110.44 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 36.7 t -111.32 -50.03 6.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.693 0.759 . . . . 0.33000000000000002 109.278 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.5 mt -103.04 150.86 23.16 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.206 -0.906 . . . . 0.29999999999999999 110.231 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 147.93 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.171 -0.922 . . . . 2.6699999999999999 109.098 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 1.5 mp0 -58.29 122.5 13.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.864 0.364 . . . . 1.25 110.161 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.49 -18.15 23.03 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.786 -0.721 . . . . 0.40999999999999998 111.701 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 94' ' ' LEU . 6.6 tt0 -83.11 121.01 26.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.748 -0.464 . . . . 1.1799999999999999 109.748 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.65 155.2 36.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.81000000000000005 111.487 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.581 HG23 HG22 ' A' ' 102' ' ' VAL . 35.3 m -131.91 149.95 33.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.884 -1.053 . . . . 0.17999999999999999 109.177 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 41' ' ' ILE . 1.4 mm -98.95 107.48 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.072 -1.455 . . . . 0.51000000000000001 107.072 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.581 HG22 HG23 ' A' ' 100' ' ' VAL . 4.4 m -145.54 135.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 0.28000000000000003 112.584 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . 0.535 ' O ' ' HB ' ' A' ' 117' ' ' THR . 18.4 pt20 -98.73 135.84 39.63 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.596 -0.891 . . . . 1.6200000000000001 108.596 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 106' ' ' LYS . 40.4 mm -80.95 99.57 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.256 0.55 . . . . 0.78000000000000003 109.71 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.32 -27.51 67.21 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 1.3 110.566 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 104' ' ' ILE . 55.0 mttp -113.63 -170.97 1.8 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 2.5699999999999998 111.411 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 50.4 mm-40 -129.6 145.79 51.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.294 -0.412 . . . . 2.5699999999999998 110.332 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.614 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 43.2 mt-10 -64.15 101.86 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.401 0.62 . . . . 3.1400000000000001 109.668 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 10.9 ptm180 -116.43 -61.63 1.7 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.237 -0.892 . . . . 3.4900000000000002 111.549 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -175.15 -63.9 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.466 -0.873 . . . . 1.74 112.519 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.88 -46.92 85.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.089 0.403 . . . . 2.8799999999999999 112.089 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.583 ' HD2' ' HB2' ' A' ' 115' ' ' ALA . 21.4 ttmm -116.19 -37.18 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.363 -0.535 . . . . 3.4500000000000002 110.436 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 80.6 -122.47 5.73 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.652 -0.979 . . . . 0.91000000000000003 110.652 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.531 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.29 127.5 33.7 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.99 -0.374 . . . . 0.52000000000000002 109.99 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.583 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . . . -118.4 126.99 53.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.729 0.3 . . . . 0.59999999999999998 110.88 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.032 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 14.6 mt -91.08 129.06 37.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.065 -0.516 . . . . 0.34999999999999998 110.177 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -90.26 146.82 23.94 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.98999999999999999 109.642 174.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.646 HG23 HD21 ' A' ' 68' ' ' LEU . 3.5 p -113.96 4.02 15.6 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.34 0.496 . . . . 1.22 112.34 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.481 ' H ' HG23 ' A' ' 117' ' ' THR . 98.8 m-85 -78.34 57.36 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.695 0.76 . . . . 4.1100000000000003 110.451 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.533 HG22 ' N ' ' A' ' 121' ' ' SER . 2.9 mp -127.99 176.08 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.645 -1.242 . . . . 0.94999999999999996 107.645 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.0 t -69.4 69.62 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.296 0.569 . . . . 1.25 110.458 176.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 101' ' ' ILE . 12.0 mt -115.13 172.22 7.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.676 -0.861 . . . . 1.3799999999999999 108.676 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.993 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . . . . . . 0 C--N 1.326 -0.447 0 O-C-N 123.683 0.615 . . . . 1.3700000000000001 110.609 175.75 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.546 0 N-CA-C 107.657 -1.238 . . . . 0.95999999999999996 107.657 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -47.62 116.97 1.63 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.853 0.721 . . . . 2.6200000000000001 111.218 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 101' ' ' ILE . 6.6 tp -84.65 139.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.107 -0.951 . . . . 0.83999999999999997 110.128 -174.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -122.68 149.71 43.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.792 0.329 . . . . 1.02 110.275 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 34.5 ttmt -115.78 94.08 4.53 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.984 -0.747 . . . . 1.1599999999999999 108.984 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.17 166.69 13.15 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.271 -0.877 . . . . 0.27000000000000002 111.073 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 1.6 mppt? -104.83 158.2 16.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.065 0.459 . . . . 1.54 111.087 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.886 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -73.52 137.19 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.075 -0.966 . . . . 0.25 109.628 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.483 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.7 p -124.33 -11.28 7.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.799 0.333 . . . . 0.39000000000000001 111.471 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ARG . . . . . 0.641 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 24.6 ttt85 -160.26 122.18 3.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.212 -0.449 . . . . 1.8500000000000001 110.462 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 46' ' ' ILE . 47.5 mt -134.89 113.46 16.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.624 -0.509 . . . . 0.26000000000000001 109.624 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 31.6 mt-10 -118.01 122.54 30.37 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 121.505 0.669 . . . . 2.2400000000000002 111.475 -176.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' PRO . . . . . 0.832 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 31.9 Cg_exo -60.65 -27.41 84.79 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.112 2.541 . . . . 0.52000000000000002 111.827 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.5 m -75.11 -21.43 58.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 1.23 111.685 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 50' ' ' GLU . 2.0 pp -118.38 8.85 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.964 -0.694 . . . . 0.46000000000000002 112.792 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 43.52 48.36 6.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.493 0.717 . . . . 2.5099999999999998 111.917 169.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.27 171.15 12.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.474 -0.784 . . . . 0.19 110.974 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ALA . . . . . 0.422 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -135.56 139.48 43.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.17999999999999999 111.539 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.641 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.9 m-85 -91.64 136.0 33.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.56000000000000005 109.633 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HB ' HD11 ' A' ' 116' ' ' LEU . 12.6 t -118.9 134.44 62.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.158 -0.682 . . . . 0.26000000000000001 109.158 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 47' ' ' THR . 36.7 t70 -109.48 111.28 22.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.187 -0.46 . . . . 0.79000000000000004 112.027 -173.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -126.81 66.75 1.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.219 -1.03 . . . . 0.89000000000000001 108.219 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.33 33.46 46.41 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.81 -0.71 . . . . 0.82999999999999996 112.46 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 65' ' ' HIS . . . -93.79 147.72 22.79 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.645 -0.326 . . . . 0.85999999999999999 110.777 -175.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.93 -51.29 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 2.4300000000000002 111.272 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 8.8 mmt180 -94.36 -11.11 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.478 -0.489 . . . . 4.5199999999999996 109.796 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 10.3 m170 76.49 145.07 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.423 1.077 . . . . 0.88 110.854 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 102.14 1.08 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.666 -0.974 . . . . 0.23999999999999999 110.666 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 2.9 t80 -88.98 104.25 16.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.842 0.353 . . . . 0.40999999999999998 110.541 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 1.133 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.72 113.35 60.15 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.16 110.307 178.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HD2' HD23 ' A' ' 68' ' ' LEU . 24.5 Cg_exo -65.27 141.72 69.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.787 2.325 . . . . 0.23000000000000001 111.607 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.625 HD13 ' HB ' ' A' ' 90' ' ' ILE . 17.8 tp -57.91 -33.46 68.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.19 111.819 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.59 -10.92 20.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 2.04 111.482 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -97.44 -23.92 15.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.12 -0.491 . . . . 0.85999999999999999 110.856 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 93' ' ' VAL . 6.1 mt -48.38 131.04 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 113.466 0.913 . . . . 0.56000000000000005 113.466 -166.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -100.22 156.67 17.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.64 -1.164 . . . . 0.39000000000000001 110.763 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.818 ' HG2' ' HA ' ' A' ' 80' ' ' ALA . 32.0 ttp180 -65.16 -12.7 53.9 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.55 0.944 . . . . 3.0099999999999998 113.55 -172.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.67 -25.76 68.36 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.795 -1.191 . . . . 1.76 110.208 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -75.84 -51.74 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.901 -0.59 . . . . 1.3999999999999999 110.291 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.528 ' HB3' HG13 ' A' ' 93' ' ' VAL . 1.1 p90 -100.37 109.46 57.0 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.584 -1.265 . . . . 0.46000000000000002 107.584 169.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.43 133.6 0.33 Allowed 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 124.616 3.544 . . . . 0.70999999999999996 113.646 -162.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -57.03 -16.44 7.15 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.563 -1.199 . . . . 0.93000000000000005 113.361 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -90.99 -0.89 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 2.6200000000000001 111.251 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -81.77 143.81 31.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 1.3300000000000001 109.976 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -71.09 100.9 2.12 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.397 -0.365 . . . . 2.1800000000000002 110.287 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.95 95.34 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.74 110.374 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -76.9 61.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.715 -0.675 . . . . 3.9900000000000002 110.928 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.47 -128.44 8.99 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.859 -0.686 . . . . 1.0600000000000001 111.631 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.85 135.41 45.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.809 0.338 . . . . 4.3700000000000001 110.32 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PRO . . . . . 0.454 ' O ' HD11 ' A' ' 70' ' ' LEU . 9.2 Cg_endo -58.41 154.7 39.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.916 2.411 . . . . 0.31 113.161 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . 0.658 ' ND2' ' HB3' ' A' ' 92' ' ' ASP . 0.3 OUTLIER -119.41 111.42 18.13 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.248 -0.887 . . . . 2.1400000000000001 109.617 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ILE . . . . . 0.625 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.2 tt -62.13 -38.87 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.724 0.638 . . . . 0.20999999999999999 112.724 -163.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LYS . . . . . 0.832 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 7.8 ptmm? -60.07 -21.37 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.212 -0.449 . . . . 3.8199999999999998 111.853 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASP . . . . . 0.658 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 34.6 t70 -119.62 12.01 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.817 0.818 . . . . 1.9099999999999999 110.343 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 73' ' ' ILE . 13.7 t -119.96 -50.57 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.33000000000000002 110.314 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -100.41 152.13 20.72 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.677 -0.692 . . . . 0.29999999999999999 110.25 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 151.8 44.21 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.361 -0.836 . . . . 2.6699999999999999 110.319 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 46' ' ' ILE . 18.1 mt-10 -65.13 126.07 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.029 -0.987 . . . . 1.25 110.456 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.05 54.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.773 -0.727 . . . . 0.40999999999999998 112.055 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.9 tt0 -87.95 135.96 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.951 -0.389 . . . . 1.1799999999999999 109.951 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.92 157.22 20.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.81000000000000005 111.37 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.553 HG23 HG22 ' A' ' 102' ' ' VAL . 35.5 m -136.75 151.79 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.189 -0.914 . . . . 0.17999999999999999 109.879 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.983 ' HB ' HD11 ' A' ' 122' ' ' LEU . 10.0 mm -97.03 110.45 25.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.004 -1.11 . . . . 0.51000000000000001 108.004 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' VAL . . . . . 0.553 HG22 HG23 ' A' ' 100' ' ' VAL . 4.3 m -146.76 139.05 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.233 0.539 . . . . 0.28000000000000003 111.974 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -112.84 142.73 45.16 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.433 -0.951 . . . . 1.6200000000000001 108.433 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ILE . . . . . 0.539 HD13 HD23 ' A' ' 116' ' ' LEU . 22.4 mm -71.89 102.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.76 0.79 . . . . 0.78000000000000003 110.771 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 35.0 t70 -83.76 -35.28 24.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.714 -1.13 . . . . 1.3 109.777 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 115' ' ' ALA . 12.7 ttpp -112.03 137.99 49.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.605 -0.725 . . . . 2.5699999999999998 109.775 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' GLU . . . . . 0.444 ' HB3' HH21 ' A' ' 109' ' ' ARG . 1.8 tm-20 -87.2 133.79 33.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.26 -0.882 . . . . 2.5699999999999998 110.914 -163.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HG3' ' HG2' ' A' ' 64' ' ' ARG . 42.6 tt0 -66.31 119.73 12.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 3.1400000000000001 110.208 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.585 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 6.6 ptp180 -139.72 -68.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.415 -0.811 . . . . 3.4900000000000002 111.115 -171.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -168.71 -66.99 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.553 -1.308 . . . . 1.74 113.722 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ASN . . . . . 0.474 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 25.6 t-20 -61.88 -50.91 70.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.958 0.379 . . . . 2.8799999999999999 111.55 -172.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 98.6 mttt -122.92 -37.49 2.73 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.68 -0.408 . . . . 3.4500000000000002 110.682 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLY . . . . . 0.585 ' HA2' ' HG2' ' A' ' 109' ' ' ARG . . . 63.79 -124.47 30.89 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.67 -0.695 . . . . 0.91000000000000003 113.937 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.56 110.66 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.249 0.617 . . . . 0.52000000000000002 111.696 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . -122.25 135.83 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.07 -0.514 . . . . 0.59999999999999998 110.566 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 1.133 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 43.2 mt -91.41 153.01 20.16 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.775 -0.648 . . . . 0.34999999999999998 109.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 8.2 t -116.69 171.47 7.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.241 -0.436 . . . . 0.98999999999999999 110.292 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 120' ' ' ILE . 26.1 p -138.27 20.93 2.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.78 0.659 . . . . 1.22 112.78 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' PHE . . . . . 0.411 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 3.2 p90 -78.45 42.42 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.499 1.142 . . . . 4.1100000000000003 109.385 170.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 121' ' ' SER . 4.4 mt -118.36 172.35 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 113.884 -1.507 . . . . 0.94999999999999996 108.015 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' SER . . . . . 0.514 ' H ' HG22 ' A' ' 120' ' ' ILE . 7.5 t -80.04 48.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.858 0.361 . . . . 1.25 111.93 -172.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LEU . . . . . 0.983 HD11 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -117.38 126.33 52.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.738 -0.21 . . . . 1.3799999999999999 111.257 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . . . . . . 0 N--CA 1.469 0.508 0 O-C-N 124.722 1.264 . . . . 1.3700000000000001 109.779 166.368 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.791 0 N-CA-C 111.793 -0.523 . . . . 9.9100000000000001 111.793 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.0 m -80.29 68.89 6.6 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.13 0.491 . . . . 7.6600000000000001 110.938 -178.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 14.3 t-160 -154.54 68.35 0.72 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.15 -0.477 . . . . 8.75 109.929 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 52.6 ttm -104.37 91.88 4.09 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.922 -0.581 . . . . 7.04 110.051 178.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 92.5 mt 61.81 -105.16 0.18 Allowed 'General case' 0 CA--C 1.534 0.336 0 CA-C-N 115.676 -0.693 . . . . 4.54 110.959 -177.588 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.428 ' HG3' ' O ' ' A' ' 38' ' ' LYS . 0.0 OUTLIER -173.16 -174.4 1.04 Allowed 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.835 -0.802 . . . . 4.0700000000000003 108.835 178.556 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 5.9 tp-100 -115.74 82.36 1.75 Allowed 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.671 -0.412 . . . . 4.3600000000000003 110.859 -179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 41.0 mmtm 58.96 20.78 8.51 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 123.651 0.594 . . . . 4.8499999999999996 112.385 173.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.505 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 41.3 pttt -131.66 -168.81 2.08 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.186 -0.461 . . . . 2.02 111.22 -175.866 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.505 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -63.37 159.8 17.41 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 108.56 -0.904 . . . . 0.95999999999999996 108.56 169.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 18.6 m120 -61.61 114.45 3.28 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 120.255 -0.578 . . . . 2.6200000000000001 110.82 -179.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.582 HD12 ' HB3' ' A' ' 103' ' ' GLN . 8.7 tp -81.27 146.12 7.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 CA-C-N 115.385 -0.825 . . . . 0.83999999999999997 109.421 179.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 57.0 m-85 -123.55 152.76 41.48 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.7 0.286 . . . . 1.02 110.296 -176.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.516 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 58.4 tttm -134.11 96.58 3.66 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-O 121.206 0.527 . . . . 1.1599999999999999 109.716 179.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.457 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -140.46 175.67 21.87 Favored Glycine 0 N--CA 1.448 -0.527 0 N-CA-C 110.952 -0.859 . . . . 0.27000000000000002 110.952 -176.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.552 ' HA ' ' HA ' ' A' ' 99' ' ' GLU . 0.0 OUTLIER -100.34 159.47 15.11 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-O 121.648 0.737 . . . . 1.54 112.054 -175.362 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.986 HG21 HD11 ' A' ' 49' ' ' ILE . 1.6 mp -67.64 138.47 22.64 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.903 0 CA-C-N 114.363 -1.29 . . . . 0.25 109.386 171.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.614 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.2 p -130.69 -7.17 4.07 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.763 0.316 . . . . 0.39000000000000001 111.725 179.835 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.627 ' HD3' ' HD2' ' A' ' 57' ' ' PHE . 29.9 ttt85 -158.43 123.02 4.17 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 116.326 -0.397 . . . . 1.8500000000000001 110.282 -179.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.986 HD11 HG21 ' A' ' 46' ' ' ILE . 56.6 mt -136.76 109.04 7.31 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.87 0 CA-C-O 121.096 0.474 . . . . 0.26000000000000001 109.877 177.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -104.32 113.2 65.38 Favored Pre-proline 0 C--N 1.314 -0.938 0 CA-C-N 115.838 -0.619 . . . . 2.2400000000000002 110.796 -179.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -59.84 -19.56 55.06 Favored 'Trans proline' 0 C--N 1.341 0.178 0 C-N-CA 123.012 2.475 . . . . 0.52000000000000002 111.274 176.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 9.4 m -73.1 -26.01 61.09 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.208 -0.905 . . . . 1.23 111.321 179.217 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.485 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.5 pp -119.71 -8.91 9.85 Favored 'General case' 0 CA--C 1.536 0.423 0 N-CA-C 113.212 0.819 . . . . 0.46000000000000002 113.212 -179.641 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 59.43 57.18 3.43 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 122.784 0.433 . . . . 2.5099999999999998 111.451 176.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.609 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -168.09 162.58 13.16 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 116.322 -0.399 . . . . 0.19 110.53 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -129.22 142.0 50.98 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.035 -0.529 . . . . 0.17999999999999999 111.956 -173.207 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.627 ' HD2' ' HD3' ' A' ' 48' ' ' ARG . 40.1 m-85 -94.3 142.07 27.83 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.691 -0.686 . . . . 0.56000000000000005 109.551 170.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.466 HG12 ' HD1' ' A' ' 60' ' ' TYR . 56.1 t -120.37 133.38 67.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 115.775 -0.648 . . . . 0.26000000000000001 109.947 -178.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.614 ' CB ' HG21 ' A' ' 47' ' ' THR . 35.4 t70 -103.69 99.67 9.47 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.899 -0.591 . . . . 0.79000000000000004 110.716 -177.64 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.466 ' HD1' HG12 ' A' ' 58' ' ' VAL . 20.4 p90 -126.8 66.59 1.26 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.703 -0.68 . . . . 0.89000000000000001 109.337 175.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.1 21.95 26.82 Favored Glycine 0 CA--C 1.524 0.644 0 C-N-CA 120.733 -0.746 . . . . 0.82999999999999996 112.436 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -97.42 118.42 33.86 Favored 'General case' 0 C--N 1.331 -0.211 0 O-C-N 122.817 -0.225 . . . . 0.85999999999999999 110.53 -176.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -73.99 -3.67 30.64 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.269 0.557 . . . . 2.4300000000000002 111.453 -174.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.468 ' HD3' ' HG3' ' A' ' 108' ' ' GLU . 0.8 OUTLIER -117.11 -13.25 10.54 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.777 -0.647 . . . . 4.5199999999999996 110.189 178.146 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 11.1 m170 63.84 141.5 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.464 0 CA-C-N 115.039 -0.982 . . . . 0.88 111.879 -172.575 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.535 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -83.12 126.43 7.48 Favored Glycine 0 N--CA 1.445 -0.762 0 C-N-CA 120.602 -0.808 . . . . 0.23999999999999999 111.193 177.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.609 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 29.0 t80 -107.18 111.47 23.9 Favored 'General case' 0 C--N 1.312 -1.051 0 CA-C-O 121.381 0.61 . . . . 0.40999999999999998 110.933 -175.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.884 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -106.8 111.56 63.78 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.128 -0.942 . . . . 0.16 110.838 -179.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.501 ' HA ' ' HB2' ' A' ' 55' ' ' ALA . 16.4 Cg_exo -69.23 145.03 58.91 Favored 'Trans proline' 0 N--CA 1.474 0.334 0 C-N-CA 123.155 2.57 . . . . 0.23000000000000001 111.981 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.612 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.4 tp -57.06 -39.69 75.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 114.804 -1.089 . . . . 0.19 113.102 -176.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.755 ' HA ' ' HD2' ' A' ' 87' ' ' ARG . 19.9 pttp -67.54 -9.73 45.2 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 120.571 -0.451 . . . . 2.04 111.174 -175.47 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.403 ' HG3' ' HD2' ' A' ' 69' ' ' PRO . 3.5 mm-40 -92.84 -21.98 19.56 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.999 -0.371 . . . . 0.85999999999999999 109.999 178.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.603 HG21 HG11 ' A' ' 93' ' ' VAL . 8.0 mt -48.76 134.75 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 113.838 1.051 . . . . 0.56000000000000005 113.838 -168.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -93.76 156.32 16.74 Favored 'General case' 0 N--CA 1.456 -0.163 0 CA-C-N 114.717 -1.128 . . . . 0.39000000000000001 110.898 178.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.747 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 12.6 tpt180 -56.84 -16.86 7.45 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.153 -0.93 . . . . 3.0099999999999998 112.127 178.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.07 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 1.8 tp10 -65.06 -24.57 67.5 Favored 'General case' 0 N--CA 1.463 0.188 0 O-C-N 121.86 -0.525 . . . . 1.76 111.001 177.263 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.542 ' HA ' ' OE1' ' A' ' 98' ' ' GLN . 10.1 m-30 -82.37 -50.73 8.59 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.459 0.647 . . . . 1.3999999999999999 110.141 -173.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.558 ' HB3' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -97.77 101.11 9.73 Favored Pre-proline 0 C--N 1.318 -0.793 0 N-CA-C 107.044 -1.465 . . . . 0.46000000000000002 107.044 169.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.406 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.9 Cg_endo -39.13 141.76 0.38 Allowed 'Trans proline' 0 CA--C 1.514 -0.501 0 C-N-CA 124.85 3.7 . . . . 0.70999999999999996 114.062 -161.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -52.71 -13.86 0.46 Allowed 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 114.779 -1.1 . . . . 0.93000000000000005 112.921 176.859 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -86.27 -11.05 53.33 Favored 'General case' 0 N--CA 1.467 0.385 0 CA-C-O 121.3 0.571 . . . . 2.6200000000000001 110.524 176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 44.3 t80 -90.66 139.56 30.6 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.682 -0.69 . . . . 1.3300000000000001 109.616 -178.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.3 m -65.62 125.56 25.61 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.812 0.339 . . . . 2.1800000000000002 111.161 -178.161 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.433 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -130.01 114.68 16.11 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.162 -0.472 . . . . 1.74 110.986 -178.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -139.62 77.25 1.6 Allowed 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 116.286 -0.415 . . . . 3.9900000000000002 110.536 179.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 128.0 -113.58 1.68 Allowed Glycine 0 N--CA 1.446 -0.641 0 C-N-CA 120.691 -0.766 . . . . 1.0600000000000001 112.498 178.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.853 ' HD3' ' HD2' ' A' ' 88' ' ' PRO . 13.5 tpp180 -121.63 121.61 28.24 Favored Pre-proline 0 C--N 1.323 -0.578 0 CA-C-O 120.63 0.252 . . . . 4.3700000000000001 110.417 -178.012 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.853 ' HD2' ' HD3' ' A' ' 87' ' ' ARG . 9.9 Cg_endo -59.84 166.23 8.81 Favored 'Trans proline' 0 CA--C 1.537 0.669 0 C-N-CA 122.999 2.466 . . . . 0.31 112.733 177.958 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -118.29 107.24 13.65 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-O 120.923 0.392 . . . . 2.1400000000000001 110.445 175.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.612 ' HB ' HD13 ' A' ' 70' ' ' LEU . 20.2 tt -56.84 -37.69 55.1 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.591 0 N-CA-C 113.115 0.783 . . . . 0.20999999999999999 113.115 -165.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.402 ' HG2' ' H ' ' A' ' 91' ' ' LYS . 5.4 pttt -56.1 -24.74 42.27 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 112.879 0.696 . . . . 3.8199999999999998 112.879 178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -125.29 20.92 8.05 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 121.845 0.831 . . . . 1.9099999999999999 110.173 177.538 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.603 HG11 HG21 ' A' ' 73' ' ' ILE . 14.2 t -117.09 -48.67 4.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.605 -0.725 . . . . 0.33000000000000002 109.893 179.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.411 ' HB3' HG12 ' A' ' 46' ' ' ILE . 42.6 mt -103.15 151.35 22.69 Favored 'General case' 0 N--CA 1.441 -0.886 0 CA-C-N 115.731 -0.668 . . . . 0.29999999999999999 109.833 176.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.81 138.84 24.63 Favored 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.603 -0.726 . . . . 2.6699999999999999 109.643 176.104 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.682 ' HA ' HG22 ' A' ' 46' ' ' ILE . 13.1 mt-10 -54.15 121.37 8.01 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.538 -0.755 . . . . 1.25 110.773 -179.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 111.2 -8.02 28.91 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.632 -0.713 . . . . 0.40999999999999998 111.791 -173.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.542 ' OE1' ' HA ' ' A' ' 77' ' ' TYR . 9.1 tt0 -90.49 129.02 36.7 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 109.876 -0.416 . . . . 1.1799999999999999 109.876 173.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.552 ' HA ' ' HA ' ' A' ' 45' ' ' LYS . 13.8 pt-20 -84.95 157.03 20.93 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 120.981 0.419 . . . . 0.81000000000000005 111.025 -179.688 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 102' ' ' VAL . 32.8 m -139.33 155.93 26.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-N 115.539 -0.755 . . . . 0.17999999999999999 110.416 176.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.548 ' O ' HD13 ' A' ' 120' ' ' ILE . 4.0 mm -102.66 110.38 29.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.038 -1.097 . . . . 0.51000000000000001 108.038 172.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -147.3 147.55 17.41 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 112.104 0.409 . . . . 0.28000000000000003 112.104 -170.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.582 ' HB3' HD12 ' A' ' 41' ' ' ILE . 13.4 pt20 -128.07 158.72 37.18 Favored 'General case' 0 C--N 1.317 -0.845 0 N-CA-C 108.72 -0.844 . . . . 1.6200000000000001 108.72 173.667 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.494 HD13 HD23 ' A' ' 116' ' ' LEU . 25.5 mm -83.94 109.66 17.67 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 CA-C-O 121.441 0.639 . . . . 0.78000000000000003 111.638 -174.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.671 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 13.5 t70 -85.4 -40.84 16.0 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.687 -1.142 . . . . 1.3 109.47 179.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.646 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 2.3 mptp? -111.52 126.09 54.6 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.552 -0.749 . . . . 2.5699999999999998 109.239 176.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -85.67 158.38 20.08 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-N 116.012 -0.54 . . . . 2.5699999999999998 110.889 -170.835 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.531 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 0.0 OUTLIER -66.97 131.07 45.11 Favored 'General case' 0 N--CA 1.439 -0.984 0 CA-C-O 121.657 0.742 . . . . 3.1400000000000001 110.14 177.281 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 1.9 ptp180 -144.1 12.13 1.59 Allowed 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 114.627 -1.169 . . . . 3.4900000000000002 108.833 -177.146 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.27 0.71 84.72 Favored Glycine 0 N--CA 1.445 -0.722 0 CA-C-N 114.974 -1.012 . . . . 1.74 112.499 178.331 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -130.5 -31.04 1.84 Allowed 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 112.76 0.652 . . . . 2.8799999999999999 112.76 -173.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 16.5 tppt? -120.25 -38.8 2.86 Favored 'General case' 0 CA--C 1.504 -0.799 0 C-N-CA 120.102 -0.639 . . . . 3.4500000000000002 110.008 -172.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.531 ' HA2' ' HG2' ' A' ' 108' ' ' GLU . . . 99.48 -159.14 19.85 Favored Glycine 0 N--CA 1.429 -1.809 0 C-N-CA 120.122 -1.037 . . . . 0.91000000000000003 111.674 169.418 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.535 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.94 90.14 7.35 Favored 'General case' 0 C--N 1.308 -1.237 0 N-CA-C 108.713 -0.847 . . . . 0.52000000000000002 108.713 173.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.646 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -85.66 126.02 33.61 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.038 0.447 . . . . 0.59999999999999998 111.695 -174.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.884 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 50.6 mt -90.27 135.42 33.69 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.746 -0.661 . . . . 0.34999999999999998 110.428 -176.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.671 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 13.1 t -95.31 172.43 8.11 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.925 -0.58 . . . . 0.98999999999999999 109.801 175.863 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.568 HG23 HD21 ' A' ' 68' ' ' LEU . 4.9 p -126.76 18.61 7.31 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.433 0.635 . . . . 1.22 110.191 173.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 20.1 t80 -81.07 46.93 0.95 Allowed 'General case' 0 CA--C 1.534 0.339 0 CA-C-O 121.962 0.887 . . . . 4.1100000000000003 109.304 176.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.572 HG12 HD11 ' A' ' 41' ' ' ILE . 1.8 mp -127.44 170.03 17.93 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 114.808 -1.087 . . . . 0.94999999999999996 108.898 -176.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.471 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.2 m -72.41 72.4 0.96 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.378 0.609 . . . . 1.25 110.92 177.693 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.526 HD11 ' O ' ' A' ' 101' ' ' ILE . 26.3 mt -116.17 171.77 7.6 Favored 'General case' 0 N--CA 1.429 -1.477 0 N-CA-C 108.886 -0.783 . . . . 1.3799999999999999 108.886 178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.07 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 72.29 80.43 0.15 Allowed 'General case' 0 C--N 1.325 -0.459 0 O-C-N 124.012 0.82 . . . . 1.3700000000000001 109.854 -179.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.62 49.36 3.06 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.552 -0.749 . . . . 2.7999999999999998 113.039 -177.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 7.1 p . . . . . 0 C--O 1.248 0.986 0 CA-C-O 118.719 -0.658 . . . . 5.1100000000000003 109.493 176.836 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.553 0 N-CA-C 112.327 -0.309 . . . . 9.9100000000000001 112.327 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 33' ' ' MET . 37.2 p -127.26 4.42 6.35 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 111.933 0.346 . . . . 7.6600000000000001 111.933 -173.962 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.411 ' HB2' ' O ' ' A' ' 31' ' ' SER . 21.6 m-70 69.85 -17.7 0.24 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 122.996 0.518 . . . . 8.75 111.608 -176.747 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.455 ' H ' ' C ' ' A' ' 31' ' ' SER . 86.3 mtp -77.09 -25.29 52.1 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-O 121.298 0.57 . . . . 7.04 110.128 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 81.6 mt -101.8 -48.31 4.32 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.183 -0.917 . . . . 4.54 110.344 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.502 ' CB ' ' HG2' ' A' ' 38' ' ' LYS . 51.4 mp0 -78.23 -43.21 28.93 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.095 -0.957 . . . . 4.0700000000000003 112.235 -177.551 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 53.3 tp60 69.65 -58.0 0.53 Allowed 'General case' 0 CA--C 1.532 0.263 0 O-C-N 123.766 0.666 . . . . 4.3600000000000003 110.298 -172.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 37.8 mmtm -142.89 -17.92 0.67 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.016 -0.538 . . . . 4.8499999999999996 110.802 175.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.502 ' HG2' ' CB ' ' A' ' 35' ' ' GLU . 10.8 ptmt -76.59 179.96 5.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.255 0.55 . . . . 2.02 111.728 -171.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -84.06 156.84 22.01 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.637 -0.875 . . . . 0.95999999999999996 108.637 171.602 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.5 HD22 ' C ' ' A' ' 40' ' ' ASN . 0.2 OUTLIER -50.66 109.52 0.32 Allowed 'General case' 0 C--N 1.325 -0.458 0 O-C-N 123.577 0.548 . . . . 2.6200000000000001 110.19 -178.932 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 7.5 tp -78.22 143.8 12.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.494 -0.775 . . . . 0.83999999999999997 109.961 -178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 64.6 m-85 -123.79 144.99 49.36 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 110.079 -0.341 . . . . 1.02 110.079 -178.551 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.404 ' HE3' ' HB2' ' A' ' 99' ' ' GLU . 1.0 OUTLIER -117.65 105.72 12.33 Favored 'General case' 0 C--N 1.316 -0.868 0 N-CA-C 107.631 -1.248 . . . . 1.1599999999999999 107.631 173.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -143.89 179.48 21.23 Favored Glycine 0 N--CA 1.445 -0.747 0 C-N-CA 120.69 -0.767 . . . . 0.27000000000000002 111.561 -174.49 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HD3' ' HA2' ' A' ' 97' ' ' GLY . 94.3 mttt -109.45 162.73 14.08 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.557 0.694 . . . . 1.54 111.917 -176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.751 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -72.44 136.75 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.111 0 CA-C-N 114.563 -1.199 . . . . 0.25 108.893 170.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.707 HG21 ' CB ' ' A' ' 59' ' ' ASP . 73.2 p -127.1 -17.64 4.77 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-O 121.05 0.452 . . . . 0.39000000000000001 111.782 -177.121 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.532 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 39.7 ttt180 -154.66 121.72 5.58 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 109.192 -0.67 . . . . 1.8500000000000001 109.192 177.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.751 ' CD1' HG21 ' A' ' 46' ' ' ILE . 96.7 mt -125.47 102.4 10.22 Favored 'Isoleucine or valine' 0 C--N 1.313 -1.0 0 N-CA-C 109.245 -0.65 . . . . 0.26000000000000001 109.245 176.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.43 ' HB3' HD11 ' A' ' 53' ' ' LEU . 12.8 tp10 -99.17 108.0 47.4 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 115.005 -0.998 . . . . 2.2400000000000002 109.933 -176.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.814 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 45.0 Cg_exo -57.12 -29.8 84.64 Favored 'Trans proline' 0 N--CA 1.465 -0.183 0 C-N-CA 122.96 2.44 . . . . 0.52000000000000002 112.093 179.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 15.0 m -59.9 -29.76 68.57 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.81 -0.632 . . . . 1.23 111.247 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.669 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.2 pp -122.56 11.28 9.85 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 111.937 0.347 . . . . 0.46000000000000002 111.937 -176.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 39.87 58.01 2.18 Favored 'General case' 0 C--N 1.346 0.441 0 C-N-CA 123.656 0.782 . . . . 2.5099999999999998 112.034 173.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.568 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -162.99 160.75 25.03 Favored 'General case' 0 N--CA 1.444 -0.741 0 CA-C-N 115.387 -0.824 . . . . 0.19 110.846 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.524 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -120.59 140.79 51.01 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.98 -0.554 . . . . 0.17999999999999999 112.285 -175.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.532 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.8 m-85 -95.17 130.79 41.76 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.109 -0.95 . . . . 0.56000000000000005 110.106 174.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . . . . . . . . . 40.0 t -110.16 132.46 58.41 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.208 -0.451 . . . . 0.26000000000000001 109.789 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.707 ' CB ' HG21 ' A' ' 47' ' ' THR . 13.8 t70 -100.81 103.32 14.53 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.95 0.405 . . . . 0.79000000000000004 111.223 -176.649 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.5 p90 -126.17 66.71 1.21 Allowed 'General case' 0 C--N 1.319 -0.724 0 N-CA-C 108.688 -0.856 . . . . 0.89000000000000001 108.688 172.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.04 31.71 56.14 Favored Glycine 0 CA--C 1.523 0.578 0 C-N-CA 120.823 -0.703 . . . . 0.82999999999999996 112.427 -175.373 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -112.74 137.89 50.37 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.588 0.232 . . . . 0.85999999999999999 110.625 -174.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -80.23 -44.24 20.05 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.252 -0.431 . . . . 2.4300000000000002 111.312 -179.677 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 36.8 mmt180 -78.09 -16.55 57.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.778 -0.369 . . . . 4.5199999999999996 110.242 178.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . . . . . . . . . 8.8 m170 68.59 146.77 0.05 Allowed 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 115.044 -0.98 . . . . 0.88 111.501 -177.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -73.9 106.07 1.94 Allowed Glycine 0 N--CA 1.443 -0.834 0 N-CA-C 110.426 -1.07 . . . . 0.23999999999999999 110.426 175.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.669 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 2.7 t80 -96.19 106.3 18.48 Favored 'General case' 0 C--N 1.312 -1.061 0 CA-C-O 121.097 0.475 . . . . 0.40999999999999998 110.709 -172.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.817 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -97.49 118.5 64.26 Favored Pre-proline 0 C--N 1.322 -0.592 0 CA-C-N 115.801 -0.636 . . . . 0.16 109.826 177.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.7 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 6.7 Cg_exo -69.91 141.04 43.57 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.128 1.885 . . . . 0.23000000000000001 111.344 175.252 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.814 ' HA ' HG13 ' A' ' 73' ' ' ILE . 9.3 tp -57.39 -32.85 67.23 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.484 -0.78 . . . . 0.19 111.184 179.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.7 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.9 ptmm? -59.76 -20.89 59.49 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.678 -0.692 . . . . 2.04 111.624 -179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -96.58 -11.91 24.72 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.315 -0.402 . . . . 0.85999999999999999 110.738 -177.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.814 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.6 mt -49.88 127.37 5.42 Favored 'Isoleucine or valine' 0 C--O 1.234 0.284 0 N-CA-C 113.588 0.958 . . . . 0.56000000000000005 113.588 -168.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.624 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -80.28 149.84 30.21 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 114.222 -1.354 . . . . 0.39000000000000001 111.211 179.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.637 ' HB3' ' H ' ' A' ' 124' ' ' GLY . 0.5 OUTLIER -66.33 -14.71 62.47 Favored 'General case' 0 C--O 1.22 -0.469 0 CA-C-N 115.901 -0.59 . . . . 3.0099999999999998 111.243 178.875 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.684 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 7.0 tp10 -69.97 -17.63 63.3 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.324 -0.86 . . . . 1.76 109.912 174.587 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 11.1 m-30 -81.01 -52.97 6.84 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.912 -0.586 . . . . 1.3999999999999999 109.733 -177.227 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.624 ' HB3' HG13 ' A' ' 93' ' ' VAL . 5.2 p90 -100.82 110.19 60.07 Favored Pre-proline 0 C--N 1.324 -0.51 0 N-CA-C 107.412 -1.329 . . . . 0.46000000000000002 107.412 169.478 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.414 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 1.7 Cg_endo -37.97 135.45 0.58 Allowed 'Trans proline' 0 CA--C 1.515 -0.454 0 C-N-CA 124.351 3.368 . . . . 0.70999999999999996 113.766 -165.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -56.51 -7.19 0.37 Allowed 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 114.712 -1.131 . . . . 0.93000000000000005 113.127 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -82.64 -14.68 54.29 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.631 0.729 . . . . 2.6200000000000001 109.391 175.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.435 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 78.9 t80 -92.43 119.37 31.88 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.281 -0.872 . . . . 1.3300000000000001 109.294 175.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 35.3 t -63.08 125.91 25.59 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.924 0.393 . . . . 2.1800000000000002 110.805 -179.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -78.01 75.93 4.54 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-O 121.36 0.6 . . . . 1.74 110.634 179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . 0.421 ' H ' ' CD2' ' A' ' 85' ' ' HIS . 3.0 p80 -78.29 111.59 14.43 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.373 -0.831 . . . . 3.9900000000000002 110.452 -178.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 70.87 -101.16 0.9 Allowed Glycine 0 N--CA 1.445 -0.727 0 CA-C-N 115.708 -0.678 . . . . 1.0600000000000001 111.651 -175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 14.9 ptt180 -138.21 150.78 68.05 Favored Pre-proline 0 C--N 1.325 -0.486 0 N-CA-C 109.329 -0.619 . . . . 4.3700000000000001 109.329 174.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.499 ' C ' HD11 ' A' ' 70' ' ' LEU . 5.6 Cg_endo -59.77 162.62 15.25 Favored 'Trans proline' 0 CA--C 1.534 0.511 0 C-N-CA 122.29 1.993 . . . . 0.31 112.983 177.527 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.726 HD22 ' HB2' ' A' ' 92' ' ' ASP . 0.8 OUTLIER -121.26 103.66 9.15 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.707 -0.679 . . . . 2.1400000000000001 109.685 176.004 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.748 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 16.3 tt -57.02 -43.32 80.83 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.283 0 N-CA-C 114.201 1.186 . . . . 0.20999999999999999 114.201 -161.444 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.814 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 18.5 pttp -62.74 -15.05 51.4 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 112.157 0.428 . . . . 3.8199999999999998 112.157 -177.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.726 ' HB2' HD22 ' A' ' 89' ' ' ASN . 24.6 m-20 -122.89 19.13 10.16 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.498 0.666 . . . . 1.9099999999999999 109.784 178.123 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.68 HG11 HG21 ' A' ' 73' ' ' ILE . 8.8 t -120.3 -51.91 3.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.41 -0.814 . . . . 0.33000000000000002 109.555 -179.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.435 ' HB3' HG12 ' A' ' 46' ' ' ILE . 96.6 mt -101.35 164.6 11.7 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-N 115.545 -0.752 . . . . 0.29999999999999999 109.404 177.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.1 152.66 32.62 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.99 -0.55 . . . . 2.6699999999999999 109.637 174.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.6 ' HA ' HG22 ' A' ' 46' ' ' ILE . 25.5 mt-10 -63.46 118.09 7.63 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.699 -0.682 . . . . 1.25 110.262 -178.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.521 ' HA2' ' HD3' ' A' ' 45' ' ' LYS . . . 112.96 -11.84 24.75 Favored Glycine 0 N--CA 1.444 -0.767 0 C-N-CA 120.707 -0.759 . . . . 0.40999999999999998 112.145 -174.592 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -86.68 137.88 32.1 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.785 -0.45 . . . . 1.1799999999999999 109.785 176.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.404 ' HB2' ' HE3' ' A' ' 43' ' ' LYS . 12.6 pt-20 -86.95 157.13 19.55 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.029 -0.532 . . . . 0.81000000000000005 112.067 -175.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.544 HG23 HG22 ' A' ' 102' ' ' VAL . 32.9 m -143.47 156.5 16.7 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-N 114.987 -1.006 . . . . 0.17999999999999999 109.833 171.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.573 ' H ' HD11 ' A' ' 122' ' ' LEU . 5.7 mm -104.92 110.83 32.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.083 -1.08 . . . . 0.51000000000000001 108.083 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.544 HG22 HG23 ' A' ' 100' ' ' VAL . 3.2 m -144.84 136.33 20.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-O 121.225 0.535 . . . . 0.28000000000000003 112.384 -169.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 14.4 pt20 -114.56 149.21 36.86 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 108.862 -0.792 . . . . 1.6200000000000001 108.862 173.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.572 HD13 HD23 ' A' ' 116' ' ' LEU . 23.2 mm -74.69 101.97 2.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 121.734 0.778 . . . . 0.78000000000000003 110.447 -179.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.75 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 32.8 t70 -83.5 -36.04 24.4 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 114.641 -1.163 . . . . 1.3 109.666 -178.722 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.89 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 12.7 mptt -111.99 121.84 46.12 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.809 -1.182 . . . . 2.5699999999999998 107.809 172.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -71.98 147.58 46.79 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 112.763 0.653 . . . . 2.5699999999999998 112.763 -164.044 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . . . . . . . . . 53.6 tt0 -66.85 90.87 0.18 Allowed 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 114.852 -1.067 . . . . 3.1400000000000001 110.002 177.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -115.47 -61.94 1.67 Allowed 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 115.238 -0.892 . . . . 3.4900000000000002 110.422 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.68 -21.9 0.92 Allowed Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 114.603 -1.18 . . . . 1.74 110.72 -173.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 23.7 t-20 -63.05 -50.85 68.99 Favored 'General case' 0 C--N 1.333 -0.117 0 CA-C-O 120.99 0.424 . . . . 2.8799999999999999 110.161 175.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 31.3 mmmt -124.56 -37.53 2.49 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.43 0.633 . . . . 3.4500000000000002 109.486 171.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . . . . . . . . . . . 113.1 -153.19 17.7 Favored Glycine 0 N--CA 1.437 -1.236 0 CA-C-N 114.874 -1.057 . . . . 0.91000000000000003 110.588 179.353 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.03 91.28 4.85 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 109.559 -0.534 . . . . 0.52000000000000002 109.559 178.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.89 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -95.1 133.3 39.06 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.134 0.492 . . . . 0.59999999999999998 111.553 -175.037 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.817 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 68.8 mt -90.23 157.09 17.86 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.853 -0.612 . . . . 0.34999999999999998 110.133 -178.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.75 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 14.0 t -116.72 170.06 8.88 Favored 'General case' 0 C--N 1.316 -0.872 0 N-CA-C 109.301 -0.629 . . . . 0.98999999999999999 109.301 175.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.606 HG23 HD21 ' A' ' 68' ' ' LEU . 15.8 p -126.39 25.67 6.52 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-O 121.271 0.558 . . . . 1.22 110.404 172.526 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.5 t80 -78.4 47.06 0.67 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 122.282 1.039 . . . . 4.1100000000000003 108.905 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.568 HD13 ' O ' ' A' ' 101' ' ' ILE . 2.7 mp -128.15 163.48 32.09 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.701 0 CA-C-N 114.472 -1.24 . . . . 0.94999999999999996 108.029 -176.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 17.5 m -74.15 53.81 0.51 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.335 0.588 . . . . 1.25 111.709 -178.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.624 ' O ' ' HB1' ' A' ' 74' ' ' ALA . 11.6 mt -116.91 109.44 17.06 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 115.481 -0.781 . . . . 1.3799999999999999 110.048 -178.355 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . 158.34 -173.89 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.755 0 O-C-N 124.469 1.106 . . . . 1.3700000000000001 109.783 170.045 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.637 ' H ' ' HB3' ' A' ' 75' ' ' ARG . . . -157.85 162.98 32.48 Favored Glycine 0 N--CA 1.443 -0.865 0 N-CA-C 111.074 -0.81 . . . . 2.7999999999999998 111.074 178.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 3.2 p . . . . . 0 C--O 1.251 1.155 0 CA-C-O 118.767 -0.635 . . . . 5.1100000000000003 110.852 -179.994 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.667 0 N-CA-C 111.532 -0.627 . . . . 9.9100000000000001 111.532 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 36.7 m -50.54 -74.33 0.03 OUTLIER 'General case' 0 C--O 1.235 0.321 0 N-CA-C 112.462 0.542 . . . . 7.6600000000000001 112.462 -175.311 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.6 p-80 -70.21 -16.75 63.1 Favored 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 120.98 -0.288 . . . . 8.75 111.175 -174.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 22.4 mmt -64.27 -39.01 93.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 7.04 110.879 179.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.471 ' O ' ' HD2' ' A' ' 38' ' ' LYS . 4.6 mm? -79.38 -94.84 0.03 OUTLIER 'General case' 0 C--N 1.318 -0.789 0 CA-C-N 115.808 -0.633 . . . . 4.54 111.217 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.534 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 8.7 pt-20 -143.94 16.89 1.77 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 120.61 0.243 . . . . 4.0700000000000003 111.593 -175.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 8.7 tp-100 -64.11 111.65 2.65 Favored 'General case' 0 C--N 1.327 -0.41 0 N-CA-C 110.019 -0.363 . . . . 4.3600000000000003 110.019 179.634 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 50.9 tttp 65.59 24.44 11.71 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.782 0.801 . . . . 4.8499999999999996 109.479 179.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.634 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 37.7 ttmt -121.36 150.02 42.09 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.21 -0.905 . . . . 2.02 110.616 -174.86 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.634 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -68.83 175.34 3.68 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.988 -0.551 . . . . 0.95999999999999996 109.705 171.559 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.427 ' HB3' ' CE2' ' A' ' 42' ' ' TYR . 43.2 m-80 -66.28 91.57 0.17 Allowed 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.326 -0.397 . . . . 2.6200000000000001 110.982 -177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.606 ' HB ' ' HD3' ' A' ' 38' ' ' LYS . 9.5 tp -78.44 137.35 22.18 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.433 -0.349 . . . . 0.83999999999999997 110.147 179.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.427 ' CE2' ' HB3' ' A' ' 40' ' ' ASN . 90.5 m-85 -138.25 138.45 38.48 Favored 'General case' 0 N--CA 1.449 -0.491 0 CA-C-O 121.216 0.531 . . . . 1.02 110.49 178.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -105.01 104.94 14.78 Favored 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 107.549 -1.278 . . . . 1.1599999999999999 107.549 172.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.463 ' O ' ' HA ' ' A' ' 99' ' ' GLU . . . -137.45 -177.77 15.39 Favored Glycine 0 N--CA 1.442 -0.937 0 C-N-CA 120.538 -0.839 . . . . 0.27000000000000002 111.636 -173.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 73.1 mttt -114.98 157.67 23.1 Favored 'General case' 0 CA--C 1.505 -0.752 0 CA-C-O 121.525 0.679 . . . . 1.54 111.016 -177.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.999 HG21 HD11 ' A' ' 49' ' ' ILE . 1.5 mp -69.63 139.57 20.1 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.126 0 CA-C-N 114.604 -1.18 . . . . 0.25 109.908 173.045 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.649 HG21 ' HB2' ' A' ' 59' ' ' ASP . 47.3 p -129.04 -23.26 3.06 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 121.096 0.474 . . . . 0.39000000000000001 111.938 -180.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.601 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 40.1 ttm180 -146.2 124.61 12.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.338 -0.392 . . . . 1.8500000000000001 110.529 179.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.999 HD11 HG21 ' A' ' 46' ' ' ILE . 40.4 mt -140.29 112.44 4.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.723 0 N-CA-C 109.408 -0.59 . . . . 0.26000000000000001 109.408 177.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.469 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 0.0 OUTLIER -119.55 130.67 24.72 Favored Pre-proline 0 C--N 1.315 -0.927 0 CA-C-O 120.828 0.347 . . . . 2.2400000000000002 110.734 -176.777 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.776 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 2.8 Cg_exo -71.04 -22.47 26.2 Favored 'Trans proline' 0 N--CA 1.463 -0.273 0 C-N-CA 122.953 2.435 . . . . 0.52000000000000002 111.409 -177.017 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.89 -15.32 61.59 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.375 -0.83 . . . . 1.23 111.315 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.452 HD13 ' HZ ' ' A' ' 67' ' ' PHE . 2.9 pp -128.3 -5.54 5.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 119.309 -0.377 . . . . 0.46000000000000002 111.488 177.38 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 41.39 64.37 1.04 Allowed 'General case' 0 C--N 1.351 0.638 0 CA-C-O 121.772 0.796 . . . . 2.5099999999999998 111.616 175.792 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.566 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -169.25 167.92 10.02 Favored 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 114.052 -1.431 . . . . 0.19 109.069 177.397 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.466 ' HA ' ' O ' ' A' ' 48' ' ' ARG . . . -135.82 142.71 44.87 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.547 0.573 . . . . 0.17999999999999999 112.547 -172.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.601 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 49.7 m-85 -96.59 134.72 39.45 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.785 -0.643 . . . . 0.56000000000000005 110.195 171.112 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.415 HG21 HG21 ' A' ' 100' ' ' VAL . 53.9 t -108.41 128.0 64.32 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.087 0 CA-C-N 115.094 -0.957 . . . . 0.26000000000000001 109.372 174.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.649 ' HB2' HG21 ' A' ' 47' ' ' THR . 13.0 t0 -98.61 108.44 21.14 Favored 'General case' 0 C--N 1.319 -0.739 0 CA-C-O 121.002 0.43 . . . . 0.79000000000000004 110.021 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -124.64 65.43 1.1 Allowed 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.459 0.647 . . . . 0.89000000000000001 109.434 177.464 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.08 34.6 52.88 Favored Glycine 0 CA--C 1.521 0.437 0 C-N-CA 120.336 -0.935 . . . . 0.82999999999999996 111.452 -172.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -116.88 115.15 24.96 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 120.655 0.264 . . . . 0.85999999999999999 110.555 -175.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.522 ' CD ' ' H ' ' A' ' 63' ' ' GLU . 0.7 OUTLIER -64.59 -27.06 68.69 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.911 -0.774 . . . . 2.4300000000000002 108.911 175.597 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.49 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 19.9 mtm-85 -84.06 -11.47 56.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 114.662 -1.154 . . . . 4.5199999999999996 110.011 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.426 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 61.28 -159.77 0.31 Allowed 'General case' 0 C--O 1.224 -0.267 0 CA-C-N 115.485 -0.779 . . . . 0.88 109.998 -172.988 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -155.79 120.24 0.98 Allowed Glycine 0 CA--C 1.503 -0.661 0 N-CA-C 109.867 -1.293 . . . . 0.23999999999999999 109.867 172.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.566 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.1 t80 -103.78 113.22 26.58 Favored 'General case' 0 C--N 1.313 -1.017 0 CA-C-O 121.192 0.52 . . . . 0.40999999999999998 111.169 -169.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.891 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -100.0 115.2 65.74 Favored Pre-proline 0 C--N 1.321 -0.665 0 CA-C-N 115.315 -0.857 . . . . 0.16 110.143 177.983 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.562 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 25.4 Cg_exo -64.66 143.61 81.54 Favored 'Trans proline' 0 C--N 1.343 0.243 0 C-N-CA 122.752 2.301 . . . . 0.23000000000000001 111.803 174.79 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.846 HD13 ' HB ' ' A' ' 90' ' ' ILE . 24.3 tp -66.4 -26.5 67.27 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.959 -0.564 . . . . 0.19 111.514 -177.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.547 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 20.9 pttp -73.05 -9.65 58.96 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 120.853 0.359 . . . . 2.04 110.999 -179.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.562 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 17.0 mm-40 -100.04 -14.93 18.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.112 -0.494 . . . . 0.85999999999999999 110.078 177.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.654 HG21 HG11 ' A' ' 93' ' ' VAL . 6.1 mm -49.04 133.57 6.9 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 N-CA-C 113.47 0.915 . . . . 0.56000000000000005 113.47 -168.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -89.11 151.06 22.44 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 114.311 -1.313 . . . . 0.39000000000000001 111.864 -176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.848 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 3.0 tmm_? -65.24 -21.69 66.78 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 115.198 -0.91 . . . . 3.0099999999999998 111.1 -178.957 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.53 ' HB3' HD23 ' A' ' 122' ' ' LEU . 4.5 tp10 -73.99 -14.95 61.11 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 121.446 -0.784 . . . . 1.76 110.852 178.064 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 22.0 m-30 -81.76 -52.71 6.86 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.856 -0.611 . . . . 1.3999999999999999 109.861 -176.899 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.562 ' HB3' ' HA ' ' A' ' 93' ' ' VAL . 8.2 p90 -96.62 109.09 46.55 Favored Pre-proline 0 C--N 1.319 -0.738 0 N-CA-C 107.14 -1.43 . . . . 0.46000000000000002 107.14 169.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.2 Cg_endo -40.56 137.14 1.68 Allowed 'Trans proline' 0 CA--C 1.512 -0.597 0 C-N-CA 123.87 3.047 . . . . 0.70999999999999996 113.025 -166.674 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.848 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -48.99 -16.98 0.15 Allowed 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 113.841 1.052 . . . . 0.93000000000000005 113.841 177.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -83.52 -7.2 59.58 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.133 0.492 . . . . 2.6200000000000001 110.786 177.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.42 ' HD2' ' HD2' ' A' ' 78' ' ' PHE . 69.6 t80 -84.89 144.01 28.66 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.099 -0.704 . . . . 1.3300000000000001 109.099 174.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.7 p -78.67 100.69 7.14 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.038 0.447 . . . . 2.1800000000000002 111.777 -175.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.451 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -81.13 120.09 24.4 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.193 -0.458 . . . . 1.74 110.525 177.055 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 16.1 p-80 -138.82 105.45 5.34 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.034 -0.53 . . . . 3.9900000000000002 110.647 -178.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 76.87 -83.74 1.04 Allowed Glycine 0 N--CA 1.448 -0.567 0 C-N-CA 120.806 -0.711 . . . . 1.0600000000000001 111.824 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.2 133.49 17.3 Favored Pre-proline 0 C--N 1.322 -0.594 0 CA-C-O 120.791 0.329 . . . . 4.3700000000000001 110.252 -179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.486 ' HB2' HG21 ' A' ' 93' ' ' VAL . 11.6 Cg_endo -59.64 153.6 54.44 Favored 'Trans proline' 0 CA--C 1.529 0.234 0 C-N-CA 122.87 2.38 . . . . 0.31 113.131 176.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.632 ' O ' HG23 ' A' ' 93' ' ' VAL . 6.9 t30 -106.28 111.26 23.77 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 108.644 -0.873 . . . . 2.1400000000000001 108.644 172.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.846 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.4 tt -62.78 -36.29 74.77 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.299 0 N-CA-C 112.691 0.626 . . . . 0.20999999999999999 112.691 -164.861 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.776 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 32.4 mmmt -67.27 -5.59 14.72 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 112.482 0.549 . . . . 3.8199999999999998 112.482 175.003 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -125.58 23.07 7.51 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.427 0.632 . . . . 1.9099999999999999 109.58 172.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.654 HG11 HG21 ' A' ' 73' ' ' ILE . 48.0 t -121.94 -54.86 3.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-N 115.12 -0.945 . . . . 0.33000000000000002 109.833 -179.806 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.775 ' HB3' HG12 ' A' ' 46' ' ' ILE . 93.5 mt -109.95 158.83 17.82 Favored 'General case' 0 C--N 1.315 -0.925 0 CA-C-N 115.071 -0.968 . . . . 0.29999999999999999 110.548 -175.259 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.44 146.0 26.38 Favored 'General case' 0 C--N 1.316 -0.864 0 CA-C-N 115.128 -0.942 . . . . 2.6699999999999999 109.352 173.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.608 ' HA ' HG22 ' A' ' 46' ' ' ILE . 47.8 mt-10 -55.6 119.48 5.75 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.293 -0.412 . . . . 1.25 110.893 -178.646 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.47 -16.49 24.2 Favored Glycine 0 N--CA 1.449 -0.498 0 CA-C-N 115.682 -0.69 . . . . 0.40999999999999998 112.129 -176.706 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.411 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.2 tt0 -82.39 138.58 34.42 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.796 -0.446 . . . . 1.1799999999999999 109.796 178.16 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.463 ' HA ' ' O ' ' A' ' 44' ' ' GLY . 12.5 pt-20 -87.54 156.73 19.39 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.256 0.55 . . . . 0.81000000000000005 111.936 -175.591 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.558 HG23 HG22 ' A' ' 102' ' ' VAL . 33.5 m -141.02 147.03 22.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 114.973 -1.012 . . . . 0.17999999999999999 109.397 171.484 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.598 ' O ' HD13 ' A' ' 120' ' ' ILE . 10.2 mm -99.57 110.29 26.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 N-CA-C 108.26 -1.015 . . . . 0.51000000000000001 108.26 171.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.558 HG22 HG23 ' A' ' 100' ' ' VAL . 3.4 m -144.64 132.5 17.07 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.015 0.436 . . . . 0.28000000000000003 111.447 -172.322 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.597 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 13.0 pt20 -107.02 133.13 52.13 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.249 -0.432 . . . . 1.6200000000000001 109.921 175.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.489 HD13 HD23 ' A' ' 116' ' ' LEU . 19.6 mm -67.14 102.98 0.56 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.7 -0.682 . . . . 0.78000000000000003 110.159 178.075 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -82.26 -38.63 24.15 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.176 -0.92 . . . . 1.3 109.531 179.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.544 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 54.9 mttp -117.77 132.51 56.45 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.358 -0.837 . . . . 2.5699999999999998 110.09 178.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -102.34 158.57 16.1 Favored 'General case' 0 N--CA 1.436 -1.134 0 CA-C-N 114.908 -1.042 . . . . 2.5699999999999998 111.0 -168.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 1.06 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 0.2 OUTLIER -52.52 117.41 2.86 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.486 -0.779 . . . . 3.1400000000000001 111.298 -176.292 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -143.98 18.91 1.79 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 114.858 -1.064 . . . . 3.4900000000000002 109.843 -177.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 87.65 -43.37 3.17 Favored Glycine 0 N--CA 1.447 -0.633 0 CA-C-N 115.824 -0.626 . . . . 1.74 112.893 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -68.55 -51.28 44.54 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 111.853 0.316 . . . . 2.8799999999999999 111.853 -172.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -125.02 -38.93 2.29 Favored 'General case' 0 CA--C 1.514 -0.421 0 CA-C-O 121.378 0.609 . . . . 3.4500000000000002 110.971 174.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 1.06 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 92.07 -126.79 8.65 Favored Glycine 0 N--CA 1.437 -1.263 0 C-N-CA 120.469 -0.872 . . . . 0.91000000000000003 111.687 -178.22 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -82.07 94.19 7.16 Favored 'General case' 0 C--N 1.314 -0.961 0 CA-C-O 120.812 0.339 . . . . 0.52000000000000002 110.747 -177.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.544 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -94.52 124.96 38.87 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.474 -0.33 . . . . 0.59999999999999998 111.604 -177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.891 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 25.1 mt -90.8 135.66 33.58 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 109.729 -0.471 . . . . 0.34999999999999998 109.729 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.416 ' OG1' ' HD2' ' A' ' 119' ' ' PHE . 7.1 t -97.38 167.57 10.92 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 109.446 -0.575 . . . . 0.98999999999999999 109.446 175.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.618 HG23 HD21 ' A' ' 68' ' ' LEU . 11.9 p -125.32 19.83 8.14 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 121.165 0.507 . . . . 1.22 111.224 173.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.416 ' HD2' ' OG1' ' A' ' 117' ' ' THR . 73.7 m-85 -80.89 54.13 2.11 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.826 0.822 . . . . 4.1100000000000003 109.918 174.267 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.629 HG22 ' H ' ' A' ' 121' ' ' SER . 2.0 mp -127.63 175.85 8.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 114.579 -1.191 . . . . 0.94999999999999996 108.054 -178.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.629 ' H ' HG22 ' A' ' 120' ' ' ILE . 1.5 m -66.85 19.75 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.425 0.898 . . . . 1.25 113.425 -175.145 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.53 HD23 ' HB3' ' A' ' 76' ' ' GLU . 6.6 mp -115.9 106.5 13.88 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 122.22 -0.3 . . . . 1.3799999999999999 110.433 -177.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.429 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . 158.44 61.54 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.73 0 C-N-CA 124.727 1.211 . . . . 1.3700000000000001 109.254 169.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . 0.565 ' HA3' HH21 ' A' ' 75' ' ' ARG . . . -73.98 164.53 54.75 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.792 -0.718 . . . . 2.7999999999999998 112.757 -176.277 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 47.1 m . . . . . 0 C--O 1.246 0.904 0 CA-C-O 118.875 -0.583 . . . . 5.1100000000000003 109.612 176.623 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.751 0 N-CA-C 111.884 -0.487 . . . . 9.9100000000000001 111.884 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.421 ' HB2' ' CD1' ' A' ' 34' ' ' LEU . 28.4 m -72.18 137.09 46.68 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.042 0.449 . . . . 7.6600000000000001 110.534 -178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 69.2 m80 -86.52 157.35 19.78 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.865 -0.607 . . . . 8.75 110.516 -179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 63.4 mtt 71.72 23.33 3.72 Favored 'General case' 0 N--CA 1.465 0.275 0 O-C-N 124.056 0.848 . . . . 7.04 111.434 179.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.421 ' CD1' ' HB2' ' A' ' 31' ' ' SER . 66.7 mt -101.38 -49.74 3.96 Favored 'General case' 0 C--N 1.325 -0.48 0 N-CA-C 108.554 -0.906 . . . . 4.54 108.554 171.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.529 ' HA ' ' HD2' ' A' ' 38' ' ' LYS . 1.8 mm-40 43.73 66.45 0.82 Allowed 'General case' 0 CA--C 1.531 0.233 0 CA-C-N 114.315 -1.311 . . . . 4.0700000000000003 110.106 173.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.426 ' H ' ' CD ' ' A' ' 36' ' ' GLN . 0.0 OUTLIER -79.47 -58.09 3.37 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-N 115.44 -0.8 . . . . 4.3600000000000003 112.942 -163.489 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 36.9 mtmm -112.14 46.97 1.1 Allowed 'General case' 0 CA--C 1.51 -0.586 0 N-CA-C 107.82 -1.178 . . . . 4.8499999999999996 107.82 174.476 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.602 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 32.0 ttmt -131.63 148.43 52.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 113.055 -1.884 . . . . 2.02 109.896 -169.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.602 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -72.3 150.35 43.63 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.459 -0.941 . . . . 0.95999999999999996 108.459 172.149 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -57.54 117.6 4.34 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.073 0.463 . . . . 2.6200000000000001 110.447 -175.638 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.407 HD11 HG12 ' A' ' 120' ' ' ILE . 7.5 tp -84.39 146.74 6.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.294 -0.866 . . . . 0.83999999999999997 111.292 -171.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 63.2 m-85 -139.78 147.29 40.59 Favored 'General case' 0 N--CA 1.454 -0.274 0 CA-C-N 116.409 -0.36 . . . . 1.02 110.556 176.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.489 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 41.3 ttmt -108.37 116.63 32.33 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 109.045 -0.724 . . . . 1.1599999999999999 109.045 167.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -136.43 169.21 23.85 Favored Glycine 0 N--CA 1.44 -1.06 0 N-CA-C 110.83 -0.908 . . . . 0.27000000000000002 110.83 -179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 68.4 mttt -102.33 161.37 13.75 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.27 0.557 . . . . 1.54 110.814 179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.824 HG12 ' HB3' ' A' ' 94' ' ' LEU . 1.8 mp -70.23 136.47 26.0 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.996 0 CA-C-N 114.842 -1.072 . . . . 0.25 109.239 169.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.858 HG21 ' HB2' ' A' ' 59' ' ' ASP . 1.9 p -121.52 -33.52 3.61 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-O 121.419 0.628 . . . . 0.39000000000000001 111.139 -178.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.617 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 39.4 ttm180 -147.68 122.14 9.73 Favored 'General case' 0 N--CA 1.443 -0.817 0 CA-C-N 115.269 -0.878 . . . . 1.8500000000000001 110.384 -178.116 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.694 HD11 HG21 ' A' ' 46' ' ' ILE . 51.1 mt -131.62 130.11 62.01 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.716 0 N-CA-C 109.525 -0.546 . . . . 0.26000000000000001 109.525 176.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.861 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 22.6 tt0 -129.29 131.51 23.7 Favored Pre-proline 0 C--N 1.316 -0.886 0 CA-C-N 115.868 -0.606 . . . . 2.2400000000000002 109.461 -176.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.746 ' HG3' ' HG3' ' A' ' 91' ' ' LYS . 9.4 Cg_exo -68.3 -24.92 36.89 Favored 'Trans proline' 0 N--CA 1.46 -0.447 0 C-N-CA 122.475 2.117 . . . . 0.52000000000000002 111.31 -178.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 6.1 m -74.33 -22.05 59.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.378 -0.828 . . . . 1.23 111.079 -178.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.861 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.1 pp -118.48 -1.85 11.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 119.086 -0.483 . . . . 0.46000000000000002 111.758 179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.5 pt-20 41.04 54.22 3.3 Favored 'General case' 0 C--N 1.352 0.682 0 CA-C-O 121.979 0.895 . . . . 2.5099999999999998 111.396 173.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.575 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.37 166.52 27.3 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 114.269 -1.332 . . . . 0.19 109.499 -179.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.497 ' CB ' HG12 ' A' ' 49' ' ' ILE . . . -133.47 134.24 43.28 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 116.406 -0.361 . . . . 0.17999999999999999 111.55 -175.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.617 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 76.4 m-85 -85.86 133.1 33.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.387 -0.597 . . . . 0.56000000000000005 109.387 173.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.544 ' HB ' HD11 ' A' ' 116' ' ' LEU . 31.5 t -115.34 128.75 72.42 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.469 -0.787 . . . . 0.26000000000000001 109.626 178.312 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.858 ' HB2' HG21 ' A' ' 47' ' ' THR . 12.3 t0 -101.94 108.77 20.33 Favored 'General case' 0 C--N 1.316 -0.883 0 CA-C-N 115.886 -0.597 . . . . 0.79000000000000004 110.321 -175.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.4 p90 -124.14 65.49 1.06 Allowed 'General case' 0 C--N 1.321 -0.636 0 N-CA-C 108.369 -0.974 . . . . 0.89000000000000001 108.369 171.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 54.48 30.5 50.04 Favored Glycine 0 CA--C 1.521 0.448 0 C-N-CA 120.525 -0.845 . . . . 0.82999999999999996 111.699 -172.079 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -93.06 153.05 18.92 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.009 0.433 . . . . 0.85999999999999999 111.552 -171.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 12.6 tp10 -95.77 -27.35 15.28 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.686 -0.688 . . . . 2.4300000000000002 110.52 -174.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.608 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 2.4 mmp_? -113.57 -9.36 13.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.083 -0.508 . . . . 4.5199999999999996 110.532 177.242 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.453 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 9.7 m170 70.34 144.37 0.06 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.243 -0.889 . . . . 0.88 111.221 -177.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.425 ' HA3' HD21 ' A' ' 116' ' ' LEU . . . -78.78 104.23 2.07 Favored Glycine 0 N--CA 1.442 -0.902 0 C-N-CA 120.413 -0.898 . . . . 0.23999999999999999 110.965 176.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.653 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 1.7 t80 -91.32 97.73 11.28 Favored 'General case' 0 C--N 1.315 -0.909 0 CA-C-O 121.178 0.513 . . . . 0.40999999999999998 110.191 -176.258 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.025 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -86.42 115.44 62.16 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.56 -0.746 . . . . 0.16 110.188 177.595 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.672 ' HB2' ' HG2' ' A' ' 71' ' ' LYS . 10.3 Cg_exo -69.52 141.33 45.92 Favored 'Trans proline' 0 N--CA 1.459 -0.53 0 C-N-CA 122.245 1.963 . . . . 0.23000000000000001 111.471 175.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' HB2' ' HB ' ' A' ' 90' ' ' ILE . 21.2 tp -54.78 -30.62 57.31 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-N 115.335 -0.848 . . . . 0.19 112.144 -178.781 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.672 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 14.0 ptmm? -61.76 -22.99 65.88 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.851 -0.613 . . . . 2.04 111.768 -178.465 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -93.57 -21.75 19.24 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.48 -0.327 . . . . 0.85999999999999999 111.256 -174.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.717 HG21 HG11 ' A' ' 93' ' ' VAL . 17.0 mt -49.01 132.21 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 N-CA-C 113.155 0.798 . . . . 0.56000000000000005 113.155 -168.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.52 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -93.67 151.9 19.34 Favored 'General case' 0 C--O 1.234 0.24 0 CA-C-N 115.197 -0.91 . . . . 0.39000000000000001 111.363 -178.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.44 ' HB3' ' HB1' ' A' ' 123' ' ' ALA . 10.0 tpt180 -54.38 -16.1 2.04 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 114.525 -1.216 . . . . 3.0099999999999998 112.777 -179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.029 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 29.7 tp10 -63.5 -29.89 71.09 Favored 'General case' 0 N--CA 1.464 0.228 0 O-C-N 121.788 -0.57 . . . . 1.76 110.823 177.029 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.644 ' CE1' HG12 ' A' ' 100' ' ' VAL . 26.1 m-85 -86.14 -41.61 14.57 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.317 -0.856 . . . . 1.3999999999999999 110.733 -172.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.531 ' HB3' HG22 ' A' ' 93' ' ' VAL . 2.1 p90 -102.3 92.13 3.03 Favored Pre-proline 0 C--N 1.318 -0.787 0 N-CA-C 107.551 -1.277 . . . . 0.46000000000000002 107.551 166.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.517 ' O ' ' HB3' ' A' ' 82' ' ' TYR . 23.4 Cg_exo -26.72 137.12 0.02 OUTLIER 'Trans proline' 0 C--N 1.351 0.662 1 C-N-CA 125.675 4.25 . . . . 0.70999999999999996 115.374 -167.504 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -53.6 -25.39 17.29 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 114.356 -1.293 . . . . 0.93000000000000005 112.579 -179.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 92.5 m-20 -83.59 -6.57 59.48 Favored 'General case' 0 N--CA 1.467 0.404 0 CA-C-O 121.196 0.522 . . . . 2.6200000000000001 111.253 177.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . 0.517 ' HB3' ' O ' ' A' ' 79' ' ' PRO . 58.1 t80 -87.85 135.38 33.42 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 109.313 -0.625 . . . . 1.3300000000000001 109.313 174.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 12.0 t -71.61 116.37 11.89 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.051 -0.722 . . . . 2.1800000000000002 109.051 176.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.483 ' CB ' ' HE2' ' A' ' 78' ' ' PHE . . . -63.73 -21.03 66.2 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 112.886 0.699 . . . . 1.74 112.886 -170.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 40.6 m80 65.55 23.93 11.77 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 121.284 0.564 . . . . 3.9900000000000002 110.412 -179.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.41 -57.93 4.18 Favored Glycine 0 N--CA 1.446 -0.682 0 CA-C-N 115.513 -0.767 . . . . 1.0600000000000001 111.953 -177.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 20.7 ptt180 -137.3 130.27 17.11 Favored Pre-proline 0 C--N 1.321 -0.655 0 CA-C-O 120.864 0.364 . . . . 4.3700000000000001 110.46 -179.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.406 ' O ' HD11 ' A' ' 70' ' ' LEU . 6.5 Cg_endo -61.4 154.59 57.78 Favored 'Trans proline' 0 CA--C 1.536 0.577 0 C-N-CA 123.163 2.575 . . . . 0.31 113.697 -178.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.462 ' O ' HG23 ' A' ' 93' ' ' VAL . 9.3 t30 -114.98 110.7 20.02 Favored 'General case' 0 N--CA 1.466 0.329 0 N-CA-C 109.24 -0.652 . . . . 2.1400000000000001 109.24 171.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 7.9 tt -55.63 -43.97 75.02 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 N-CA-C 113.649 0.981 . . . . 0.20999999999999999 113.649 -164.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.746 ' HG3' ' HG3' ' A' ' 51' ' ' PRO . 4.7 mmmp? -56.7 -26.37 56.6 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 113.245 0.831 . . . . 3.8199999999999998 113.245 177.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -110.18 9.38 23.91 Favored 'General case' 0 N--CA 1.467 0.384 0 CA-C-O 121.145 0.497 . . . . 1.9099999999999999 111.079 -177.78 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.717 HG11 HG21 ' A' ' 73' ' ' ILE . 53.2 t -115.21 -51.79 4.87 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.751 0 CA-C-N 115.638 -0.71 . . . . 0.33000000000000002 109.849 -178.856 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.824 ' HB3' HG12 ' A' ' 46' ' ' ILE . 83.1 mt -103.16 154.05 19.7 Favored 'General case' 0 C--N 1.317 -0.845 0 CA-C-N 115.44 -0.8 . . . . 0.29999999999999999 109.691 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.404 ' O ' ' HB ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -148.15 151.99 36.52 Favored 'General case' 0 C--N 1.315 -0.934 0 CA-C-N 115.521 -0.763 . . . . 2.6699999999999999 108.95 174.886 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.571 ' HA ' HG22 ' A' ' 46' ' ' ILE . 36.6 mt-10 -62.06 118.69 7.65 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.048 -0.524 . . . . 1.25 110.237 -176.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 113.35 -18.33 20.79 Favored Glycine 0 N--CA 1.448 -0.511 0 CA-C-N 115.85 -0.614 . . . . 0.40999999999999998 112.209 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 22.9 tt0 -78.02 135.86 37.84 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.479 -0.563 . . . . 1.1799999999999999 109.479 177.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -86.9 157.37 19.53 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.136 0.493 . . . . 0.81000000000000005 111.361 -177.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.644 HG12 ' CE1' ' A' ' 77' ' ' TYR . 35.0 m -138.07 151.3 25.13 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.761 0 CA-C-N 115.169 -0.923 . . . . 0.17999999999999999 109.959 173.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.563 HG12 HD21 ' A' ' 122' ' ' LEU . 3.5 mm -103.06 110.14 28.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 N-CA-C 107.67 -1.233 . . . . 0.51000000000000001 107.67 171.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.534 HG22 HG23 ' A' ' 100' ' ' VAL . 3.5 m -143.61 134.79 22.58 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 121.273 0.559 . . . . 0.28000000000000003 111.783 -170.215 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 10.7 pt20 -108.33 141.26 40.41 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 108.56 -0.904 . . . . 1.6200000000000001 108.56 174.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.432 HD13 ' HA ' ' A' ' 104' ' ' ILE . 18.3 mm -74.98 104.53 3.39 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 121.667 0.746 . . . . 0.78000000000000003 111.367 -176.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -77.47 -43.33 32.64 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 114.686 -1.143 . . . . 1.3 109.776 178.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.658 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 60.4 mttp -118.04 137.42 52.92 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.66 -0.7 . . . . 2.5699999999999998 109.895 179.423 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 -80.64 144.38 32.36 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-N 115.007 -0.997 . . . . 2.5699999999999998 112.547 -159.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.608 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 40.8 tt0 -71.63 90.91 1.06 Allowed 'General case' 0 N--CA 1.447 -0.587 0 CA-C-N 115.31 -0.859 . . . . 3.1400000000000001 110.321 179.454 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.599 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 17.8 mtt180 -105.53 -82.71 0.52 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.453 -0.794 . . . . 3.4900000000000002 110.665 -178.03 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -164.93 -47.19 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.781 0 C-N-CA 120.561 -0.828 . . . . 1.74 112.569 -179.644 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.427 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 21.6 t-20 -61.59 -49.71 75.51 Favored 'General case' 0 N--CA 1.464 0.23 0 N-CA-C 111.579 0.214 . . . . 2.8799999999999999 111.579 -175.409 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.427 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 29.3 mtpp -123.55 -38.05 2.58 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-O 121.321 0.581 . . . . 3.4500000000000002 109.812 171.719 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.599 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 85.64 -132.71 11.28 Favored Glycine 0 N--CA 1.434 -1.488 0 CA-C-N 115.149 -0.932 . . . . 0.91000000000000003 112.531 174.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.449 ' HB3' ' O ' ' A' ' 65' ' ' HIS . . . -75.57 108.01 8.1 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 115.148 -0.526 . . . . 0.52000000000000002 111.326 -171.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.658 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -104.22 125.24 50.34 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.213 -0.449 . . . . 0.59999999999999998 110.431 178.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.025 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 30.4 mt -90.8 148.72 22.34 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.989 0.423 . . . . 0.34999999999999998 109.965 -179.545 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . . . . . . . . . 12.7 t -113.93 175.46 5.45 Favored 'General case' 0 C--N 1.313 -0.986 0 N-CA-C 109.17 -0.678 . . . . 0.98999999999999999 109.17 175.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 10.3 p -125.27 26.99 6.73 Favored 'General case' 0 N--CA 1.445 -0.697 0 CA-C-O 121.401 0.619 . . . . 1.22 110.274 173.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -78.15 44.45 0.49 Allowed 'General case' 0 CA--C 1.536 0.415 0 CA-C-O 122.547 1.165 . . . . 4.1100000000000003 109.141 173.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.517 HD13 ' O ' ' A' ' 101' ' ' ILE . 3.3 mp -128.46 161.73 36.56 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.711 0 CA-C-N 114.839 -1.073 . . . . 0.94999999999999996 108.982 -175.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -71.06 66.82 0.4 Allowed 'General case' 0 CA--C 1.537 0.467 0 CA-C-O 120.967 0.413 . . . . 1.25 111.301 -178.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.563 HD21 HG12 ' A' ' 101' ' ' ILE . 1.9 mt -116.25 173.31 6.66 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 109.112 -0.699 . . . . 1.3799999999999999 109.112 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.029 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 76.94 56.21 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.92 0.762 . . . . 1.3700000000000001 110.622 174.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 112.29 43.85 0.89 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.279 -0.873 . . . . 2.7999999999999998 111.967 179.312 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.245 0.864 0 CA-C-O 118.335 -0.84 . . . . 5.1100000000000003 110.871 179.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.669 0 N-CA-C 112.383 -0.287 . . . . 9.9100000000000001 112.383 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 4.9 p -69.24 128.14 35.54 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-O 121.379 0.609 . . . . 7.6600000000000001 110.682 -178.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 41.7 m80 -99.26 52.24 0.95 Allowed 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.971 -0.559 . . . . 8.75 110.945 -175.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 72.8 mtm -87.06 -11.85 49.03 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.821 0.82 . . . . 7.04 109.002 172.001 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -107.27 173.87 6.13 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.607 -1.179 . . . . 4.54 108.782 171.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.457 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 33.8 mt-10 -61.78 -62.36 1.85 Allowed 'General case' 0 C--N 1.32 -0.675 0 O-C-N 123.036 0.21 . . . . 4.0700000000000003 110.514 -179.961 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 23.5 mm-40 65.35 74.02 0.39 Allowed 'General case' 0 C--O 1.235 0.295 0 O-C-N 123.486 0.491 . . . . 4.3600000000000003 110.233 -179.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 97.6 mttt 59.82 44.09 14.31 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.582 0.706 . . . . 4.8499999999999996 110.132 -178.029 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.681 ' HG2' ' O ' ' A' ' 39' ' ' ALA . 4.3 ttmp? -130.72 143.16 50.55 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.222 -0.899 . . . . 2.02 110.925 -173.65 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.681 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -71.19 158.26 36.72 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 108.614 -0.884 . . . . 0.95999999999999996 108.614 169.131 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 34.8 t-20 -52.79 119.77 4.97 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 121.206 0.527 . . . . 2.6200000000000001 110.665 -176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.678 HD11 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -89.52 138.62 18.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.218 -0.901 . . . . 0.83999999999999997 110.326 -175.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -133.25 156.41 47.6 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.021 0.438 . . . . 1.02 110.343 -179.529 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.601 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 30.8 ttmt -118.49 121.66 40.82 Favored 'General case' 0 C--N 1.317 -0.821 0 N-CA-C 108.795 -0.817 . . . . 1.1599999999999999 108.795 167.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.82 166.95 25.78 Favored Glycine 0 N--CA 1.442 -0.961 0 N-CA-C 110.675 -0.97 . . . . 0.27000000000000002 110.675 178.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.501 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 90.4 mttt -100.21 156.88 16.97 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.41 0.624 . . . . 1.54 111.114 -179.142 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.891 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -69.86 134.69 29.69 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.095 0 CA-C-N 114.661 -1.154 . . . . 0.25 109.822 173.441 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.602 HG21 ' HB2' ' A' ' 59' ' ' ASP . 61.6 p -123.87 -18.41 6.01 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.357 0.599 . . . . 0.39000000000000001 111.314 176.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.526 ' HG2' ' HD2' ' A' ' 57' ' ' PHE . 7.2 ttm180 -150.6 131.3 14.02 Favored 'General case' 0 N--CA 1.438 -1.033 0 CA-C-N 115.361 -0.836 . . . . 1.8500000000000001 110.524 179.322 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.891 HD11 HG21 ' A' ' 46' ' ' ILE . 58.0 mt -139.81 101.36 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 108.657 -0.868 . . . . 0.26000000000000001 108.657 176.07 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.597 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -98.57 112.46 62.53 Favored Pre-proline 0 C--N 1.316 -0.873 0 CA-C-N 116.0 -0.545 . . . . 2.2400000000000002 110.015 -177.06 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.996 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 52.9 Cg_exo -57.12 -22.37 47.37 Favored 'Trans proline' 0 N--CA 1.467 -0.054 0 C-N-CA 122.953 2.435 . . . . 0.52000000000000002 111.894 178.071 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 23.9 t -71.69 -20.09 61.97 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.288 -0.869 . . . . 1.23 111.764 -178.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.597 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.0 OUTLIER -128.36 12.74 6.53 Favored 'General case' 0 CA--C 1.532 0.259 0 N-CA-C 113.811 1.041 . . . . 0.46000000000000002 113.811 -176.056 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 53' ' ' LEU . 0.3 OUTLIER 47.73 40.78 12.82 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.737 0.815 . . . . 2.5099999999999998 112.818 173.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.668 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -161.54 170.24 20.25 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 120.801 0.334 . . . . 0.19 111.076 -179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.477 ' O ' ' HA ' ' A' ' 67' ' ' PHE . . . -137.63 149.12 46.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.086 -0.506 . . . . 0.17999999999999999 112.032 -173.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.526 ' HD2' ' HG2' ' A' ' 48' ' ' ARG . 63.4 m-85 -98.38 137.64 36.79 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.849 -0.614 . . . . 0.56000000000000005 109.826 173.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.637 ' HB ' HD11 ' A' ' 116' ' ' LEU . 24.3 t -118.72 131.78 70.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.962 0 CA-C-N 115.347 -0.842 . . . . 0.26000000000000001 109.832 -178.621 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.602 ' HB2' HG21 ' A' ' 47' ' ' THR . 22.2 t70 -100.43 104.86 16.29 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.781 -0.645 . . . . 0.79000000000000004 110.649 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -127.11 65.4 1.3 Allowed 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 108.973 -0.751 . . . . 0.89000000000000001 108.973 174.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 48.41 52.18 19.6 Favored Glycine 0 CA--C 1.522 0.48 0 C-N-CA 120.336 -0.935 . . . . 0.82999999999999996 111.328 -171.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -114.96 168.48 9.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.715 0.293 . . . . 0.85999999999999999 111.193 -170.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . 0.416 ' HB3' ' OE2' ' A' ' 108' ' ' GLU . 7.4 tp10 -93.78 -53.54 3.98 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.905 -0.318 . . . . 2.4300000000000002 111.381 -176.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.459 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 1.4 ptm180 -109.16 6.54 24.89 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.132 -0.627 . . . . 4.5199999999999996 110.778 178.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.459 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 15.7 m170 71.25 143.28 0.06 Allowed 'General case' 0 N--CA 1.468 0.44 0 CA-C-N 115.24 -0.891 . . . . 0.88 111.511 -179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -74.53 117.33 5.46 Favored Glycine 0 N--CA 1.44 -1.043 0 N-CA-C 110.829 -0.909 . . . . 0.23999999999999999 110.829 176.175 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.668 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 21.6 t80 -99.83 98.73 9.5 Favored 'General case' 0 C--N 1.315 -0.923 0 CA-C-O 121.166 0.508 . . . . 0.40999999999999998 110.375 -175.643 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.925 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -87.34 117.54 68.71 Favored Pre-proline 0 C--N 1.328 -0.355 0 CA-C-N 115.506 -0.77 . . . . 0.16 111.05 179.573 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.484 ' HD2' HD23 ' A' ' 68' ' ' LEU . 21.3 Cg_exo -67.65 141.85 56.37 Favored 'Trans proline' 0 CA--C 1.53 0.298 0 C-N-CA 122.821 2.347 . . . . 0.23000000000000001 111.721 172.646 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.699 HD13 ' HB ' ' A' ' 90' ' ' ILE . 18.0 tp -59.34 -35.09 73.21 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.599 -0.728 . . . . 0.19 112.035 -178.5 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 16.4 pttm -67.83 -8.22 34.34 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.394 -0.366 . . . . 2.04 111.786 -179.175 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 8.0 mm-40 -96.31 -26.98 15.18 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.641 -0.254 . . . . 0.85999999999999999 110.349 176.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.545 HG21 HG11 ' A' ' 93' ' ' VAL . 33.9 mt -49.85 135.06 8.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.405 0 N-CA-C 113.436 0.902 . . . . 0.56000000000000005 113.436 -167.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.485 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -91.07 148.99 22.0 Favored 'General case' 0 N--CA 1.448 -0.527 0 CA-C-N 114.394 -1.275 . . . . 0.39000000000000001 111.432 -178.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.662 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 13.6 ttp180 -58.41 -14.49 7.8 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-N 114.937 -1.029 . . . . 3.0099999999999998 112.583 -177.332 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.673 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 10.4 tp10 -54.36 -38.82 66.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.9 0.381 . . . . 1.76 111.789 -179.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.92 ' OH ' ' HA ' ' A' ' 100' ' ' VAL . 39.2 m-85 -99.47 -23.94 14.94 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 112.581 0.586 . . . . 1.3999999999999999 112.581 -168.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.662 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 12.5 p90 -97.91 88.58 0.65 Allowed Pre-proline 0 C--N 1.321 -0.636 0 N-CA-C 105.996 -1.853 . . . . 0.46000000000000002 105.996 158.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -39.08 143.65 0.28 Allowed 'Trans proline' 0 C--N 1.349 0.587 0 C-N-CA 124.876 3.717 . . . . 0.70999999999999996 114.216 -157.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -58.95 -7.35 1.02 Allowed 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 114.907 -1.042 . . . . 0.93000000000000005 112.65 -177.204 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -82.7 -21.94 34.69 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.472 0.653 . . . . 2.6200000000000001 109.607 175.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 94.0 t80 -77.64 130.67 37.14 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.11 -0.95 . . . . 1.3300000000000001 109.466 178.389 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.3 m -68.57 100.35 1.1 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.032 0.444 . . . . 2.1800000000000002 110.339 179.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.414 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -83.22 103.02 12.3 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.683 -0.69 . . . . 1.74 110.634 -178.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 18.6 p80 -130.76 131.89 44.98 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 115.824 -0.625 . . . . 3.9900000000000002 109.856 177.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 81.15 -102.32 2.16 Favored Glycine 0 N--CA 1.444 -0.811 0 C-N-CA 120.558 -0.829 . . . . 1.0600000000000001 111.84 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 25.3 mmt180 -136.94 133.12 18.54 Favored Pre-proline 0 C--N 1.325 -0.495 0 N-CA-C 110.138 -0.319 . . . . 4.3700000000000001 110.138 -177.784 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 8.2 Cg_endo -60.0 156.48 38.87 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 121.417 1.412 . . . . 0.31 111.091 167.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.642 HD21 ' HG3' ' A' ' 91' ' ' LYS . 10.4 t30 -118.34 101.4 8.16 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.676 -0.49 . . . . 2.1400000000000001 109.676 -178.742 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.699 ' HB ' HD13 ' A' ' 70' ' ' LEU . 19.9 tt -54.79 -45.3 74.09 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.479 0 N-CA-C 113.598 0.962 . . . . 0.20999999999999999 113.598 -164.219 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.996 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 17.0 ptmt -56.42 -16.54 5.94 Favored 'General case' 0 CA--C 1.542 0.663 0 N-CA-C 112.838 0.681 . . . . 3.8199999999999998 112.838 176.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.503 ' HB3' HD22 ' A' ' 89' ' ' ASN . 34.6 t70 -118.18 1.34 11.91 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 121.521 0.676 . . . . 1.9099999999999999 110.624 179.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.564 HG22 ' HB3' ' A' ' 78' ' ' PHE . 45.3 t -105.58 -50.64 8.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.655 0.741 . . . . 0.33000000000000002 109.543 -175.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.681 ' HB3' HG12 ' A' ' 46' ' ' ILE . 81.6 mt -100.84 152.72 20.18 Favored 'General case' 0 N--CA 1.436 -1.151 0 CA-C-N 115.354 -0.839 . . . . 0.29999999999999999 109.172 178.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.75 149.09 30.8 Favored 'General case' 0 C--N 1.309 -1.171 0 CA-C-N 115.355 -0.839 . . . . 2.6699999999999999 109.389 174.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.538 ' HA ' HG22 ' A' ' 46' ' ' ILE . 31.0 mt-10 -56.24 123.93 16.24 Favored 'General case' 0 C--N 1.328 -0.367 0 O-C-N 123.722 0.639 . . . . 1.25 111.203 -174.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 109.2 -19.3 29.8 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-N 115.615 -0.721 . . . . 0.40999999999999998 112.151 -177.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.501 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 8.4 tt0 -77.14 133.4 38.99 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.054 -0.35 . . . . 1.1799999999999999 110.054 177.822 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -81.43 158.1 24.71 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.63 -0.714 . . . . 0.81000000000000005 110.97 179.014 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.92 ' HA ' ' OH ' ' A' ' 77' ' ' TYR . 27.5 m -137.41 146.19 28.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.043 -0.526 . . . . 0.17999999999999999 110.549 170.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.989 ' HB ' ' HG ' ' A' ' 122' ' ' LEU . 16.6 mm -93.83 110.14 23.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 N-CA-C 108.237 -1.023 . . . . 0.51000000000000001 108.237 169.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.539 ' CG2' HD22 ' A' ' 116' ' ' LEU . 3.4 m -144.32 129.76 14.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.759 0 CA-C-O 121.199 0.523 . . . . 0.28000000000000003 111.26 -172.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.523 ' HA ' ' HA ' ' A' ' 41' ' ' ILE . 15.6 pt20 -93.53 138.87 31.37 Favored 'General case' 0 C--N 1.314 -0.966 0 N-CA-C 108.507 -0.923 . . . . 1.6200000000000001 108.507 174.036 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.569 ' CD1' HD23 ' A' ' 116' ' ' LEU . 41.7 mm -80.54 96.21 2.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.615 0.721 . . . . 0.78000000000000003 109.338 176.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -72.87 -29.49 63.23 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 114.727 -1.124 . . . . 1.3 109.852 -178.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.438 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 32.3 mttm -129.07 123.97 33.64 Favored 'General case' 0 N--CA 1.445 -0.687 0 CA-C-N 114.958 -1.019 . . . . 2.5699999999999998 109.578 -175.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -79.26 158.71 27.52 Favored 'General case' 0 N--CA 1.442 -0.826 0 CA-C-N 115.95 -0.568 . . . . 2.5699999999999998 110.305 -176.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.898 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 22.5 tt0 -70.63 90.84 0.77 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.56 0.695 . . . . 3.1400000000000001 110.717 -174.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 14.4 ptm180 -111.26 6.98 20.95 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 114.862 -1.063 . . . . 3.4900000000000002 110.974 -177.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 97.36 -46.55 1.66 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.643 -0.789 . . . . 1.74 113.432 178.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 14.5 m120 -61.65 -50.84 70.89 Favored 'General case' 0 N--CA 1.471 0.603 0 CA-C-N 117.007 0.403 . . . . 2.8799999999999999 111.064 -174.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -121.8 -37.28 2.89 Favored 'General case' 0 C--N 1.319 -0.727 0 N-CA-C 108.631 -0.877 . . . . 3.4500000000000002 108.631 169.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.898 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 83.52 -133.4 11.85 Favored Glycine 0 N--CA 1.433 -1.559 0 CA-C-N 114.823 -1.081 . . . . 0.91000000000000003 111.098 175.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.476 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -73.02 96.87 2.22 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 121.155 0.502 . . . . 0.52000000000000002 110.309 -179.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.438 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -104.03 124.42 49.01 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.976 -0.556 . . . . 0.59999999999999998 111.528 -177.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.925 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 31.4 mt -91.4 159.77 15.81 Favored 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 109.049 -0.723 . . . . 0.34999999999999998 109.049 175.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.431 ' O ' HG12 ' A' ' 102' ' ' VAL . 12.8 t -138.08 153.4 49.31 Favored 'General case' 0 C--N 1.312 -1.061 0 N-CA-C 109.186 -0.672 . . . . 0.98999999999999999 109.186 168.001 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.413 HG23 HD11 ' A' ' 68' ' ' LEU . 0.7 OUTLIER -126.86 34.49 4.76 Favored 'General case' 0 C--N 1.315 -0.921 0 CA-C-O 121.302 0.572 . . . . 1.22 111.015 172.143 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -80.25 45.03 0.72 Allowed 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.357 -0.979 . . . . 4.1100000000000003 108.357 166.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.631 ' HB ' HD12 ' A' ' 122' ' ' LEU . 11.0 mt -121.36 168.14 14.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 114.471 -1.24 . . . . 0.94999999999999996 108.37 -171.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.444 ' H ' HG22 ' A' ' 120' ' ' ILE . 0.1 OUTLIER -85.03 33.48 0.54 Allowed 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 112.947 0.721 . . . . 1.25 112.947 -172.016 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.989 ' HG ' ' HB ' ' A' ' 101' ' ' ILE . 0.0 OUTLIER -117.2 100.19 7.54 Favored 'General case' 0 C--O 1.221 -0.443 0 CA-C-O 121.684 0.754 . . . . 1.3799999999999999 109.882 175.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.673 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . -161.66 37.67 0.13 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.712 -0.676 . . . . 1.3700000000000001 109.907 -179.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 62.49 -162.19 29.64 Favored Glycine 0 N--CA 1.447 -0.597 0 CA-C-N 115.052 -0.976 . . . . 2.7999999999999998 112.556 -176.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 49.2 m . . . . . 0 C--O 1.248 1.007 0 CA-C-O 118.845 -0.598 . . . . 5.1100000000000003 109.831 176.569 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.71 0 N-CA-C 111.985 -0.446 . . . . 9.9100000000000001 111.985 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -129.73 67.07 1.46 Allowed 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 120.981 0.419 . . . . 7.6600000000000001 109.972 177.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 21.9 t-80 -152.02 47.72 0.78 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.39 0.614 . . . . 8.75 110.269 -179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 1.9 mpt? -88.7 -44.86 10.27 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.518 0.675 . . . . 7.04 109.854 178.681 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 94.1 mt -128.48 -74.38 0.57 Allowed 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.067 -0.969 . . . . 4.54 110.497 179.131 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 38' ' ' LYS . 0.9 OUTLIER -139.34 -175.46 4.19 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.77 -0.65 . . . . 4.0700000000000003 110.555 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . 0.416 ' H ' ' CD ' ' A' ' 35' ' ' GLU . 28.8 mt-30 -122.38 100.49 6.97 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.048 -0.524 . . . . 4.3600000000000003 110.362 -172.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 54.9 mttp 65.31 20.22 11.81 Favored 'General case' 0 N--CA 1.468 0.452 0 CA-C-N 115.811 -0.631 . . . . 4.8499999999999996 110.19 -176.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.57 ' HE3' HG23 ' A' ' 120' ' ' ILE . 23.8 ttmm -131.31 162.96 28.89 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.441 -0.8 . . . . 2.02 109.905 -178.121 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.74 175.46 6.44 Favored 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 109.194 -0.669 . . . . 0.95999999999999996 109.194 171.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 64.2 t30 -55.69 124.03 16.09 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 121.084 0.469 . . . . 2.6200000000000001 110.948 -178.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.574 HG12 HG22 ' A' ' 101' ' ' ILE . 6.5 tp -95.33 144.35 10.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.881 -0.6 . . . . 0.83999999999999997 109.663 -178.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 88.6 m-85 -125.22 135.45 52.58 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-O 120.627 0.251 . . . . 1.02 110.449 -177.433 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 100' ' ' VAL . 40.0 ttmt -98.75 103.67 15.64 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 108.911 -0.774 . . . . 1.1599999999999999 108.911 167.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -124.94 161.89 19.35 Favored Glycine 0 N--CA 1.437 -1.245 0 N-CA-C 110.691 -0.964 . . . . 0.27000000000000002 110.691 179.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 84.6 mttt -94.45 158.06 15.73 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-O 121.171 0.51 . . . . 1.54 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.769 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.8 mp -74.57 133.69 31.02 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.593 0 N-CA-C 108.144 -1.058 . . . . 0.25 108.144 169.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.587 HG21 ' CB ' ' A' ' 59' ' ' ASP . 57.5 p -117.57 -20.09 9.14 Favored 'General case' 0 C--N 1.307 -1.27 0 CA-C-O 121.436 0.636 . . . . 0.39000000000000001 110.525 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.525 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 24.4 ttt180 -146.6 121.42 9.92 Favored 'General case' 0 N--CA 1.439 -0.982 0 CA-C-N 115.136 -0.938 . . . . 1.8500000000000001 109.677 178.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.769 ' CD1' HG21 ' A' ' 46' ' ' ILE . 75.4 mt -125.91 109.0 20.46 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.961 0 N-CA-C 109.147 -0.686 . . . . 0.26000000000000001 109.147 172.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.532 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 7.0 tp10 -104.47 107.78 58.77 Favored Pre-proline 0 C--N 1.318 -0.804 0 CA-C-N 115.221 -0.9 . . . . 2.2400000000000002 109.488 -175.682 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.605 ' HB3' ' CD ' ' A' ' 91' ' ' LYS . 54.3 Cg_exo -53.95 -37.94 86.08 Favored 'Trans proline' 0 N--CA 1.467 -0.07 0 C-N-CA 123.309 2.673 . . . . 0.52000000000000002 112.578 -178.295 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 36.5 t -62.28 -22.12 65.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.808 -0.633 . . . . 1.23 112.158 -176.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.532 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 2.0 pp -123.59 8.25 8.91 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 112.15 0.426 . . . . 0.46000000000000002 112.15 -176.527 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.43 ' HB2' HD23 ' A' ' 70' ' ' LEU . 8.0 pt-20 39.23 60.23 1.55 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 123.705 0.802 . . . . 2.5099999999999998 112.197 174.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.544 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -165.67 158.47 15.44 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 115.248 -0.887 . . . . 0.19 110.405 176.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.563 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -122.91 144.49 49.19 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 112.546 0.572 . . . . 0.17999999999999999 112.546 -174.13 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.552 ' HD1' ' HB2' ' A' ' 65' ' ' HIS . 63.1 m-85 -97.02 137.09 36.64 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.417 -0.811 . . . . 0.56000000000000005 109.844 173.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.449 ' HB ' HD11 ' A' ' 116' ' ' LEU . 38.4 t -120.47 129.67 75.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 116.019 -0.537 . . . . 0.26000000000000001 109.675 -179.351 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.587 ' CB ' HG21 ' A' ' 47' ' ' THR . 29.2 t70 -102.41 112.68 25.5 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 116.319 -0.401 . . . . 0.79000000000000004 111.384 -175.071 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 9.5 p90 -127.0 67.45 1.27 Allowed 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 109.047 -0.723 . . . . 0.89000000000000001 109.047 172.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 52.8 41.33 58.05 Favored Glycine 0 CA--C 1.521 0.412 0 CA-C-N 115.728 -0.669 . . . . 0.82999999999999996 112.153 -174.632 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -119.21 147.61 44.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.758 0.313 . . . . 0.85999999999999999 111.271 -172.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -78.66 -51.26 10.11 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.803 -0.814 . . . . 2.4300000000000002 108.803 177.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.911 ' HB2' ' HG3' ' A' ' 108' ' ' GLU . 26.7 mmm180 -96.23 106.61 18.83 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.224 -0.898 . . . . 4.5199999999999996 108.793 169.258 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.576 ' CE1' ' HB2' ' A' ' 59' ' ' ASP . 18.9 m170 -61.56 149.83 37.89 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.56 -0.745 . . . . 0.88 111.51 -176.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.538 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.08 110.31 3.14 Favored Glycine 0 N--CA 1.443 -0.891 0 N-CA-C 110.771 -0.931 . . . . 0.23999999999999999 110.771 175.185 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.544 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 9.5 t80 -98.87 100.58 11.78 Favored 'General case' 0 C--N 1.315 -0.894 0 CA-C-O 121.326 0.584 . . . . 0.40999999999999998 110.827 -173.38 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.94 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -92.15 115.09 64.06 Favored Pre-proline 0 C--N 1.323 -0.552 0 CA-C-N 115.09 -0.959 . . . . 0.16 110.94 -179.701 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.653 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.0 Cg_exo -64.07 141.07 75.14 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.864 2.376 . . . . 0.23000000000000001 111.562 172.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.831 ' HA ' HG13 ' A' ' 73' ' ' ILE . 10.3 tp -63.07 -34.93 78.65 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.605 -0.725 . . . . 0.19 111.722 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.0 pttm -63.08 -14.8 52.76 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.982 0.42 . . . . 2.04 111.083 -177.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.653 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 1.6 mm-40 -99.19 -14.45 19.31 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.049 -0.523 . . . . 0.85999999999999999 110.534 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.831 HG13 ' HA ' ' A' ' 70' ' ' LEU . 3.8 mt -49.31 134.05 7.47 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.518 0 N-CA-C 113.151 0.797 . . . . 0.56000000000000005 113.151 -169.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.521 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -87.05 146.5 26.07 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 114.814 -1.084 . . . . 0.39000000000000001 110.922 179.042 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.604 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 18.2 ttm180 -62.19 -13.51 28.29 Favored 'General case' 0 C--O 1.221 -0.434 0 CA-C-N 115.384 -0.825 . . . . 3.0099999999999998 111.806 -179.399 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.684 ' N ' ' HA ' ' A' ' 123' ' ' ALA . 15.0 tp10 -60.87 -27.22 67.96 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.084 0.468 . . . . 1.76 110.757 176.675 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.429 ' HD2' HG23 ' A' ' 73' ' ' ILE . 14.8 m-85 -87.45 -44.17 11.53 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.447 -0.797 . . . . 1.3999999999999999 110.353 -171.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.604 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.1 p90 -96.17 97.34 3.08 Favored Pre-proline 0 CA--C 1.511 -0.546 0 N-CA-C 107.098 -1.445 . . . . 0.46000000000000002 107.098 166.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.416 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.1 Cg_endo -38.65 138.02 0.54 Allowed 'Trans proline' 0 C--N 1.35 0.641 0 C-N-CA 124.306 3.337 . . . . 0.70999999999999996 112.776 -163.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . . . . . . . . . . . -54.69 -10.28 0.43 Allowed 'General case' 0 C--N 1.317 -0.813 0 CA-C-N 115.395 -0.821 . . . . 0.93000000000000005 113.193 -177.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -87.02 -12.6 46.87 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.349 0.595 . . . . 2.6200000000000001 110.317 176.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -75.88 143.5 41.7 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.782 -0.644 . . . . 1.3300000000000001 109.688 177.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 6.9 m -79.52 100.64 7.83 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.37 -0.377 . . . . 2.1800000000000002 110.957 -177.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.476 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -87.04 123.4 32.08 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.381 -0.372 . . . . 1.74 110.182 176.141 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 7.3 t60 -96.57 -20.43 18.35 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.007 0.432 . . . . 3.9900000000000002 110.373 -176.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 174.72 -77.14 0.08 OUTLIER Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.914 -0.66 . . . . 1.0600000000000001 111.572 179.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 15.3 ptm180 -104.84 132.57 20.77 Favored Pre-proline 0 C--N 1.322 -0.594 0 N-CA-C 110.043 -0.355 . . . . 4.3700000000000001 110.043 176.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.417 ' C ' HD11 ' A' ' 70' ' ' LEU . 11.5 Cg_endo -64.66 161.78 34.2 Favored 'Trans proline' 0 N--CA 1.457 -0.645 0 C-N-CA 122.116 1.877 . . . . 0.31 111.975 171.719 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.894 HD22 ' HB3' ' A' ' 92' ' ' ASP . 0.3 OUTLIER -122.11 102.62 8.26 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 116.04 -0.527 . . . . 2.1400000000000001 109.78 177.361 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.684 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 17.3 tt -54.85 -40.16 51.41 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.417 0 N-CA-C 113.699 1.0 . . . . 0.20999999999999999 113.699 -162.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.605 ' CD ' ' HB3' ' A' ' 51' ' ' PRO . 43.2 pttt -67.65 -11.6 58.59 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 111.953 0.353 . . . . 3.8199999999999998 111.953 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.894 ' HB3' HD22 ' A' ' 89' ' ' ASN . 37.0 t70 -125.53 18.25 8.14 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 122.159 0.98 . . . . 1.9099999999999999 109.359 177.54 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.576 HG13 ' HB3' ' A' ' 78' ' ' PHE . 18.1 t -122.5 -54.77 2.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.107 -0.951 . . . . 0.33000000000000002 110.198 -178.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.524 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 47.8 mt -101.09 153.34 19.65 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-N 115.429 -0.805 . . . . 0.29999999999999999 109.55 178.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . 0.768 ' HD3' HE21 ' A' ' 98' ' ' GLN . 0.1 OUTLIER -125.43 150.53 47.21 Favored 'General case' 0 N--CA 1.439 -0.999 0 N-CA-C 109.106 -0.702 . . . . 2.6699999999999999 109.106 173.727 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.66 ' HA ' HG22 ' A' ' 46' ' ' ILE . 42.2 mt-10 -69.95 109.31 4.44 Favored 'General case' 0 C--N 1.31 -1.117 0 N-CA-C 108.257 -1.016 . . . . 1.25 108.257 173.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 115.21 -11.46 19.81 Favored Glycine 0 N--CA 1.443 -0.881 0 CA-C-N 115.438 -0.801 . . . . 0.40999999999999998 112.15 -168.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.768 HE21 ' HD3' ' A' ' 95' ' ' ARG . 9.1 tt0 -80.29 144.71 32.6 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-N 117.206 0.503 . . . . 1.1799999999999999 109.966 173.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -87.69 153.71 21.15 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 121.32 0.581 . . . . 0.81000000000000005 111.612 179.379 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 102' ' ' VAL . 27.3 m -136.29 146.4 29.12 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.088 -0.96 . . . . 0.17999999999999999 109.018 169.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.896 ' HB ' HD11 ' A' ' 122' ' ' LEU . 4.3 mm -100.42 109.12 24.37 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 N-CA-C 107.571 -1.27 . . . . 0.51000000000000001 107.571 171.488 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.523 ' CG2' HD22 ' A' ' 116' ' ' LEU . 4.8 m -145.5 142.63 22.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 116.021 -0.536 . . . . 0.28000000000000003 110.717 -170.317 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.48 ' HG3' HG22 ' A' ' 117' ' ' THR . 0.0 OUTLIER -104.4 166.28 10.51 Favored 'General case' 0 C--N 1.318 -0.77 0 N-CA-C 109.381 -0.6 . . . . 1.6200000000000001 109.381 175.807 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.477 ' CD1' HD23 ' A' ' 116' ' ' LEU . 18.7 mm -108.53 98.13 6.61 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.829 0 CA-C-O 121.629 0.728 . . . . 0.78000000000000003 110.072 179.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -83.71 -29.41 27.56 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.066 -0.97 . . . . 1.3 110.381 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 36.1 mmtm -117.65 136.35 53.38 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.211 -0.449 . . . . 2.5699999999999998 109.895 174.444 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.526 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 28.2 mt-10 -97.56 158.25 15.59 Favored 'General case' 0 N--CA 1.44 -0.933 0 CA-C-N 115.417 -0.81 . . . . 2.5699999999999998 110.447 -166.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.911 ' HG3' ' HB2' ' A' ' 64' ' ' ARG . 24.8 tt0 -51.25 112.21 0.7 Allowed 'General case' 0 C--N 1.331 -0.239 0 O-C-N 123.547 0.529 . . . . 3.1400000000000001 110.803 -178.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.917 ' H ' ' HA2' ' A' ' 113' ' ' GLY . 12.7 ptm180 -146.65 49.28 1.15 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.454 -0.794 . . . . 3.4900000000000002 110.382 -175.345 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 75.34 -96.25 1.0 Allowed Glycine 0 N--CA 1.448 -0.514 0 CA-C-N 115.788 -0.642 . . . . 1.74 113.991 176.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 27.3 t-20 -60.66 -47.86 84.34 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 113.004 0.742 . . . . 2.8799999999999999 113.004 -167.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 22.2 tptm -110.86 -40.28 4.58 Favored 'General case' 0 CA--C 1.512 -0.486 0 C-N-CA 120.143 -0.623 . . . . 3.4500000000000002 110.144 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.917 ' HA2' ' H ' ' A' ' 109' ' ' ARG . . . 60.88 -121.51 26.8 Favored Glycine 0 N--CA 1.437 -1.255 0 CA-C-N 115.487 -0.778 . . . . 0.91000000000000003 112.509 174.268 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.538 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -72.99 101.08 3.12 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.164 0.506 . . . . 0.52000000000000002 110.607 -177.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.622 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -98.59 124.0 43.11 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 116.248 -0.433 . . . . 0.59999999999999998 110.907 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.94 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 46.9 mt -90.93 136.75 32.86 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.942 -0.572 . . . . 0.34999999999999998 109.732 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.48 HG22 ' HG3' ' A' ' 103' ' ' GLN . 5.0 t -96.82 168.17 10.65 Favored 'General case' 0 C--N 1.32 -0.698 0 N-CA-C 109.284 -0.635 . . . . 0.98999999999999999 109.284 173.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.61 HG23 HD21 ' A' ' 68' ' ' LEU . 2.0 p -136.01 13.99 3.33 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 121.155 0.502 . . . . 1.22 111.159 174.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -80.91 57.52 3.08 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.246 -1.02 . . . . 4.1100000000000003 108.246 171.685 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 121' ' ' SER . 8.1 mt -127.9 175.5 9.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-N 113.975 -1.466 . . . . 0.94999999999999996 108.648 -171.516 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.586 ' H ' HG22 ' A' ' 120' ' ' ILE . 14.6 m -75.61 33.52 0.11 Allowed 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 112.448 0.536 . . . . 1.25 112.448 -176.616 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.896 HD11 ' HB ' ' A' ' 101' ' ' ILE . 4.2 mp -116.34 124.22 49.56 Favored 'General case' 0 C--N 1.321 -0.638 0 O-C-N 122.349 -0.219 . . . . 1.3799999999999999 111.496 -178.01 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.684 ' HA ' ' N ' ' A' ' 76' ' ' GLU . . . 159.07 34.45 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.441 0 O-C-N 124.911 1.382 . . . . 1.3700000000000001 109.149 170.263 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 88.09 -90.18 1.65 Allowed Glycine 0 N--CA 1.444 -0.767 0 N-CA-C 110.669 -0.972 . . . . 2.7999999999999998 110.669 -173.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 64.7 m . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.667 -0.682 . . . . 5.1100000000000003 109.789 174.468 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.774 -0.531 . . . . 9.9100000000000001 111.774 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -92.62 62.96 3.93 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.629 -0.508 . . . . 7.6600000000000001 109.629 -179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -56.95 -22.58 39.01 Favored 'General case' 0 N--CA 1.466 0.342 0 N-CA-C 113.032 0.753 . . . . 8.75 113.032 -175.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 65.6 mtt -67.72 -27.31 66.7 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.317 0.58 . . . . 7.04 110.454 177.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 88.6 mt -103.0 -46.37 4.67 Favored 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 115.459 -0.791 . . . . 4.54 110.315 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.518 ' O ' ' HG2' ' A' ' 38' ' ' LYS . 31.6 mt-10 -61.73 -64.04 1.07 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.25 -0.886 . . . . 4.0700000000000003 111.187 -179.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 67.12 -69.06 0.14 Allowed 'General case' 0 N--CA 1.465 0.316 0 O-C-N 123.918 0.761 . . . . 4.3600000000000003 111.011 178.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 31.8 ttpt -122.5 -21.15 5.82 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.25 -0.432 . . . . 4.8499999999999996 109.954 178.161 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.518 ' HG2' ' O ' ' A' ' 35' ' ' GLU . 15.1 pttm -87.58 175.56 7.86 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.277 -0.42 . . . . 2.02 110.597 -177.21 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -88.11 173.59 8.75 Favored 'General case' 0 N--CA 1.446 -0.633 0 N-CA-C 108.676 -0.861 . . . . 0.95999999999999996 108.676 173.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 9.1 t-20 -61.66 124.95 22.11 Favored 'General case' 0 C--N 1.318 -0.775 0 CA-C-O 121.378 0.609 . . . . 2.6200000000000001 110.783 -175.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.477 HD12 ' HB3' ' A' ' 103' ' ' GLN . 7.3 tp -94.18 143.96 10.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.871 0 CA-C-N 115.194 -0.912 . . . . 0.83999999999999997 110.098 -174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 93.1 m-85 -128.22 144.09 51.09 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.05 0.452 . . . . 1.02 110.968 -177.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 99' ' ' GLU . 2.4 tppp? -112.42 117.61 32.9 Favored 'General case' 0 C--N 1.317 -0.822 0 CA-C-N 115.307 -0.86 . . . . 1.1599999999999999 109.389 173.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -153.11 177.63 30.64 Favored Glycine 0 N--CA 1.44 -1.054 0 N-CA-C 110.629 -0.988 . . . . 0.27000000000000002 110.629 -179.147 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.451 ' HD2' ' HA2' ' A' ' 97' ' ' GLY . 39.2 mtmt -116.52 159.11 22.58 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.64 0.733 . . . . 1.54 111.88 -179.24 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.749 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -68.42 137.77 23.8 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.04 0 CA-C-N 114.322 -1.308 . . . . 0.25 110.089 176.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.689 HG21 ' HB2' ' A' ' 59' ' ' ASP . 47.5 p -126.56 -20.18 4.41 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.132 -0.485 . . . . 0.39000000000000001 111.689 179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.684 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 8.3 ttm180 -148.08 122.02 9.4 Favored 'General case' 0 N--CA 1.442 -0.839 0 CA-C-N 116.072 -0.513 . . . . 1.8500000000000001 110.09 176.152 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.749 ' CD1' HG21 ' A' ' 46' ' ' ILE . 88.2 mt -128.87 108.74 17.67 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.851 0 N-CA-C 109.146 -0.687 . . . . 0.26000000000000001 109.146 174.474 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.568 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 17.3 tt0 -102.89 121.05 50.59 Favored Pre-proline 0 C--N 1.319 -0.752 0 CA-C-N 115.894 -0.594 . . . . 2.2400000000000002 109.688 -174.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.569 ' HG3' ' CD ' ' A' ' 91' ' ' LYS . 12.2 Cg_exo -65.8 -31.25 48.71 Favored 'Trans proline' 0 N--CA 1.464 -0.237 0 C-N-CA 122.977 2.451 . . . . 0.52000000000000002 112.759 -171.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 24.8 t -77.03 -10.11 59.15 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.231 -0.44 . . . . 1.23 111.657 -175.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.568 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 3.1 pp -127.82 5.77 6.06 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 112.728 0.64 . . . . 0.46000000000000002 112.728 -179.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.405 ' HB2' HD23 ' A' ' 70' ' ' LEU . 11.2 pt-20 43.47 55.55 4.81 Favored 'General case' 0 C--N 1.347 0.464 0 CA-C-O 121.352 0.596 . . . . 2.5099999999999998 112.095 170.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.48 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -163.0 158.98 22.86 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.461 -0.79 . . . . 0.19 110.365 178.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.546 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -129.1 140.26 51.64 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 112.873 0.694 . . . . 0.17999999999999999 112.873 -171.824 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.711 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 53.0 m-85 -92.43 128.61 38.34 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.134 -0.939 . . . . 0.56000000000000005 110.119 172.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.535 HG12 ' HD1' ' A' ' 60' ' ' TYR . 76.5 t -108.54 131.01 60.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.754 0 CA-C-O 121.25 0.547 . . . . 0.26000000000000001 109.884 176.617 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.689 ' HB2' HG21 ' A' ' 47' ' ' THR . 10.6 t70 -101.49 96.49 7.17 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.715 -0.675 . . . . 0.79000000000000004 110.664 -177.62 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.661 ' OH ' HD11 ' A' ' 104' ' ' ILE . 15.5 p90 -126.88 66.29 1.27 Allowed 'General case' 0 C--N 1.32 -0.706 0 N-CA-C 109.032 -0.729 . . . . 0.89000000000000001 109.032 173.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 59.39 11.67 15.03 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 120.759 -0.734 . . . . 0.82999999999999996 112.533 -173.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -83.61 110.71 18.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 CA-C-O 120.843 0.354 . . . . 0.85999999999999999 110.305 -177.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.2 mt-10 -74.63 -18.68 60.51 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 115.749 -0.66 . . . . 2.4300000000000002 110.637 -177.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.677 ' HA ' ' HE ' ' A' ' 64' ' ' ARG . 2.9 mmp_? -95.63 -6.82 39.25 Favored 'General case' 0 C--N 1.321 -0.659 0 CA-C-N 115.893 -0.594 . . . . 4.5199999999999996 110.371 173.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.711 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.4 OUTLIER 59.18 107.07 0.02 OUTLIER 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 115.238 -0.892 . . . . 0.88 111.924 -179.44 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.461 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -59.61 122.06 28.8 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.431 -0.89 . . . . 0.23999999999999999 111.151 -179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.506 ' HZ ' HD13 ' A' ' 53' ' ' LEU . 5.7 t80 -111.28 107.67 17.04 Favored 'General case' 0 C--N 1.315 -0.906 0 CA-C-O 121.283 0.563 . . . . 0.40999999999999998 110.524 -173.422 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.762 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.3 118.58 67.71 Favored Pre-proline 0 C--N 1.322 -0.616 0 CA-C-N 115.326 -0.852 . . . . 0.16 110.84 179.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.57 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 27.5 Cg_exo -64.87 134.9 42.16 Favored 'Trans proline' 0 N--CA 1.465 -0.204 0 C-N-CA 122.501 2.134 . . . . 0.23000000000000001 111.052 169.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.691 ' HA ' HG13 ' A' ' 73' ' ' ILE . 12.3 tp -57.19 -31.91 65.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.916 -0.583 . . . . 0.19 111.961 -178.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.525 ' HG3' ' OE2' ' A' ' 72' ' ' GLU . 21.3 pttp -70.2 -8.18 47.88 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 116.448 -0.342 . . . . 2.04 111.529 -178.269 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.57 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 6.1 mm-40 -103.65 -10.03 18.71 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 110.423 -0.214 . . . . 0.85999999999999999 110.423 179.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.691 HG13 ' HA ' ' A' ' 70' ' ' LEU . 18.5 mt -60.77 133.54 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.245 0 N-CA-C 112.658 0.614 . . . . 0.56000000000000005 112.658 -170.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.443 ' HB2' ' O ' ' A' ' 118' ' ' THR . . . -77.92 140.51 39.28 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.254 -0.884 . . . . 0.39000000000000001 111.208 178.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.753 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 29.6 ttp180 -58.62 -13.81 6.71 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 115.223 -0.899 . . . . 3.0099999999999998 112.397 177.517 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.927 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 25.3 tp10 -56.25 -29.94 61.73 Favored 'General case' 0 N--CA 1.469 0.51 0 O-C-N 121.437 -0.79 . . . . 1.76 111.351 177.76 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.543 ' CZ ' HD22 ' A' ' 122' ' ' LEU . 34.0 m-85 -85.32 -41.03 15.88 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.555 -0.748 . . . . 1.3999999999999999 110.894 -172.002 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.753 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 6.4 p90 -102.0 96.73 7.15 Favored Pre-proline 0 C--N 1.321 -0.646 0 N-CA-C 106.963 -1.495 . . . . 0.46000000000000002 106.963 167.365 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.478 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.7 Cg_endo -32.01 138.7 0.05 OUTLIER 'Trans proline' 0 C--N 1.346 0.441 1 C-N-CA 125.676 4.251 . . . . 0.70999999999999996 114.704 -162.186 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.634 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -51.13 -24.17 3.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 114.638 -1.164 . . . . 0.93000000000000005 113.699 -176.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 62.4 t30 -92.92 4.8 53.29 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 121.58 0.705 . . . . 2.6200000000000001 110.67 -179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -84.78 132.13 34.46 Favored 'General case' 0 C--N 1.32 -0.674 0 N-CA-C 108.662 -0.866 . . . . 1.3300000000000001 108.662 175.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 1.4 p -65.81 99.96 0.51 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 2.1800000000000002 111.821 -175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.468 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -90.25 58.22 3.99 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.575 -0.738 . . . . 1.74 110.041 178.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 8.3 p80 -80.17 56.66 2.5 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 121.442 0.639 . . . . 3.9900000000000002 110.48 -177.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 147.5 -120.82 1.29 Allowed Glycine 0 N--CA 1.443 -0.836 0 CA-C-N 115.732 -0.667 . . . . 1.0600000000000001 111.995 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 78.5 mtm180 -119.68 130.95 24.58 Favored Pre-proline 0 C--N 1.318 -0.767 0 N-CA-C 109.804 -0.443 . . . . 4.3700000000000001 109.804 -179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.569 ' HB2' HG21 ' A' ' 93' ' ' VAL . 8.5 Cg_endo -58.74 144.71 97.9 Favored 'Trans proline' 0 N--CA 1.461 -0.423 0 C-N-CA 121.987 1.792 . . . . 0.31 111.742 174.346 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 93' ' ' VAL . 7.9 t30 -98.75 118.55 35.74 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.346 -0.612 . . . . 2.1400000000000001 109.346 174.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.579 ' HB ' ' HB2' ' A' ' 70' ' ' LEU . 13.7 tt -57.63 -47.54 85.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 113.863 1.06 . . . . 0.20999999999999999 113.863 -164.143 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.569 ' CD ' ' HG3' ' A' ' 51' ' ' PRO . 15.1 mtpt -66.25 -6.52 14.05 Favored 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.076 0.769 . . . . 3.8199999999999998 113.076 177.712 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -112.76 5.04 17.39 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.377 0.608 . . . . 1.9099999999999999 110.22 176.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.569 HG21 ' HB2' ' A' ' 88' ' ' PRO . 69.0 t -117.62 -52.74 4.27 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.463 -0.789 . . . . 0.33000000000000002 109.852 -179.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.441 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.6 mt -101.7 154.78 18.58 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-N 115.244 -0.889 . . . . 0.29999999999999999 109.175 177.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -146.34 150.42 35.68 Favored 'General case' 0 C--N 1.316 -0.891 0 N-CA-C 109.535 -0.543 . . . . 2.6699999999999999 109.535 172.382 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.65 ' HA ' HG22 ' A' ' 46' ' ' ILE . 48.3 mt-10 -57.0 110.97 0.91 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.949 -0.569 . . . . 1.25 109.991 178.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . 0.451 ' HA2' ' HD2' ' A' ' 45' ' ' LYS . . . 112.96 -1.05 25.7 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.857 -0.687 . . . . 0.40999999999999998 112.242 -174.117 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.482 ' NE2' ' HB3' ' A' ' 77' ' ' TYR . 22.8 tt0 -95.96 135.53 37.61 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.832 -0.433 . . . . 1.1799999999999999 109.832 175.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . 0.401 ' HB2' ' HD2' ' A' ' 43' ' ' LYS . 11.7 pt-20 -82.77 157.54 23.18 Favored 'General case' 0 C--N 1.324 -0.523 0 O-C-N 123.463 0.477 . . . . 0.81000000000000005 111.815 -177.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.512 HG23 HG22 ' A' ' 102' ' ' VAL . 34.2 m -141.2 152.59 19.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.594 0 CA-C-N 115.115 -0.948 . . . . 0.17999999999999999 109.741 171.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.801 ' HB ' HD11 ' A' ' 122' ' ' LEU . 23.5 mm -103.35 110.66 30.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 N-CA-C 108.356 -0.979 . . . . 0.51000000000000001 108.356 168.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.512 HG22 HG23 ' A' ' 100' ' ' VAL . 2.5 m -139.1 130.57 35.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.803 0 CA-C-O 121.218 0.532 . . . . 0.28000000000000003 112.127 -170.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.481 ' OE1' ' HB2' ' A' ' 38' ' ' LYS . 10.1 pt20 -104.68 157.32 17.26 Favored 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.167 -1.049 . . . . 1.6200000000000001 108.167 170.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.661 HD11 ' OH ' ' A' ' 60' ' ' TYR . 20.6 mm -81.02 102.92 7.32 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.855 0 CA-C-O 121.779 0.799 . . . . 0.78000000000000003 110.861 -179.301 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.467 ' OD2' ' HG3' ' A' ' 106' ' ' LYS . 8.9 t70 -71.44 -44.24 65.2 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 114.104 -1.407 . . . . 1.3 110.33 -179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.467 ' HG3' ' OD2' ' A' ' 105' ' ' ASP . 63.0 mttp -125.37 156.76 38.26 Favored 'General case' 0 CA--C 1.503 -0.831 0 CA-C-O 121.48 0.657 . . . . 2.5699999999999998 111.183 177.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -92.3 155.88 17.64 Favored 'General case' 0 N--CA 1.436 -1.162 0 CA-C-N 114.597 -1.183 . . . . 2.5699999999999998 111.548 -162.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.613 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 19.1 mt-10 -69.17 89.59 0.46 Allowed 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.113 -0.949 . . . . 3.1400000000000001 110.783 -172.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 56.1 mtp180 -93.3 9.25 37.06 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.494 -1.23 . . . . 3.4900000000000002 110.497 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 79.27 -63.92 3.84 Favored Glycine 0 N--CA 1.449 -0.469 0 C-N-CA 120.92 -0.657 . . . . 1.74 112.157 -176.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.8 t-20 -64.7 -31.85 73.25 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.503 0.192 . . . . 2.8799999999999999 111.505 -179.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 38.9 mtpt -118.84 -39.68 2.94 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 121.388 0.614 . . . . 3.4500000000000002 109.464 178.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.613 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 75.85 -140.05 25.3 Favored Glycine 0 N--CA 1.44 -1.099 0 CA-C-N 114.726 -1.125 . . . . 0.91000000000000003 112.858 167.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.461 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -81.72 91.71 6.5 Favored 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 120.944 0.402 . . . . 0.52000000000000002 110.821 -174.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.451 ' HB3' ' H ' ' A' ' 106' ' ' LYS . . . -79.15 123.66 27.59 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.208 -0.451 . . . . 0.59999999999999998 111.295 -176.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.762 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 65.4 mt -91.91 161.06 14.98 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 116.08 -0.509 . . . . 0.34999999999999998 110.014 178.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.595 HG23 HD11 ' A' ' 120' ' ' ILE . 15.3 t -141.31 156.3 45.87 Favored 'General case' 0 C--N 1.316 -0.877 0 N-CA-C 108.888 -0.782 . . . . 0.98999999999999999 108.888 171.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.443 ' O ' ' HB2' ' A' ' 74' ' ' ALA . 0.7 OUTLIER -137.33 41.86 2.4 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.451 0.643 . . . . 1.22 112.507 178.677 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 91.9 m-85 -96.53 33.17 1.86 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.148 -1.056 . . . . 4.1100000000000003 108.148 167.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.595 HD11 HG23 ' A' ' 117' ' ' THR . 0.8 OUTLIER -119.77 93.85 2.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 114.684 -1.143 . . . . 0.94999999999999996 111.06 -171.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . . . . . . . . . 24.3 m 69.84 -30.03 0.19 Allowed 'General case' 0 CA--C 1.545 0.78 0 N-CA-C 114.602 1.334 . . . . 1.25 114.602 170.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.801 HD11 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -83.25 173.47 11.59 Favored 'General case' 0 C--O 1.235 0.302 0 O-C-N 121.687 -0.633 . . . . 1.3799999999999999 111.264 -176.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.927 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 88.77 47.1 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.413 0 O-C-N 124.966 1.416 . . . . 1.3700000000000001 109.979 -178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 74.03 -122.29 7.46 Favored Glycine 0 N--CA 1.443 -0.89 0 CA-C-N 114.911 -1.04 . . . . 2.7999999999999998 112.119 -179.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.688 -0.672 . . . . 5.1100000000000003 109.958 179.098 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.633 0 N-CA-C 111.882 -0.487 . . . . 9.9100000000000001 111.882 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 13.3 m -127.9 21.6 6.35 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-O 120.47 0.176 . . . . 7.6600000000000001 110.838 -177.155 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . 0.534 ' O ' ' HG3' ' A' ' 33' ' ' MET . 38.7 m80 61.0 -153.4 0.37 Allowed 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 109.202 -0.666 . . . . 8.75 109.202 -174.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . 0.585 ' SD ' ' HG ' ' A' ' 34' ' ' LEU . 4.7 ppp? 51.67 8.8 0.06 Allowed 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 124.272 1.029 . . . . 7.04 112.413 -175.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.585 ' HG ' ' SD ' ' A' ' 33' ' ' MET . 73.0 mt -137.21 -173.35 3.44 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 108.514 -0.921 . . . . 4.54 108.514 176.073 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -86.27 105.17 16.45 Favored 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 113.018 0.747 . . . . 4.0700000000000003 113.018 -170.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -81.77 67.37 7.72 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.21 -0.663 . . . . 4.3600000000000003 109.21 167.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 87.2 mttt 67.63 20.28 9.65 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 115.779 -0.646 . . . . 4.8499999999999996 110.901 -176.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.519 ' HG3' ' O ' ' A' ' 39' ' ' ALA . 0.2 OUTLIER -115.24 -172.22 2.1 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.123 -0.49 . . . . 2.02 110.376 -178.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.519 ' O ' ' HG3' ' A' ' 38' ' ' LYS . . . -81.38 171.85 14.27 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.585 -0.895 . . . . 0.95999999999999996 108.585 169.176 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.495 ' O ' ' HA ' ' A' ' 103' ' ' GLN . 39.7 m-80 -62.35 102.2 0.29 Allowed 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.847 0.356 . . . . 2.6200000000000001 111.395 -177.048 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.831 HD11 HG22 ' A' ' 101' ' ' ILE . 9.6 tp -82.71 134.47 26.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.958 -0.564 . . . . 0.83999999999999997 110.365 -178.637 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 69.8 m-85 -132.02 145.58 51.54 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 121.226 0.536 . . . . 1.02 110.72 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.3 tptm -109.65 107.27 17.26 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 115.184 -0.916 . . . . 1.1599999999999999 108.81 177.035 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -145.34 166.25 27.69 Favored Glycine 0 N--CA 1.444 -0.77 0 C-N-CA 120.153 -1.022 . . . . 0.27000000000000002 111.855 -175.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.454 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 30.9 mtmt -106.09 159.39 16.11 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.3 0.571 . . . . 1.54 111.262 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.828 HG21 ' CD1' ' A' ' 49' ' ' ILE . 1.7 mp -70.58 141.89 16.4 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 CA-C-N 114.876 -1.056 . . . . 0.25 110.436 176.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.556 HG21 ' HB2' ' A' ' 59' ' ' ASP . 65.3 p -131.22 -0.21 4.09 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.203 -0.453 . . . . 0.39000000000000001 111.501 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.448 ' HB3' ' HB2' ' A' ' 57' ' ' PHE . 31.3 ttt-85 -164.52 125.02 2.06 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 116.314 -0.403 . . . . 1.8500000000000001 110.409 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.828 ' CD1' HG21 ' A' ' 46' ' ' ILE . 88.5 mt -141.45 119.28 8.79 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.877 0 N-CA-C 109.622 -0.51 . . . . 0.26000000000000001 109.622 176.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.484 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 3.5 mt-10 -117.86 130.1 24.93 Favored Pre-proline 0 C--N 1.316 -0.875 0 CA-C-N 116.205 -0.452 . . . . 2.2400000000000002 110.847 178.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.956 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 16.0 Cg_exo -68.95 -14.94 39.62 Favored 'Trans proline' 0 N--CA 1.463 -0.274 0 C-N-CA 122.755 2.303 . . . . 0.52000000000000002 111.324 175.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 2.6 m -73.09 -36.32 66.78 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.613 -0.721 . . . . 1.23 110.817 178.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.4 HD11 ' HB2' ' A' ' 50' ' ' GLU . 1.1 pp -118.24 5.8 11.93 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.064 -0.516 . . . . 0.46000000000000002 112.157 -172.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 40.43 57.35 2.54 Favored 'General case' 0 C--O 1.236 0.373 0 O-C-N 123.953 0.783 . . . . 2.5099999999999998 111.537 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.444 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.16 166.63 16.87 Favored 'General case' 0 N--CA 1.447 -0.596 0 CA-C-N 115.303 -0.862 . . . . 0.19 110.568 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.501 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -136.34 148.08 47.72 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 112.642 0.608 . . . . 0.17999999999999999 112.642 -172.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.624 ' HD1' ' HB3' ' A' ' 65' ' ' HIS . 45.1 m-85 -101.13 132.3 46.66 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.526 -0.761 . . . . 0.56000000000000005 110.09 173.428 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.495 ' HB ' HD11 ' A' ' 116' ' ' LEU . 25.0 t -108.9 136.62 44.16 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-O 121.066 0.46 . . . . 0.26000000000000001 110.218 177.778 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.556 ' HB2' HG21 ' A' ' 47' ' ' THR . 27.4 t70 -108.88 107.72 18.23 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.812 -0.631 . . . . 0.79000000000000004 111.396 -178.223 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.411 ' HD1' HG12 ' A' ' 58' ' ' VAL . 23.3 p90 -127.24 65.8 1.31 Allowed 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 108.939 -0.763 . . . . 0.89000000000000001 108.939 171.567 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 55.48 19.32 18.28 Favored Glycine 0 CA--C 1.522 0.528 0 C-N-CA 120.708 -0.758 . . . . 0.82999999999999996 112.054 -171.191 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.9 141.81 37.31 Favored 'General case' 0 CA--C 1.517 -0.307 0 C-N-CA 122.408 0.283 . . . . 0.85999999999999999 110.873 -173.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -96.79 -21.21 17.67 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.132 -0.485 . . . . 2.4300000000000002 110.994 -175.324 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.608 ' HA ' ' NE ' ' A' ' 64' ' ' ARG . 2.6 mmp_? -106.38 -13.14 15.45 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.646 0.26 . . . . 4.5199999999999996 110.802 174.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.624 ' HB3' ' HD1' ' A' ' 57' ' ' PHE . 0.5 OUTLIER 70.51 116.27 0.04 OUTLIER 'General case' 0 N--CA 1.468 0.434 0 CA-C-N 115.435 -0.802 . . . . 0.88 111.755 178.581 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -63.88 118.19 12.66 Favored Glycine 0 N--CA 1.448 -0.515 0 CA-C-N 115.518 -0.764 . . . . 0.23999999999999999 111.877 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.444 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 15.8 t80 -105.16 112.25 25.3 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-O 121.169 0.509 . . . . 0.40999999999999998 110.806 -175.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.983 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -101.31 117.69 61.6 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 115.517 -0.765 . . . . 0.16 111.137 179.228 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.479 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 35.1 Cg_exo -63.84 145.03 90.08 Favored 'Trans proline' 0 CA--C 1.528 0.182 0 C-N-CA 122.882 2.388 . . . . 0.23000000000000001 111.637 170.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.684 HD13 ' HB ' ' A' ' 90' ' ' ILE . 13.2 tp -65.87 -34.48 78.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.106 -0.497 . . . . 0.19 111.649 -179.189 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 54.7 pttt -61.51 -22.87 65.5 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 121.045 0.45 . . . . 2.04 110.835 -179.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.479 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 29.5 mm-40 -79.22 -29.78 42.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.914 -0.585 . . . . 0.85999999999999999 110.387 178.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.749 HG21 HG11 ' A' ' 93' ' ' VAL . 5.5 mt -48.03 125.63 2.43 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.237 0 N-CA-C 113.386 0.884 . . . . 0.56000000000000005 113.386 -165.618 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -87.53 155.35 20.02 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 114.298 -1.319 . . . . 0.39000000000000001 110.369 176.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.639 ' HA ' ' CE1' ' A' ' 78' ' ' PHE . 24.7 ttm180 -61.99 -13.72 28.36 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.003 -0.998 . . . . 3.0099999999999998 112.407 -177.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 1.076 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 6.8 tp10 -60.79 -23.37 64.97 Favored 'General case' 0 N--CA 1.471 0.588 0 O-C-N 121.624 -0.673 . . . . 1.76 110.477 175.853 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.432 ' CD2' HG23 ' A' ' 73' ' ' ILE . 10.2 m-30 -84.88 -46.16 11.57 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.553 -0.749 . . . . 1.3999999999999999 109.617 -175.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.639 ' CE1' ' HA ' ' A' ' 75' ' ' ARG . 3.5 p90 -103.64 94.71 6.42 Favored Pre-proline 0 C--N 1.326 -0.443 0 N-CA-C 107.895 -1.15 . . . . 0.46000000000000002 107.895 170.023 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 31.0 Cg_exo -26.93 137.08 0.02 OUTLIER 'Trans proline' 0 C--N 1.349 0.594 1 C-N-CA 125.67 4.246 . . . . 0.70999999999999996 115.468 -166.696 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.432 ' HA ' ' CD ' ' A' ' 75' ' ' ARG . . . -50.36 -18.32 0.61 Allowed 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 114.044 1.128 . . . . 0.93000000000000005 114.044 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 80.2 m-20 -95.9 -7.23 37.3 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 120.785 0.326 . . . . 2.6200000000000001 111.406 179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 60.1 t80 -71.34 141.36 50.43 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.481 -0.563 . . . . 1.3300000000000001 109.481 -179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 49.0 m -66.84 102.79 1.0 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 121.098 0.475 . . . . 2.1800000000000002 111.072 -176.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -109.08 99.76 9.03 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.92 -0.582 . . . . 1.74 110.949 -178.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -118.67 91.65 3.61 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.329 -0.396 . . . . 3.9900000000000002 110.363 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 112.79 -101.08 1.17 Allowed Glycine 0 N--CA 1.446 -0.64 0 C-N-CA 120.754 -0.736 . . . . 1.0600000000000001 112.794 177.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 94.0 mtt180 -132.23 131.96 22.7 Favored Pre-proline 0 C--N 1.326 -0.426 0 CA-C-O 120.628 0.251 . . . . 4.3700000000000001 110.742 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.4 ' O ' HD11 ' A' ' 70' ' ' LEU . 11.3 Cg_endo -60.54 145.59 98.49 Favored 'Trans proline' 0 N--CA 1.462 -0.36 0 C-N-CA 122.42 2.08 . . . . 0.31 112.296 174.45 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.66 ' ND2' ' HB2' ' A' ' 92' ' ' ASP . 0.2 OUTLIER -108.57 115.41 30.05 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.05 -0.523 . . . . 2.1400000000000001 109.925 173.232 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.684 ' HB ' HD13 ' A' ' 70' ' ' LEU . 15.9 tt -59.33 -35.49 58.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 112.882 0.697 . . . . 0.20999999999999999 112.882 -164.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.956 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 21.3 pttp -61.86 -21.84 65.02 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 112.095 0.406 . . . . 3.8199999999999998 112.095 178.423 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.66 ' HB2' ' ND2' ' A' ' 89' ' ' ASN . 12.3 m-20 -117.04 18.07 14.73 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.091 0.472 . . . . 1.9099999999999999 110.177 179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.749 HG11 HG21 ' A' ' 73' ' ' ILE . 45.0 t -123.51 -47.27 2.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.332 0.587 . . . . 0.33000000000000002 110.364 -177.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.516 ' HA ' ' NE2' ' A' ' 98' ' ' GLN . 95.8 mt -108.34 163.41 13.22 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 115.953 -0.567 . . . . 0.29999999999999999 109.953 176.636 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.17 147.67 27.32 Favored 'General case' 0 C--N 1.316 -0.89 0 N-CA-C 108.935 -0.765 . . . . 2.6699999999999999 108.935 174.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.646 ' HA ' HG22 ' A' ' 46' ' ' ILE . 49.1 mt-10 -59.85 113.27 2.19 Favored 'General case' 0 C--N 1.323 -0.587 0 O-C-N 123.465 0.478 . . . . 1.25 109.901 179.184 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.38 -0.16 26.49 Favored Glycine 0 N--CA 1.445 -0.754 0 CA-C-N 115.632 -0.713 . . . . 0.40999999999999998 112.35 -174.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.516 ' NE2' ' HA ' ' A' ' 94' ' ' LEU . 6.8 tt0 -96.83 133.29 41.62 Favored 'General case' 0 CA--C 1.519 -0.224 0 N-CA-C 109.842 -0.429 . . . . 1.1799999999999999 109.842 174.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -78.56 156.99 28.91 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.134 0.492 . . . . 0.81000000000000005 111.439 -178.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.588 HG23 HG22 ' A' ' 102' ' ' VAL . 27.8 m -140.19 152.21 21.73 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.746 0 CA-C-N 115.201 -0.908 . . . . 0.17999999999999999 109.85 172.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.831 HG22 HD11 ' A' ' 41' ' ' ILE . 7.2 mm -96.99 110.06 24.28 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.544 -1.28 . . . . 0.51000000000000001 107.544 169.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.588 HG22 HG23 ' A' ' 100' ' ' VAL . 2.4 m -140.98 123.87 15.71 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-O 121.227 0.537 . . . . 0.28000000000000003 111.954 -174.515 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.75 HE21 HG12 ' A' ' 120' ' ' ILE . 10.3 pt20 -97.48 135.14 39.76 Favored 'General case' 0 N--CA 1.439 -1.017 0 N-CA-C 108.041 -1.096 . . . . 1.6200000000000001 108.041 173.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.547 ' CD1' HD23 ' A' ' 116' ' ' LEU . 20.4 mm -73.18 103.37 1.85 Allowed 'Isoleucine or valine' 0 C--N 1.314 -0.947 0 CA-C-N 115.39 -0.823 . . . . 0.78000000000000003 110.772 -175.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 11.3 t70 -68.64 -43.46 76.25 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 114.752 -1.113 . . . . 1.3 109.668 179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.504 ' HB2' ' HB3' ' A' ' 115' ' ' ALA . 37.4 mttp -119.59 121.95 40.48 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.187 -0.915 . . . . 2.5699999999999998 108.629 175.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.676 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 52.3 mt-10 -82.93 159.33 22.31 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-N 116.267 -0.424 . . . . 2.5699999999999998 110.13 -174.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 114' ' ' ALA . 31.1 mt-10 -62.68 91.13 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 121.468 0.651 . . . . 3.1400000000000001 109.601 179.495 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.676 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 3.6 ptp180 -129.83 41.12 3.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 114.85 -1.068 . . . . 3.4900000000000002 109.751 -176.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 81.23 -82.04 1.58 Allowed Glycine 0 N--CA 1.448 -0.562 0 CA-C-N 115.234 -0.894 . . . . 1.74 113.84 176.481 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -66.1 -26.37 67.44 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 113.692 0.997 . . . . 2.8799999999999999 113.692 -168.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.44 ' HG2' ' HD3' ' A' ' 106' ' ' LYS . 9.9 mptt -116.5 -37.18 3.77 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-O 121.172 0.51 . . . . 3.4500000000000002 110.028 -179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.536 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 74.89 -146.92 35.82 Favored Glycine 0 N--CA 1.434 -1.491 0 CA-C-N 115.077 -0.965 . . . . 0.91000000000000003 110.814 -179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.59 ' HB2' ' HG2' ' A' ' 108' ' ' GLU . . . -88.82 104.62 17.09 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.934 0.397 . . . . 0.52000000000000002 110.558 -175.267 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.504 ' HB3' ' HB2' ' A' ' 106' ' ' LYS . . . -107.14 123.24 47.97 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.349 -0.387 . . . . 0.59999999999999998 111.09 -179.315 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.983 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 17.4 mt -90.37 154.74 19.45 Favored 'General case' 0 C--N 1.322 -0.61 0 N-CA-C 108.999 -0.741 . . . . 0.34999999999999998 108.999 179.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.452 HG22 ' O ' ' A' ' 103' ' ' GLN . 6.6 t -125.78 173.11 9.28 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 116.454 -0.339 . . . . 0.98999999999999999 110.131 177.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 21.1 p -129.34 17.95 5.94 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 121.165 0.507 . . . . 1.22 110.84 175.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . . . . . . . . . 31.0 t80 -77.96 46.34 0.58 Allowed 'General case' 0 CA--C 1.533 0.307 0 CA-C-O 122.121 0.962 . . . . 4.1100000000000003 108.708 174.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.75 HG12 HE21 ' A' ' 103' ' ' GLN . 4.3 mt -129.56 173.34 14.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.511 0 CA-C-N 114.492 -1.231 . . . . 0.94999999999999996 109.52 -169.657 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.494 ' H ' HG22 ' A' ' 120' ' ' ILE . 13.0 m -74.81 67.73 1.65 Allowed 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.067 0.46 . . . . 1.25 110.902 176.813 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.568 HD11 ' O ' ' A' ' 101' ' ' ILE . 11.4 mt -116.15 172.15 7.35 Favored 'General case' 0 N--CA 1.446 -0.641 0 N-CA-C 109.453 -0.573 . . . . 1.3799999999999999 109.453 177.758 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 1.076 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 77.34 59.43 0.03 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 O-C-N 123.921 0.763 . . . . 1.3700000000000001 111.002 176.105 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 82.15 34.79 22.8 Favored Glycine 0 N--CA 1.442 -0.942 0 CA-C-N 115.488 -0.778 . . . . 2.7999999999999998 111.977 176.474 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.1 m . . . . . 0 C--O 1.253 1.264 0 CA-C-O 118.303 -0.856 . . . . 5.1100000000000003 110.288 -179.241 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.82 0 N-CA-C 111.64 -0.584 . . . . 9.9100000000000001 111.64 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 10.9 p -125.54 8.26 7.68 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 116.943 0.371 . . . . 7.6600000000000001 111.646 -176.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 28.9 m-70 -80.81 33.95 0.33 Allowed 'General case' 0 N--CA 1.466 0.364 0 CA-C-O 121.182 0.515 . . . . 8.75 111.736 -179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 3.3 mpp? -134.86 9.29 3.57 Favored 'General case' 0 C--N 1.318 -0.769 0 N-CA-C 108.322 -0.992 . . . . 7.04 108.322 174.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 79.4 mt -115.91 -59.57 1.97 Allowed 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.044 -0.98 . . . . 4.54 110.751 -172.12 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.511 ' O ' ' HB3' ' A' ' 38' ' ' LYS . 0.5 OUTLIER 51.63 38.3 22.23 Favored 'General case' 0 CA--C 1.537 0.473 0 O-C-N 123.604 0.565 . . . . 4.0700000000000003 112.033 178.068 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 61.42 -118.16 0.7 Allowed 'General case' 0 N--CA 1.469 0.503 0 CA-C-N 116.243 -0.435 . . . . 4.3600000000000003 111.152 -179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 8.2 mtpp -98.9 1.1 45.37 Favored 'General case' 0 CA--C 1.521 -0.169 0 CA-C-O 121.246 0.546 . . . . 4.8499999999999996 110.233 175.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.536 ' HE2' HG23 ' A' ' 120' ' ' ILE . 19.9 ttpp -85.9 153.08 22.46 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-N 115.444 -0.798 . . . . 2.02 109.316 177.118 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.32 167.98 20.56 Favored 'General case' 0 C--N 1.319 -0.718 0 N-CA-C 109.44 -0.578 . . . . 0.95999999999999996 109.44 177.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.491 ' HA ' ' OE2' ' A' ' 35' ' ' GLU . 2.9 t-20 -49.02 118.75 2.79 Favored 'General case' 0 C--N 1.323 -0.551 0 O-C-N 123.557 0.536 . . . . 2.6200000000000001 110.202 178.058 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.714 HG12 HG22 ' A' ' 101' ' ' ILE . 5.0 tp -83.7 138.66 18.87 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.889 0 N-CA-C 109.585 -0.524 . . . . 0.83999999999999997 109.585 -176.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.403 ' CD2' HG12 ' A' ' 104' ' ' ILE . 87.1 m-85 -115.1 118.87 34.58 Favored 'General case' 0 N--CA 1.443 -0.793 0 CA-C-O 121.517 0.675 . . . . 1.02 110.7 -176.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.438 ' HD3' HD12 ' A' ' 101' ' ' ILE . 8.5 mmmm -89.64 102.67 15.35 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.858 -1.065 . . . . 1.1599999999999999 109.671 177.513 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -140.25 163.78 26.32 Favored Glycine 0 CA--C 1.499 -0.959 0 N-CA-C 110.555 -1.018 . . . . 0.27000000000000002 110.555 -177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.7 mppt? -118.14 161.97 18.98 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.461 0.648 . . . . 1.54 111.347 -177.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.725 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -65.05 146.09 13.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.867 0 CA-C-N 114.299 -1.319 . . . . 0.25 111.254 177.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.718 HG21 ' HB2' ' A' ' 59' ' ' ASP . 76.2 p -128.94 -32.05 2.11 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.009 0.433 . . . . 0.39000000000000001 111.854 173.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.655 ' HD2' ' CD2' ' A' ' 57' ' ' PHE . 13.9 ttm180 -140.27 126.12 19.45 Favored 'General case' 0 CA--C 1.507 -0.685 0 CA-C-N 116.351 -0.386 . . . . 1.8500000000000001 110.668 -178.459 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.725 HD11 HG21 ' A' ' 46' ' ' ILE . 91.2 mt -133.8 120.36 36.25 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.08 0 CA-C-N 115.652 -0.704 . . . . 0.26000000000000001 109.585 177.506 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.633 ' HB3' ' HG ' ' A' ' 53' ' ' LEU . 15.7 tp10 -111.94 111.21 53.81 Favored Pre-proline 0 C--N 1.315 -0.932 0 CA-C-N 115.896 -0.593 . . . . 2.2400000000000002 109.708 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.845 ' HB3' ' HD3' ' A' ' 91' ' ' LYS . 51.9 Cg_exo -54.0 -25.82 38.1 Favored 'Trans proline' 0 CA--C 1.521 -0.172 0 C-N-CA 123.361 2.707 . . . . 0.52000000000000002 112.068 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 11.7 m -73.82 -22.48 59.78 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.503 -0.771 . . . . 1.23 111.824 -177.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.633 ' HG ' ' HB3' ' A' ' 50' ' ' GLU . 1.5 pp -123.78 7.48 8.76 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 113.598 0.962 . . . . 0.46000000000000002 113.598 -174.437 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . 0.456 ' HB2' ' HB3' ' A' ' 70' ' ' LEU . 4.6 pt-20 48.56 49.76 17.96 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 124.408 1.083 . . . . 2.5099999999999998 112.824 174.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.612 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -160.98 162.67 31.95 Favored 'General case' 0 C--N 1.324 -0.5 0 C-N-CA 120.081 -0.648 . . . . 0.19 112.208 -179.497 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.597 ' HB2' HD11 ' A' ' 90' ' ' ILE . . . -131.22 138.06 49.19 Favored 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.669 -0.696 . . . . 0.17999999999999999 112.167 -174.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.655 ' CD2' ' HD2' ' A' ' 48' ' ' ARG . 65.7 m-85 -89.44 136.17 33.18 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.904 -0.589 . . . . 0.56000000000000005 109.818 171.594 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.515 ' HB ' HD11 ' A' ' 116' ' ' LEU . 2.2 t -112.74 139.49 37.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.095 0.474 . . . . 0.26000000000000001 110.997 179.797 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.718 ' HB2' HG21 ' A' ' 47' ' ' THR . 17.9 t70 -103.14 102.3 12.29 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.621 -0.718 . . . . 0.79000000000000004 110.65 179.328 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -128.11 67.35 1.35 Allowed 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 109.509 -0.552 . . . . 0.89000000000000001 109.509 172.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 46.09 42.16 11.9 Favored Glycine 0 CA--C 1.52 0.346 0 C-N-CA 121.089 -0.577 . . . . 0.82999999999999996 111.899 -173.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -100.72 160.01 14.71 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.171 0.51 . . . . 0.85999999999999999 111.092 -170.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -87.83 -45.38 10.35 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 121.626 0.726 . . . . 2.4300000000000002 109.173 178.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.498 ' HD2' ' HB3' ' A' ' 108' ' ' GLU . 48.7 mtt180 -125.71 94.15 4.04 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.85 -1.068 . . . . 4.5199999999999996 108.403 -179.751 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.473 ' HB3' ' HB3' ' A' ' 57' ' ' PHE . 15.4 m170 -35.9 131.22 0.56 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 114.147 1.165 . . . . 0.88 114.147 -170.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.531 ' HA2' ' O ' ' A' ' 114' ' ' ALA . . . -62.8 118.65 14.74 Favored Glycine 0 CA--C 1.506 -0.495 0 CA-C-N 114.871 -1.059 . . . . 0.23999999999999999 111.498 178.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.612 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 5.2 t80 -104.79 97.73 7.57 Favored 'General case' 0 C--N 1.316 -0.868 0 CA-C-O 121.138 0.494 . . . . 0.40999999999999998 111.282 -171.461 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.032 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.5 OUTLIER -85.38 121.2 73.73 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 115.498 -0.774 . . . . 0.16 111.365 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.59 ' HB2' ' HG2' ' A' ' 72' ' ' GLU . 19.6 Cg_exo -69.56 142.78 49.78 Favored 'Trans proline' 0 CA--C 1.53 0.318 0 C-N-CA 123.087 2.525 . . . . 0.23000000000000001 112.104 172.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.717 HD13 ' HB ' ' A' ' 90' ' ' ILE . 12.6 tp -60.8 -39.07 87.54 Favored 'General case' 0 N--CA 1.463 0.188 0 CA-C-N 115.491 -0.777 . . . . 0.19 112.263 -178.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 11.0 pttm -64.13 -13.34 47.32 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.644 0.259 . . . . 2.04 111.651 -179.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . 0.59 ' HG2' ' HB2' ' A' ' 69' ' ' PRO . 7.2 mm-40 -96.09 -13.07 23.93 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.756 0.312 . . . . 0.85999999999999999 110.413 179.12 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.501 HG23 ' CD2' ' A' ' 77' ' ' TYR . 8.0 mt -57.86 138.48 18.73 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 CA-C-O 121.636 0.731 . . . . 0.56000000000000005 112.823 -171.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.547 ' HB1' ' HB2' ' A' ' 123' ' ' ALA . . . -102.25 153.53 19.89 Favored 'General case' 0 N--CA 1.452 -0.374 0 CA-C-N 114.836 -1.075 . . . . 0.39000000000000001 110.518 178.519 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.66 ' HD3' ' HA ' ' A' ' 80' ' ' ALA . 41.1 ttm180 -55.27 -14.68 1.89 Allowed 'General case' 0 CA--C 1.537 0.472 0 CA-C-N 115.522 -0.763 . . . . 3.0099999999999998 112.662 179.151 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . 0.993 ' HB2' ' H ' ' A' ' 123' ' ' ALA . 24.3 tp10 -61.96 -19.71 63.05 Favored 'General case' 0 N--CA 1.466 0.329 0 O-C-N 121.487 -0.758 . . . . 1.76 110.759 175.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.501 ' CD2' HG23 ' A' ' 73' ' ' ILE . 7.9 m-30 -92.65 -44.61 8.48 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.797 -0.638 . . . . 1.3999999999999999 109.759 -175.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.464 ' HE2' ' HB2' ' A' ' 84' ' ' ALA . 5.7 p90 -98.68 95.94 3.49 Favored Pre-proline 0 C--N 1.325 -0.46 0 N-CA-C 107.277 -1.379 . . . . 0.46000000000000002 107.277 168.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . 0.421 ' HD2' ' HA ' ' A' ' 78' ' ' PHE . 2.3 Cg_endo -38.51 139.98 0.38 Allowed 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 124.577 3.518 . . . . 0.70999999999999996 113.797 -162.065 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.66 ' HA ' ' HD3' ' A' ' 75' ' ' ARG . . . -55.55 -11.93 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.143 -0.935 . . . . 0.93000000000000005 113.288 -176.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -82.28 -21.11 36.32 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.235 0.54 . . . . 2.6200000000000001 109.97 177.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 64.8 t80 -78.2 146.14 35.15 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.724 -0.671 . . . . 1.3300000000000001 110.626 -177.401 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 2.2 p -81.98 106.49 13.94 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.741 -0.663 . . . . 2.1800000000000002 111.566 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . 0.464 ' HB2' ' HE2' ' A' ' 78' ' ' PHE . . . -91.81 136.48 33.12 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.949 -0.569 . . . . 1.74 109.848 176.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 12.1 t60 -96.42 -40.61 9.01 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 121.136 0.493 . . . . 3.9900000000000002 110.225 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -167.11 -88.1 0.07 OUTLIER Glycine 0 N--CA 1.446 -0.64 0 CA-C-N 115.504 -0.771 . . . . 1.0600000000000001 111.265 178.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 41.5 mtm105 -97.04 128.39 35.51 Favored Pre-proline 0 C--N 1.322 -0.587 0 CA-C-O 121.033 0.444 . . . . 4.3700000000000001 110.804 176.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . . . . . . . . . 14.5 Cg_endo -61.86 165.49 13.99 Favored 'Trans proline' 0 C--O 1.234 0.31 0 C-N-CA 123.272 2.648 . . . . 0.31 112.981 177.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -120.6 98.31 5.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.866 -0.606 . . . . 2.1400000000000001 109.951 175.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.717 ' HB ' HD13 ' A' ' 70' ' ' LEU . 21.2 tt -54.02 -39.7 42.4 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 113.497 0.925 . . . . 0.20999999999999999 113.497 -165.475 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.845 ' HD3' ' HB3' ' A' ' 51' ' ' PRO . 36.8 pttt -55.7 -21.78 20.13 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 113.009 0.744 . . . . 3.8199999999999998 113.009 -179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -125.96 18.69 7.82 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-O 121.932 0.872 . . . . 1.9099999999999999 110.44 176.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.514 ' HB ' ' HA ' ' A' ' 90' ' ' ILE . 36.7 t -111.32 -50.03 6.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-O 121.693 0.759 . . . . 0.33000000000000002 109.278 178.377 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.591 ' HB3' HG12 ' A' ' 46' ' ' ILE . 80.5 mt -103.04 150.86 23.16 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-N 115.206 -0.906 . . . . 0.29999999999999999 110.231 178.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -147.73 147.93 30.44 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.171 -0.922 . . . . 2.6699999999999999 109.098 175.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.495 ' HA ' ' O ' ' A' ' 46' ' ' ILE . 1.5 mp0 -58.29 122.5 13.36 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.864 0.364 . . . . 1.25 110.161 -176.599 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 112.49 -18.15 23.03 Favored Glycine 0 N--CA 1.442 -0.913 0 C-N-CA 120.786 -0.721 . . . . 0.40999999999999998 111.701 -175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.472 ' NE2' ' HA ' ' A' ' 94' ' ' LEU . 6.6 tt0 -83.11 121.01 26.5 Favored 'General case' 0 C--O 1.234 0.276 0 N-CA-C 109.748 -0.464 . . . . 1.1799999999999999 109.748 177.14 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -75.65 155.2 36.04 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.489 0.661 . . . . 0.81000000000000005 111.487 -177.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.581 HG23 HG22 ' A' ' 102' ' ' VAL . 35.3 m -131.91 149.95 33.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.048 0 CA-C-N 114.884 -1.053 . . . . 0.17999999999999999 109.177 171.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.714 HG22 HG12 ' A' ' 41' ' ' ILE . 1.4 mm -98.95 107.48 20.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 N-CA-C 107.072 -1.455 . . . . 0.51000000000000001 107.072 174.695 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.581 HG22 HG23 ' A' ' 100' ' ' VAL . 4.4 m -145.54 135.12 18.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-O 121.339 0.59 . . . . 0.28000000000000003 112.584 -172.306 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . 0.535 ' O ' ' HB ' ' A' ' 117' ' ' THR . 18.4 pt20 -98.73 135.84 39.63 Favored 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 108.596 -0.891 . . . . 1.6200000000000001 108.596 173.503 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.659 HG22 ' O ' ' A' ' 106' ' ' LYS . 40.4 mm -80.95 99.57 4.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 CA-C-O 121.256 0.55 . . . . 0.78000000000000003 109.71 -179.571 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -67.32 -27.51 67.21 Favored 'General case' 0 CA--C 1.515 -0.393 0 CA-C-N 115.13 -0.941 . . . . 1.3 110.566 -179.755 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.659 ' O ' HG22 ' A' ' 104' ' ' ILE . 55.0 mttp -113.63 -170.97 1.8 Allowed 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 115.742 -0.663 . . . . 2.5699999999999998 111.411 -176.238 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.492 ' O ' ' HG2' ' A' ' 109' ' ' ARG . 50.4 mm-40 -129.6 145.79 51.46 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 116.294 -0.412 . . . . 2.5699999999999998 110.332 -177.211 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.614 ' HA ' ' HA2' ' A' ' 113' ' ' GLY . 43.2 mt-10 -64.15 101.86 0.45 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.401 0.62 . . . . 3.1400000000000001 109.668 176.836 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.492 ' HG2' ' O ' ' A' ' 107' ' ' GLU . 10.9 ptm180 -116.43 -61.63 1.7 Allowed 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.237 -0.892 . . . . 3.4900000000000002 111.549 -170.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.452 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -175.15 -63.9 0.05 OUTLIER Glycine 0 N--CA 1.446 -0.683 0 C-N-CA 120.466 -0.873 . . . . 1.74 112.519 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . . . . . . . . . 90.6 m-20 -62.88 -46.92 85.6 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 112.089 0.403 . . . . 2.8799999999999999 112.089 -175.193 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.583 ' HD2' ' HB2' ' A' ' 115' ' ' ALA . 21.4 ttmm -116.19 -37.18 3.86 Favored 'General case' 0 C--N 1.324 -0.511 0 C-N-CA 120.363 -0.535 . . . . 3.4500000000000002 110.436 -177.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.614 ' HA2' ' HA ' ' A' ' 108' ' ' GLU . . . 80.6 -122.47 5.73 Favored Glycine 0 N--CA 1.437 -1.238 0 N-CA-C 110.652 -0.979 . . . . 0.91000000000000003 110.652 -175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.531 ' O ' ' HA2' ' A' ' 66' ' ' GLY . . . -83.29 127.5 33.7 Favored 'General case' 0 C--N 1.308 -1.208 0 N-CA-C 109.99 -0.374 . . . . 0.52000000000000002 109.99 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.583 ' HB2' ' HD2' ' A' ' 112' ' ' LYS . . . -118.4 126.99 53.23 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-O 120.729 0.3 . . . . 0.59999999999999998 110.88 -177.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.032 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 14.6 mt -91.08 129.06 37.12 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.065 -0.516 . . . . 0.34999999999999998 110.177 -179.093 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.568 ' O ' HG12 ' A' ' 102' ' ' VAL . 1.0 OUTLIER -90.26 146.82 23.94 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-N 115.619 -0.719 . . . . 0.98999999999999999 109.642 174.048 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.646 HG23 HD21 ' A' ' 68' ' ' LEU . 3.5 p -113.96 4.02 15.6 Favored 'General case' 0 C--N 1.333 -0.128 0 N-CA-C 112.34 0.496 . . . . 1.22 112.34 178.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.481 ' H ' HG23 ' A' ' 117' ' ' THR . 98.8 m-85 -78.34 57.36 1.89 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.695 0.76 . . . . 4.1100000000000003 110.451 176.575 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.536 HG23 ' HE2' ' A' ' 38' ' ' LYS . 2.9 mp -127.99 176.08 8.38 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 N-CA-C 107.645 -1.242 . . . . 0.94999999999999996 107.645 178.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.533 ' N ' HG22 ' A' ' 120' ' ' ILE . 16.0 t -69.4 69.62 0.25 Allowed 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 121.296 0.569 . . . . 1.25 110.458 176.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.479 HD11 ' O ' ' A' ' 101' ' ' ILE . 12.0 mt -115.13 172.22 7.2 Favored 'General case' 0 N--CA 1.448 -0.571 0 N-CA-C 108.676 -0.861 . . . . 1.3799999999999999 108.676 176.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.993 ' H ' ' HB2' ' A' ' 76' ' ' GLU . . . 73.95 37.33 0.65 Allowed 'General case' 0 C--N 1.326 -0.447 0 O-C-N 123.683 0.615 . . . . 1.3700000000000001 110.609 175.75 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 124.43 44.76 0.28 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.278 -0.874 . . . . 2.7999999999999998 111.198 -176.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 4.5 t . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.283 -0.865 . . . . 5.1100000000000003 109.7 179.228 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.625 0 N-CA-C 112.017 -0.433 . . . . 9.9100000000000001 112.017 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 45.2 t -131.98 -87.17 0.46 Allowed 'General case' 0 N--CA 1.45 -0.45 0 N-CA-C 110.377 -0.231 . . . . 7.6600000000000001 110.377 177.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' HIS . . . . . . . . . . . . . 22.6 m170 61.84 5.16 1.27 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 123.025 0.53 . . . . 8.75 111.728 -177.69 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' MET . . . . . . . . . . . . . 69.0 mtm -142.19 176.4 9.0 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 122.001 0.12 . . . . 7.04 110.725 -173.395 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.3 mm? 58.53 13.57 2.6 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 123.813 0.696 . . . . 4.54 111.8 179.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.999 ' HA ' ' HB3' ' A' ' 38' ' ' LYS . 12.3 pt-20 40.47 38.03 0.53 Allowed 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.408 1.083 . . . . 4.0700000000000003 112.423 -176.167 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLN . . . . . . . . . . . . . 17.4 mm-40 -78.86 -66.94 0.8 Allowed 'General case' 0 N--CA 1.463 0.196 0 CA-C-N 116.172 -0.467 . . . . 4.3600000000000003 109.845 178.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LYS . . . . . . . . . . . . . 47.5 tttp -102.0 36.27 2.14 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 107.658 -1.238 . . . . 4.8499999999999996 107.658 172.86 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' LYS . . . . . 0.999 ' HB3' ' HA ' ' A' ' 35' ' ' GLU . 32.8 tttp -130.39 137.9 50.1 Favored 'General case' 0 N--CA 1.442 -0.827 0 CA-C-N 114.156 -1.384 . . . . 2.02 110.13 -172.465 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.481 ' O ' ' HG2' ' A' ' 38' ' ' LYS . . . -65.43 138.4 58.09 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 107.657 -1.238 . . . . 0.95999999999999996 107.657 170.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 19.5 m120 -47.62 116.97 1.63 Allowed 'General case' 0 C--N 1.326 -0.45 0 O-C-N 123.853 0.721 . . . . 2.6200000000000001 111.218 -172.704 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.467 HD11 HG22 ' A' ' 101' ' ' ILE . 6.6 tp -84.65 139.86 16.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.758 0 CA-C-N 115.107 -0.951 . . . . 0.83999999999999997 110.128 -174.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 80.5 m-85 -122.68 149.71 43.68 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-O 120.792 0.329 . . . . 1.02 110.275 -177.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.526 ' HE2' ' CD1' ' A' ' 101' ' ' ILE . 34.5 ttmt -115.78 94.08 4.53 Favored 'General case' 0 C--N 1.317 -0.82 0 N-CA-C 108.984 -0.747 . . . . 1.1599999999999999 108.984 171.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -119.17 166.69 13.15 Favored Glycine 0 N--CA 1.44 -1.082 0 CA-C-N 115.271 -0.877 . . . . 0.27000000000000002 111.073 -174.555 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' HA ' ' O ' ' A' ' 98' ' ' GLN . 1.6 mppt? -104.83 158.2 16.68 Favored 'General case' 0 C--N 1.315 -0.899 0 CA-C-O 121.065 0.459 . . . . 1.54 111.087 -176.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.886 HG21 HD11 ' A' ' 49' ' ' ILE . 1.7 mp -73.52 137.19 23.82 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.164 0 CA-C-N 115.075 -0.966 . . . . 0.25 109.628 175.361 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.483 HG21 ' CB ' ' A' ' 59' ' ' ASP . 64.7 p -124.33 -11.28 7.44 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-O 120.799 0.333 . . . . 0.39000000000000001 111.471 177.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ARG . . . . . 0.641 ' HD3' ' CD1' ' A' ' 57' ' ' PHE . 24.6 ttt85 -160.26 122.18 3.21 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.212 -0.449 . . . . 1.8500000000000001 110.462 -176.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.886 HD11 HG21 ' A' ' 46' ' ' ILE . 47.5 mt -134.89 113.46 16.21 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.958 0 N-CA-C 109.624 -0.509 . . . . 0.26000000000000001 109.624 177.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . 0.457 ' HA ' ' HD3' ' A' ' 51' ' ' PRO . 31.6 mt-10 -118.01 122.54 30.37 Favored Pre-proline 0 C--N 1.317 -0.833 0 CA-C-O 121.505 0.669 . . . . 2.2400000000000002 111.475 -176.047 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' PRO . . . . . 0.832 ' HB3' ' HD2' ' A' ' 91' ' ' LYS . 31.9 Cg_exo -60.65 -27.41 84.79 Favored 'Trans proline' 0 CA--C 1.519 -0.264 0 C-N-CA 123.112 2.541 . . . . 0.52000000000000002 111.827 179.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' SER . . . . . . . . . . . . . 49.5 m -75.11 -21.43 58.9 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.849 -0.614 . . . . 1.23 111.685 -179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.455 ' CG ' ' HB2' ' A' ' 50' ' ' GLU . 2.0 pp -118.38 8.85 12.26 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 119.964 -0.694 . . . . 0.46000000000000002 112.792 179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 43.52 48.36 6.26 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 123.493 0.717 . . . . 2.5099999999999998 111.917 169.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ALA . . . . . 0.565 ' HB3' ' CZ ' ' A' ' 67' ' ' PHE . . . -166.27 171.15 12.46 Favored 'General case' 0 N--CA 1.447 -0.576 0 CA-C-N 115.474 -0.784 . . . . 0.19 110.974 -176.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ALA . . . . . 0.422 ' HB2' HG12 ' A' ' 49' ' ' ILE . . . -135.56 139.48 43.94 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.042 0.448 . . . . 0.17999999999999999 111.539 -177.23 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.641 ' CD1' ' HD3' ' A' ' 48' ' ' ARG . 84.9 m-85 -91.64 136.0 33.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.702 -0.681 . . . . 0.56000000000000005 109.633 174.394 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' VAL . . . . . 0.591 ' HB ' HD11 ' A' ' 116' ' ' LEU . 12.6 t -118.9 134.44 62.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 N-CA-C 109.158 -0.682 . . . . 0.26000000000000001 109.158 179.043 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ASP . . . . . 0.483 ' CB ' HG21 ' A' ' 47' ' ' THR . 36.7 t70 -109.48 111.28 22.72 Favored 'General case' 0 C--N 1.313 -0.983 0 CA-C-N 116.187 -0.46 . . . . 0.79000000000000004 112.027 -173.783 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -126.81 66.75 1.26 Allowed 'General case' 0 C--N 1.324 -0.536 0 N-CA-C 108.219 -1.03 . . . . 0.89000000000000001 108.219 166.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 53.33 33.46 46.41 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 120.81 -0.71 . . . . 0.82999999999999996 112.46 -172.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 65' ' ' HIS . . . -93.79 147.72 22.79 Favored 'General case' 0 C--N 1.33 -0.257 0 O-C-N 122.645 -0.326 . . . . 0.85999999999999999 110.777 -175.227 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLU . . . . . . . . . . . . . 29.0 mm-40 -75.93 -51.29 12.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 2.4300000000000002 111.272 -177.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.54 ' O ' ' HB2' ' A' ' 65' ' ' HIS . 8.8 mmt180 -94.36 -11.11 30.64 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.478 -0.489 . . . . 4.5199999999999996 109.796 -179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' HIS . . . . . 0.54 ' HB2' ' O ' ' A' ' 64' ' ' ARG . 10.3 m170 76.49 145.07 0.08 Allowed 'General case' 0 N--CA 1.469 0.499 0 O-C-N 124.423 1.077 . . . . 0.88 110.854 -174.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -71.58 102.14 1.08 Allowed Glycine 0 N--CA 1.442 -0.949 0 N-CA-C 110.666 -0.974 . . . . 0.23999999999999999 110.666 177.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PHE . . . . . 0.565 ' CZ ' ' HB3' ' A' ' 55' ' ' ALA . 2.9 t80 -88.98 104.25 16.8 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-O 120.842 0.353 . . . . 0.40999999999999998 110.541 -174.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 1.133 ' HG ' ' HB2' ' A' ' 116' ' ' LEU . 0.4 OUTLIER -93.72 113.35 60.15 Favored Pre-proline 0 C--N 1.326 -0.455 0 CA-C-N 115.932 -0.576 . . . . 0.16 110.307 178.135 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.456 ' HD2' HD23 ' A' ' 68' ' ' LEU . 24.5 Cg_exo -65.27 141.72 69.98 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.787 2.325 . . . . 0.23000000000000001 111.607 174.569 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.625 HD13 ' HB ' ' A' ' 90' ' ' ILE . 17.8 tp -57.91 -33.46 68.8 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.897 -0.592 . . . . 0.19 111.819 -179.331 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 22.4 pttp -63.59 -10.92 20.82 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.866 0.365 . . . . 2.04 111.482 -177.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLU . . . . . . . . . . . . . 14.0 mm-40 -97.44 -23.92 15.84 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.12 -0.491 . . . . 0.85999999999999999 110.856 -179.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.693 HG21 HG11 ' A' ' 93' ' ' VAL . 6.1 mt -48.38 131.04 5.69 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.45 0 N-CA-C 113.466 0.913 . . . . 0.56000000000000005 113.466 -166.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB1' ' O ' ' A' ' 122' ' ' LEU . . . -100.22 156.67 17.09 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 114.64 -1.164 . . . . 0.39000000000000001 110.763 178.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.818 ' HG2' ' HA ' ' A' ' 80' ' ' ALA . 32.0 ttp180 -65.16 -12.7 53.9 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 113.55 0.944 . . . . 3.0099999999999998 113.55 -172.478 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -63.67 -25.76 68.36 Favored 'General case' 0 N--CA 1.472 0.635 0 O-C-N 120.795 -1.191 . . . . 1.76 110.208 172.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 10.8 m-30 -75.84 -51.74 11.89 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.901 -0.59 . . . . 1.3999999999999999 110.291 -175.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.528 ' HB3' HG13 ' A' ' 93' ' ' VAL . 1.1 p90 -100.37 109.46 57.0 Favored Pre-proline 0 C--N 1.325 -0.498 0 N-CA-C 107.584 -1.265 . . . . 0.46000000000000002 107.584 169.19 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -36.43 133.6 0.33 Allowed 'Trans proline' 0 CA--C 1.513 -0.542 0 C-N-CA 124.616 3.544 . . . . 0.70999999999999996 113.646 -162.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ALA . . . . . 0.818 ' HA ' ' HG2' ' A' ' 75' ' ' ARG . . . -57.03 -16.44 7.15 Favored 'General case' 0 C--N 1.312 -1.055 0 CA-C-N 114.563 -1.199 . . . . 0.93000000000000005 113.361 -174.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ASN . . . . . . . . . . . . . 94.7 m-20 -90.99 -0.89 57.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.878 0.371 . . . . 2.6200000000000001 111.251 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' TYR . . . . . . . . . . . . . 80.3 t80 -81.77 143.81 31.54 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.012 -0.54 . . . . 1.3300000000000001 109.976 178.24 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 20.0 m -71.09 100.9 2.12 Favored 'General case' 0 C--O 1.235 0.304 0 CA-C-N 116.397 -0.365 . . . . 2.1800000000000002 110.287 178.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ALA . . . . . . . . . . . . . . . -69.95 95.34 0.93 Allowed 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.133 -0.485 . . . . 1.74 110.374 179.056 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' HIS . . . . . . . . . . . . . 5.2 p80 -76.9 61.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.715 -0.675 . . . . 3.9900000000000002 110.928 -179.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 87.47 -128.44 8.99 Favored Glycine 0 N--CA 1.446 -0.699 0 C-N-CA 120.859 -0.686 . . . . 1.0600000000000001 111.631 -178.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 86.8 mtt180 -82.85 135.41 45.52 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.809 0.338 . . . . 4.3700000000000001 110.32 179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PRO . . . . . 0.454 ' O ' HD11 ' A' ' 70' ' ' LEU . 9.2 Cg_endo -58.41 154.7 39.83 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.916 2.411 . . . . 0.31 113.161 179.215 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . 0.658 ' ND2' ' HB3' ' A' ' 92' ' ' ASP . 0.3 OUTLIER -119.41 111.42 18.13 Favored 'General case' 0 C--O 1.219 -0.511 0 CA-C-N 115.248 -0.887 . . . . 2.1400000000000001 109.617 176.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ILE . . . . . 0.625 ' HB ' HD13 ' A' ' 70' ' ' LEU . 8.2 tt -62.13 -38.87 81.97 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 N-CA-C 112.724 0.638 . . . . 0.20999999999999999 112.724 -163.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LYS . . . . . 0.832 ' HD2' ' HB3' ' A' ' 51' ' ' PRO . 7.8 ptmm? -60.07 -21.37 61.37 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.212 -0.449 . . . . 3.8199999999999998 111.853 177.145 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASP . . . . . 0.658 ' HB3' ' ND2' ' A' ' 89' ' ' ASN . 34.6 t70 -119.62 12.01 12.17 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.817 0.818 . . . . 1.9099999999999999 110.343 -176.066 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.693 HG11 HG21 ' A' ' 73' ' ' ILE . 13.7 t -119.96 -50.57 3.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.806 -0.634 . . . . 0.33000000000000002 110.314 -176.576 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 37.2 mt -100.41 152.13 20.72 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.677 -0.692 . . . . 0.29999999999999999 110.25 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.13 151.8 44.21 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.361 -0.836 . . . . 2.6699999999999999 110.319 174.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLU . . . . . 0.676 ' HA ' HG22 ' A' ' 46' ' ' ILE . 18.1 mt-10 -65.13 126.07 26.95 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.029 -0.987 . . . . 1.25 110.456 -176.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' GLY . . . . . . . . . . . . . . . 102.42 -8.05 54.64 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.773 -0.727 . . . . 0.40999999999999998 112.055 -176.384 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLN . . . . . 0.42 ' O ' ' HA ' ' A' ' 45' ' ' LYS . 21.9 tt0 -87.95 135.96 33.17 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.951 -0.389 . . . . 1.1799999999999999 109.951 177.357 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -85.92 157.22 20.21 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.81000000000000005 111.37 -177.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.553 HG23 HG22 ' A' ' 102' ' ' VAL . 35.5 m -136.75 151.79 28.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-N 115.189 -0.914 . . . . 0.17999999999999999 109.879 174.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.983 ' HB ' HD11 ' A' ' 122' ' ' LEU . 10.0 mm -97.03 110.45 25.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 N-CA-C 108.004 -1.11 . . . . 0.51000000000000001 108.004 171.358 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' VAL . . . . . 0.553 HG22 HG23 ' A' ' 100' ' ' VAL . 4.3 m -146.76 139.05 19.34 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 CA-C-O 121.233 0.539 . . . . 0.28000000000000003 111.974 -172.943 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -112.84 142.73 45.16 Favored 'General case' 0 C--N 1.314 -0.961 0 N-CA-C 108.433 -0.951 . . . . 1.6200000000000001 108.433 172.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ILE . . . . . 0.539 HD13 HD23 ' A' ' 116' ' ' LEU . 22.4 mm -71.89 102.33 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-O 121.76 0.79 . . . . 0.78000000000000003 110.771 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ASP . . . . . 0.606 ' HB2' ' HB ' ' A' ' 117' ' ' THR . 35.0 t70 -83.76 -35.28 24.49 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 114.714 -1.13 . . . . 1.3 109.777 -179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LYS . . . . . 0.541 ' HB3' ' HB3' ' A' ' 115' ' ' ALA . 12.7 ttpp -112.03 137.99 49.3 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.605 -0.725 . . . . 2.5699999999999998 109.775 179.206 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLU . . . . . 0.444 ' HB3' HH21 ' A' ' 109' ' ' ARG . 1.8 tm-20 -87.2 133.79 33.61 Favored 'General case' 0 C--N 1.311 -1.075 0 CA-C-N 115.26 -0.882 . . . . 2.5699999999999998 110.914 -163.284 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.514 ' HG3' ' HG2' ' A' ' 64' ' ' ARG . 42.6 tt0 -66.31 119.73 12.06 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 121.309 0.576 . . . . 3.1400000000000001 110.208 -178.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.585 ' HG2' ' HA2' ' A' ' 113' ' ' GLY . 6.6 ptp180 -139.72 -68.66 0.42 Allowed 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.415 -0.811 . . . . 3.4900000000000002 111.115 -171.255 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.529 ' H ' ' HG3' ' A' ' 109' ' ' ARG . . . -168.71 -66.99 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 C-N-CA 119.553 -1.308 . . . . 1.74 113.722 178.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ASN . . . . . 0.474 ' OD1' ' HG3' ' A' ' 112' ' ' LYS . 25.6 t-20 -61.88 -50.91 70.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.958 0.379 . . . . 2.8799999999999999 111.55 -172.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.474 ' HG3' ' OD1' ' A' ' 111' ' ' ASN . 98.6 mttt -122.92 -37.49 2.73 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.68 -0.408 . . . . 3.4500000000000002 110.682 174.405 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLY . . . . . 0.585 ' HA2' ' HG2' ' A' ' 109' ' ' ARG . . . 63.79 -124.47 30.89 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 115.67 -0.695 . . . . 0.91000000000000003 113.937 172.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -64.56 110.66 2.4 Favored 'General case' 0 C--N 1.328 -0.361 0 O-C-N 124.249 0.617 . . . . 0.52000000000000002 111.696 -173.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ALA . . . . . 0.541 ' HB3' ' HB3' ' A' ' 106' ' ' LYS . . . -122.25 135.83 54.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.07 -0.514 . . . . 0.59999999999999998 110.566 177.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 1.133 ' HB2' ' HG ' ' A' ' 68' ' ' LEU . 43.2 mt -91.41 153.01 20.16 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.775 -0.648 . . . . 0.34999999999999998 109.644 -179.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' THR . . . . . 0.606 ' HB ' ' HB2' ' A' ' 105' ' ' ASP . 8.2 t -116.69 171.47 7.85 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 116.241 -0.436 . . . . 0.98999999999999999 110.292 178.165 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.464 ' C ' ' H ' ' A' ' 120' ' ' ILE . 26.1 p -138.27 20.93 2.78 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 112.78 0.659 . . . . 1.22 112.78 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' PHE . . . . . 0.411 ' O ' ' HD1' ' A' ' 119' ' ' PHE . 3.2 p90 -78.45 42.42 0.43 Allowed 'General case' 0 N--CA 1.47 0.532 0 CA-C-O 122.499 1.142 . . . . 4.1100000000000003 109.385 170.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.514 HG22 ' H ' ' A' ' 121' ' ' SER . 4.4 mt -118.36 172.35 5.81 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 CA-C-N 113.884 -1.507 . . . . 0.94999999999999996 108.015 -172.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' SER . . . . . 0.514 ' H ' HG22 ' A' ' 120' ' ' ILE . 7.5 t -80.04 48.76 1.01 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.858 0.361 . . . . 1.25 111.93 -172.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LEU . . . . . 0.983 HD11 ' HB ' ' A' ' 101' ' ' ILE . 5.8 mp -117.38 126.33 52.49 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.738 -0.21 . . . . 1.3799999999999999 111.257 178.092 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ALA . . . . . 0.458 ' HB2' ' O ' ' A' ' 122' ' ' LEU . . . 163.62 25.17 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.508 0 O-C-N 124.722 1.264 . . . . 1.3700000000000001 109.779 166.368 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 168.75 58.35 0.03 OUTLIER Glycine 0 N--CA 1.446 -0.635 0 N-CA-C 110.983 -0.847 . . . . 2.7999999999999998 110.983 -174.02 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 33.9 m . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.684 -0.674 . . . . 5.1100000000000003 110.379 -175.883 . . . . . . . . 0 0 . 1 stop_ save_